archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO FOREBRAIN NEURON FATE COMMITMENT,9.0551e-05,0.9173,0.8793,1,1
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021689,0.59425,0.58532,1,1
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,7.547e-05,0.57006,0.603,1,1
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00018427,0.55755,0.53144,1,1
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,8.1192e-05,0.43517,0.45891,1,1
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00092958,0.43458,0.42883,1,1
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,6.0504e-05,0.42322,0.52557,1,1
1,GO GANGLION DEVELOPMENT,0.001228,0.42277,0.42668,1,1
1,GO NEURON FATE COMMITMENT,1.0184e-05,0.40699,0.46364,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0013457,0.37075,0.42319,1,1
1,GO SPINAL CORD PATTERNING,0.00084609,0.34178,0.36551,1,1
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0066042,0.34075,0.29295,1,1
1,GO KINETOCHORE ASSEMBLY,0.00011241,0.33819,0.26031,1,1
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00010462,0.3379,0.38836,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00098941,0.33782,0.33312,1,1
1,GO SEGMENT SPECIFICATION,0.017549,0.33627,0.27073,1,1
1,GO MYOBLAST MIGRATION,0.001662,0.33318,0.36832,1,1
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0085714,0.33144,0.29015,1,1
1,GO SINGLE STRAND BREAK REPAIR,1.4039e-05,0.29223,0.25547,1,1
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,9.389e-05,0.28646,0.24582,1,1
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0054795,0.28199,0.2627,1,1
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.045624,0.28004,0.26665,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.015953,0.27695,0.19153,1,1
1,GO KINETOCHORE ORGANIZATION,0.00017796,0.25907,0.25591,1,1
1,GO APICAL PROTEIN LOCALIZATION,0.00020448,0.25853,0.24438,1,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0042883,0.25615,0.22571,1,1
1,GO CENTROMERE COMPLEX ASSEMBLY,7.547e-05,0.25208,0.2223,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0090226,0.24969,0.22809,1,1
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00031859,0.24856,0.23426,1,1
1,GO DENDRITE SELF AVOIDANCE,0.0090226,0.24787,0.20178,1,1
1,GO POST ANAL TAIL MORPHOGENESIS,0.00038934,0.24666,0.21991,1,1
1,GO MITOTIC DNA REPLICATION,0.0031536,0.24315,0.18747,1,1
1,GO CHROMATIN REMODELING AT CENTROMERE,7.547e-05,0.2424,0.23654,1,1
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.044685,0.23337,0.2169,1,1
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00011241,0.22722,0.21336,1,1
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037747,0.22261,0.23515,1,1
1,GO ESCRT COMPLEX DISASSEMBLY,0.021165,0.22183,0.1464,1,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0006154,0.22003,0.17786,1,1
1,GO REGULATION OF SISTER CHROMATID COHESION,0.0026572,0.21515,0.168,1,1
1,GO HISTONE H4 K16 ACETYLATION,5.9841e-06,0.21251,0.23946,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.02843,0.21102,0.15913,1,1
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.013139,0.21063,0.18887,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00037661,0.19894,0.15986,1,1
1,GO MRNA SPLICE SITE SELECTION,0.0017641,0.19719,0.22316,1,1
1,GO NEPHRON TUBULE FORMATION,0.045624,0.19595,0.20706,1,1
1,GO VIRAL LATENCY,0.01282,0.19582,0.14455,1,1
1,GO HISTONE H3 K9 TRIMETHYLATION,0.0006154,0.19125,0.18096,1,1
1,GO FOREBRAIN REGIONALIZATION,0.014841,0.19095,0.20213,1,1
1,GO ATP DEPENDENT CHROMATIN REMODELING,5.2837e-06,0.18939,0.19512,1,1
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00026003,0.18578,0.18914,1,1
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.034637,0.18281,0.13615,1,1
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0023671,0.18043,0.16594,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0094949,0.17856,0.20399,1,1
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.016734,0.17698,0.15303,1,1
1,GO HISTONE EXCHANGE,0.00072223,0.17508,0.1491,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.02068,0.17204,0.2265,1,1
1,GO HISTONE H4 K5 ACETYLATION,0.00050664,0.17139,0.20863,1,1
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0051916,0.16869,0.14651,1,1
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00032948,0.16598,0.17824,1,1
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.004408,0.16579,0.18721,1,1
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00012512,0.16518,0.18372,1,1
1,GO POSITIVE REGULATION OF DNA REPAIR,0.00028792,0.16124,0.13878,1,1
1,GO REGULATION OF HELICASE ACTIVITY,0.0071468,0.15891,0.17739,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.016734,0.15615,0.14783,1,1
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00030804,0.15188,0.16784,1,1
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00065623,0.14947,0.13833,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.031748,0.14876,0.13344,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.031059,0.14665,0.10901,1,1
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0056288,0.14497,0.18825,1,1
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0038387,0.14329,0.1321,1,1
1,GO SPINAL CORD DEVELOPMENT,0.022165,0.14033,0.13177,1,1
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.023741,0.13966,0.12442,1,1
1,GO NUCLEOSOME ASSEMBLY,0.00069957,0.13888,0.16382,1,1
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00040247,0.13635,0.13401,1,1
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.024288,0.13607,0.1959,1,1
1,GO CENTROSOME DUPLICATION,0.0060989,0.13425,0.11631,1,1
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.023741,0.13194,0.090214,1,1
1,GO DNA STRAND ELONGATION,0.0049174,0.12926,0.12958,1,1
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0066042,0.12915,0.13425,1,1
1,GO HISTONE H3 K4 METHYLATION,0.00044439,0.12775,0.14725,1,1
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.035393,0.1275,0.11792,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.012203,0.12571,0.12097,1,1
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.001191,0.1257,0.14973,1,1
1,GO NUCLEOSOME ORGANIZATION,0.00032948,0.12553,0.12845,1,1
1,GO MITOTIC CHROMOSOME CONDENSATION,0.0047853,0.1249,0.15248,1,1
1,GO HISTONE MONOUBIQUITINATION,0.0021062,0.12048,0.11959,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.031748,0.11848,0.13282,1,1
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11596,0.12593,1,1
1,GO CELL CYCLE DNA REPLICATION,0.0067808,0.11454,0.10186,1,1
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.02068,0.11414,0.098551,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.010773,0.11386,0.10834,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0079323,0.11377,0.085878,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0085714,0.11293,0.10833,1,1
1,GO HISTONE H2A ACETYLATION,0.00353,0.11229,0.17447,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.0017123,0.1121,0.10136,1,1
1,GO G0 TO G1 TRANSITION,0.0028957,0.11183,0.11861,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.034637,0.11158,0.078474,1,1
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.047551,0.11087,0.1328,1,1
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0011549,0.11085,0.19248,1,1
1,GO CHROMATIN SILENCING,0.011612,0.10926,0.092347,1,1
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0016129,0.10636,0.098217,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.029719,0.10505,0.12455,1,1
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00013433,0.10503,0.13417,1,1
1,GO DNA REPLICATION INITIATION,0.018398,0.10424,0.099683,1,1
1,GO HISTONE H4 ACETYLATION,0.00045924,0.10078,0.11882,1,1
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.034637,0.099997,0.075342,1,1
1,GO REGULATION OF MRNA PROCESSING,0.009256,0.099215,0.085085,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.025414,0.09432,0.070677,1,1
1,GO MRNA PROCESSING,0.010245,0.09383,0.063472,1,1
1,GO PEPTIDYL LYSINE METHYLATION,0.0014738,0.09231,0.090475,1,1
1,GO PEPTIDYL LYSINE ACETYLATION,0.00022676,0.090549,0.087649,1,1
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02068,0.090432,0.083375,1,1
1,GO RNA SPLICING,0.0087944,0.090344,0.069266,1,1
1,GO REGULATION OF DNA REPAIR,0.0099891,0.089952,0.076285,1,1
1,GO DNA GEOMETRIC CHANGE,0.044685,0.089177,0.05672,1,1
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0097392,0.088497,0.10006,1,1
1,GO REPLICATION FORK PROCESSING,0.023741,0.088346,0.087783,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.018836,0.088293,0.088846,1,1
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0071468,0.086444,0.10266,1,1
1,GO DNA PACKAGING,0.00063551,0.085236,0.10766,1,1
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00030804,0.08435,0.12125,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.010245,0.083709,0.10556,1,1
1,GO DNA DEPENDENT DNA REPLICATION,0.038561,0.083261,0.064311,1,1
1,GO DNA CONFORMATION CHANGE,0.0029794,0.081802,0.077517,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.031059,0.081327,0.11549,1,1
1,GO REGULATION OF PROTEIN ACETYLATION,0.03939,0.080845,0.061325,1,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.022165,0.079163,0.067815,1,1
1,GO CHROMATIN REMODELING,0.00081984,0.079061,0.10882,1,1
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.014486,0.078138,0.09727,1,1
1,GO RECOMBINATIONAL REPAIR,0.043763,0.07368,0.048736,1,1
1,GO INTERSTRAND CROSS LINK REPAIR,0.029068,0.071299,0.068966,1,1
1,GO PROTEIN ACETYLATION,0.011047,0.067564,0.05242,1,1
1,GO PEPTIDYL LYSINE MODIFICATION,0.0050528,0.067307,0.05242,1,1
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.044685,0.064995,0.072617,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.044685,0.060533,0.06492,1,1
1,GO CHROMOSOME SEGREGATION,0.038561,0.059468,0.052624,1,1
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.029068,0.059453,0.058666,1,1
1,GO CHROMATIN ORGANIZATION,0.011047,0.052102,0.055499,1,1
1,GO CELL CYCLE CHECKPOINT,0.033166,0.050958,0.047562,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00017796,1.4705,1.17,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,8.4205e-05,1.3173,1.0187,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00026903,0.9206,0.65971,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,5.2139e-05,0.85973,0.91274,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0021689,0.84781,0.83089,1,1
2,GO CYTIDINE TO URIDINE EDITING,0.00055855,0.82178,0.62492,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00032948,0.78837,0.56721,1,1
2,GO TOLERANCE INDUCTION,3.7145e-05,0.78315,0.66158,1,1
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.7323e-05,0.77401,0.75079,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.389e-05,0.75104,0.57637,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,5.8301e-05,0.73405,0.67497,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0022332,0.73387,0.57588,1,1
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.0184e-05,0.7143,0.57837,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00074557,0.69462,0.4364,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,4.2876e-06,0.68781,0.63371,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00095906,0.68012,0.49591,1,1
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00016595,0.67015,0.56536,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00026003,0.66963,0.58022,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,1.5201e-05,0.66155,0.60309,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0023671,0.65899,0.39752,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.035393,0.65647,0.41211,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00090094,0.65436,0.49711,1,1
2,GO RESPONSE TO TYPE I INTERFERON,5.4121e-05,0.65391,0.60068,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.4878e-05,0.6448,0.46354,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00050664,0.63881,0.44696,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0015653,0.63631,0.41989,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00098941,0.63355,0.5041,1,1
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,4.6597e-05,0.62823,0.50048,1,1
2,GO TYPE B PANCREATIC CELL PROLIFERATION,8.628e-07,0.61781,0.6616,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,8.1192e-05,0.61642,0.60146,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,5.7413e-06,0.6017,0.65024,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.013139,0.59631,0.36194,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00037661,0.59546,0.40519,1,1
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,9.3916e-06,0.5953,0.65177,1,1
2,GO SEROTONIN METABOLIC PROCESS,1.0184e-05,0.5912,0.60635,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,8.6584e-06,0.59022,0.51398,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS,6.5149e-05,0.58922,0.45604,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.6307e-05,0.58844,0.70451,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,9.7801e-06,0.58839,0.5575,1,1
2,GO CORTICOSTEROID HORMONE SECRETION,0.00010845,0.58326,0.43273,1,1
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,2.2658e-06,0.57886,0.57453,1,1
2,GO DETECTION OF OTHER ORGANISM,0.00010462,0.57735,0.48483,1,1
2,GO LIPID DROPLET FORMATION,6.0504e-05,0.57423,0.58788,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0025817,0.5738,0.38816,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,1.4039e-05,0.57247,0.572,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.7728e-06,0.56884,0.48687,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.0226e-05,0.56637,0.4285,1,1
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001191,0.56603,0.50745,1,1
2,GO IMMUNOGLOBULIN SECRETION,0.00012964,0.56546,0.41118,1,1
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0010859,0.56488,0.45657,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.9263e-05,0.56463,0.51644,1,1
2,GO HISTAMINE SECRETION,0.0033369,0.56401,0.45405,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00095906,0.5616,0.39007,1,1
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.0604e-05,0.55875,0.5284,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,7.2754e-05,0.55828,0.40464,1,1
2,GO REGULATION OF VASCULOGENESIS,3.4421e-05,0.5562,0.52103,1,1
2,GO LIVER MORPHOGENESIS,2.7343e-05,0.55591,0.49829,1,1
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00012512,0.54847,0.43742,1,1
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.9532e-05,0.54804,0.51696,1,1
2,GO GLIAL CELL FATE COMMITMENT,0.00027832,0.54798,0.49336,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0016129,0.54291,0.39401,1,1
2,GO KERATINOCYTE DEVELOPMENT,0.00074557,0.54256,0.42705,1,1
2,GO EOSINOPHIL MIGRATION,0.0013872,0.54044,0.4402,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,9.389e-05,0.53865,0.5526,1,1
2,GO EOSINOPHIL CHEMOTAXIS,0.0017123,0.53797,0.4554,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.00072223,0.53139,0.3609,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.1964e-05,0.52962,0.48278,1,1
2,GO GERMINAL CENTER FORMATION,0.0014299,0.52748,0.47133,1,1
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,2.5774e-06,0.52674,0.6417,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0017641,0.52524,0.36785,1,1
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0011199,0.52522,0.52277,1,1
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,3.3132e-05,0.52481,0.5306,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,6.2786e-05,0.52306,0.36706,1,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0069616,0.5218,0.38273,1,1
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0017123,0.52172,0.43962,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00012074,0.52073,0.41251,1,1
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,5.8301e-05,0.5111,0.49415,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0050528,0.50976,0.55544,1,1
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,7.547e-05,0.50882,0.5464,1,1
2,GO O GLYCAN PROCESSING,0.00074557,0.50708,0.34327,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.0028957,0.50656,0.38528,1,1
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00029782,0.50648,0.4666,1,1
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.00072223,0.50509,0.39518,1,1
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0031536,0.50342,0.47591,1,1
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00021909,0.50141,0.52289,1,1
2,GO N GLYCAN PROCESSING,4.6623e-06,0.50059,0.47923,1,1
2,GO REGULATION OF PLATELET AGGREGATION,3.5759e-05,0.49994,0.4489,1,1
2,GO RESPONSE TO WATER,8.1192e-05,0.49941,0.42887,1,1
2,GO REGULATION OF RECEPTOR CLUSTERING,8.7323e-05,0.49909,0.46487,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00050664,0.49695,0.33042,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0045306,0.49589,0.33594,1,1
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.00012074,0.49531,0.50104,1,1
2,GO HISTAMINE TRANSPORT,0.0017123,0.4927,0.41872,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,1.1267e-06,0.4917,0.48034,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.6902e-06,0.48967,0.45762,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0015653,0.48762,0.42928,1,1
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,4.6597e-05,0.48716,0.40076,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00063551,0.48588,0.44111,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,0.48396,0.35797,1,1
2,GO LIPOXYGENASE PATHWAY,0.00055855,0.48291,0.41117,1,1
2,GO REFLEX,0.0062634,0.48269,0.43445,1,1
2,GO DNA DEAMINATION,0.0097392,0.4824,0.31613,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.004408,0.48048,0.33436,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014418,0.47967,0.40374,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.4039e-05,0.47952,0.49599,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,3.1888e-05,0.47789,0.41491,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0022992,0.47606,0.32649,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0006154,0.4757,0.30777,1,1
2,GO PROSTATE GLAND MORPHOGENESIS,0.0090226,0.47519,0.33852,1,1
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,8.7323e-05,0.4712,0.45029,1,1
2,GO LUNG CELL DIFFERENTIATION,0.00012074,0.471,0.5018,1,1
2,GO REGULATION OF TRANSPOSITION,0.00052342,0.46589,0.37105,1,1
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00014418,0.46555,0.45466,1,1
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.8583e-05,0.46542,0.43374,1,1
2,GO T CELL MEDIATED IMMUNITY,0.00035231,0.46362,0.29606,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00030804,0.46361,0.3358,1,1
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0090226,0.46329,0.32236,1,1
2,GO SYNAPSE MATURATION,0.00041602,0.46258,0.48323,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0022332,0.46216,0.39096,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0015653,0.46157,0.4813,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00019079,0.46141,0.39586,1,1
2,GO ENDOTHELIAL CELL CHEMOTAXIS,1.2454e-05,0.46048,0.44633,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0011199,0.46035,0.38469,1,1
2,GO RESPONSE TO INTERLEUKIN 18,0.0041716,0.46017,0.34641,1,1
2,GO MITOCHONDRIAL DEPOLARIZATION,0.00036427,0.45577,0.31599,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00026903,0.45403,0.42756,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.00072223,0.45299,0.41288,1,1
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,1.2454e-05,0.45188,0.41621,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,8.1192e-05,0.45171,0.31226,1,1
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.0012662,0.45098,0.3695,1,1
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.00095906,0.44926,0.39102,1,1
2,GO MYELIN MAINTENANCE,6.2367e-06,0.44886,0.45633,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0012662,0.44872,0.36669,1,1
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,4.1617e-05,0.44788,0.40945,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.01282,0.44746,0.31903,1,1
2,GO EPITHELIAL CELL MORPHOGENESIS,0.00030804,0.44739,0.4123,1,1
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.7118e-05,0.44678,0.37012,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0067808,0.44677,0.23859,1,1
2,GO MICROVILLUS ASSEMBLY,0.0011549,0.44592,0.37962,1,1
2,GO NEURONAL ION CHANNEL CLUSTERING,0.00017796,0.44495,0.45732,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0013872,0.44474,0.26376,1,1
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00090094,0.44457,0.45494,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00020448,0.44411,0.44191,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0007696,0.44321,0.41829,1,1
2,GO RESPONSE TO COLD,1.8521e-05,0.4426,0.38122,1,1
2,GO RESPONSE TO PAIN,0.0017123,0.44201,0.28913,1,1
2,GO GLIAL CELL APOPTOTIC PROCESS,0.00079435,0.44183,0.44899,1,1
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00022676,0.4413,0.37198,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00028792,0.44097,0.31138,1,1
2,GO MYOBLAST FUSION,0.00019753,0.43896,0.33289,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00036427,0.43886,0.27495,1,1
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.03245,0.43868,0.30757,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00092958,0.43627,0.30281,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00010462,0.43602,0.33867,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0049174,0.43544,0.27156,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.7145e-05,0.4344,0.41149,1,1
2,GO TRANSPOSITION,7.013e-05,0.43392,0.39051,1,1
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.011047,0.43358,0.33801,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.4878e-05,0.43325,0.40592,1,1
2,GO STEROID HORMONE SECRETION,0.00011241,0.43318,0.35223,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00040247,0.43136,0.30683,1,1
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,3.8583e-05,0.4295,0.35907,1,1
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,9.0179e-06,0.42898,0.52616,1,1
2,GO REGULATION OF EXOSOMAL SECRETION,0.0001547,0.42821,0.29734,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00030804,0.4266,0.36579,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0022992,0.42564,0.32049,1,1
2,GO ZYMOGEN ACTIVATION,0.00044439,0.42489,0.37464,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.9263e-05,0.42449,0.38888,1,1
2,GO REGULATION OF GLIAL CELL PROLIFERATION,2.0033e-05,0.42435,0.36588,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00065623,0.42349,0.4085,1,1
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0045306,0.42289,0.30769,1,1
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00027832,0.42232,0.41997,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0042883,0.42215,0.26423,1,1
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00040247,0.42212,0.43602,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0021689,0.42139,0.37792,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0064317,0.42028,0.29,1,1
2,GO SIALYLATION,0.0015653,0.41957,0.31781,1,1
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.021165,0.41952,0.41683,1,1
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,1.2962e-05,0.41899,0.45396,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.013798,0.41874,0.27741,1,1
2,GO CAMP BIOSYNTHETIC PROCESS,2.6307e-05,0.41758,0.39945,1,1
2,GO CELLULAR DEFENSE RESPONSE,0.0031536,0.41631,0.23474,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,7.8282e-05,0.41601,0.4084,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00092958,0.41586,0.39684,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00011241,0.41575,0.3851,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00030804,0.41481,0.27609,1,1
2,GO FUCOSE METABOLIC PROCESS,0.00016023,0.41471,0.3092,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,7.2754e-05,0.41455,0.48196,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00028792,0.41361,0.42896,1,1
2,GO REGULATION OF MYOBLAST FUSION,0.0073363,0.41356,0.2911,1,1
2,GO REGULATION OF PLATELET ACTIVATION,7.2754e-05,0.4132,0.36905,1,1
2,GO REGULATION OF WATER LOSS VIA SKIN,0.00047456,0.4131,0.38867,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,5.2837e-06,0.41288,0.35073,1,1
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.0087944,0.41254,0.39114,1,1
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0028957,0.41241,0.28244,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00019753,0.40983,0.33835,1,1
2,GO MYELIN ASSEMBLY,0.00026003,0.40967,0.33067,1,1
2,GO LUNG EPITHELIUM DEVELOPMENT,2.9532e-05,0.40925,0.38996,1,1
2,GO RESPONSE TO DIETARY EXCESS,0.00017186,0.40908,0.41308,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.40906,0.27366,1,1
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,7.547e-05,0.40891,0.32494,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,7.547e-05,0.40878,0.34322,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00059588,0.40766,0.29233,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,1.9263e-05,0.40622,0.39025,1,1
2,GO PROTEIN O LINKED GLYCOSYLATION,0.00037661,0.40593,0.25096,1,1
2,GO LUNG ALVEOLUS DEVELOPMENT,3.4728e-06,0.40589,0.37282,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,3.8583e-05,0.40557,0.34287,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0030654,0.40511,0.26942,1,1
2,GO REGULATION OF BONE REMODELING,9.7346e-05,0.40482,0.31747,1,1
2,GO GLIAL CELL PROLIFERATION,0.00038934,0.40442,0.27907,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0064317,0.40396,0.31311,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00022676,0.4039,0.31411,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.00012512,0.40359,0.39105,1,1
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.001191,0.40106,0.3758,1,1
2,GO RESPONSE TO AUDITORY STIMULUS,2.8418e-05,0.40039,0.42082,1,1
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00019753,0.40039,0.39171,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0006154,0.40012,0.33284,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.001986,0.39962,0.31609,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.0081404,0.39926,0.24616,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0012662,0.39915,0.37058,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0042883,0.39895,0.27908,1,1
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,1.4039e-05,0.39864,0.35101,1,1
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.4121e-05,0.39859,0.45841,1,1
2,GO MAGNESIUM ION TRANSPORT,0.00010092,0.39815,0.29342,1,1
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.001986,0.39804,0.39507,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.1904e-06,0.39744,0.50954,1,1
2,GO PROTEIN KINASE C SIGNALING,0.00013433,0.39736,0.35171,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.508e-06,0.3969,0.42055,1,1
2,GO STEROID ESTERIFICATION,0.00049035,0.39682,0.42797,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0054795,0.39459,0.25544,1,1
2,GO VIRAL GENOME REPLICATION,0.0026572,0.39392,0.25109,1,1
2,GO RELAXATION OF CARDIAC MUSCLE,0.0053338,0.39385,0.31638,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,2.6307e-05,0.39289,0.45814,1,1
2,GO NERVE DEVELOPMENT,3.1904e-06,0.39288,0.36064,1,1
2,GO AMYLOID FIBRIL FORMATION,0.0022332,0.39251,0.30383,1,1
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00045924,0.3925,0.34827,1,1
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,7.2754e-05,0.39235,0.4714,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012662,0.39135,0.34592,1,1
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00059588,0.39108,0.41953,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,2.0033e-05,0.3908,0.34295,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,7.6603e-06,0.39036,0.40141,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00031859,0.3903,0.33778,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.023205,0.38998,0.2814,1,1
2,GO ALPHA BETA T CELL PROLIFERATION,0.0001165,0.38925,0.34348,1,1
2,GO VASCULAR WOUND HEALING,2.7343e-05,0.38848,0.46922,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.4421e-05,0.38827,0.31829,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0021689,0.38803,0.34698,1,1
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0022992,0.38755,0.3689,1,1
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014935,0.38748,0.39814,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00084609,0.38743,0.27421,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,5.2139e-05,0.38693,0.37731,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,6.2786e-05,0.38668,0.37158,1,1
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00035231,0.38658,0.32987,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.2139e-05,0.38574,0.38658,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,6.7728e-06,0.38551,0.32446,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.018398,0.38543,0.26822,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.00038934,0.38528,0.29925,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00040247,0.38474,0.39884,1,1
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00049035,0.3847,0.34225,1,1
2,GO SMOOTH MUSCLE CELL MIGRATION,7.8282e-05,0.38462,0.33328,1,1
2,GO REGULATION OF TISSUE REMODELING,0.00017796,0.38448,0.28397,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,8.7323e-05,0.38431,0.31075,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00084609,0.38428,0.42754,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.0010528,0.3841,0.26066,1,1
2,GO GLAND MORPHOGENESIS,0.00013917,0.38335,0.32344,1,1
2,GO COCHLEA MORPHOGENESIS,0.0075304,0.3825,0.23959,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00026903,0.38244,0.26347,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.001191,0.38211,0.33651,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,2.0833e-05,0.382,0.35925,1,1
2,GO BONE RESORPTION,0.00054072,0.38143,0.25884,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00014418,0.38134,0.31262,1,1
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00021909,0.38126,0.32799,1,1
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0056288,0.38109,0.27557,1,1
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1267e-06,0.38093,0.35498,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,5.0226e-05,0.37983,0.32228,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00065623,0.37975,0.28853,1,1
2,GO OLIGODENDROCYTE DEVELOPMENT,2.9301e-06,0.37887,0.32083,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.1617e-05,0.37837,0.35225,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.038561,0.37736,0.32114,1,1
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.017549,0.37709,0.52276,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,4.1617e-05,0.37684,0.30152,1,1
2,GO ESTROUS CYCLE,7.547e-05,0.37674,0.36999,1,1
2,GO B CELL APOPTOTIC PROCESS,0.0013054,0.3767,0.35004,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0039469,0.37666,0.32425,1,1
2,GO VOCALIZATION BEHAVIOR,0.0094949,0.37636,0.4099,1,1
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00035231,0.37608,0.30297,1,1
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.00067758,0.37596,0.42544,1,1
2,GO BRONCHUS DEVELOPMENT,0.0017641,0.37562,0.40139,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.0073e-05,0.37531,0.36127,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,6.2367e-06,0.37519,0.402,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,1.7806e-05,0.37481,0.32147,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00030804,0.37478,0.28367,1,1
2,GO EPITHELIAL CELL MATURATION,0.00010092,0.3744,0.37058,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.014841,0.37429,0.24854,1,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.027803,0.37356,0.27108,1,1
2,GO LIPID DROPLET ORGANIZATION,1.104e-05,0.37349,0.34697,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.7343e-05,0.37334,0.35427,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00055855,0.37306,0.29438,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00021167,0.37291,0.44189,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0090226,0.37249,0.28847,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.031748,0.37205,0.21529,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0019282,0.37194,0.32606,1,1
2,GO TOXIN METABOLIC PROCESS,0.00090094,0.37189,0.34614,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.011047,0.37185,0.28572,1,1
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00079435,0.37184,0.37603,1,1
2,GO ASTROCYTE ACTIVATION,1.9263e-05,0.37182,0.37734,1,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.00017186,0.37165,0.37331,1,1
2,GO ASYMMETRIC CELL DIVISION,0.0038387,0.3715,0.26998,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00020448,0.37109,0.35703,1,1
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0010206,0.37075,0.38093,1,1
2,GO RENAL FILTRATION,0.011612,0.37062,0.33934,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00019079,0.37039,0.23697,1,1
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00023468,0.37021,0.28396,1,1
2,GO GALACTOSE METABOLIC PROCESS,0.0075304,0.36957,0.25916,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00028792,0.36918,0.29255,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.02068,0.36904,0.34142,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00037661,0.3688,0.27643,1,1
2,GO TONGUE DEVELOPMENT,0.031059,0.36861,0.2587,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00013433,0.36853,0.23759,1,1
2,GO REGULATION OF AMINO ACID TRANSPORT,0.00028792,0.36844,0.29059,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.00072223,0.36807,0.31695,1,1
2,GO OSTEOBLAST PROLIFERATION,2.6307e-05,0.36775,0.36192,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.4039e-05,0.36751,0.29313,1,1
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.018398,0.36749,0.26156,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.8418e-05,0.36693,0.3091,1,1
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.004408,0.36647,0.39811,1,1
2,GO CRANIAL NERVE DEVELOPMENT,5.508e-06,0.36617,0.34017,1,1
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.024288,0.36542,0.31032,1,1
2,GO OPTIC NERVE DEVELOPMENT,0.00090094,0.36464,0.37739,1,1
2,GO MESENCHYMAL CELL PROLIFERATION,0.0010206,0.36464,0.28377,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00054072,0.36423,0.30286,1,1
2,GO GLYCINE TRANSPORT,0.025414,0.3641,0.27049,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0010859,0.36368,0.26999,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.03939,0.36358,0.27892,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.018398,0.36182,0.25694,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0081404,0.36086,0.2717,1,1
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00022676,0.36048,0.31906,1,1
2,GO VASODILATION,0.00353,0.3604,0.24819,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0036303,0.36032,0.26472,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0099891,0.36005,0.3421,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,3.7791e-06,0.35932,0.3477,1,1
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00010462,0.35887,0.3106,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00040247,0.35876,0.2549,1,1
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00010845,0.3586,0.30849,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.012203,0.35831,0.28826,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0019282,0.3583,0.3037,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.001228,0.35803,0.28651,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00095906,0.35717,0.29763,1,1
2,GO RESPONSE TO THYROID HORMONE,0.0019282,0.35641,0.31157,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.042857,0.3563,0.2328,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0001165,0.35614,0.27993,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010092,0.35606,0.36233,1,1
2,GO RESPONSE TO COPPER ION,0.0028141,0.35584,0.29646,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00017796,0.35571,0.27646,1,1
2,GO B CELL MEDIATED IMMUNITY,0.00021909,0.35547,0.33139,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,1.4609e-05,0.35545,0.33507,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00067758,0.35516,0.22197,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0023671,0.35488,0.26507,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0071468,0.35479,0.25628,1,1
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0021062,0.35475,0.26796,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00035231,0.3546,0.22712,1,1
2,GO RETINAL ROD CELL DIFFERENTIATION,0.011612,0.35441,0.2695,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00092958,0.35398,0.32496,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,5.8301e-05,0.35358,0.27885,1,1
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,7.547e-05,0.35355,0.30694,1,1
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00040247,0.35335,0.32665,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00016023,0.35311,0.28733,1,1
2,GO ENDOCARDIUM DEVELOPMENT,9.7346e-05,0.35277,0.38677,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0090226,0.35274,0.2656,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.00013917,0.3525,0.28426,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00017186,0.35237,0.28745,1,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.7118e-05,0.35217,0.34147,1,1
2,GO AMMONIUM TRANSPORT,0.00010845,0.35196,0.33547,1,1
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00072223,0.3518,0.30341,1,1
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.00022676,0.35176,0.25343,1,1
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00028792,0.35142,0.46759,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.0090226,0.35083,0.24112,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.0226e-05,0.35082,0.27503,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00028792,0.35076,0.3317,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00079435,0.35074,0.24693,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0011549,0.3507,0.28244,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.5816e-05,0.3506,0.27944,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0031536,0.35049,0.28526,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0010528,0.35027,0.2992,1,1
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0012662,0.35021,0.26219,1,1
2,GO AMINE BIOSYNTHETIC PROCESS,0.00055855,0.35006,0.31487,1,1
2,GO FOAM CELL DIFFERENTIATION,0.00017186,0.34981,0.35755,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,1.1493e-05,0.34961,0.33545,1,1
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00084609,0.34945,0.27844,1,1
2,GO ENDOTHELIAL CELL DEVELOPMENT,2.7343e-05,0.34933,0.2798,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00035231,0.34931,0.36663,1,1
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0046564,0.34907,0.27653,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.00045924,0.34818,0.30055,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,8.628e-07,0.34817,0.31214,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00021909,0.34815,0.27545,1,1
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,7.5427e-07,0.34807,0.33252,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0021062,0.34807,0.21304,1,1
2,GO SYNCYTIUM FORMATION,0.00032948,0.34746,0.25646,1,1
2,GO T CELL CYTOKINE PRODUCTION,0.00047456,0.34742,0.22882,1,1
2,GO GABAERGIC NEURON DIFFERENTIATION,0.0050528,0.34738,0.46185,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00042998,0.34731,0.25587,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00042998,0.3473,0.31289,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.012203,0.34687,0.28805,1,1
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00027832,0.3465,0.3173,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0001165,0.34588,0.30944,1,1
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,3.8583e-05,0.34514,0.30951,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00023468,0.34409,0.28293,1,1
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.001228,0.3439,0.26129,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00072223,0.3438,0.29632,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.011326,0.34369,0.43345,1,1
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00098941,0.3431,0.35387,1,1
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0025817,0.34307,0.40714,1,1
2,GO LUNG MORPHOGENESIS,0.0028957,0.34264,0.22718,1,1
2,GO MAST CELL MEDIATED IMMUNITY,4.6597e-05,0.34231,0.30693,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00028792,0.3418,0.34329,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00032948,0.34169,0.27337,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.5759e-05,0.34156,0.39365,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,2.0033e-05,0.34134,0.28454,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0051916,0.34116,0.25457,1,1
2,GO PLASMINOGEN ACTIVATION,0.043763,0.34098,0.22933,1,1
2,GO MEMBRANE BIOGENESIS,0.00065623,0.34075,0.2782,1,1
2,GO MICROVILLUS ORGANIZATION,0.010245,0.33954,0.24374,1,1
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0021689,0.3395,0.33896,1,1
2,GO ENDOTHELIUM DEVELOPMENT,3.0576e-06,0.33937,0.29298,1,1
2,GO SEQUESTERING OF ACTIN MONOMERS,0.00036427,0.33934,0.42919,1,1
2,GO CELL MIGRATION IN HINDBRAIN,0.00032948,0.33929,0.37399,1,1
2,GO MAST CELL ACTIVATION,1.104e-05,0.33885,0.30707,1,1
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00010092,0.33883,0.34835,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00095906,0.33874,0.27946,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00027832,0.33866,0.25581,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.014841,0.33845,0.26032,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,6.5149e-05,0.33828,0.28594,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0013872,0.33813,0.27838,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.00021167,0.33808,0.28073,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00037661,0.33742,0.26608,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0075304,0.33742,0.28368,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00034072,0.33721,0.21341,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0015653,0.33701,0.26453,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.0015653,0.33625,0.28619,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0013054,0.33603,0.29619,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,5.0226e-05,0.3359,0.28261,1,1
2,GO REGULATION OF B CELL ACTIVATION,3.7145e-05,0.33582,0.2666,1,1
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0064317,0.33569,0.2094,1,1
2,GO PROTEIN DEMANNOSYLATION,0.00042998,0.33557,0.2624,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0050528,0.33449,0.35865,1,1
2,GO FAT CELL DIFFERENTIATION,5.4977e-07,0.33447,0.28818,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0030654,0.33433,0.24687,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00020448,0.33433,0.29246,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.00098941,0.33423,0.31995,1,1
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00013433,0.33415,0.30198,1,1
2,GO GLIAL CELL DEVELOPMENT,3.4728e-06,0.33396,0.29701,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,6.2786e-05,0.33381,0.2772,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.00087311,0.33361,0.36309,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,7.8282e-05,0.33353,0.28174,1,1
2,GO LIPID TRANSLOCATION,2.8077e-06,0.33301,0.33719,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0015189,0.33282,0.30755,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00035231,0.33209,0.27396,1,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.015953,0.33172,0.15412,1,1
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0001165,0.33118,0.27748,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0021689,0.33114,0.28186,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0020453,0.33085,0.30405,1,1
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0042883,0.33063,0.28297,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,9.7346e-05,0.33062,0.29018,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0090226,0.33054,0.20432,1,1
2,GO REGULATION OF ANOIKIS,0.00063551,0.33001,0.39069,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,8.6584e-06,0.32978,0.27609,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.03245,0.32966,0.21536,1,1
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,6.7596e-05,0.32947,0.31583,1,1
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00011241,0.3294,0.2977,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0083534,0.32912,0.21827,1,1
2,GO REGULATION OF ENDOCRINE PROCESS,6.2367e-06,0.32865,0.29387,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0017641,0.32863,0.23712,1,1
2,GO PREPULSE INHIBITION,0.0085714,0.32819,0.36803,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.013798,0.32806,0.26052,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00036427,0.32805,0.31201,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00025131,0.32802,0.31624,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00014935,0.32787,0.23997,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00047456,0.32771,0.28885,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00057693,0.32686,0.26736,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.5201e-05,0.32663,0.29744,1,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.017969,0.32631,0.17349,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00074557,0.32629,0.21199,1,1
2,GO MALE SEX DETERMINATION,0.0059384,0.32626,0.2741,1,1
2,GO REGULATION OF POSITIVE CHEMOTAXIS,4.4878e-05,0.32581,0.33067,1,1
2,GO GANGLION DEVELOPMENT,0.013139,0.32571,0.35929,1,1
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,5.6174e-05,0.32562,0.37021,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00014418,0.32536,0.32793,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.00019079,0.32501,0.32564,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,6.7728e-06,0.32498,0.33048,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00019753,0.3249,0.34851,1,1
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,3.4421e-05,0.32482,0.29338,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.6228e-06,0.32433,0.29785,1,1
2,GO BONE REMODELING,0.00013917,0.32424,0.29115,1,1
2,GO POSITIVE REGULATION OF OSSIFICATION,4.6597e-05,0.32416,0.32869,1,1
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00054072,0.32414,0.37937,1,1
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.025414,0.32404,0.22518,1,1
2,GO CELLULAR RESPONSE TO VITAMIN,0.0042883,0.32399,0.29312,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.0060989,0.32398,0.30631,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.004408,0.32324,0.29158,1,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00014418,0.3225,0.27968,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,0.32246,0.35239,1,1
2,GO REGULATION OF CELL MATRIX ADHESION,2.7343e-05,0.32238,0.29232,1,1
2,GO ENGULFMENT OF APOPTOTIC CELL,6.5149e-05,0.32224,0.32822,1,1
2,GO REGULATION OF ORGANIC ACID TRANSPORT,3.7145e-05,0.32223,0.27576,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.0081404,0.3222,0.24621,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00027832,0.32202,0.32585,1,1
2,GO NEURON CELL CELL ADHESION,0.0054795,0.32178,0.44689,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0018173,0.32155,0.1839,1,1
2,GO REGULATION OF SODIUM ION TRANSPORT,1.2454e-05,0.32148,0.27754,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.00092958,0.32141,0.36063,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00019079,0.32141,0.28946,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,4.6623e-06,0.32082,0.28893,1,1
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0026572,0.32065,0.27952,1,1
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0050528,0.3206,0.20565,1,1
2,GO SECONDARY PALATE DEVELOPMENT,1.104e-05,0.32037,0.36518,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,4.0073e-05,0.32021,0.28211,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00055855,0.31993,0.30008,1,1
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,8.1192e-05,0.31943,0.29909,1,1
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.00036427,0.31903,0.24952,1,1
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.8379e-05,0.31868,0.36006,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.014486,0.31823,0.36762,1,1
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0071468,0.31787,0.34107,1,1
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0038387,0.31779,0.35504,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.8379e-05,0.31759,0.27949,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00049035,0.3174,0.43113,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00010092,0.31732,0.23275,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.001191,0.31721,0.2604,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,3.4421e-05,0.31719,0.30614,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00012074,0.31709,0.22533,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.00031859,0.31668,0.33012,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00013433,0.31653,0.2619,1,1
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0049174,0.31647,0.23002,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00098941,0.31645,0.28293,1,1
2,GO TISSUE REMODELING,0.00024286,0.31632,0.25785,1,1
2,GO RESPONSE TO LITHIUM ION,0.00072223,0.31624,0.34386,1,1
2,GO EPITHELIAL CELL DEVELOPMENT,5.2837e-06,0.31623,0.26327,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00027832,0.3159,0.29704,1,1
2,GO PRO B CELL DIFFERENTIATION,0.0064317,0.31546,0.24538,1,1
2,GO REGULATION OF CELL KILLING,0.0006154,0.3154,0.24358,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0011549,0.31538,0.3619,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0020453,0.31535,0.30004,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0049174,0.31507,0.22391,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00095906,0.31492,0.20738,1,1
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.027803,0.31489,0.25546,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,3.8583e-05,0.31476,0.2661,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0045306,0.31459,0.20263,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00017796,0.31449,0.33717,1,1
2,GO ENERGY HOMEOSTASIS,2.8418e-05,0.31427,0.3083,1,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0021689,0.31413,0.26683,1,1
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00052342,0.31411,0.28369,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00023468,0.31355,0.28394,1,1
2,GO AMYLOID BETA FORMATION,0.00010845,0.3134,0.31247,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,3.1888e-05,0.31302,0.25448,1,1
2,GO DIGESTIVE SYSTEM DEVELOPMENT,1.1493e-05,0.31254,0.25724,1,1
2,GO RESPIRATORY SYSTEM DEVELOPMENT,4.6597e-05,0.31242,0.24878,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.00014935,0.31236,0.26926,1,1
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,6.0198e-07,0.31227,0.31109,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.0184e-05,0.31206,0.26853,1,1
2,GO CELLULAR RESPONSE TO VITAMIN D,0.015203,0.31203,0.25275,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.00098941,0.31195,0.25431,1,1
2,GO RESPONSE TO VIRUS,0.0012662,0.31192,0.21354,1,1
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0038387,0.31187,0.23825,1,1
2,GO MECHANORECEPTOR DIFFERENTIATION,1.4039e-05,0.31181,0.25366,1,1
2,GO AMMONIUM ION METABOLIC PROCESS,0.00074557,0.31178,0.28887,1,1
2,GO APICAL JUNCTION ASSEMBLY,4.3218e-05,0.31176,0.30491,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0073363,0.31167,0.21532,1,1
2,GO INTERLEUKIN 10 PRODUCTION,9.0551e-05,0.31163,0.26943,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.025994,0.31141,0.19917,1,1
2,GO RESPONSE TO UV B,0.019283,0.31138,0.19544,1,1
2,GO REGULATION OF CARDIAC CONDUCTION,1.5201e-05,0.31135,0.27987,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0023671,0.31113,0.27181,1,1
2,GO ADRENAL GLAND DEVELOPMENT,9.389e-05,0.31078,0.37422,1,1
2,GO POLYSACCHARIDE METABOLIC PROCESS,1.0779e-06,0.31054,0.27246,1,1
2,GO SUPEROXIDE ANION GENERATION,0.00054072,0.31039,0.30314,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00028792,0.31027,0.22676,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.8301e-05,0.31007,0.29373,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,4.4878e-05,0.30996,0.31337,1,1
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.00014418,0.3096,0.3117,1,1
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,4.8379e-05,0.3096,0.32135,1,1
2,GO REGULATION OF GTP BINDING,0.023741,0.3094,0.2202,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00059588,0.30891,0.21807,1,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001986,0.30854,0.36681,1,1
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00011241,0.30853,0.4003,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0022332,0.30822,0.18367,1,1
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,6.2985e-07,0.30805,0.30656,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011326,0.30796,0.2346,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,2.6902e-06,0.30783,0.28055,1,1
2,GO INTERFERON BETA PRODUCTION,0.0011199,0.30783,0.21861,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0047853,0.30761,0.2685,1,1
2,GO LIPID STORAGE,3.5759e-05,0.30741,0.25138,1,1
2,GO RESPONSE TO PROTOZOAN,0.0047853,0.30731,0.23837,1,1
2,GO MIDGUT DEVELOPMENT,0.0026572,0.30715,0.33287,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.30659,0.1856,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.02166,0.30599,0.2765,1,1
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00044439,0.30596,0.25981,1,1
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00032948,0.30589,0.24199,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0028141,0.30588,0.29872,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00049035,0.30579,0.23671,1,1
2,GO NEPHRON MORPHOGENESIS,0.00017796,0.30562,0.22524,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00022676,0.30545,0.22667,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.0057817,0.30527,0.17571,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.0087944,0.30521,0.19113,1,1
2,GO KERATINOCYTE PROLIFERATION,0.018398,0.30475,0.18336,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00021909,0.30455,0.22213,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0028141,0.30432,0.21951,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013457,0.30426,0.24847,1,1
2,GO SPINAL CORD PATTERNING,0.0049174,0.30404,0.29941,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00031859,0.30395,0.32678,1,1
2,GO DEVELOPMENTAL INDUCTION,7.9801e-06,0.30388,0.28868,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0001165,0.30354,0.23728,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00016023,0.30352,0.2417,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00037661,0.30335,0.30062,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00016595,0.30334,0.29489,1,1
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.0184e-05,0.30331,0.27788,1,1
2,GO REGULATION OF COAGULATION,0.0047853,0.30309,0.21791,1,1
2,GO MEMBRANE LIPID METABOLIC PROCESS,7.547e-05,0.30295,0.21742,1,1
2,GO REGULATION OF CELL CELL ADHESION,1.0184e-05,0.30238,0.25314,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0045306,0.30211,0.26826,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00012964,0.30211,0.24604,1,1
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.0033e-05,0.30203,0.26763,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0028141,0.30165,0.23392,1,1
2,GO REGULATION OF ODONTOGENESIS,0.0021062,0.30103,0.32689,1,1
2,GO SKIN EPIDERMIS DEVELOPMENT,0.00095906,0.30088,0.18485,1,1
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00032948,0.30078,0.27143,1,1
2,GO MACROPHAGE DIFFERENTIATION,7.2754e-05,0.30058,0.23987,1,1
2,GO B CELL PROLIFERATION,0.00065623,0.30054,0.22775,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00012964,0.30053,0.28452,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00022676,0.30045,0.44657,1,1
2,GO EPITHELIAL CELL PROLIFERATION,2.7343e-05,0.30007,0.24526,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0011549,0.3,0.3264,1,1
2,GO ADIPOSE TISSUE DEVELOPMENT,3.9418e-06,0.29983,0.2856,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.4205e-05,0.29971,0.31019,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.007729,0.29967,0.2531,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00063551,0.29952,0.20086,1,1
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.29945,0.25123,1,1
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00013917,0.29903,0.29141,1,1
2,GO MYOTUBE DIFFERENTIATION,2.6307e-05,0.29893,0.23907,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.03245,0.29874,0.26619,1,1
2,GO REGULATION OF WOUND HEALING,0.00090094,0.29818,0.24381,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.02843,0.29798,0.17226,1,1
2,GO RENAL TUBULE DEVELOPMENT,0.00028792,0.29778,0.221,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.00050664,0.2975,0.27758,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,1.9263e-05,0.29713,0.25804,1,1
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0017641,0.29692,0.36016,1,1
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.29637,0.23992,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.0504e-05,0.29608,0.31801,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0011199,0.29603,0.19634,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0028141,0.29562,0.19076,1,1
2,GO CHEMOKINE PRODUCTION,8.7323e-05,0.29549,0.2751,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.015953,0.29539,0.26865,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,7.547e-05,0.29537,0.21057,1,1
2,GO MUSCLE CELL MIGRATION,0.00025131,0.2953,0.28039,1,1
2,GO KETONE CATABOLIC PROCESS,0.012508,0.29524,0.29768,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.038561,0.29501,0.28106,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0087944,0.29489,0.26386,1,1
2,GO INNATE IMMUNE RESPONSE,0.00055855,0.29469,0.20493,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.00081984,0.29439,0.28415,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.547e-05,0.29427,0.2579,1,1
2,GO RESPONSE TO MECHANICAL STIMULUS,4.8612e-06,0.29414,0.27329,1,1
2,GO RESPONSE TO AXON INJURY,0.00052342,0.29412,0.23164,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.009256,0.29407,0.24078,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0025083,0.29383,0.3444,1,1
2,GO OLIGODENDROCYTE DIFFERENTIATION,3.3287e-06,0.29362,0.28725,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.043763,0.29359,0.15857,1,1
2,GO MEMBRANE DEPOLARIZATION,0.00044439,0.2932,0.25747,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00021909,0.29309,0.26494,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00010092,0.29294,0.25681,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00023468,0.29292,0.24593,1,1
2,GO PROTEIN TARGETING TO LYSOSOME,0.010245,0.29289,0.23853,1,1
2,GO SKELETAL MUSCLE ADAPTATION,3.5759e-05,0.29268,0.30588,1,1
2,GO RESPONSE TO AMPHETAMINE,0.0010859,0.29257,0.27096,1,1
2,GO SPHINGOID METABOLIC PROCESS,0.00047456,0.29242,0.25638,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0034322,0.29235,0.21331,1,1
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,9.8628e-07,0.29192,0.28555,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00072223,0.29184,0.26336,1,1
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00074557,0.29151,0.2626,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0010528,0.29144,0.27636,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,8.1192e-05,0.29132,0.30246,1,1
2,GO COCHLEA DEVELOPMENT,0.0015653,0.29099,0.22852,1,1
2,GO RESPONSE TO IRON ION,0.00032948,0.29098,0.24474,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0094949,0.29087,0.22037,1,1
2,GO ENDOTHELIAL CELL PROLIFERATION,2.9532e-05,0.29081,0.26047,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,5.8301e-05,0.29057,0.24837,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.8418e-05,0.29029,0.23857,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.6603e-06,0.29011,0.27352,1,1
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.041093,0.28999,0.25877,1,1
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00011241,0.28992,0.22749,1,1
2,GO HEART VALVE FORMATION,0.041093,0.28986,0.2554,1,1
2,GO REGULATION OF RESPIRATORY BURST,0.0021689,0.28975,0.25532,1,1
2,GO REGULATION OF CARTILAGE DEVELOPMENT,1.8521e-05,0.28946,0.30693,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00084609,0.28931,0.38531,1,1
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00010462,0.28929,0.24129,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.011047,0.2892,0.176,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00087311,0.28919,0.23672,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,7.6603e-06,0.28911,0.26785,1,1
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.0833e-05,0.289,0.24428,1,1
2,GO KIDNEY MORPHOGENESIS,0.00029782,0.28899,0.22075,1,1
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00042998,0.28898,0.34849,1,1
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.5331e-06,0.28893,0.25232,1,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.0020453,0.28883,0.29262,1,1
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0013457,0.28849,0.22036,1,1
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,1.6455e-05,0.28841,0.35763,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.00079435,0.28819,0.26073,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00013433,0.28802,0.24698,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.015953,0.28794,0.25581,1,1
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00010845,0.28767,0.23016,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.007729,0.28755,0.23905,1,1
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0060989,0.28748,0.32536,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021909,0.28746,0.23913,1,1
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,2.2658e-06,0.28718,0.28908,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0025083,0.28687,0.31091,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00032948,0.28682,0.22928,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00034072,0.28678,0.22215,1,1
2,GO PLATELET ACTIVATION,0.00040247,0.28675,0.1978,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,7.547e-05,0.28672,0.25556,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00041602,0.28666,0.29062,1,1
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,6.2985e-07,0.28622,0.28546,1,1
2,GO GLYCOSYLATION,0.00011241,0.28621,0.21497,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,2.9532e-05,0.28603,0.21763,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00018427,0.28593,0.3002,1,1
2,GO LEUKOCYTE PROLIFERATION,5.6174e-05,0.28562,0.2327,1,1
2,GO TRANSMISSION OF NERVE IMPULSE,0.0007696,0.28526,0.27216,1,1
2,GO TOOTH MINERALIZATION,0.0030654,0.28524,0.25867,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00024286,0.28522,0.23795,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.004408,0.28507,0.2261,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00027832,0.28497,0.27604,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0066042,0.28467,0.29169,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,7.547e-05,0.28453,0.22072,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0006154,0.2845,0.20254,1,1
2,GO GLIAL CELL DIFFERENTIATION,5.508e-06,0.2844,0.26094,1,1
2,GO ANOIKIS,8.7323e-05,0.28438,0.34114,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,9.389e-05,0.28434,0.22725,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.001228,0.28408,0.24412,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.6174e-05,0.28397,0.22058,1,1
2,GO CAMP METABOLIC PROCESS,0.001662,0.2837,0.20921,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00041602,0.28339,0.23525,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00025131,0.28328,0.22108,1,1
2,GO DORSAL AORTA DEVELOPMENT,0.019739,0.28318,0.23906,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0030654,0.28295,0.22147,1,1
2,GO OVARIAN FOLLICLE DEVELOPMENT,1.5201e-05,0.28282,0.26958,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00084609,0.28279,0.2055,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00012512,0.28247,0.23473,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00012512,0.28241,0.20913,1,1
2,GO LONG TERM SYNAPTIC POTENTIATION,0.0001547,0.28226,0.26802,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,3.7145e-05,0.28224,0.2138,1,1
2,GO PLACENTA DEVELOPMENT,0.00016595,0.28206,0.22308,1,1
2,GO PLASMA MEMBRANE FUSION,0.001986,0.28205,0.25666,1,1
2,GO SPHINGOLIPID METABOLIC PROCESS,5.8301e-05,0.28199,0.21431,1,1
2,GO REGULATION OF CELL ADHESION,5.6174e-05,0.28193,0.22844,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0090226,0.28162,0.23275,1,1
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,9.8628e-07,0.28153,0.26503,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0012662,0.28138,0.22814,1,1
2,GO REGULATION OF CELL ACTIVATION,4.1617e-05,0.28133,0.20372,1,1
2,GO B CELL ACTIVATION,7.547e-05,0.28122,0.20724,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00021167,0.28119,0.2137,1,1
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00037661,0.28116,0.24349,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,2.6307e-05,0.28106,0.24873,1,1
2,GO EMBRYONIC HEMOPOIESIS,0.00067758,0.28105,0.24297,1,1
2,GO ALPHA BETA T CELL ACTIVATION,7.2754e-05,0.28101,0.24058,1,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0027346,0.28047,0.20522,1,1
2,GO MONOCYTE CHEMOTAXIS,0.0075304,0.28038,0.17767,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00065623,0.28036,0.24397,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.0033369,0.28019,0.35565,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0025083,0.28008,0.16751,1,1
2,GO CELL CELL ADHESION,9.3916e-06,0.27989,0.22002,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00040247,0.27972,0.20771,1,1
2,GO CELL MATRIX ADHESION,7.013e-05,0.27968,0.23159,1,1
2,GO INNERVATION,0.0054795,0.27966,0.32557,1,1
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0073363,0.27946,0.21163,1,1
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0087944,0.2791,0.25039,1,1
2,GO RESPONSE TO MAGNESIUM ION,0.017969,0.27904,0.22997,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0038387,0.27879,0.24505,1,1
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,1.7118e-05,0.27849,0.2536,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.389e-05,0.27838,0.28156,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0037331,0.27832,0.50706,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00065623,0.27824,0.24984,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00021167,0.27816,0.23926,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0014299,0.27813,0.20861,1,1
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0047853,0.27799,0.23022,1,1
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.00069957,0.27798,0.2423,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0087944,0.27791,0.1745,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00090094,0.27777,0.22607,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0060989,0.27773,0.2169,1,1
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00092958,0.2774,0.32045,1,1
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0050528,0.27719,0.23302,1,1
2,GO CHONDROCYTE DIFFERENTIATION,0.0011199,0.27714,0.21146,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.00045924,0.27698,0.19867,1,1
2,GO REGULATION OF RESPONSE TO FOOD,2.2524e-05,0.27693,0.28258,1,1
2,GO AXIS ELONGATION,0.0073363,0.27678,0.20408,1,1
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00055855,0.27664,0.24771,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.016339,0.27652,0.2791,1,1
2,GO EPITHELIAL CELL FATE COMMITMENT,0.0031536,0.27646,0.34044,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00017186,0.27601,0.25805,1,1
2,GO GLIOGENESIS,1.1493e-05,0.27577,0.24013,1,1
2,GO EMBRYONIC BODY MORPHOGENESIS,0.0032441,0.27529,0.29061,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0026572,0.27502,0.23796,1,1
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00010462,0.27499,0.2052,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.4421e-05,0.27497,0.23059,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00014418,0.2749,0.27042,1,1
2,GO STARTLE RESPONSE,0.0010206,0.27443,0.29232,1,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00016595,0.27439,0.30129,1,1
2,GO RESPONSE TO ACIDIC PH,0.00079435,0.27438,0.27445,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.00081984,0.27428,0.34736,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.00092958,0.27424,0.19445,1,1
2,GO CARDIAC CONDUCTION,6.5149e-05,0.27406,0.25394,1,1
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,7.3528e-06,0.27405,0.28127,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.27395,0.23014,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.036948,0.27391,0.20589,1,1
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0021062,0.27378,0.26346,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0029794,0.27367,0.28312,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.00010092,0.27362,0.27018,1,1
2,GO RECEPTOR CLUSTERING,0.00353,0.27355,0.1917,1,1
2,GO CGMP METABOLIC PROCESS,0.030383,0.27344,0.19253,1,1
2,GO CELL CHEMOTAXIS,4.0073e-05,0.27325,0.23973,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00063551,0.27313,0.24726,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0022992,0.27295,0.27619,1,1
2,GO REGULATION OF GLIOGENESIS,1.5816e-05,0.27293,0.24482,1,1
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,7.547e-05,0.27282,0.28552,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00057693,0.2728,0.23163,1,1
2,GO LEUKOCYTE MIGRATION,4.4878e-05,0.27256,0.22729,1,1
2,GO REGULATION OF T CELL ACTIVATION,2.7343e-05,0.27254,0.22335,1,1
2,GO INTERLEUKIN 12 PRODUCTION,0.00016023,0.2725,0.25052,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.5201e-05,0.27239,0.24661,1,1
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00038934,0.27233,0.20831,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.0013457,0.27232,0.22112,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00044439,0.27221,0.22549,1,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00052342,0.27214,0.26922,1,1
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0001547,0.27207,0.29589,1,1
2,GO MEMBRANE REPOLARIZATION,0.0020453,0.27172,0.22851,1,1
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0026572,0.2712,0.20431,1,1
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0029794,0.27115,0.22258,1,1
2,GO STEROL HOMEOSTASIS,0.00010092,0.27086,0.22356,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00065623,0.2706,0.24247,1,1
2,GO REGULATION OF NEURON MATURATION,0.0042883,0.27049,0.26,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.27041,0.22737,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00069957,0.26993,0.18789,1,1
2,GO HEART TRABECULA FORMATION,0.0040578,0.26985,0.27644,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00038934,0.26957,0.2229,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00052342,0.2694,0.19186,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00014418,0.26926,0.23693,1,1
2,GO METANEPHROS DEVELOPMENT,0.0011199,0.26921,0.19174,1,1
2,GO CELLULAR GLUCAN METABOLIC PROCESS,8.3127e-06,0.26902,0.25708,1,1
2,GO METANEPHROS MORPHOGENESIS,0.00016595,0.26893,0.27853,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0023671,0.26864,0.29191,1,1
2,GO ENAMEL MINERALIZATION,0.0085714,0.26863,0.2547,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00027832,0.26829,0.18242,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0085714,0.26817,0.23888,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.0041716,0.26772,0.20526,1,1
2,GO LEUKOCYTE CHEMOTAXIS,0.00011241,0.26764,0.21195,1,1
2,GO FORELIMB MORPHOGENESIS,0.016734,0.26754,0.21457,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,5.2139e-05,0.26751,0.21203,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.004408,0.26749,0.17851,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0038387,0.26739,0.20326,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.4346e-05,0.26738,0.21367,1,1
2,GO WATER HOMEOSTASIS,5.8301e-05,0.26729,0.25736,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0075304,0.26702,0.25064,1,1
2,GO INTERACTION WITH HOST,0.0087944,0.26696,0.14251,1,1
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.012508,0.26682,0.20247,1,1
2,GO FUCOSYLATION,4.4878e-05,0.26661,0.26598,1,1
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,2.5308e-05,0.26644,0.30388,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.024288,0.26629,0.2955,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,9.0551e-05,0.2661,0.19872,1,1
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00020448,0.26607,0.22374,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,7.2754e-05,0.26594,0.20957,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0014738,0.26576,0.19289,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0017123,0.26565,0.1983,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.017137,0.26558,0.16861,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0034322,0.2654,0.31026,1,1
2,GO CERAMIDE METABOLIC PROCESS,0.00036427,0.26532,0.1969,1,1
2,GO SODIUM ION TRANSPORT,1.7474e-06,0.26528,0.23765,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.349e-05,0.26525,0.25837,1,1
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00012512,0.26506,0.24166,1,1
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00072223,0.26468,0.21025,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.00069957,0.26465,0.24333,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0014738,0.26453,0.24767,1,1
2,GO MESONEPHROS DEVELOPMENT,1.5201e-05,0.26436,0.26639,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.014138,0.26426,0.252,1,1
2,GO T CELL ACTIVATION,5.6174e-05,0.26402,0.21389,1,1
2,GO RESPONSE TO CYTOKINE,0.0006154,0.26399,0.17942,1,1
2,GO TUBE MORPHOGENESIS,6.7596e-05,0.26397,0.19598,1,1
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00021167,0.26396,0.27531,1,1
2,GO STRIATED MUSCLE ADAPTATION,0.00057693,0.2639,0.23132,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0010859,0.26381,0.26315,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0033369,0.26381,0.27816,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,9.7346e-05,0.2638,0.21509,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00081984,0.26373,0.26181,1,1
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0062634,0.26355,0.20461,1,1
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,3.0689e-05,0.26334,0.2314,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.01282,0.26332,0.27881,1,1
2,GO REGULATION OF ACROSOME REACTION,0.030383,0.26266,0.17067,1,1
2,GO GLIAL CELL MIGRATION,0.0024367,0.26246,0.1872,1,1
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0094949,0.26242,0.20769,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00031859,0.26237,0.20556,1,1
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.00030804,0.26228,0.20397,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.00020448,0.26218,0.23477,1,1
2,GO RENAL SYSTEM PROCESS,1.2962e-05,0.26217,0.23315,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.00024286,0.26212,0.25306,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,0.011326,0.26211,0.24439,1,1
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,3.0689e-05,0.26189,0.23625,1,1
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,9.389e-05,0.26175,0.23395,1,1
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.01282,0.26174,0.21734,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0067808,0.26174,0.33147,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0007696,0.26107,0.18879,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.014138,0.26089,0.20812,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.033894,0.26081,0.12666,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00038934,0.26021,0.2236,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.016734,0.26021,0.30923,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.00092958,0.26017,0.22937,1,1
2,GO EATING BEHAVIOR,3.0576e-06,0.26015,0.2744,1,1
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001191,0.26013,0.21941,1,1
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0051916,0.25997,0.21608,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.009256,0.25987,0.16421,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.00023468,0.25983,0.31694,1,1
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.012203,0.2596,0.32893,1,1
2,GO GONADOTROPIN SECRETION,0.0020453,0.25954,0.27889,1,1
2,GO SODIUM ION HOMEOSTASIS,0.0001165,0.25919,0.23685,1,1
2,GO BIOLOGICAL ADHESION,4.8379e-05,0.25917,0.20279,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.011612,0.25911,0.22916,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0075304,0.2591,0.25615,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.00028792,0.25882,0.19131,1,1
2,GO INFLAMMATORY RESPONSE,5.2139e-05,0.25875,0.2161,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,4.8379e-05,0.25852,0.24334,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,8.4205e-05,0.2585,0.23704,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00010462,0.2584,0.21154,1,1
2,GO INTERLEUKIN 6 PRODUCTION,1.5816e-05,0.25816,0.22463,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0032441,0.25802,0.17762,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.017549,0.25789,0.2287,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.004408,0.25785,0.16775,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00010845,0.25776,0.22935,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.0025817,0.25769,0.33929,1,1
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.036948,0.25765,0.22401,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.6307e-05,0.25751,0.245,1,1
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.00087311,0.25751,0.22145,1,1
2,GO RESPONSE TO INSECTICIDE,0.00353,0.25723,0.29188,1,1
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017796,0.25702,0.21233,1,1
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.25702,0.20919,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00095906,0.25702,0.24679,1,1
2,GO REGULATION OF FATTY ACID TRANSPORT,1.0604e-05,0.257,0.30285,1,1
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0030654,0.25673,0.22554,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.035393,0.25666,0.2635,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0054795,0.25663,0.20659,1,1
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0038387,0.25658,0.23536,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.2139e-05,0.25613,0.1895,1,1
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,7.547e-05,0.25611,0.22294,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.044685,0.25609,0.19012,1,1
2,GO RESPONSE TO NICOTINE,0.00013433,0.25606,0.25168,1,1
2,GO RESPONSE TO WOUNDING,0.00081984,0.25603,0.1905,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.3418e-05,0.25583,0.21151,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00017186,0.25579,0.25287,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0073363,0.25555,0.23196,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0049174,0.25548,0.19216,1,1
2,GO ODONTOGENESIS,0.0028957,0.25545,0.19795,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00014935,0.25524,0.29294,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.027188,0.25501,0.21947,1,1
2,GO SEX DETERMINATION,0.00027832,0.25492,0.2709,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00032948,0.25476,0.18327,1,1
2,GO DIOL METABOLIC PROCESS,0.0017641,0.25472,0.21068,1,1
2,GO OXALATE TRANSPORT,0.0081404,0.25468,0.16939,1,1
2,GO DEFENSE RESPONSE,0.00018427,0.25467,0.19714,1,1
2,GO LIPOPROTEIN METABOLIC PROCESS,1.6455e-05,0.25464,0.23809,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00050664,0.25438,0.2799,1,1
2,GO ENDOCRINE HORMONE SECRETION,1.0779e-06,0.25436,0.31677,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,6.2786e-05,0.25424,0.23011,1,1
2,GO BASIC AMINO ACID TRANSPORT,0.024288,0.25398,0.10384,1,1
2,GO HAIR CELL DIFFERENTIATION,0.00019753,0.25397,0.21745,1,1
2,GO MACROPHAGE MIGRATION,0.00095906,0.2537,0.21249,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0066042,0.25364,0.13843,1,1
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0013054,0.2535,0.22261,1,1
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.1964e-05,0.25348,0.22559,1,1
2,GO INACTIVATION OF MAPK ACTIVITY,0.0029794,0.25332,0.26275,1,1
2,GO POSITIVE CHEMOTAXIS,0.00038934,0.25328,0.24017,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0023671,0.25305,0.2878,1,1
2,GO LYMPHOCYTE MIGRATION,0.0001165,0.25253,0.21187,1,1
2,GO CELL KILLING,0.00063551,0.25244,0.19153,1,1
2,GO MAST CELL MIGRATION,0.011047,0.25244,0.37182,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.0073363,0.25238,0.19079,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0014738,0.2523,0.24587,1,1
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.1617e-05,0.25219,0.19418,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00030804,0.25218,0.2281,1,1
2,GO LYMPHOCYTE ACTIVATION,6.0504e-05,0.25177,0.18662,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.037747,0.25177,0.18104,1,1
2,GO CYTOKINE PRODUCTION,0.00024286,0.25153,0.201,1,1
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.0027346,0.25153,0.20318,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.00084609,0.25149,0.19075,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.018398,0.25149,0.20885,1,1
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.001986,0.25148,0.21307,1,1
2,GO URETER DEVELOPMENT,0.023741,0.25135,0.23211,1,1
2,GO CELL ACTIVATION,0.00035231,0.25127,0.17682,1,1
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.021165,0.25123,0.18963,1,1
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0011549,0.25119,0.23144,1,1
2,GO REGULATION OF APPETITE,0.00017796,0.25076,0.23241,1,1
2,GO REGULATION OF DOPAMINE SECRETION,0.011612,0.25039,0.35299,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,0.25037,0.17152,1,1
2,GO NEGATIVE REGULATION OF GLIOGENESIS,3.1888e-05,0.25025,0.35078,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.004408,0.25001,0.24606,1,1
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0032441,0.24983,0.21829,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00074557,0.24963,0.37194,1,1
2,GO ACTIVATION OF JUN KINASE ACTIVITY,3.4728e-06,0.24923,0.24777,1,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.00037661,0.24919,0.20881,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,5.2139e-05,0.24889,0.21414,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.00024286,0.24884,0.20779,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,6.7596e-05,0.2488,0.17724,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00063551,0.24871,0.24373,1,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,1.104e-05,0.2486,0.19852,1,1
2,GO DNA DEMETHYLATION,0.0042883,0.24851,0.18676,1,1
2,GO RESPONSE TO BMP,0.00010462,0.24841,0.21402,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00025131,0.24834,0.21475,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.034637,0.24804,0.17903,1,1
2,GO VIRAL LIFE CYCLE,0.016339,0.24789,0.14119,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.5149e-05,0.24786,0.21355,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,4.3218e-05,0.24778,0.22594,1,1
2,GO POSITIVE REGULATION OF CELL DIVISION,3.8583e-05,0.24777,0.22451,1,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0069616,0.24769,0.2947,1,1
2,GO KIDNEY EPITHELIUM DEVELOPMENT,6.7596e-05,0.24745,0.23239,1,1
2,GO ALANINE TRANSPORT,0.0075304,0.24733,0.17878,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.8379e-05,0.24731,0.23422,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.00092958,0.2473,0.20915,1,1
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00030804,0.24727,0.23619,1,1
2,GO BRAIN MORPHOGENESIS,0.0038387,0.2472,0.17336,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,7.6603e-06,0.24718,0.24291,1,1
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,8.1192e-05,0.24716,0.19903,1,1
2,GO VASCULATURE DEVELOPMENT,0.00042998,0.24712,0.17086,1,1
2,GO T CELL PROLIFERATION,6.0504e-05,0.24674,0.23138,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,2.9532e-05,0.24662,0.20129,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.016339,0.24657,0.15749,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.004408,0.2464,0.19319,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.1192e-05,0.24636,0.18689,1,1
2,GO CARDIAC CELL DEVELOPMENT,0.00030804,0.24634,0.19009,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00026003,0.24613,0.22653,1,1
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.010245,0.24609,0.17829,1,1
2,GO MUSCLE ATROPHY,0.016339,0.24602,0.18798,1,1
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.9301e-06,0.24587,0.26779,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0075304,0.24587,0.32044,1,1
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.5759e-05,0.24575,0.21199,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,0.00029782,0.24557,0.18266,1,1
2,GO STEM CELL DIVISION,0.012203,0.24549,0.16179,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.2786e-05,0.24542,0.20445,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00042998,0.24541,0.28444,1,1
2,GO ANION HOMEOSTASIS,0.0021689,0.24538,0.17734,1,1
2,GO REGULATION OF ICOSANOID SECRETION,0.00012074,0.2452,0.26696,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001872,0.24514,0.17007,1,1
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00047456,0.24512,0.24389,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00017186,0.24484,0.18187,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,0.24482,0.22038,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.011904,0.24441,0.23548,1,1
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.045624,0.24437,0.19353,1,1
2,GO MOLTING CYCLE,0.00074557,0.24433,0.16183,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.017137,0.24412,0.18147,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00031859,0.24389,0.23102,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0022992,0.24385,0.17904,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0010528,0.24376,0.28106,1,1
2,GO MULTICELLULAR ORGANISMAL SIGNALING,4.1617e-05,0.24375,0.24346,1,1
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0014299,0.24349,0.30067,1,1
2,GO LIPID LOCALIZATION,0.00014935,0.24345,0.17466,1,1
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0032441,0.24339,0.25234,1,1
2,GO REGULATION OF OSSIFICATION,3.8583e-05,0.24338,0.26371,1,1
2,GO NOTCH SIGNALING PATHWAY,1.0184e-05,0.24329,0.2309,1,1
2,GO ENERGY RESERVE METABOLIC PROCESS,1.1493e-05,0.24307,0.23849,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00013917,0.24292,0.1892,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00025131,0.24267,0.22267,1,1
2,GO AMELOGENESIS,0.0018173,0.24255,0.26638,1,1
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.6455e-05,0.24254,0.3466,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.001872,0.2424,0.15913,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00092958,0.2421,0.23483,1,1
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0030654,0.24209,0.23321,1,1
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0038387,0.24205,0.21359,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00042998,0.24192,0.25111,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00098941,0.24183,0.22164,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0090226,0.24178,0.1815,1,1
2,GO TUBE DEVELOPMENT,4.3218e-05,0.24173,0.1913,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0019282,0.24161,0.15993,1,1
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1.0184e-05,0.24144,0.19785,1,1
2,GO CALCINEURIN MEDIATED SIGNALING,0.00017186,0.24128,0.2102,1,1
2,GO REGULATION OF HISTONE DEACETYLATION,0.00035231,0.24114,0.22385,1,1
2,GO GLAND DEVELOPMENT,4.2876e-06,0.2411,0.21011,1,1
2,GO NEUROINFLAMMATORY RESPONSE,0.00059588,0.2411,0.21077,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00026903,0.24102,0.20506,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,9.0551e-05,0.24097,0.21313,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00019753,0.24076,0.22467,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,8.7323e-05,0.24067,0.2484,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00032948,0.24064,0.1771,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.0017123,0.2406,0.25089,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.02068,0.24058,0.1928,1,1
2,GO AMINOGLYCAN METABOLIC PROCESS,0.00057693,0.24049,0.20198,1,1
2,GO LACTATE METABOLIC PROCESS,0.0073363,0.24034,0.22478,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045924,0.24022,0.24429,1,1
2,GO RESPONSE TO INTERLEUKIN 6,0.00063551,0.24016,0.21179,1,1
2,GO RESPONSE TO CAFFEINE,0.0057817,0.24013,0.2042,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0013872,0.24011,0.16142,1,1
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0017641,0.23992,0.17815,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00084609,0.23992,0.20676,1,1
2,GO PROTEIN PROCESSING,0.00052342,0.23977,0.17699,1,1
2,GO B CELL DIFFERENTIATION,1.1964e-05,0.23959,0.19524,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.00024286,0.23952,0.21695,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0001547,0.23943,0.2186,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00012964,0.23941,0.19426,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0045306,0.23919,0.18239,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,4.8379e-05,0.23903,0.20529,1,1
2,GO INTESTINAL ABSORPTION,0.0049174,0.23872,0.20838,1,1
2,GO DIENCEPHALON DEVELOPMENT,1.5201e-05,0.23866,0.29775,1,1
2,GO BONE MINERALIZATION,0.00020448,0.23821,0.22994,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00017186,0.23821,0.26128,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0099891,0.23812,0.18162,1,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.0059384,0.23797,0.1807,1,1
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0046564,0.23789,0.22664,1,1
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00026903,0.23783,0.22366,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0021062,0.23775,0.21793,1,1
2,GO BODY MORPHOGENESIS,0.0049174,0.23758,0.18805,1,1
2,GO LEYDIG CELL DIFFERENTIATION,0.029719,0.23735,0.2516,1,1
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00029782,0.2373,0.27722,1,1
2,GO ORGANIC CATION TRANSPORT,0.00014418,0.23714,0.24618,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.00035231,0.23695,0.18274,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0046564,0.23689,0.21281,1,1
2,GO NEURAL CREST CELL DIFFERENTIATION,0.012203,0.23671,0.16013,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00012964,0.2367,0.23093,1,1
2,GO STEROID METABOLIC PROCESS,0.00042998,0.2366,0.17688,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0083534,0.23648,0.27983,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00081984,0.23644,0.17614,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028957,0.23626,0.19193,1,1
2,GO CYTOKINE SECRETION,0.00034072,0.2362,0.20772,1,1
2,GO AMINE TRANSPORT,0.00084609,0.23618,0.28964,1,1
2,GO REGULATION OF MAP KINASE ACTIVITY,1.5201e-05,0.23616,0.21653,1,1
2,GO CELL SUBSTRATE ADHESION,0.00092958,0.23616,0.19701,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.2754e-05,0.23599,0.17313,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.011904,0.23597,0.298,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0064317,0.23596,0.27333,1,1
2,GO ADHERENS JUNCTION ASSEMBLY,0.00059588,0.23582,0.26258,1,1
2,GO WOUND HEALING,0.0017641,0.23575,0.17309,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00035231,0.23572,0.339,1,1
2,GO RESPONSE TO VITAMIN A,0.013798,0.23569,0.17799,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.0046564,0.23553,0.15418,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0034322,0.23545,0.16529,1,1
2,GO CATECHOLAMINE UPTAKE,0.0097392,0.23507,0.23318,1,1
2,GO RESPONSE TO POTASSIUM ION,0.00084609,0.23473,0.29307,1,1
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,7.8282e-05,0.23466,0.22816,1,1
2,GO INTERLEUKIN 4 PRODUCTION,0.00032948,0.23458,0.23734,1,1
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00040247,0.23451,0.21997,1,1
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.0012662,0.23434,0.21289,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0041716,0.23433,0.16272,1,1
2,GO CHLORIDE ION HOMEOSTASIS,0.0038387,0.23417,0.17703,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0014738,0.23416,0.18625,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,5.6174e-05,0.23388,0.21917,1,1
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,5.4121e-05,0.23383,0.18224,1,1
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,5.8301e-05,0.23377,0.2648,1,1
2,GO ENSHEATHMENT OF NEURONS,5.4121e-05,0.23369,0.20505,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00018427,0.23351,0.17518,1,1
2,GO RESPONSE TO STEROL,0.001228,0.23346,0.20165,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.00072223,0.23343,0.19782,1,1
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.025994,0.23337,0.15421,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.00010092,0.23325,0.17514,1,1
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.014138,0.23308,0.18315,1,1
2,GO ACTIVATED T CELL PROLIFERATION,1.4609e-05,0.23305,0.24137,1,1
2,GO ACTIN CROSSLINK FORMATION,0.0057817,0.23304,0.20086,1,1
2,GO POTASSIUM ION HOMEOSTASIS,2.8418e-05,0.23292,0.25828,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00019079,0.23292,0.17915,1,1
2,GO ENDOCRINE SYSTEM DEVELOPMENT,8.7323e-05,0.23277,0.2277,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.001986,0.23257,0.20633,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,2.2524e-05,0.23233,0.17491,1,1
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.02068,0.23226,0.18688,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0018173,0.23226,0.17212,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0028957,0.23225,0.2213,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.001872,0.23187,0.17529,1,1
2,GO DIOL BIOSYNTHETIC PROCESS,0.0085714,0.23179,0.14803,1,1
2,GO NEURON MATURATION,3.3132e-05,0.23169,0.2816,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.00030804,0.23153,0.19749,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00019753,0.23151,0.23224,1,1
2,GO STEROL METABOLIC PROCESS,0.0033369,0.23137,0.15853,1,1
2,GO REGULATION OF CHEMOTAXIS,6.2786e-05,0.23108,0.21221,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0069616,0.23095,0.21575,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,4.0073e-05,0.23088,0.21537,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.009256,0.23078,0.22217,1,1
2,GO MUSCLE CELL DIFFERENTIATION,2.4346e-05,0.23074,0.19228,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.00052342,0.2306,0.16823,1,1
2,GO GRANULOCYTE MIGRATION,0.0022332,0.2306,0.15994,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23057,0.16029,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0087944,0.23054,0.22655,1,1
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.0062634,0.23049,0.18298,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.5816e-05,0.23046,0.21156,1,1
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00028792,0.23045,0.21866,1,1
2,GO DISACCHARIDE METABOLIC PROCESS,0.0016129,0.23043,0.21858,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,1.1493e-05,0.23041,0.20706,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0031536,0.23033,0.22688,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00087311,0.23023,0.23107,1,1
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.00027832,0.23011,0.24108,1,1
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.00017186,0.22994,0.24969,1,1
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0013054,0.22993,0.18886,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.009256,0.22991,0.20564,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0013054,0.22981,0.17111,1,1
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00018427,0.2298,0.16996,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0041716,0.22978,0.19338,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00052342,0.22976,0.215,1,1
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00017796,0.22968,0.19539,1,1
2,GO ENDOCRINE PROCESS,0.00024286,0.2295,0.21856,1,1
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00067758,0.2295,0.31345,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0028141,0.22924,0.21753,1,1
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00016023,0.22912,0.20538,1,1
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00010092,0.22907,0.21548,1,1
2,GO BIOMINERALIZATION,0.00010462,0.22907,0.21612,1,1
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0018173,0.22883,0.22935,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.0017123,0.22872,0.2397,1,1
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0016129,0.22871,0.24843,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.043763,0.22866,0.14812,1,1
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,9.7346e-05,0.22858,0.23179,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00069957,0.22845,0.18942,1,1
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0011199,0.22843,0.2116,1,1
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0027346,0.22829,0.26048,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.2281,0.22934,1,1
2,GO TISSUE REGENERATION,0.016339,0.22782,0.17146,1,1
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,2.3418e-05,0.22767,0.20217,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0007696,0.22763,0.17461,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045924,0.22752,0.1838,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0001165,0.22751,0.18345,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00030804,0.22749,0.17843,1,1
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0028141,0.22749,0.21354,1,1
2,GO REGULATION OF BLOOD CIRCULATION,5.2837e-06,0.22747,0.23018,1,1
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00016023,0.22708,0.20195,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0032441,0.22698,0.1935,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.037747,0.22681,0.28301,1,1
2,GO GROWTH HORMONE SECRETION,0.0007696,0.22673,0.33399,1,1
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00041602,0.22657,0.19185,1,1
2,GO NEUROPEPTIDE SIGNALING PATHWAY,8.1192e-05,0.2265,0.25219,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0021689,0.22645,0.2589,1,1
2,GO REGULATION OF ANION TRANSPORT,0.00025131,0.22644,0.18928,1,1
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,6.0504e-05,0.22638,0.17864,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.011047,0.22589,0.2159,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015653,0.22586,0.16607,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.00095906,0.22583,0.16318,1,1
2,GO STEROL TRANSPORT,0.0023671,0.22579,0.15756,1,1
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0023671,0.2257,0.17343,1,1
2,GO NEURON PROJECTION REGENERATION,0.001191,0.22567,0.20269,1,1
2,GO POSITIVE REGULATION OF HEART RATE,0.0051916,0.22559,0.26765,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.00353,0.2255,0.26495,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.023205,0.2255,0.19242,1,1
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0013457,0.2255,0.15845,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0015189,0.2255,0.19452,1,1
2,GO FIBROBLAST MIGRATION,0.0025083,0.22541,0.17796,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0016129,0.22528,0.17131,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00090094,0.22523,0.18824,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00017186,0.22475,0.16792,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.014841,0.22463,0.22851,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0083534,0.22456,0.1382,1,1
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.5759e-05,0.22453,0.22144,1,1
2,GO DECIDUALIZATION,0.010773,0.22444,0.20998,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0049174,0.22438,0.23615,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00045924,0.22435,0.20688,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0010859,0.2243,0.20271,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.02068,0.22408,0.23942,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00038934,0.22407,0.16536,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0054795,0.22386,0.19749,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.0020453,0.22362,0.19266,1,1
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00010462,0.22347,0.22141,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00028792,0.22334,0.26283,1,1
2,GO CARDIAC ATRIUM DEVELOPMENT,0.0049174,0.22333,0.19125,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00017796,0.22306,0.2067,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0036303,0.22285,0.21449,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0071468,0.22279,0.22274,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.001662,0.22269,0.18217,1,1
2,GO MYOTUBE CELL DEVELOPMENT,0.0015653,0.22265,0.20646,1,1
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00079435,0.22247,0.19239,1,1
2,GO NEPHRON DEVELOPMENT,0.00041602,0.22223,0.18726,1,1
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0022992,0.22215,0.20724,1,1
2,GO BILE ACID METABOLIC PROCESS,0.0026572,0.222,0.16361,1,1
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0001165,0.2218,0.17419,1,1
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00044439,0.22173,0.19466,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00037661,0.22164,0.19573,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00044439,0.22163,0.23465,1,1
2,GO MUSCLE HYPERTROPHY,0.001228,0.2215,0.17552,1,1
2,GO CELL MOTILITY,6.5149e-05,0.22149,0.17978,1,1
2,GO SPERM CAPACITATION,0.00024286,0.22134,0.20516,1,1
2,GO EPIDERMIS DEVELOPMENT,0.00020448,0.22121,0.18984,1,1
2,GO PANCREAS DEVELOPMENT,0.0014738,0.22112,0.2208,1,1
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0045306,0.22105,0.28257,1,1
2,GO PHOSPHOLIPID TRANSPORT,2.2524e-05,0.22097,0.20377,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0026572,0.22094,0.15745,1,1
2,GO COAGULATION,0.00353,0.22048,0.14632,1,1
2,GO MAMMARY GLAND DEVELOPMENT,7.013e-05,0.22047,0.1937,1,1
2,GO CELL MATURATION,5.0194e-07,0.22044,0.21008,1,1
2,GO REGULATION OF MUSCLE ADAPTATION,0.00079435,0.22037,0.19167,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0087944,0.22037,0.19393,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,2.7343e-05,0.22035,0.18052,1,1
2,GO MESENCHYME DEVELOPMENT,0.001191,0.22022,0.15912,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0036303,0.22019,0.17776,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00063551,0.22014,0.17437,1,1
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.017137,0.21992,0.17228,1,1
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,3.3132e-05,0.21978,0.17941,1,1
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00010092,0.21965,0.19373,1,1
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.00024286,0.21964,0.15587,1,1
2,GO RESPONSE TO TUMOR CELL,0.0046564,0.2196,0.25262,1,1
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.00017796,0.2195,0.18537,1,1
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,5.8301e-05,0.21933,0.2679,1,1
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0075304,0.21931,0.20138,1,1
2,GO RESPONSE TO NUTRIENT,0.001191,0.21923,0.17414,1,1
2,GO REGULATION OF VASCULAR PERMEABILITY,6.7596e-05,0.21911,0.23801,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0029794,0.21908,0.19477,1,1
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.6623e-06,0.21908,0.20743,1,1
2,GO DRUG CATABOLIC PROCESS,0.0060989,0.21902,0.15274,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001872,0.21894,0.16824,1,1
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0040578,0.21852,0.20639,1,1
2,GO REGULATION OF MEMBRANE POTENTIAL,0.00017186,0.21818,0.20133,1,1
2,GO REGULATION OF FIBROBLAST MIGRATION,0.0031536,0.21818,0.17993,1,1
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0031536,0.21798,0.19873,1,1
2,GO PEPTIDE SECRETION,1.5331e-06,0.21792,0.2084,1,1
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.033894,0.21788,0.1472,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.00074557,0.21779,0.18817,1,1
2,GO REGULATION OF HEMOPOIESIS,0.00011241,0.21759,0.16278,1,1
2,GO TRANSLESION SYNTHESIS,0.0013457,0.21758,0.1545,1,1
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00047456,0.21756,0.20651,1,1
2,GO RESPONSE TO FOOD,0.00065623,0.21724,0.16406,1,1
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0049174,0.21712,0.17742,1,1
2,GO CELL JUNCTION ASSEMBLY,8.4205e-05,0.21706,0.18396,1,1
2,GO REGULATION OF COLLATERAL SPROUTING,0.0081404,0.21702,0.22255,1,1
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.016339,0.21677,0.15468,1,1
2,GO GLYCOPROTEIN METABOLIC PROCESS,9.0551e-05,0.21669,0.18506,1,1
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.00074557,0.21647,0.18726,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.001986,0.21617,0.18903,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.004408,0.21612,0.20615,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,0.016734,0.21612,0.1683,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.02166,0.21602,0.18209,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,5.8301e-05,0.21588,0.20492,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.029068,0.21585,0.19047,1,1
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0017123,0.2158,0.18236,1,1
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.018398,0.21576,0.23477,1,1
2,GO REGULATION OF HEART RATE,0.00065623,0.21571,0.2194,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0020453,0.21561,0.15947,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.0013457,0.21538,0.22343,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,3.8131e-07,0.21536,0.2299,1,1
2,GO DETECTION OF MECHANICAL STIMULUS,3.0689e-05,0.21525,0.21922,1,1
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.1663e-05,0.21522,0.22781,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.046579,0.21521,0.17094,1,1
2,GO RESPONSE TO RETINOIC ACID,0.0045306,0.21519,0.1526,1,1
2,GO GPI ANCHOR METABOLIC PROCESS,0.0018173,0.21499,0.16972,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.001191,0.21483,0.19651,1,1
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.025994,0.21476,0.14218,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0054795,0.21456,0.16331,1,1
2,GO LEUKOCYTE DIFFERENTIATION,2.7343e-05,0.21443,0.18118,1,1
2,GO CELLULAR ANION HOMEOSTASIS,0.0056288,0.21439,0.23326,1,1
2,GO REGULATION OF DENDRITE EXTENSION,0.015953,0.21432,0.31846,1,1
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.0604e-05,0.21405,0.21337,1,1
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.9263e-05,0.21396,0.17978,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0010206,0.21363,0.20047,1,1
2,GO POSITIVE REGULATION OF SECRETION,2.1702e-06,0.21358,0.2143,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0010528,0.21354,0.21551,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.025414,0.21334,0.11623,1,1
2,GO EXOCYTOSIS,0.00036427,0.2133,0.16015,1,1
2,GO MONONUCLEAR CELL MIGRATION,0.0049174,0.21291,0.17454,1,1
2,GO MONOAMINE TRANSPORT,0.0010206,0.21284,0.28002,1,1
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0075304,0.21281,0.36521,1,1
2,GO EAR DEVELOPMENT,0.00032948,0.21275,0.17149,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.031059,0.21269,0.21173,1,1
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,1.104e-05,0.2125,0.20679,1,1
2,GO PROTEIN PALMITOYLATION,0.00013433,0.21247,0.23356,1,1
2,GO REGULATION OF PEPTIDE SECRETION,1.0311e-06,0.21245,0.20819,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.017969,0.21241,0.15362,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00065623,0.21233,0.18086,1,1
2,GO SKIN DEVELOPMENT,0.00026903,0.2121,0.2002,1,1
2,GO IMPORT ACROSS PLASMA MEMBRANE,8.1192e-05,0.21209,0.19607,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.043763,0.21201,0.16889,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.00079435,0.21194,0.15347,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.00040247,0.21192,0.19724,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.019283,0.2119,0.23104,1,1
2,GO OSSIFICATION,9.389e-05,0.2119,0.22386,1,1
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.038561,0.21161,0.2203,1,1
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00069957,0.21153,0.20779,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.030383,0.2115,0.12242,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00067758,0.21147,0.22036,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0028957,0.2114,0.19603,1,1
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.001191,0.21133,0.22754,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.014486,0.21125,0.20086,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0054795,0.21116,0.16339,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.03245,0.21113,0.12801,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0029794,0.21104,0.15479,1,1
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0045306,0.21097,0.20796,1,1
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.026586,0.21094,0.21145,1,1
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00034072,0.21084,0.19985,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.041967,0.21074,0.16692,1,1
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.019739,0.21066,0.24102,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00067758,0.21063,0.1722,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,0.0015653,0.21062,0.15538,1,1
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00023468,0.21061,0.21172,1,1
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00012074,0.21031,0.1896,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,4.6597e-05,0.21017,0.18048,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0011199,0.21013,0.18538,1,1
2,GO ORGAN INDUCTION,0.0007696,0.2101,0.20659,1,1
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,7.8282e-05,0.21002,0.18428,1,1
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00025131,0.21001,0.17395,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0021062,0.21,0.18321,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.00019079,0.20999,0.17,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0033369,0.20997,0.18282,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00042998,0.20988,0.22235,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION,3.7145e-05,0.20978,0.2106,1,1
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00065623,0.20974,0.18437,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,0.00017186,0.20956,0.18212,1,1
2,GO TISSUE MIGRATION,0.0031536,0.20941,0.1757,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,4.1617e-05,0.20922,0.16777,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.2139e-05,0.20902,0.17706,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0079323,0.20888,0.16432,1,1
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.010506,0.20863,0.34905,1,1
2,GO LYTIC VACUOLE ORGANIZATION,0.004408,0.20856,0.14661,1,1
2,GO ETHER METABOLIC PROCESS,0.043763,0.20851,0.14657,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.0087944,0.20834,0.21009,1,1
2,GO REGULATION OF TUBE SIZE,0.00012964,0.20831,0.17675,1,1
2,GO REGULATION OF SYSTEM PROCESS,8.6584e-06,0.20822,0.18269,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0064317,0.20817,0.21199,1,1
2,GO FLUID TRANSPORT,0.0059384,0.20814,0.16356,1,1
2,GO LOCOMOTORY BEHAVIOR,0.0012662,0.20793,0.18379,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0090226,0.20792,0.16579,1,1
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0097392,0.20783,0.18475,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0062634,0.20777,0.16645,1,1
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,4.6597e-05,0.20762,0.20138,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0024367,0.20759,0.15375,1,1
2,GO RESPONSE TO CATECHOLAMINE,0.00050664,0.20752,0.19185,1,1
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,4.4878e-05,0.20743,0.185,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.00044439,0.20735,0.17765,1,1
2,GO STRESS FIBER ASSEMBLY,0.00065623,0.20731,0.19754,1,1
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00040247,0.20729,0.15397,1,1
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0075304,0.20726,0.19753,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.047551,0.20719,0.15998,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,9.0551e-05,0.20697,0.20062,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00031859,0.20677,0.2099,1,1
2,GO MEMORY,0.00049035,0.20669,0.19235,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0020453,0.20661,0.15196,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00057693,0.20641,0.19701,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.017549,0.20639,0.19262,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.023741,0.20636,0.1508,1,1
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,5.6174e-05,0.20636,0.17661,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.011612,0.20635,0.13476,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.6623e-06,0.20624,0.26106,1,1
2,GO NEURAL NUCLEUS DEVELOPMENT,0.00034072,0.20622,0.27455,1,1
2,GO T CELL DIFFERENTIATION,6.2786e-05,0.20616,0.17815,1,1
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00019079,0.20581,0.26599,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,2.2524e-05,0.20569,0.22352,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.035393,0.20547,0.17505,1,1
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00353,0.2054,0.25242,1,1
2,GO TISSUE HOMEOSTASIS,0.00021167,0.20529,0.15714,1,1
2,GO POSITIVE REGULATION OF HORMONE SECRETION,2.9532e-05,0.20515,0.22514,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.00095906,0.20495,0.17189,1,1
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00017186,0.2048,0.18943,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.001228,0.20443,0.23126,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00098941,0.2042,0.19486,1,1
2,GO REGULATION OF PROTEIN DEACETYLATION,6.0504e-05,0.20418,0.20923,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0025083,0.20417,0.20618,1,1
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0029794,0.2041,0.16775,1,1
2,GO TISSUE MORPHOGENESIS,0.00034072,0.20404,0.15136,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,1.7806e-05,0.20402,0.16768,1,1
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0001165,0.20381,0.20398,1,1
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00019753,0.20369,0.19266,1,1
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00010462,0.20366,0.17268,1,1
2,GO INNER EAR MORPHOGENESIS,0.00035231,0.20352,0.17516,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.00035231,0.20341,0.19326,1,1
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00079435,0.20328,0.15697,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00059588,0.20324,0.14929,1,1
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0087944,0.20321,0.15964,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.012203,0.20296,0.14275,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.0010528,0.20279,0.14789,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,4.8612e-06,0.2027,0.1885,1,1
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00042998,0.2025,0.18025,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.00013917,0.20238,0.15535,1,1
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00013917,0.20204,0.18023,1,1
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0010859,0.20185,0.21651,1,1
2,GO DEVELOPMENTAL MATURATION,2.2658e-06,0.20166,0.20511,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0025817,0.2016,0.20873,1,1
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00012964,0.20155,0.16019,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0007696,0.2013,0.16886,1,1
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,5.6174e-05,0.2013,0.2041,1,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0020453,0.2013,0.15602,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00026903,0.20129,0.15574,1,1
2,GO EPITHELIUM DEVELOPMENT,5.6174e-05,0.20116,0.17061,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00045924,0.20114,0.23898,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0075304,0.20099,0.20511,1,1
2,GO CARBOHYDRATE HOMEOSTASIS,1.349e-05,0.20089,0.1953,1,1
2,GO HEART PROCESS,1.1493e-05,0.20084,0.21775,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0027346,0.20075,0.15852,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00032948,0.20074,0.17498,1,1
2,GO ACUTE PHASE RESPONSE,0.00030804,0.20065,0.19885,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.030383,0.2005,0.14043,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0075304,0.2005,0.16503,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0081404,0.20043,0.12616,1,1
2,GO REGULATION OF JUN KINASE ACTIVITY,3.4421e-05,0.20042,0.19706,1,1
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.042857,0.20028,0.19418,1,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.017137,0.20024,0.15855,1,1
2,GO LOCALIZATION WITHIN MEMBRANE,0.0064317,0.20007,0.14579,1,1
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0019282,0.19999,0.1761,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.9263e-05,0.19996,0.19293,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION,8.1192e-05,0.1997,0.2034,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0024367,0.19957,0.20177,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.036164,0.19955,0.18481,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00027832,0.1993,0.23522,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.017969,0.19916,0.12534,1,1
2,GO B CELL HOMEOSTASIS,0.0045306,0.19915,0.22127,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.00035231,0.19907,0.16476,1,1
2,GO GANGLIOSIDE METABOLIC PROCESS,0.001986,0.19892,0.18583,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0071468,0.19874,0.21448,1,1
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,2.8418e-05,0.19873,0.16399,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.001228,0.1987,0.20811,1,1
2,GO POSITIVE REGULATION OF SIGNALING,1.0604e-05,0.19853,0.15884,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.041093,0.19844,0.16286,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.0019282,0.19841,0.18369,1,1
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0013054,0.19821,0.23122,1,1
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0018173,0.19814,0.22784,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0039469,0.19799,0.16,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00026003,0.19787,0.18041,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,6.2786e-05,0.1975,0.17851,1,1
2,GO CHLORIDE TRANSPORT,0.00010092,0.19736,0.18554,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0010528,0.19732,0.1376,1,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.043763,0.19722,0.15326,1,1
2,GO LIPID HOMEOSTASIS,0.00013917,0.19709,0.16132,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0023671,0.19707,0.17022,1,1
2,GO SECRETION,2.2524e-05,0.19689,0.16338,1,1
2,GO TERPENOID METABOLIC PROCESS,0.0018173,0.19687,0.15656,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00016595,0.19681,0.18042,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.011326,0.19677,0.15799,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0099891,0.19676,0.1351,1,1
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0054795,0.19666,0.17708,1,1
2,GO REGULATION OF LIPID STORAGE,0.00017796,0.19657,0.20596,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.001662,0.19652,0.1568,1,1
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,9.0551e-05,0.19648,0.15695,1,1
2,GO RESPONSE TO GONADOTROPIN,0.02166,0.19647,0.14258,1,1
2,GO INTEGRIN ACTIVATION,0.0046564,0.19647,0.19943,1,1
2,GO THYMIC T CELL SELECTION,0.00013433,0.19641,0.18969,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.001986,0.19641,0.30382,1,1
2,GO TUBULIN DEACETYLATION,0.0079323,0.19637,0.1903,1,1
2,GO NATURAL KILLER CELL ACTIVATION,0.0013457,0.19634,0.17054,1,1
2,GO CATECHOLAMINE SECRETION,0.0037331,0.19631,0.29504,1,1
2,GO CELL JUNCTION ORGANIZATION,7.547e-05,0.19627,0.17493,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00010845,0.19616,0.16866,1,1
2,GO MITOTIC CELL CYCLE ARREST,0.011326,0.19605,0.1848,1,1
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0090226,0.19568,0.16136,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0053338,0.19551,0.17339,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0001165,0.1955,0.18607,1,1
2,GO ANIMAL ORGAN MORPHOGENESIS,0.00010092,0.19537,0.16221,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0026572,0.19531,0.16159,1,1
2,GO MEMBRANE HYPERPOLARIZATION,0.0073363,0.19524,0.23413,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0081404,0.19524,0.11805,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.0079323,0.1952,0.14482,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.015953,0.19519,0.1949,1,1
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,8.7323e-05,0.19517,0.16342,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00353,0.19505,0.13089,1,1
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,2.6307e-05,0.19502,0.20796,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.046579,0.19498,0.14592,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0013054,0.1949,0.16006,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00021167,0.19476,0.15314,1,1
2,GO RESPONSE TO FATTY ACID,0.0040578,0.19458,0.16262,1,1
2,GO REGULATION OF FERTILIZATION,0.029719,0.19446,0.12587,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00059588,0.19441,0.19839,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0079323,0.19435,0.21552,1,1
2,GO HUMORAL IMMUNE RESPONSE,1.8521e-05,0.19426,0.24589,1,1
2,GO MALE SEX DIFFERENTIATION,0.00042998,0.19425,0.16157,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.0045306,0.19411,0.16307,1,1
2,GO RESPONSE TO DRUG,0.00092958,0.1937,0.15244,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,6.0504e-05,0.19356,0.16321,1,1
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.19352,0.20889,1,1
2,GO REGULATION OF PROTEOLYSIS,0.001872,0.19349,0.15141,1,1
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00040247,0.19343,0.14715,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0046564,0.1934,0.17344,1,1
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.00045924,0.19334,0.26432,1,1
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.011904,0.19332,0.21971,1,1
2,GO DRINKING BEHAVIOR,0.011047,0.19328,0.33529,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0060989,0.19325,0.14131,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0032441,0.19285,0.27839,1,1
2,GO PROTEIN MATURATION,0.0020453,0.1927,0.1294,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0039469,0.19249,0.17193,1,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,8.7323e-05,0.19248,0.16048,1,1
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0019282,0.19243,0.16313,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00052342,0.19237,0.1588,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.00054072,0.19226,0.15891,1,1
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.00019753,0.19224,0.16416,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00079435,0.19212,0.17383,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0011549,0.19181,0.17766,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.026586,0.19155,0.21086,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.0049174,0.19144,0.15614,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00040247,0.19136,0.15142,1,1
2,GO MULTICELLULAR ORGANISM AGING,0.00030804,0.19104,0.19546,1,1
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.00032948,0.1909,0.17155,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.004408,0.19086,0.15855,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.001986,0.19086,0.17136,1,1
2,GO REGULATION OF SECRETION,3.1904e-06,0.19057,0.1849,1,1
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00012964,0.19044,0.17813,1,1
2,GO SLEEP,0.0019282,0.19032,0.15862,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.0033e-05,0.19029,0.18015,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.013465,0.19005,0.14179,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0051916,0.18997,0.15731,1,1
2,GO HORMONE TRANSPORT,7.3528e-06,0.18997,0.21933,1,1
2,GO RESPONSE TO UV C,0.0085714,0.18995,0.13549,1,1
2,GO HINDBRAIN MORPHOGENESIS,0.0073363,0.18974,0.1469,1,1
2,GO REGULATION OF CHROMATIN BINDING,0.0028141,0.18951,0.17595,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0062634,0.18938,0.15785,1,1
2,GO RELAXATION OF MUSCLE,0.015574,0.18932,0.17357,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0094949,0.18927,0.24858,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.013465,0.18926,0.16246,1,1
2,GO REGULATION OF HORMONE LEVELS,3.9418e-06,0.18924,0.19842,1,1
2,GO RESPONSE TO DOPAMINE,0.0011199,0.18919,0.18238,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.02166,0.18912,0.10779,1,1
2,GO REGULATION OF HORMONE SECRETION,1.7118e-05,0.18905,0.20632,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.0073e-05,0.18903,0.16578,1,1
2,GO RESPONSE TO CALCIUM ION,0.00087311,0.18892,0.16381,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00035231,0.18886,0.23594,1,1
2,GO RESPONSE TO ISCHEMIA,0.0013054,0.18878,0.17214,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.014841,0.18875,0.20981,1,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00016023,0.18849,0.15427,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.001228,0.18844,0.24409,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00067758,0.18839,0.16957,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00011241,0.18837,0.15328,1,1
2,GO REGULATION OF VASOCONSTRICTION,0.00054072,0.18832,0.16409,1,1
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0029794,0.18821,0.1747,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.018398,0.18818,0.12125,1,1
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.4994e-06,0.18812,0.19039,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.7118e-05,0.18797,0.1875,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0013872,0.18796,0.18764,1,1
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.023741,0.18794,0.2389,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00010462,0.18791,0.17061,1,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00050664,0.18783,0.12916,1,1
2,GO MUSCLE CELL DEVELOPMENT,0.00028792,0.1878,0.18219,1,1
2,GO RESPONSE TO BACTERIUM,0.0014738,0.18759,0.15778,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00017186,0.18749,0.16376,1,1
2,GO PLASMA MEMBRANE ORGANIZATION,0.00072223,0.18745,0.18707,1,1
2,GO ERBB SIGNALING PATHWAY,0.0014299,0.18745,0.16711,1,1
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,3.7145e-05,0.18743,0.17059,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0027346,0.18721,0.15006,1,1
2,GO ACTION POTENTIAL,0.001191,0.1871,0.18853,1,1
2,GO ENDOCYTIC RECYCLING,0.0006154,0.18693,0.1651,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010506,0.18691,0.13623,1,1
2,GO MUSCLE ADAPTATION,0.0021062,0.18688,0.16434,1,1
2,GO REGULATION OF PHOSPHORYLATION,5.4121e-05,0.18687,0.15061,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.3218e-05,0.18669,0.14461,1,1
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00079435,0.18666,0.19462,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010845,0.18665,0.19479,1,1
2,GO BONE MATURATION,0.016339,0.18651,0.16777,1,1
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0039469,0.18648,0.15075,1,1
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,8.1192e-05,0.18641,0.17836,1,1
2,GO LIPID EXPORT FROM CELL,0.014841,0.18626,0.14966,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.0015189,0.18618,0.16622,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00017796,0.1861,0.20862,1,1
2,GO REGULATION OF CELL DIFFERENTIATION,1.9263e-05,0.18608,0.16169,1,1
2,GO P38MAPK CASCADE,0.0083534,0.18606,0.16673,1,1
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0079323,0.18598,0.17365,1,1
2,GO NEUTROPHIL MIGRATION,0.0051916,0.18587,0.11753,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0045306,0.18575,0.13572,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.02068,0.18573,0.12928,1,1
2,GO FIBROBLAST PROLIFERATION,0.0023671,0.1856,0.2364,1,1
2,GO ANATOMICAL STRUCTURE MATURATION,1.6729e-06,0.18544,0.17648,1,1
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,6.5149e-05,0.18525,0.15801,1,1
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.044685,0.1852,0.11618,1,1
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00013433,0.18514,0.15559,1,1
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,6.0504e-05,0.18514,0.15459,1,1
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00045924,0.18503,0.23168,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0023671,0.18501,0.17662,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.0059384,0.18496,0.18216,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.001872,0.18495,0.18765,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00047456,0.18483,0.18116,1,1
2,GO POTASSIUM ION TRANSPORT,0.00017186,0.18478,0.20405,1,1
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0001165,0.18477,0.16374,1,1
2,GO TAXIS,3.7145e-05,0.18462,0.17386,1,1
2,GO AMINE METABOLIC PROCESS,0.0056288,0.18453,0.13118,1,1
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00029782,0.18451,0.17667,1,1
2,GO REGULATION OF ION TRANSPORT,5.0226e-05,0.18447,0.1688,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.036164,0.18446,0.14895,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.040234,0.18444,0.099619,1,1
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,4.8379e-05,0.18402,0.17469,1,1
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0032441,0.18387,0.21417,1,1
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0023671,0.18382,0.2007,1,1
2,GO THYROID HORMONE METABOLIC PROCESS,0.001986,0.18378,0.1959,1,1
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.9263e-05,0.18376,0.15323,1,1
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0085714,0.18373,0.17176,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0054795,0.18348,0.22338,1,1
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.00057693,0.18328,0.15982,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00035231,0.18326,0.13961,1,1
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0059384,0.18311,0.17368,1,1
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.024288,0.183,0.16534,1,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.014841,0.18297,0.12357,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0022332,0.18297,0.18775,1,1
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,9.0551e-05,0.18289,0.14127,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.010506,0.18288,0.16702,1,1
2,GO INORGANIC ANION TRANSPORT,0.00012964,0.18285,0.16508,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0050528,0.18267,0.13311,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0007696,0.18247,0.14302,1,1
2,GO MEMBRANE FUSION,0.0017641,0.18217,0.15563,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,1.4039e-05,0.18181,0.16928,1,1
2,GO ADULT FEEDING BEHAVIOR,0.022165,0.18175,0.16982,1,1
2,GO NEGATIVE REGULATION OF GROWTH,6.2786e-05,0.18161,0.17308,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.001986,0.18151,0.25418,1,1
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.001191,0.1814,0.14349,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0073363,0.18138,0.1297,1,1
2,GO REGULATION OF MAPK CASCADE,0.00012964,0.18136,0.19184,1,1
2,GO CELL GROWTH,2.6307e-05,0.18126,0.17144,1,1
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0017641,0.18122,0.17975,1,1
2,GO ER OVERLOAD RESPONSE,0.040234,0.18122,0.1412,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0021062,0.18084,0.17763,1,1
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00032948,0.18075,0.23897,1,1
2,GO LIPID METABOLIC PROCESS,0.00021167,0.18073,0.14366,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.011047,0.18067,0.16603,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.001872,0.18059,0.12942,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00014418,0.18025,0.14431,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00047456,0.17988,0.18149,1,1
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.00011241,0.17959,0.15365,1,1
2,GO REGULATION OF CELL SHAPE,0.00049035,0.1794,0.18096,1,1
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0019282,0.17934,0.15506,1,1
2,GO RESPONSE TO LIPID,0.0013457,0.17924,0.14365,1,1
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,2.4346e-05,0.17908,0.20057,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.013139,0.17885,0.19204,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00095906,0.17877,0.13664,1,1
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.00098941,0.17867,0.15674,1,1
2,GO TEMPERATURE HOMEOSTASIS,2.5774e-06,0.17865,0.2011,1,1
2,GO RESPONSE TO STEROID HORMONE,0.0010528,0.17861,0.14825,1,1
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00042998,0.1786,0.13391,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0034322,0.17839,0.2349,1,1
2,GO RESPONSE TO PROGESTERONE,0.0067808,0.17831,0.18274,1,1
2,GO EAR MORPHOGENESIS,0.00055855,0.17822,0.14571,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.004408,0.17813,0.1213,1,1
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0011199,0.17798,0.13992,1,1
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,2.0833e-05,0.17793,0.14878,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.018836,0.17785,0.12858,1,1
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0094949,0.17782,0.20393,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00072223,0.1776,0.12932,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00050664,0.17742,0.13779,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00028792,0.17741,0.18234,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING,0.0026572,0.1774,0.17042,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.012508,0.17728,0.19174,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0023671,0.17724,0.14836,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00063551,0.17723,0.12954,1,1
2,GO FEEDING BEHAVIOR,0.00019753,0.17721,0.15956,1,1
2,GO RESPONSE TO ACETYLCHOLINE,0.011326,0.17708,0.21207,1,1
2,GO REGULATION OF PH,0.0020453,0.17693,0.10922,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.033894,0.1769,0.13446,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00013433,0.17686,0.14116,1,1
2,GO APOPTOTIC SIGNALING PATHWAY,0.00087311,0.17651,0.13711,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.023205,0.1761,0.10319,1,1
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,4.6597e-05,0.1761,0.14379,1,1
2,GO IMPORT INTO CELL,0.00044439,0.17609,0.17285,1,1
2,GO ACID SECRETION,0.00095906,0.17603,0.19304,1,1
2,GO PEPTIDE HORMONE SECRETION,4.6597e-05,0.176,0.20924,1,1
2,GO DIET INDUCED THERMOGENESIS,0.014138,0.17595,0.1519,1,1
2,GO LIPID MODIFICATION,0.00013433,0.17584,0.14606,1,1
2,GO CIRCULATORY SYSTEM PROCESS,7.6603e-06,0.1758,0.17974,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.015574,0.17561,0.21575,1,1
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0010528,0.1755,0.18365,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.010773,0.17543,0.10304,1,1
2,GO ANIMAL ORGAN MATURATION,0.00090094,0.17537,0.2217,1,1
2,GO SKELETAL MUSCLE CONTRACTION,0.0013054,0.17532,0.18664,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0016129,0.17505,0.15593,1,1
2,GO REGULATION OF HAIR CYCLE,0.0019282,0.17504,0.16969,1,1
2,GO CALCIUM MEDIATED SIGNALING,1.2962e-05,0.1749,0.15524,1,1
2,GO MONOVALENT INORGANIC CATION TRANSPORT,2.6307e-05,0.17488,0.1805,1,1
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0015653,0.17454,0.14682,1,1
2,GO RESPONSE TO GROWTH FACTOR,0.00037661,0.17452,0.1565,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,9.7346e-05,0.17449,0.14149,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.0069616,0.17447,0.14362,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.0184e-05,0.17443,0.16282,1,1
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.013465,0.17423,0.22614,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.015953,0.17408,0.11205,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.17406,0.19346,1,1
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0018173,0.17404,0.12912,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.00041602,0.17375,0.16981,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.00026003,0.17374,0.13149,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.0010206,0.17373,0.15866,1,1
2,GO RESPONSE TO METAL ION,2.9532e-05,0.17365,0.18527,1,1
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00045924,0.17361,0.14677,1,1
2,GO CHEMICAL HOMEOSTASIS,6.2367e-06,0.17343,0.16235,1,1
2,GO LENS FIBER CELL DIFFERENTIATION,0.0028141,0.17342,0.20106,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0025083,0.17322,0.17617,1,1
2,GO ACROSOME REACTION,0.0069616,0.17312,0.15701,1,1
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00032948,0.17278,0.12561,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00012512,0.17267,0.1653,1,1
2,GO SENSORY PERCEPTION OF PAIN,0.0018173,0.17256,0.15593,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,2.0033e-05,0.17206,0.1505,1,1
2,GO EXCRETION,5.8301e-05,0.17204,0.19029,1,1
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041093,0.1718,0.15307,1,1
2,GO INSULIN SECRETION,9.0551e-05,0.17172,0.19988,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0024367,0.1716,0.18684,1,1
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0017641,0.17125,0.23545,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.045624,0.17115,0.076891,1,1
2,GO DETECTION OF ABIOTIC STIMULUS,5.8301e-05,0.17114,0.16995,1,1
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.00087311,0.171,0.17602,1,1
2,GO POSITIVE T CELL SELECTION,0.00069957,0.17099,0.15425,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0006154,0.17077,0.18892,1,1
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.014486,0.17068,0.11668,1,1
2,GO RESPONSE TO ESTRADIOL,0.00084609,0.17066,0.14821,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00021167,0.17059,0.12285,1,1
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00020448,0.17022,0.14626,1,1
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,9.0551e-05,0.17007,0.17478,1,1
2,GO MULTICELLULAR ORGANISM GROWTH,0.00028792,0.17004,0.12969,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.001191,0.16993,0.23999,1,1
2,GO STRIATED MUSCLE CONTRACTION,0.00049035,0.16984,0.15823,1,1
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00012512,0.1696,0.17049,1,1
2,GO MUSCLE FIBER DEVELOPMENT,0.011612,0.1692,0.14021,1,1
2,GO NEGATIVE REGULATION OF SIGNALING,9.389e-05,0.16911,0.14206,1,1
2,GO RESPONSE TO INSULIN,0.00030804,0.1691,0.13819,1,1
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0053338,0.16907,0.19381,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0085714,0.16888,0.1428,1,1
2,GO RESPONSE TO ENDOGENOUS STIMULUS,9.389e-05,0.16877,0.14186,1,1
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.3218e-05,0.16872,0.18289,1,1
2,GO CELL AGGREGATION,0.01282,0.16866,0.1717,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0025083,0.16841,0.15018,1,1
2,GO VACUOLAR TRANSPORT,0.004408,0.16838,0.11096,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,8.3127e-06,0.16817,0.23302,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0039469,0.16789,0.11835,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0038387,0.16772,0.14299,1,1
2,GO JNK CASCADE,0.00012964,0.16761,0.15501,1,1
2,GO T CELL SELECTION,0.00028792,0.16751,0.15927,1,1
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0011199,0.1674,0.13196,1,1
2,GO DETECTION OF STIMULUS,1.7118e-05,0.16735,0.14912,1,1
2,GO AUTOPHAGOSOME ORGANIZATION,0.00069957,0.16729,0.14375,1,1
2,GO TRANSFERRIN TRANSPORT,0.042857,0.16724,0.094828,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.017137,0.16707,0.13421,1,1
2,GO METAL ION HOMEOSTASIS,2.3418e-05,0.16707,0.14516,1,1
2,GO PIGMENTATION,0.0014738,0.16697,0.12165,1,1
2,GO ION HOMEOSTASIS,2.9532e-05,0.1664,0.14063,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.001872,0.16639,0.13033,1,1
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00022676,0.16633,0.15871,1,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,8.1192e-05,0.16629,0.12981,1,1
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00012074,0.16619,0.14258,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.02068,0.16615,0.20227,1,1
2,GO LIPID OXIDATION,0.0018173,0.16612,0.16932,1,1
2,GO RHYTHMIC BEHAVIOR,0.0026572,0.1661,0.15178,1,1
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.013798,0.16605,0.19711,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.015574,0.16598,0.15419,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0040578,0.16597,0.12439,1,1
2,GO RESPONSE TO FUNGUS,0.00065623,0.16593,0.17523,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00054072,0.16583,0.16574,1,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00014418,0.16576,0.14175,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.027803,0.16563,0.095492,1,1
2,GO SENSORY PERCEPTION OF SMELL,0.00063551,0.16555,0.13154,1,1
2,GO REGULATION OF TRANSPORT,1.6455e-05,0.1654,0.14297,1,1
2,GO HOMEOSTATIC PROCESS,5.2139e-05,0.16516,0.12608,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0023671,0.16498,0.14399,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.040234,0.16477,0.085509,1,1
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,9.7346e-05,0.16469,0.15946,1,1
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0015189,0.16456,0.14405,1,1
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.0030654,0.16456,0.16241,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0040578,0.1645,0.17256,1,1
2,GO REGULATION OF GLUTAMATE SECRETION,0.017969,0.16434,0.2396,1,1
2,GO COLLATERAL SPROUTING,0.011326,0.16433,0.17903,1,1
2,GO VACUOLE ORGANIZATION,0.00052342,0.16424,0.13116,1,1
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.019739,0.16421,0.16865,1,1
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.015574,0.1642,0.1281,1,1
2,GO CIRCADIAN RHYTHM,1.3441e-06,0.16407,0.1736,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0014738,0.16397,0.13303,1,1
2,GO CHOLESTEROL STORAGE,0.0026572,0.1639,0.22089,1,1
2,GO LYSOSOME LOCALIZATION,0.00042998,0.16388,0.15494,1,1
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014138,0.16388,0.16402,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,0.0013872,0.16388,0.16197,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,9.389e-05,0.16374,0.13476,1,1
2,GO HINDBRAIN DEVELOPMENT,0.00020448,0.16368,0.20154,1,1
2,GO METAL ION TRANSPORT,4.6597e-05,0.16327,0.14645,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.011047,0.16315,0.11766,1,1
2,GO EXPLORATION BEHAVIOR,0.010245,0.16304,0.20654,1,1
2,GO CELL CELL SIGNALING,5.0226e-05,0.16288,0.14982,1,1
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00047456,0.16269,0.12533,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00037661,0.16266,0.17562,1,1
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0011549,0.16256,0.12238,1,1
2,GO PROTEOLYSIS,0.0013872,0.16243,0.10365,1,1
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0031536,0.16238,0.10125,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.0066042,0.16232,0.18945,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.001662,0.16229,0.11897,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00090094,0.16213,0.2193,1,1
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.033894,0.16202,0.18034,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.024846,0.16194,0.12899,1,1
2,GO ORGANELLE MEMBRANE FUSION,0.013798,0.16127,0.12651,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00092958,0.16118,0.12871,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,7.8282e-05,0.16106,0.19649,1,1
2,GO NEUROMUSCULAR PROCESS,0.0024367,0.16097,0.15703,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020453,0.16087,0.18617,1,1
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00098941,0.1608,0.16496,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.0011199,0.16079,0.24828,1,1
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.011047,0.16067,0.13811,1,1
2,GO GLUTAMATE METABOLIC PROCESS,0.0062634,0.16041,0.13204,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.0015189,0.16037,0.11027,1,1
2,GO NEGATIVE REGULATION OF NEURON DEATH,2.2524e-05,0.16014,0.14625,1,1
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.02068,0.16012,0.15812,1,1
2,GO ADULT LOCOMOTORY BEHAVIOR,0.0069616,0.16001,0.17739,1,1
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.0073e-05,0.15994,0.16759,1,1
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0062634,0.15982,0.18957,1,1
2,GO RESPONSE TO HORMONE,0.00055855,0.15957,0.12757,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00011241,0.15941,0.15579,1,1
2,GO NOTCH RECEPTOR PROCESSING,0.013798,0.15933,0.28707,1,1
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00029782,0.15906,0.13713,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.021165,0.15885,0.13133,1,1
2,GO CATION TRANSPORT,7.2754e-05,0.15877,0.14187,1,1
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0069616,0.15874,0.20836,1,1
2,GO VESICLE ORGANIZATION,0.0017123,0.15867,0.11485,1,1
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.001986,0.15857,0.1183,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0024367,0.15854,0.14501,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0019282,0.1584,0.13294,1,1
2,GO IRON ION TRANSPORT,0.014841,0.15829,0.085159,1,1
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.00012964,0.15824,0.12949,1,1
2,GO GLUCOSE METABOLIC PROCESS,5.4121e-05,0.15813,0.15747,1,1
2,GO OSTEOCLAST DIFFERENTIATION,0.0025083,0.15805,0.12903,1,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.0038387,0.15798,0.17807,1,1
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.037747,0.15797,0.13309,1,1
2,GO EMBRYONIC MORPHOGENESIS,0.00021909,0.15787,0.14837,1,1
2,GO EMBRYONIC ORGAN DEVELOPMENT,4.1617e-05,0.15781,0.16362,1,1
2,GO GROWTH,7.8282e-05,0.15779,0.14369,1,1
2,GO SCHWANN CELL DEVELOPMENT,0.0057817,0.15772,0.14207,1,1
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0006154,0.15762,0.1474,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0057817,0.15759,0.14324,1,1
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.0007696,0.15749,0.11494,1,1
2,GO SYNAPSE ORGANIZATION,0.0046564,0.15714,0.16291,1,1
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,5.4121e-05,0.15714,0.1698,1,1
2,GO CATION TRANSMEMBRANE TRANSPORT,0.00013917,0.1571,0.1383,1,1
2,GO CELLULAR RESPONSE TO STARVATION,0.00010092,0.15709,0.1734,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,0.025994,0.15708,0.11248,1,1
2,GO BEHAVIOR,0.00042998,0.15692,0.15202,1,1
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0083534,0.15647,0.16685,1,1
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0053338,0.15641,0.16785,1,1
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00063551,0.15637,0.15693,1,1
2,GO RESPONSE TO COCAINE,0.012508,0.15634,0.16009,1,1
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00065623,0.15632,0.16826,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0085714,0.15627,0.16403,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.012203,0.15625,0.12998,1,1
2,GO REGULATION OF CELL MORPHOGENESIS,0.0025083,0.15606,0.1388,1,1
2,GO NEUTROPHIL CHEMOTAXIS,0.0097392,0.15585,0.10677,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.016734,0.15579,0.096959,1,1
2,GO PROTEIN DESTABILIZATION,0.0016129,0.15566,0.14682,1,1
2,GO REGULATION OF INSULIN SECRETION,0.00026903,0.1556,0.17726,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00057693,0.15558,0.17029,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,0.0075304,0.15554,0.18304,1,1
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,4.8379e-05,0.15549,0.16384,1,1
2,GO ACTIVATION OF MAPKK ACTIVITY,0.0022992,0.15545,0.19153,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.041967,0.15528,0.086037,1,1
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00032948,0.15502,0.12993,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.014841,0.15472,0.20865,1,1
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0026572,0.15465,0.14969,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,9.7346e-05,0.15465,0.12541,1,1
2,GO RECEPTOR METABOLIC PROCESS,0.00081984,0.15453,0.1303,1,1
2,GO RESPONSE TO ACID CHEMICAL,0.0019282,0.15444,0.14697,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.00032948,0.15421,0.14049,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00031859,0.15409,0.16084,1,1
2,GO SINGLE FERTILIZATION,0.0015189,0.154,0.11106,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.00079435,0.15399,0.12733,1,1
2,GO LYSOSOMAL TRANSPORT,0.0025817,0.15394,0.1297,1,1
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00016595,0.15394,0.14042,1,1
2,GO CELLULAR RESPONSE TO ALKALOID,0.00098941,0.15381,0.18093,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00049035,0.15359,0.13549,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.024846,0.15353,0.098757,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00045924,0.15351,0.16041,1,1
2,GO PRESYNAPSE ORGANIZATION,0.018836,0.15343,0.18272,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.036948,0.15341,0.13325,1,1
2,GO DIGESTION,0.001872,0.15317,0.15554,1,1
2,GO EXECUTION PHASE OF APOPTOSIS,6.0504e-05,0.15277,0.14802,1,1
2,GO HORMONE METABOLIC PROCESS,0.00040247,0.15274,0.15401,1,1
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0017641,0.1526,0.14571,1,1
2,GO ANION TRANSPORT,0.00013917,0.15257,0.12251,1,1
2,GO RESPONSE TO ABIOTIC STIMULUS,0.00049035,0.15237,0.10915,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0019282,0.15234,0.1299,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0017123,0.15232,0.14751,1,1
2,GO NEGATIVE REGULATION OF CELL GROWTH,4.6597e-05,0.15226,0.17844,1,1
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0075304,0.15204,0.13318,1,1
2,GO CANONICAL WNT SIGNALING PATHWAY,0.001872,0.152,0.12055,1,1
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0020453,0.15194,0.15635,1,1
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00029782,0.15193,0.13953,1,1
2,GO DENDRITIC SPINE MAINTENANCE,0.0099891,0.15176,0.14411,1,1
2,GO REGULATION OF CELLULAR PH,0.014486,0.1511,0.084235,1,1
2,GO CELLULAR EXTRAVASATION,0.00353,0.15101,0.14139,1,1
2,GO APOPTOTIC PROCESS,0.00035231,0.15097,0.12144,1,1
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00098941,0.15088,0.19284,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.021165,0.15084,0.25942,1,1
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0045306,0.15081,0.22832,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0099891,0.15045,0.10779,1,1
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0033369,0.15008,0.15411,1,1
2,GO NEGATIVE T CELL SELECTION,0.0081404,0.14991,0.19907,1,1
2,GO REGULATION OF PEPTIDE TRANSPORT,6.4994e-06,0.14985,0.14542,1,1
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0081404,0.14982,0.14206,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.0031536,0.14971,0.12328,1,1
2,GO MUSCLE SYSTEM PROCESS,0.00054072,0.14968,0.12766,1,1
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0029794,0.1496,0.16065,1,1
2,GO ION TRANSPORT,4.6597e-05,0.14951,0.14138,1,1
2,GO ADAPTIVE THERMOGENESIS,1.5816e-05,0.14949,0.18931,1,1
2,GO NEURON APOPTOTIC PROCESS,8.1192e-05,0.14943,0.13646,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.00079435,0.14942,0.16843,1,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.00016023,0.14924,0.14298,1,1
2,GO REGULATION OF GROWTH,1.9263e-05,0.1492,0.15621,1,1
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017796,0.14917,0.15224,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.012203,0.14893,0.1289,1,1
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00021909,0.14865,0.1274,1,1
2,GO GLUCOSE IMPORT,0.012203,0.14865,0.1136,1,1
2,GO ENDOSOME ORGANIZATION,0.030383,0.14856,0.082715,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0022332,0.14846,0.11997,1,1
2,GO RESPONSE TO KETONE,0.0059384,0.14829,0.12461,1,1
2,GO ZINC ION TRANSPORT,0.015203,0.14815,0.11726,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0033369,0.14803,0.096246,1,1
2,GO NEUROBLAST PROLIFERATION,0.0081404,0.14795,0.16121,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00353,0.1478,0.10196,1,1
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00021909,0.14779,0.13309,1,1
2,GO FACE DEVELOPMENT,0.040234,0.14776,0.12783,1,1
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0036303,0.14772,0.15164,1,1
2,GO RESPONSE TO PEPTIDE,0.00032948,0.14758,0.12687,1,1
2,GO MEMBRANE ORGANIZATION,0.0006154,0.14746,0.11821,1,1
2,GO REPRODUCTION,0.00012074,0.14743,0.12393,1,1
2,GO ION TRANSMEMBRANE TRANSPORT,5.8301e-05,0.14735,0.14289,1,1
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.00023468,0.14718,0.12706,1,1
2,GO SENSORY PERCEPTION,1.5816e-05,0.14709,0.13095,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0007696,0.14704,0.11825,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.019283,0.14702,0.11628,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION,0.00014418,0.14695,0.11893,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0046564,0.14695,0.1044,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.036164,0.14694,0.18419,1,1
2,GO LIPID CATABOLIC PROCESS,0.0013054,0.1468,0.12661,1,1
2,GO CAMERA TYPE EYE DEVELOPMENT,0.00084609,0.14678,0.12201,1,1
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.001662,0.14662,0.12533,1,1
2,GO NERVOUS SYSTEM PROCESS,5.6174e-05,0.14661,0.14144,1,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00010845,0.14647,0.12251,1,1
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.00020448,0.14626,0.18009,1,1
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.024288,0.14625,0.10427,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.00055855,0.14618,0.12729,1,1
2,GO CELL VOLUME HOMEOSTASIS,0.0010859,0.14608,0.12738,1,1
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.0013054,0.14607,0.12088,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.146,0.13439,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0042883,0.14595,0.13204,1,1
2,GO DEVELOPMENTAL CELL GROWTH,0.0014738,0.1459,0.16276,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0025083,0.14588,0.14011,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0010206,0.14574,0.1309,1,1
2,GO MAINTENANCE OF LOCATION,0.0014738,0.14556,0.12354,1,1
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.00072223,0.14552,0.13747,1,1
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00037661,0.14523,0.12521,1,1
2,GO REGULATION OF MUSCLE CONTRACTION,0.0014738,0.14516,0.12385,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.0011199,0.14508,0.13751,1,1
2,GO RESPONSE TO STARVATION,0.00012512,0.14495,0.1711,1,1
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.0020453,0.14482,0.13007,1,1
2,GO AGING,0.0037331,0.14481,0.111,1,1
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,6.5149e-05,0.14479,0.13102,1,1
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0023671,0.14469,0.15091,1,1
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,5.2139e-05,0.14468,0.13492,1,1
2,GO DEVELOPMENTAL GROWTH,0.00054072,0.14444,0.13343,1,1
2,GO REGULATION OF CELL DEATH,0.00065623,0.14434,0.11647,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.016339,0.14429,0.1146,1,1
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0010206,0.1441,0.13825,1,1
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0013054,0.14403,0.15212,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.016339,0.14398,0.14686,1,1
2,GO RESPONSE TO NITROGEN COMPOUND,0.00020448,0.14383,0.12108,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0015189,0.14383,0.12349,1,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.025414,0.1436,0.083046,1,1
2,GO RESPONSE TO MONOSACCHARIDE,0.00037661,0.14325,0.13379,1,1
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.001662,0.14299,0.16379,1,1
2,GO GOLGI RIBBON FORMATION,0.013798,0.14295,0.15403,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.025994,0.14283,0.11201,1,1
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00090094,0.14258,0.1374,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.00019079,0.14256,0.14071,1,1
2,GO MIDBRAIN DEVELOPMENT,0.00074557,0.14246,0.13128,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0007696,0.14245,0.11978,1,1
2,GO RHYTHMIC PROCESS,2.4346e-05,0.14233,0.13236,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.0019282,0.14228,0.14866,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0034322,0.14218,0.15683,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0021062,0.14187,0.10548,1,1
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0017123,0.14145,0.13165,1,1
2,GO REGULATION OF GLUCOSE IMPORT,0.033894,0.14133,0.097754,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0031536,0.14131,0.12693,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.017137,0.14122,0.089112,1,1
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00035231,0.14101,0.14445,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0071468,0.1409,0.15982,1,1
2,GO SENSORY ORGAN MORPHOGENESIS,0.00049035,0.14085,0.13147,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.046579,0.14063,0.18223,1,1
2,GO ESTABLISHMENT OF CELL POLARITY,0.017549,0.1403,0.096688,1,1
2,GO NEGATIVE CHEMOTAXIS,0.041093,0.14027,0.14741,1,1
2,GO RESPONSE TO CARBOHYDRATE,0.00063551,0.13973,0.12516,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0037331,0.13954,0.20114,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.007729,0.13947,0.15789,1,1
2,GO ORGANIC ANION TRANSPORT,0.00036427,0.13941,0.11447,1,1
2,GO EYE MORPHOGENESIS,0.0011549,0.13921,0.13875,1,1
2,GO KERATINOCYTE MIGRATION,0.013798,0.13904,0.14526,1,1
2,GO TRANSMEMBRANE TRANSPORT,0.00021167,0.13898,0.11881,1,1
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00037661,0.13896,0.14291,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.007729,0.13884,0.24987,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0038387,0.13873,0.16295,1,1
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.023205,0.13871,0.13138,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00050664,0.13813,0.1469,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0028141,0.13782,0.12778,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.018836,0.13762,0.11588,1,1
2,GO WATER TRANSPORT,0.025414,0.13757,0.1186,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.030383,0.13756,0.15449,1,1
2,GO REGULATION OF T CELL MIGRATION,0.00050664,0.13754,0.19239,1,1
2,GO DEMETHYLATION,0.00010462,0.1375,0.14843,1,1
2,GO ANION TRANSMEMBRANE TRANSPORT,0.00012964,0.13736,0.13114,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0025083,0.13691,0.15033,1,1
2,GO HEART DEVELOPMENT,0.0023671,0.13688,0.11121,1,1
2,GO POSITIVE REGULATION OF CELL GROWTH,0.00011241,0.13657,0.15438,1,1
2,GO CELLULAR RESPONSE TO KETONE,0.027803,0.13644,0.11155,1,1
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0013457,0.13625,0.13128,1,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0033369,0.13619,0.12641,1,1
2,GO NEURON DEATH,9.7801e-06,0.13616,0.1497,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.011612,0.13566,0.14601,1,1
2,GO SMOOTH MUSCLE CONTRACTION,0.010506,0.13546,0.12683,1,1
2,GO POSTREPLICATION REPAIR,0.016734,0.13524,0.095953,1,1
2,GO SEX DIFFERENTIATION,0.00026003,0.13513,0.13127,1,1
2,GO HEART VALVE DEVELOPMENT,0.035393,0.13489,0.12321,1,1
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.010773,0.13483,0.14159,1,1
2,GO FEMALE SEX DIFFERENTIATION,0.00014418,0.13465,0.16421,1,1
2,GO RESPONSE TO PEPTIDE HORMONE,0.00092958,0.13464,0.1095,1,1
2,GO MUSCLE TISSUE DEVELOPMENT,0.0025817,0.13424,0.099444,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.00025131,0.1341,0.123,1,1
2,GO REGULATION OF PROTEIN STABILITY,0.043763,0.13402,0.06588,1,1
2,GO RESPONSE TO ETHANOL,0.0023671,0.13397,0.13309,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0015189,0.13392,0.10605,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0020453,0.13369,0.096778,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00020448,0.13367,0.11867,1,1
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.0045306,0.13359,0.11091,1,1
2,GO ROOF OF MOUTH DEVELOPMENT,0.024846,0.13355,0.12623,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0073363,0.13335,0.083333,1,1
2,GO CELLULAR ION HOMEOSTASIS,7.2754e-05,0.13322,0.12253,1,1
2,GO REGULATION OF ENDOCYTOSIS,0.0085714,0.13312,0.1018,1,1
2,GO RUFFLE ASSEMBLY,0.024846,0.13302,0.13952,1,1
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.022165,0.13292,0.085692,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.018398,0.1329,0.21775,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.00032948,0.13288,0.13032,1,1
2,GO CELLULAR PIGMENTATION,0.020205,0.13286,0.094853,1,1
2,GO REGULATION OF CIRCADIAN RHYTHM,0.0032441,0.13275,0.12889,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0060989,0.13274,0.11162,1,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.009256,0.13258,0.13087,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,4.1617e-05,0.13256,0.14338,1,1
2,GO SIGNAL RELEASE,2.7343e-05,0.13255,0.17618,1,1
2,GO ENDOCYTOSIS,0.0022332,0.13251,0.11174,1,1
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00047456,0.1325,0.18211,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0025083,0.13223,0.10374,1,1
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0040578,0.13206,0.11965,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.0042883,0.13199,0.14072,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.036164,0.13197,0.097552,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0023671,0.1319,0.10559,1,1
2,GO SENSORY ORGAN DEVELOPMENT,0.00028792,0.13153,0.13574,1,1
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.00095906,0.13149,0.14656,1,1
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.018836,0.13145,0.10873,1,1
2,GO MACROPHAGE ACTIVATION,0.0017641,0.13142,0.20793,1,1
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0015189,0.13133,0.15497,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00012512,0.13128,0.11444,1,1
2,GO HEART MORPHOGENESIS,0.0050528,0.13089,0.11971,1,1
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0017123,0.1307,0.13128,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.001191,0.13041,0.11592,1,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.023205,0.13033,0.12214,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.016339,0.13033,0.089584,1,1
2,GO ADHERENS JUNCTION ORGANIZATION,0.0054795,0.13014,0.15774,1,1
2,GO REGIONALIZATION,0.00037661,0.13007,0.16152,1,1
2,GO STEM CELL PROLIFERATION,0.0021689,0.13003,0.14886,1,1
2,GO ONE CARBON COMPOUND TRANSPORT,0.0087944,0.13002,0.15772,1,1
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.0097392,0.12999,0.13914,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0017641,0.12989,0.1106,1,1
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00021909,0.12954,0.13261,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0081404,0.12953,0.20977,1,1
2,GO APPENDAGE DEVELOPMENT,0.035393,0.12949,0.11655,1,1
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.02068,0.12946,0.15111,1,1
2,GO RETINOL METABOLIC PROCESS,0.030383,0.12944,0.10826,1,1
2,GO RESPONSE TO CHEMOKINE,0.0017641,0.12937,0.1243,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.00047456,0.12935,0.12111,1,1
2,GO REGULATION OF DNA BINDING,0.0011549,0.12931,0.12456,1,1
2,GO REGULATION OF AUTOPHAGY,0.00037661,0.12919,0.10707,1,1
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.024288,0.12895,0.15548,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0087944,0.12892,0.12596,1,1
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0041716,0.12872,0.1096,1,1
2,GO PHOSPHATE ION TRANSPORT,0.02268,0.12828,0.1179,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00022676,0.12827,0.14183,1,1
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0056288,0.12824,0.11016,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0013054,0.12817,0.12085,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0047853,0.12813,0.11261,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0059384,0.12807,0.15983,1,1
2,GO SKELETAL SYSTEM DEVELOPMENT,0.0020453,0.12801,0.11697,1,1
2,GO REGULATION OF CELL DEVELOPMENT,0.00044439,0.12788,0.14149,1,1
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0028141,0.12783,0.15053,1,1
2,GO REGULATION OF BINDING,0.00030804,0.12756,0.12312,1,1
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0011549,0.12743,0.12192,1,1
2,GO CARDIAC MUSCLE CONTRACTION,0.0064317,0.12732,0.13555,1,1
2,GO CELL CELL SIGNALING BY WNT,0.0014299,0.12725,0.11352,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0007696,0.12715,0.12793,1,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0083534,0.12702,0.12357,1,1
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.02843,0.12697,0.13068,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.030383,0.12679,0.15043,1,1
2,GO REGULATION OF VACUOLE ORGANIZATION,0.0097392,0.1265,0.11358,1,1
2,GO ACTIN MEDIATED CELL CONTRACTION,0.014486,0.12641,0.11399,1,1
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.025414,0.1264,0.092812,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0013054,0.12622,0.19131,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.042857,0.12621,0.11801,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,2.9532e-05,0.12607,0.12397,1,1
2,GO COGNITION,0.0036303,0.12595,0.13973,1,1
2,GO MUSCLE CONTRACTION,0.0010206,0.12544,0.12573,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0059384,0.12522,0.099093,1,1
2,GO SENSORY SYSTEM DEVELOPMENT,0.001228,0.125,0.12338,1,1
2,GO REGULATION OF CELL SIZE,0.0020453,0.12494,0.13447,1,1
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0066042,0.12481,0.083416,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.01282,0.12475,0.13813,1,1
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0010528,0.12456,0.11787,1,1
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0010859,0.12454,0.14634,1,1
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.00040247,0.1245,0.14802,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00098941,0.12438,0.10831,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0040578,0.12426,0.09731,1,1
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0019282,0.12424,0.12466,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0037331,0.1241,0.11744,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.025414,0.12405,0.15677,1,1
2,GO RETINA HOMEOSTASIS,0.018836,0.12394,0.082178,1,1
2,GO CELL MORPHOGENESIS,0.0031536,0.12394,0.11931,1,1
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.027803,0.1239,0.11371,1,1
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00063551,0.12378,0.16679,1,1
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00016023,0.12373,0.12716,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0013054,0.12351,0.14425,1,1
2,GO RESPONSE TO ALCOHOL,0.011326,0.12285,0.10118,1,1
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0094949,0.12264,0.083235,1,1
2,GO REGULATION OF NEURON DIFFERENTIATION,0.001872,0.12257,0.15053,1,1
2,GO T CELL LINEAGE COMMITMENT,0.0042883,0.12256,0.12849,1,1
2,GO NEGATIVE REGULATION OF BINDING,0.0007696,0.12242,0.12615,1,1
2,GO CALCIUM ION IMPORT,0.009256,0.12212,0.12935,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.013465,0.12212,0.12814,1,1
2,GO LEARNING,0.021165,0.12212,0.14576,1,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.011326,0.12208,0.12771,1,1
2,GO PEPTIDYL SERINE MODIFICATION,0.00067758,0.122,0.10059,1,1
2,GO SULFATE TRANSPORT,0.044685,0.12189,0.10984,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02843,0.12169,0.10349,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0069616,0.12118,0.088645,1,1
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.047551,0.12118,0.10644,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0094949,0.12113,0.079216,1,1
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00017796,0.12101,0.14901,1,1
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.036164,0.12096,0.12302,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0038387,0.12095,0.09687,1,1
2,GO FATTY ACID TRANSPORT,0.014138,0.12066,0.096458,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.00050664,0.12043,0.11898,1,1
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0010528,0.12009,0.092662,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.03245,0.11998,0.078329,1,1
2,GO REGULATION OF PROTEIN BINDING,0.00059588,0.11984,0.13629,1,1
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.013798,0.11976,0.13702,1,1
2,GO POSITIVE REGULATION OF GROWTH,0.00014935,0.11933,0.13725,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.015574,0.1187,0.10959,1,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.8379e-05,0.11865,0.11377,1,1
2,GO CELLULAR HOMEOSTASIS,0.00028792,0.11839,0.11027,1,1
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00063551,0.11839,0.13594,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0037331,0.11814,0.10585,1,1
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.004408,0.11811,0.087568,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0033369,0.11808,0.10319,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0024367,0.11808,0.098899,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.035393,0.11807,0.11501,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.012203,0.11798,0.095263,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.036164,0.11777,0.11835,1,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.00044439,0.11723,0.084994,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.026586,0.11696,0.08046,1,1
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.045624,0.11679,0.13857,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0028957,0.11679,0.13784,1,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00041602,0.11672,0.12886,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00030804,0.11658,0.1087,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.027188,0.11626,0.10707,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0060989,0.11528,0.11777,1,1
2,GO ORGANELLE FUSION,0.024846,0.11519,0.092053,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00035231,0.11506,0.12879,1,1
2,GO ORGAN GROWTH,0.015953,0.11478,0.088219,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.009256,0.11478,0.10534,1,1
2,GO EMBRYO DEVELOPMENT,0.0007696,0.11454,0.11036,1,1
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.015203,0.11433,0.16663,1,1
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0099891,0.11426,0.13797,1,1
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00037661,0.11411,0.13221,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.016339,0.11401,0.1237,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,0.026586,0.11396,0.11736,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.036164,0.11386,0.12163,1,1
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0010859,0.1135,0.11481,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.031059,0.11325,0.14956,1,1
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00016023,0.11315,0.096433,1,1
2,GO RUFFLE ORGANIZATION,0.035393,0.11312,0.12255,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00045924,0.11312,0.16139,1,1
2,GO MULTI ORGANISM PROCESS,0.00092958,0.11298,0.094502,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0041716,0.11271,0.084959,1,1
2,GO PROTEIN DEPHOSPHORYLATION,0.0050528,0.11233,0.073777,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.5149e-05,0.11187,0.12497,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.015574,0.11169,0.11788,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.025994,0.11164,0.083676,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.040234,0.11158,0.11287,1,1
2,GO POSITIVE REGULATION OF BINDING,0.015953,0.11119,0.089664,1,1
2,GO EXOCYTIC PROCESS,0.02843,0.1106,0.13931,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092958,0.11018,0.13503,1,1
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.038561,0.11015,0.14156,1,1
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.040234,0.10959,0.1318,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.011904,0.10933,0.11084,1,1
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.042857,0.10926,0.091935,1,1
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0011199,0.10907,0.10352,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.010506,0.1085,0.10187,1,1
2,GO REGULATION OF AXONOGENESIS,0.025994,0.1076,0.14008,1,1
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00036427,0.10752,0.11683,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.026586,0.10733,0.13877,1,1
2,GO DEPHOSPHORYLATION,0.00092958,0.10732,0.090764,1,1
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.019739,0.10729,0.16013,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0045306,0.1067,0.12836,1,1
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00049035,0.10646,0.1048,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.012508,0.10642,0.12551,1,1
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0012662,0.10581,0.12681,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.011326,0.10579,0.076131,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.0087944,0.10496,0.10689,1,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00035231,0.10494,0.084679,1,1
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.033166,0.10487,0.067062,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0037331,0.10408,0.11982,1,1
2,GO NEGATIVE REGULATION OF TRANSPORT,0.0028957,0.10393,0.090433,1,1
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.017549,0.10374,0.08488,1,1
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0047853,0.10367,0.084835,1,1
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001986,0.10361,0.13438,1,1
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.010245,0.10328,0.088268,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0047853,0.10326,0.093244,1,1
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.013465,0.103,0.10714,1,1
2,GO MUSCLE ORGAN DEVELOPMENT,0.0025083,0.10268,0.09334,1,1
2,GO REGULATION OF CELL DIVISION,0.007729,0.10237,0.093569,1,1
2,GO REGULATION OF CELLULAR LOCALIZATION,0.0021062,0.10229,0.084136,1,1
2,GO REGULATION OF TORC1 SIGNALING,0.027803,0.10203,0.077834,1,1
2,GO GOLGI LOCALIZATION,0.024846,0.10155,0.11424,1,1
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0057817,0.10149,0.082453,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.00095906,0.10134,0.12218,1,1
2,GO ORGANIC ACID TRANSPORT,0.0021689,0.10088,0.08458,1,1
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00098941,0.10027,0.09262,1,1
2,GO NEUROGENESIS,0.0013457,0.10027,0.12885,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.022165,0.10019,0.14495,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0075304,0.099633,0.10655,1,1
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.033894,0.099217,0.10097,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.043763,0.099079,0.062038,1,1
2,GO GOLGI ORGANIZATION,0.0097392,0.099056,0.080586,1,1
2,GO REGULATION OF GLUCONEOGENESIS,0.029719,0.098622,0.082797,1,1
2,GO OOGENESIS,0.013465,0.097786,0.092882,1,1
2,GO RECEPTOR INTERNALIZATION,0.025414,0.097638,0.097208,1,1
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0014299,0.097315,0.095825,1,1
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00098941,0.097202,0.080517,1,1
2,GO SEXUAL REPRODUCTION,0.001662,0.096918,0.084731,1,1
2,GO GERM CELL DEVELOPMENT,0.0027346,0.096506,0.097806,1,1
2,GO CELL FATE COMMITMENT,0.0029794,0.095949,0.133,1,1
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.041967,0.095341,0.090619,1,1
2,GO CELL PROJECTION ORGANIZATION,0.0017123,0.095264,0.11447,1,1
2,GO HEAD DEVELOPMENT,0.00049035,0.09502,0.13814,1,1
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0021689,0.094975,0.091476,1,1
2,GO REGULATION OF TOR SIGNALING,0.00092958,0.094837,0.099958,1,1
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.024288,0.094221,0.10012,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.014138,0.093983,0.08991,1,1
2,GO OVULATION CYCLE,0.027803,0.093737,0.10503,1,1
2,GO NEURON DIFFERENTIATION,0.0060989,0.093715,0.12459,1,1
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.023741,0.093447,0.15421,1,1
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0040578,0.092791,0.13677,1,1
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013139,0.09272,0.08188,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.0099891,0.091482,0.13047,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.0075304,0.091469,0.095664,1,1
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0054795,0.090935,0.077563,1,1
2,GO NEURON DEVELOPMENT,0.007729,0.090341,0.12683,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0069616,0.089397,0.1044,1,1
2,GO ENDOSOMAL TRANSPORT,0.022165,0.089267,0.066553,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0066042,0.088467,0.16927,1,1
2,GO REGULATION OF EXOCYTOSIS,0.0045306,0.088074,0.15913,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.013465,0.087673,0.064518,1,1
2,GO SYNAPTIC SIGNALING,0.013465,0.087229,0.14923,1,1
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.025414,0.086413,0.081984,1,1
2,GO MYOFIBRIL ASSEMBLY,0.043763,0.085067,0.085345,1,1
2,GO FERTILIZATION,0.0046564,0.084976,0.088313,1,1
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.031059,0.084329,0.083631,1,1
2,GO DNA CATABOLIC PROCESS,0.00090094,0.084224,0.12069,1,1
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.017969,0.083675,0.077681,1,1
2,GO PEPTIDYL THREONINE MODIFICATION,0.0085714,0.083224,0.093123,1,1
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.047551,0.083184,0.079806,1,1
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.007729,0.08264,0.079584,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.010773,0.082618,0.076646,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.035393,0.082563,0.097882,1,1
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.033166,0.082542,0.076344,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.019283,0.082209,0.077826,1,1
2,GO AXON DEVELOPMENT,0.041093,0.082023,0.11965,1,1
2,GO CELL CYCLE ARREST,0.015574,0.081973,0.066938,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.010506,0.08133,0.092676,1,1
2,GO MACROMOLECULE DEACYLATION,0.0085714,0.080842,0.07389,1,1
2,GO POLYOL METABOLIC PROCESS,0.026586,0.080833,0.071274,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.036948,0.080118,0.093659,1,1
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00353,0.079946,0.07145,1,1
2,GO PROTEIN HOMOOLIGOMERIZATION,0.0050528,0.079585,0.080516,1,1
2,GO GAMETE GENERATION,0.0049174,0.077942,0.078735,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.035393,0.076486,0.079101,1,1
2,GO CYTOSKELETON ORGANIZATION,0.0079323,0.074469,0.082076,1,1
2,GO TOR SIGNALING,0.0090226,0.074227,0.063033,1,1
2,GO REGULATION OF DEPHOSPHORYLATION,0.0012662,0.073658,0.08143,1,1
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0094949,0.072345,0.12382,1,1
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00098941,0.071512,0.087057,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.0053338,0.071464,0.11143,1,1
2,GO PROTEIN INSERTION INTO MEMBRANE,0.047551,0.071236,0.091191,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.025994,0.070707,0.053164,1,1
2,GO STEM CELL DIFFERENTIATION,0.03939,0.070398,0.074945,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.024846,0.068888,0.08946,1,1
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.033166,0.068522,0.10456,1,1
2,GO NEURON PROJECTION EXTENSION,0.023205,0.06844,0.13911,1,1
2,GO MALE GAMETE GENERATION,0.0099891,0.064423,0.072228,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.029719,0.063834,0.060896,1,1
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0075304,0.063583,0.084225,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.046579,0.060413,0.045525,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.041967,0.059879,0.072836,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE,0.015574,0.059172,0.058577,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.024846,0.058499,0.05431,1,1
2,GO FOREBRAIN DEVELOPMENT,0.0085714,0.05837,0.13542,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.033894,0.058245,0.057184,1,1
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.045624,0.057741,0.071811,1,1
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.027803,0.054909,0.043862,1,1
3,GO ETHER BIOSYNTHETIC PROCESS,7.889e-07,1.2188,0.9552,1,1
3,GO ETHANOL OXIDATION,2.9301e-06,0.97262,0.82318,1,1
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00016023,0.96721,0.73654,1,1
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,7.8282e-05,0.82445,0.70794,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.6015e-06,0.82265,0.75691,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.1192e-05,0.799,0.54757,1,1
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.2879e-07,0.77703,0.70378,1,1
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,1.1493e-05,0.764,0.68603,1,1
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00034072,0.75365,0.63141,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.4609e-05,0.70935,0.69537,1,1
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.025414,0.69156,0.74252,1,1
3,GO RESPONSE TO INTERLEUKIN 18,9.7346e-05,0.68969,0.68465,1,1
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.8612e-06,0.68144,0.51343,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.6414e-07,0.68021,0.52869,1,1
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.4977e-07,0.67989,0.6221,1,1
3,GO T HELPER 1 CELL DIFFERENTIATION,4.8612e-06,0.67581,0.64131,1,1
3,GO BIOLOGICAL PHASE,2.1663e-05,0.67252,0.67402,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00020448,0.65356,0.53952,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00087311,0.65048,0.49737,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0021689,0.64671,0.48034,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00041602,0.63924,0.58755,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.389e-05,0.62672,0.52091,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,1.6455e-05,0.61743,0.5325,1,1
3,GO MYOBLAST MIGRATION,0.0037331,0.61589,0.53006,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.3287e-06,0.61141,0.56732,1,1
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.4674e-06,0.59842,0.5472,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,0.59147,0.46613,1,1
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019079,0.58885,0.54153,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0026572,0.58809,0.44817,1,1
3,GO PROSTATE GLAND GROWTH,1.0604e-05,0.58277,0.62851,1,1
3,GO HAIR FOLLICLE MATURATION,4.2876e-06,0.57317,0.50929,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7791e-06,0.5727,0.42028,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0226e-05,0.5693,0.54481,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.3218e-05,0.56446,0.57641,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0040578,0.56154,0.40596,1,1
3,GO MUCUS SECRETION,0.0015189,0.5613,0.54353,1,1
3,GO ETHER METABOLIC PROCESS,1.1493e-05,0.55969,0.49063,1,1
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0010206,0.55619,0.51876,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0087944,0.54879,0.39014,1,1
3,GO OTIC VESICLE DEVELOPMENT,5.0226e-05,0.54762,0.49616,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,0.0028957,0.54436,0.38993,1,1
3,GO LYSINE METABOLIC PROCESS,0.00047456,0.54427,0.49105,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1702e-06,0.53953,0.52154,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.0025083,0.539,0.417,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0032441,0.53516,0.40135,1,1
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00014935,0.53459,0.46176,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,7.0571e-06,0.53315,0.46472,1,1
3,GO ACTIN FILAMENT SEVERING,0.0067808,0.53247,0.37707,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0024367,0.52756,0.50617,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.906e-06,0.52628,0.49368,1,1
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0001547,0.52516,0.43691,1,1
3,GO PROSTANOID METABOLIC PROCESS,3.8583e-05,0.51843,0.45281,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00024286,0.51167,0.45479,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.4044e-06,0.50989,0.45644,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.0226e-05,0.50824,0.40987,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,3.3132e-05,0.50532,0.55247,1,1
3,GO REGULATION OF GASTRIC ACID SECRETION,7.547e-05,0.50048,0.46764,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0016129,0.49837,0.42673,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,7.547e-05,0.49801,0.3979,1,1
3,GO HEPATOCYTE DIFFERENTIATION,0.0057817,0.49763,0.39211,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00041602,0.48942,0.43739,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0016129,0.48346,0.35981,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.015574,0.48307,0.39056,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00044439,0.48059,0.46447,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.4728e-06,0.47901,0.42254,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,8.1192e-05,0.4752,0.43373,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.2962e-05,0.47187,0.43418,1,1
3,GO REGULATION OF HIPPO SIGNALING,0.020205,0.46834,0.2461,1,1
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7118e-05,0.46809,0.41513,1,1
3,GO NEURAL CREST FORMATION,0.00025131,0.46561,0.36549,1,1
3,GO MUSCLE ATROPHY,0.023741,0.4645,0.3159,1,1
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.046579,0.46191,0.30855,1,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,7.2754e-05,0.45356,0.33365,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,9.3916e-06,0.45162,0.42813,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0022992,0.45013,0.36154,1,1
3,GO NEPHRON TUBULE FORMATION,0.0027346,0.44818,0.31656,1,1
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,3.3132e-05,0.44716,0.41667,1,1
3,GO SKELETAL MUSCLE TISSUE REGENERATION,1.104e-05,0.44531,0.3719,1,1
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00057693,0.44499,0.4096,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.7596e-05,0.44416,0.38692,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.013798,0.44249,0.40489,1,1
3,GO OTIC VESICLE MORPHOGENESIS,0.00044439,0.43886,0.41696,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.00010092,0.43707,0.36734,1,1
3,GO DENDRITIC CELL MIGRATION,2.0833e-05,0.43567,0.3916,1,1
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0030654,0.43454,0.36715,1,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0038387,0.43358,0.35544,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00021909,0.43184,0.44266,1,1
3,GO REGULATION OF PROTEIN IMPORT,7.8282e-05,0.42768,0.30988,1,1
3,GO REGULATION OF GLOMERULAR FILTRATION,0.012508,0.42068,0.36337,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3654e-06,0.41888,0.40362,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00035231,0.41597,0.3914,1,1
3,GO ETHANOL METABOLIC PROCESS,1.2454e-05,0.41328,0.49637,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.2524e-05,0.41126,0.32599,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0045306,0.40954,0.36044,1,1
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.001986,0.40915,0.33747,1,1
3,GO LEFT RIGHT AXIS SPECIFICATION,0.00017186,0.40752,0.45169,1,1
3,GO OXYGEN TRANSPORT,0.017137,0.40266,0.41156,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.031059,0.40254,0.42595,1,1
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.031748,0.39751,0.26461,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00028792,0.39535,0.3855,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.39496,0.38613,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.012203,0.39338,0.27462,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,1.7806e-05,0.39275,0.35727,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0032441,0.39103,0.35845,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00014935,0.391,0.30692,1,1
3,GO PORE COMPLEX ASSEMBLY,5.0683e-06,0.39017,0.37634,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00024286,0.38945,0.35612,1,1
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.0032441,0.38886,0.36542,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.001986,0.38839,0.31981,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,2.5308e-05,0.38812,0.33751,1,1
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.035393,0.38807,0.22265,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,2.8891e-07,0.38804,0.4015,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00095906,0.38802,0.35929,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.021165,0.38378,0.33778,1,1
3,GO HEME METABOLIC PROCESS,0.00019079,0.38291,0.3461,1,1
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.013798,0.38097,0.2391,1,1
3,GO PENTOSE METABOLIC PROCESS,7.2754e-05,0.37984,0.3666,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00025131,0.379,0.32135,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0011549,0.3771,0.33166,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00098941,0.37689,0.34472,1,1
3,GO LIMB BUD FORMATION,0.0025817,0.37637,0.47345,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,4.2876e-06,0.37556,0.34868,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.00054072,0.3738,0.32363,1,1
3,GO RESPONSE TO CADMIUM ION,0.0041716,0.37301,0.26983,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00017186,0.37234,0.31354,1,1
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,5.9841e-06,0.3715,0.34682,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.001872,0.36948,0.28068,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00092958,0.36619,0.34981,1,1
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,7.2754e-05,0.36599,0.30981,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.5759e-05,0.36571,0.30245,1,1
3,GO MYELOID CELL APOPTOTIC PROCESS,0.007729,0.36497,0.25223,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.027188,0.36279,0.2515,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,7.547e-05,0.35899,0.34698,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0054795,0.35869,0.25094,1,1
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00019753,0.35727,0.30906,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.034637,0.35712,0.28081,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,7.013e-05,0.35549,0.3547,1,1
3,GO HISTONE SERINE PHOSPHORYLATION,0.00017186,0.35413,0.28419,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00016595,0.35355,0.29327,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,7.6603e-06,0.35275,0.38288,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00023468,0.35038,0.32538,1,1
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.7728e-06,0.3499,0.31293,1,1
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0033369,0.34927,0.26525,1,1
3,GO FATTY ACID HOMEOSTASIS,0.014138,0.34829,0.20772,1,1
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00052342,0.34769,0.30775,1,1
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00019079,0.34747,0.26544,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00022676,0.34744,0.29864,1,1
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.023741,0.34735,0.27251,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0019282,0.34718,0.37952,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.7728e-06,0.34683,0.3541,1,1
3,GO RETINAL METABOLIC PROCESS,0.035393,0.34646,0.2657,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.017969,0.34269,0.24991,1,1
3,GO PRE MIRNA PROCESSING,0.001872,0.34144,0.22852,1,1
3,GO REGULATION OF DNA METHYLATION,4.6597e-05,0.34129,0.2736,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0011199,0.33906,0.29875,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0039469,0.33816,0.24768,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0007696,0.33813,0.29412,1,1
3,GO TONGUE MORPHOGENESIS,0.0060989,0.33749,0.34097,1,1
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.029068,0.33733,0.20486,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.0010528,0.33547,0.32311,1,1
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00013433,0.33505,0.4769,1,1
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0079323,0.33474,0.24572,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.029068,0.33405,0.20609,1,1
3,GO RNA DECAPPING,3.8583e-05,0.33388,0.23697,1,1
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0025083,0.3337,0.44137,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,5.2139e-05,0.33295,0.36286,1,1
3,GO MICROVILLUS ASSEMBLY,0.0019282,0.3326,0.35386,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0022992,0.33239,0.23539,1,1
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.024288,0.33166,0.34474,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.0012662,0.33092,0.24905,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,8.6584e-06,0.33032,0.36231,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.001986,0.32972,0.32609,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.00017796,0.3288,0.27356,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.0081404,0.32827,0.20526,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00067758,0.32825,0.28442,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.00019079,0.3282,0.32944,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.014138,0.32789,0.29309,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00079435,0.32675,0.31189,1,1
3,GO ZINC ION HOMEOSTASIS,0.013798,0.32435,0.32015,1,1
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0025817,0.32427,0.21957,1,1
3,GO IMP METABOLIC PROCESS,0.034637,0.3242,0.27509,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.0022992,0.32379,0.22993,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00059588,0.32312,0.25202,1,1
3,GO RETINOL METABOLIC PROCESS,0.00069957,0.32205,0.24299,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.3201,0.28802,1,1
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.0081404,0.3199,0.30841,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00016595,0.31908,0.42139,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0007696,0.31892,0.26076,1,1
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0032441,0.31862,0.3256,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.906e-06,0.31751,0.2648,1,1
3,GO NOTOCHORD DEVELOPMENT,0.00052342,0.3174,0.48821,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.5149e-05,0.31702,0.28095,1,1
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0028141,0.31633,0.26712,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0014299,0.31594,0.27115,1,1
3,GO PROTEIN DEMANNOSYLATION,0.0045306,0.31534,0.19096,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083534,0.31384,0.29439,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0099891,0.31381,0.28726,1,1
3,GO GAS TRANSPORT,0.0064317,0.31363,0.35374,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0050528,0.31333,0.32658,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,0.0034322,0.31298,0.38202,1,1
3,GO CARNITINE SHUTTLE,5.6174e-05,0.31298,0.31693,1,1
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8418e-05,0.31107,0.251,1,1
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0056288,0.31092,0.29792,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0007696,0.3107,0.28635,1,1
3,GO DETOXIFICATION,0.00019079,0.3095,0.26205,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.021165,0.30928,0.24237,1,1
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0069616,0.3082,0.24922,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,9.7801e-06,0.30811,0.31182,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0032441,0.30795,0.23311,1,1
3,GO AMP METABOLIC PROCESS,0.016734,0.30722,0.2298,1,1
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00019753,0.30708,0.39671,1,1
3,GO DNA LIGATION,0.0014738,0.30662,0.22878,1,1
3,GO INTERLEUKIN 2 PRODUCTION,3.8583e-05,0.30565,0.2651,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.043763,0.30557,0.18349,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00020448,0.3038,0.31849,1,1
3,GO RESPIRATORY BURST,0.0025083,0.30358,0.237,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00036427,0.30352,0.26929,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0021062,0.30294,0.24919,1,1
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0028141,0.30198,0.23833,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,9.7346e-05,0.3008,0.29486,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,7.013e-05,0.30064,0.32568,1,1
3,GO KERATINOCYTE PROLIFERATION,0.02843,0.30059,0.28596,1,1
3,GO FOREGUT MORPHOGENESIS,0.0025817,0.29939,0.34239,1,1
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00014418,0.29938,0.33314,1,1
3,GO OVULATION,0.0013872,0.29899,0.25418,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,2.7343e-05,0.29814,0.29384,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0015189,0.29678,0.24938,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00072223,0.29601,0.2591,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0017123,0.29582,0.19052,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001191,0.29556,0.20799,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0013457,0.29527,0.29306,1,1
3,GO NUCLEAR PORE ORGANIZATION,1.4039e-05,0.29527,0.34743,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,5.4121e-05,0.29466,0.25256,1,1
3,GO VIRAL TRANSLATION,0.00012512,0.29435,0.33713,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,3.3202e-07,0.29425,0.27593,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0017123,0.29374,0.26928,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00057693,0.29317,0.31209,1,1
3,GO PODOSOME ASSEMBLY,0.0010528,0.29268,0.27419,1,1
3,GO RESPONSE TO TUMOR CELL,0.0067808,0.29259,0.22318,1,1
3,GO GASTRIC ACID SECRETION,0.001228,0.29234,0.24359,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.00049035,0.29142,0.25472,1,1
3,GO MATURATION OF LSU RRNA,0.0013457,0.29137,0.32786,1,1
3,GO RESPONSE TO COPPER ION,0.033894,0.28891,0.27089,1,1
3,GO URETER DEVELOPMENT,0.033166,0.28875,0.25547,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0050528,0.28853,0.2686,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.001228,0.28853,0.22133,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011904,0.28848,0.22255,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00026903,0.28826,0.26289,1,1
3,GO RIG I SIGNALING PATHWAY,4.0073e-05,0.2881,0.26385,1,1
3,GO RESPONSE TO STEROL DEPLETION,0.00065623,0.28801,0.27519,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00054072,0.2875,0.29619,1,1
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.00030804,0.28722,0.23232,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.00025131,0.28659,0.44109,1,1
3,GO BLASTODERM SEGMENTATION,0.019283,0.28649,0.2911,1,1
3,GO FIBROBLAST ACTIVATION,0.00081984,0.28636,0.32039,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00045924,0.28599,0.28621,1,1
3,GO T CELL CHEMOTAXIS,0.00011241,0.28576,0.25846,1,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00081984,0.28519,0.26861,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.28494,0.26199,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.7343e-05,0.28428,0.28317,1,1
3,GO MATURATION OF 5 8S RRNA,0.00040247,0.28384,0.29683,1,1
3,GO RESPONSE TO INTERLEUKIN 12,0.00016023,0.28381,0.25682,1,1
3,GO PROSTATE GLAND DEVELOPMENT,0.0025817,0.28291,0.34626,1,1
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.022165,0.28275,0.37956,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,4.0073e-05,0.28207,0.27596,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0027346,0.28166,0.22208,1,1
3,GO REGULATION OF LIPASE ACTIVITY,5.2139e-05,0.2814,0.22573,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00026903,0.28082,0.31561,1,1
3,GO HYPEROSMOTIC RESPONSE,0.00095906,0.28062,0.27633,1,1
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3418e-05,0.28029,0.31852,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0066042,0.28016,0.20091,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.001191,0.2798,0.23862,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.00029782,0.27925,0.22482,1,1
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.007729,0.27922,0.25443,1,1
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0034322,0.27907,0.17663,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0011549,0.27896,0.44222,1,1
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0007696,0.27849,0.21344,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00032948,0.27777,0.28294,1,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0019282,0.27752,0.24763,1,1
3,GO HIPPO SIGNALING,0.0006154,0.27723,0.34983,1,1
3,GO REGULATION OF TELOMERASE ACTIVITY,3.1888e-05,0.27718,0.24309,1,1
3,GO CHROMATIN DISASSEMBLY,0.00055855,0.2771,0.22681,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00065623,0.27632,0.25228,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.021165,0.27533,0.19528,1,1
3,GO VIRAL GENE EXPRESSION,0.00054072,0.27526,0.25999,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.001228,0.27447,0.18005,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.042857,0.27425,0.2203,1,1
3,GO ARACHIDONIC ACID SECRETION,7.8282e-05,0.274,0.28469,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00059588,0.27392,0.28376,1,1
3,GO MIRNA METABOLIC PROCESS,3.6228e-06,0.27377,0.23931,1,1
3,GO MUSCLE CELL FATE COMMITMENT,0.024288,0.2733,0.26082,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.035393,0.27318,0.23067,1,1
3,GO VESICLE CARGO LOADING,5.6174e-05,0.27306,0.27992,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.00041602,0.2726,0.39181,1,1
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.014138,0.27083,0.30597,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00017186,0.27047,0.35446,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0099891,0.2692,0.17031,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00055855,0.26874,0.25877,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.022165,0.26844,0.25348,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,9.0551e-05,0.26805,0.24172,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,0.0027346,0.26734,0.24392,1,1
3,GO GTP METABOLIC PROCESS,0.00084609,0.26711,0.28782,1,1
3,GO MRNA MODIFICATION,0.001986,0.26692,0.2032,1,1
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00010092,0.26647,0.25791,1,1
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017549,0.26631,0.32264,1,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00037661,0.26616,0.3567,1,1
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00016023,0.26608,0.21856,1,1
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.0054795,0.26545,0.20872,1,1
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0056288,0.26544,0.31048,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.8418e-05,0.26504,0.24453,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0025083,0.26382,0.25223,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0025817,0.26369,0.21768,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0017123,0.26309,0.23199,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.021165,0.263,0.22577,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00052342,0.26278,0.24923,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0054795,0.26253,0.2678,1,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,1.6455e-05,0.26201,0.24882,1,1
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00016595,0.26186,0.22582,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0040578,0.26155,0.19656,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00026003,0.26047,0.26666,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.0051916,0.2603,0.2011,1,1
3,GO FOREBRAIN MORPHOGENESIS,0.033166,0.25902,0.17177,1,1
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00032948,0.25894,0.24645,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.00057693,0.25867,0.30394,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0011549,0.25857,0.20856,1,1
3,GO NUCLEAR MIGRATION,0.0032441,0.25854,0.19574,1,1
3,GO LAMELLIPODIUM ORGANIZATION,7.0571e-06,0.25798,0.27198,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.02268,0.25722,0.21145,1,1
3,GO MATURATION OF SSU RRNA,0.00063551,0.25673,0.29897,1,1
3,GO AMINE CATABOLIC PROCESS,0.0039469,0.25667,0.28814,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00017186,0.25637,0.25222,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.0067808,0.25616,0.18758,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.043763,0.25595,0.16439,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0014299,0.25469,0.29201,1,1
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.011326,0.25458,0.16623,1,1
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.8418e-05,0.2542,0.27233,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.7118e-05,0.25402,0.24833,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.001228,0.25355,0.22522,1,1
3,GO MICROVILLUS ORGANIZATION,0.010506,0.25289,0.29662,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0034322,0.25283,0.28348,1,1
3,GO HISTONE H3 K9 ACETYLATION,1.1964e-05,0.2527,0.25829,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.041967,0.25241,0.12555,1,1
3,GO PLATELET MORPHOGENESIS,0.00010092,0.2509,0.24738,1,1
3,GO TRNA METHYLATION,0.00018427,0.25004,0.2326,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,2.7343e-05,0.24997,0.21133,1,1
3,GO CELL REDOX HOMEOSTASIS,0.00049035,0.249,0.21458,1,1
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00045924,0.24878,0.22397,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0050528,0.24796,0.25006,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00084609,0.24754,0.28323,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.041093,0.247,0.21567,1,1
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.047551,0.24699,0.20009,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.033894,0.24699,0.21548,1,1
3,GO PEPTIDE CROSS LINKING,0.02166,0.2463,0.19565,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00021909,0.24535,0.22389,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.013139,0.24511,0.21954,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,6.0504e-05,0.24489,0.27913,1,1
3,GO AMINO ACID ACTIVATION,0.00016023,0.2448,0.2837,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00353,0.24479,0.37055,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.00090094,0.24478,0.22728,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,7.547e-05,0.24431,0.20645,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.016339,0.24257,0.14627,1,1
3,GO CYTOPLASM ORGANIZATION,0.0016129,0.24231,0.29117,1,1
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0011549,0.2422,0.18878,1,1
3,GO NADP METABOLIC PROCESS,0.0047853,0.24197,0.2056,1,1
3,GO LAMELLIPODIUM ASSEMBLY,3.3132e-05,0.24152,0.23922,1,1
3,GO RESPONSE TO X RAY,0.00024286,0.24149,0.32402,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.2401,0.22733,1,1
3,GO HISTONE H4 DEACETYLATION,0.00050664,0.2399,0.29464,1,1
3,GO ERYTHROCYTE MATURATION,0.0045306,0.2397,0.30878,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.00090094,0.23959,0.18272,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00092958,0.23909,0.23647,1,1
3,GO CHONDROCYTE PROLIFERATION,0.013139,0.23834,0.3206,1,1
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.036948,0.2383,0.17781,1,1
3,GO MITOCHONDRIAL DNA REPLICATION,0.00020448,0.23789,0.22389,1,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.00021167,0.23774,0.2392,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028141,0.23771,0.20837,1,1
3,GO PROTEASOME ASSEMBLY,0.0054795,0.23755,0.169,1,1
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0021689,0.23742,0.21593,1,1
3,GO L SERINE METABOLIC PROCESS,0.011047,0.23703,0.27423,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0006154,0.23666,0.24345,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0007696,0.23604,0.227,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00013917,0.23598,0.20923,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,4.8379e-05,0.23583,0.20121,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0017123,0.23472,0.25322,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0019282,0.23438,0.21695,1,1
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0032441,0.23371,0.23687,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0056288,0.23315,0.20294,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.00042998,0.2324,0.1869,1,1
3,GO RESPONSE TO MANGANESE ION,0.0013872,0.23176,0.22346,1,1
3,GO NIK NF KAPPAB SIGNALING,0.00037661,0.23138,0.19719,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.0504e-05,0.23121,0.20817,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00098941,0.23059,0.21719,1,1
3,GO RNA STABILIZATION,0.00044439,0.23037,0.16942,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00057693,0.22963,0.21305,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,1.0604e-05,0.22963,0.20316,1,1
3,GO MALE GENITALIA DEVELOPMENT,0.0028141,0.22959,0.23036,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.011326,0.22907,0.19088,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00022676,0.22791,0.28044,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.016734,0.22789,0.18534,1,1
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.02268,0.22781,0.17166,1,1
3,GO REGULATION OF HAIR CYCLE,0.001872,0.22735,0.25656,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.024288,0.22724,0.20338,1,1
3,GO THYMUS DEVELOPMENT,0.00019753,0.22665,0.2155,1,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.001191,0.22652,0.17774,1,1
3,GO SECRETION BY TISSUE,0.0024367,0.22636,0.22809,1,1
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00035231,0.22558,0.23081,1,1
3,GO RIBOSOME BIOGENESIS,0.00016595,0.22553,0.26312,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001872,0.22512,0.16017,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.22422,0.20102,1,1
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.010245,0.22405,0.18815,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0010206,0.22342,0.23372,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0049174,0.22256,0.21257,1,1
3,GO NUCLEUS LOCALIZATION,0.00079435,0.22255,0.1868,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00079435,0.22102,0.23142,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.2454e-05,0.22099,0.22174,1,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00040247,0.22049,0.21836,1,1
3,GO MAGNESIUM ION HOMEOSTASIS,0.015953,0.21971,0.27628,1,1
3,GO MAINTENANCE OF CELL NUMBER,2.6307e-05,0.21917,0.21794,1,1
3,GO INTERLEUKIN 10 PRODUCTION,0.0028957,0.2176,0.18385,1,1
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.00081984,0.2173,0.24259,1,1
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.027188,0.21718,0.23403,1,1
3,GO STEM CELL DIVISION,0.0019282,0.21697,0.23401,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00049035,0.21673,0.19453,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00041602,0.21655,0.15771,1,1
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00041602,0.21534,0.22117,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0085714,0.21529,0.22025,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0015189,0.21507,0.15272,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0022992,0.21502,0.20257,1,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.038561,0.21489,0.21355,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0064317,0.21476,0.17098,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0040578,0.21452,0.15301,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.0023671,0.21432,0.1737,1,1
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.023741,0.21428,0.15194,1,1
3,GO B CELL HOMEOSTASIS,0.018836,0.21403,0.12761,1,1
3,GO INTESTINAL ABSORPTION,0.015574,0.2139,0.161,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.016339,0.21382,0.17499,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.3418e-05,0.21369,0.19953,1,1
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00049035,0.2133,0.218,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00026903,0.21311,0.18568,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00024286,0.21304,0.22839,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00092958,0.2129,0.17685,1,1
3,GO LIPID OXIDATION,0.0042883,0.21207,0.1526,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0087944,0.21191,0.20875,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0001547,0.21182,0.22917,1,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0057817,0.2118,0.19447,1,1
3,GO B CELL APOPTOTIC PROCESS,0.016339,0.21164,0.13949,1,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.21123,0.13068,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0011549,0.21117,0.32387,1,1
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.0184e-05,0.21036,0.20298,1,1
3,GO RNA POLYADENYLATION,0.00031859,0.21025,0.16167,1,1
3,GO RRNA TRANSCRIPTION,0.00047456,0.21018,0.23609,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.033166,0.21012,0.178,1,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0028957,0.20965,0.15391,1,1
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.027803,0.20962,0.21634,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012662,0.20928,0.2034,1,1
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.012203,0.2092,0.17019,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0073363,0.20875,0.17631,1,1
3,GO REGULATION OF CELL MATURATION,0.016339,0.20845,0.15292,1,1
3,GO MULTI ORGANISM LOCALIZATION,0.00040247,0.2083,0.16718,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.036164,0.20821,0.13773,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.018398,0.20819,0.13833,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.1964e-05,0.20772,0.1959,1,1
3,GO RRNA MODIFICATION,0.0022992,0.20725,0.22037,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.00041602,0.20714,0.26655,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0066042,0.20642,0.153,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0032441,0.20625,0.17197,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0032441,0.20555,0.21581,1,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.022165,0.20545,0.23801,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00020448,0.20513,0.18087,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.013139,0.20513,0.18246,1,1
3,GO GOLGI LOCALIZATION,0.041967,0.20466,0.15169,1,1
3,GO BLASTOCYST FORMATION,0.00028792,0.20426,0.19953,1,1
3,GO NCRNA PROCESSING,0.00021167,0.20423,0.22567,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,1.1493e-05,0.20398,0.2503,1,1
3,GO CORNIFICATION,0.0033369,0.20373,0.26876,1,1
3,GO SCHWANN CELL DIFFERENTIATION,0.0025083,0.20275,0.16388,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0039469,0.20256,0.21596,1,1
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.0083534,0.2022,0.17764,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.0081404,0.20207,0.20708,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.014841,0.202,0.14098,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,0.20191,0.2049,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00054072,0.20151,0.18924,1,1
3,GO TRNA 5 LEADER REMOVAL,0.00092958,0.20129,0.22494,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.037747,0.20016,0.12294,1,1
3,GO REGULATION OF CELLULAR RESPIRATION,0.024846,0.19993,0.16812,1,1
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0001547,0.19988,0.19481,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.001191,0.19911,0.25754,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.023205,0.1984,0.22334,1,1
3,GO RNA DESTABILIZATION,0.0081404,0.19819,0.13718,1,1
3,GO RNA METHYLATION,0.0013872,0.19798,0.15871,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.001872,0.19782,0.18255,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017796,0.1976,0.21277,1,1
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0059384,0.19753,0.20271,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.001662,0.19743,0.16348,1,1
3,GO HISTONE DEUBIQUITINATION,8.4205e-05,0.19705,0.18145,1,1
3,GO PEPTIDYL METHIONINE MODIFICATION,0.0056288,0.19613,0.20436,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00036427,0.19609,0.16007,1,1
3,GO RESPONSE TO SALT STRESS,0.017549,0.19588,0.20532,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0064317,0.19572,0.156,1,1
3,GO LEFT RIGHT PATTERN FORMATION,0.0053338,0.19557,0.25304,1,1
3,GO FATTY ACID BETA OXIDATION,0.016339,0.19511,0.11874,1,1
3,GO RRNA METABOLIC PROCESS,0.00017796,0.1949,0.2428,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.031059,0.19474,0.2108,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.027188,0.19468,0.13298,1,1
3,GO PEPTIDYL ARGININE MODIFICATION,2.8418e-05,0.19463,0.22081,1,1
3,GO REGULATION OF GENE SILENCING,7.3528e-06,0.19462,0.19869,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011612,0.19441,0.16649,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.029719,0.19381,0.17445,1,1
3,GO TRANSLATIONAL TERMINATION,0.0020453,0.19306,0.21297,1,1
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00084609,0.19286,0.19104,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.036948,0.19285,0.13854,1,1
3,GO APICAL JUNCTION ASSEMBLY,0.0067808,0.19259,0.20547,1,1
3,GO INTERACTION WITH SYMBIONT,0.00026003,0.19257,0.21133,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.043763,0.19232,0.11543,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0031536,0.19195,0.14251,1,1
3,GO V D J RECOMBINATION,0.011047,0.19192,0.22247,1,1
3,GO AEROBIC RESPIRATION,0.0015189,0.19184,0.19142,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00040247,0.19153,0.23328,1,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.035393,0.19144,0.12765,1,1
3,GO TRNA TRANSPORT,1.2454e-05,0.19136,0.24443,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.00044439,0.19126,0.21118,1,1
3,GO B CELL PROLIFERATION,0.0022332,0.19115,0.15619,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.036948,0.19088,0.1628,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.015953,0.19062,0.1778,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0085714,0.19047,0.13959,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0099891,0.19038,0.176,1,1
3,GO TRNA METABOLIC PROCESS,0.00011241,0.19017,0.19466,1,1
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.031748,0.18975,0.14015,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.6902e-06,0.18902,0.20025,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00069957,0.18899,0.15451,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.037747,0.18875,0.11938,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.015574,0.18871,0.14948,1,1
3,GO NCRNA METABOLIC PROCESS,0.00021167,0.18855,0.20332,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0067808,0.18827,0.1506,1,1
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.018836,0.18819,0.18593,1,1
3,GO RESPONSE TO ZINC ION,0.047551,0.18803,0.20233,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0041716,0.18801,0.17313,1,1
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.00017796,0.18795,0.20671,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.015203,0.18787,0.16961,1,1
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.0023671,0.18686,0.17654,1,1
3,GO LIVER REGENERATION,0.037747,0.18645,0.13785,1,1
3,GO GLUTAMINE METABOLIC PROCESS,0.00063551,0.18622,0.24136,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.02843,0.18611,0.11896,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0060989,0.18602,0.17283,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00012964,0.18602,0.19013,1,1
3,GO RNA INTERFERENCE,0.009256,0.18581,0.17558,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.024288,0.18579,0.17767,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00016595,0.18563,0.20033,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.047551,0.18537,0.14968,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.00012512,0.18527,0.22399,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.023741,0.18466,0.12192,1,1
3,GO AXIS ELONGATION,0.011904,0.18446,0.27909,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.00017186,0.18423,0.20917,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.02268,0.18404,0.13676,1,1
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.013139,0.18333,0.1907,1,1
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.021165,0.18281,0.18305,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.0030654,0.18176,0.16886,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00050664,0.18169,0.17714,1,1
3,GO TRNA MODIFICATION,0.00065623,0.18139,0.17772,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.036164,0.18061,0.11407,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00016595,0.18052,0.19441,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.018836,0.1805,0.13101,1,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.029719,0.18044,0.13715,1,1
3,GO FEVER GENERATION,0.029068,0.18031,0.17002,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.0045306,0.18021,0.192,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.020205,0.18005,0.26963,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0046564,0.17973,0.17011,1,1
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00013433,0.17868,0.18281,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0011199,0.17842,0.16062,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00026903,0.17836,0.22362,1,1
3,GO PRIMARY MIRNA PROCESSING,0.0087944,0.17817,0.17025,1,1
3,GO RNA MODIFICATION,0.00034072,0.17762,0.16128,1,1
3,GO SYMBIOTIC PROCESS,8.7323e-05,0.17731,0.16324,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00087311,0.17713,0.17085,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010245,0.1771,0.14983,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.00034072,0.17669,0.1801,1,1
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00010845,0.17655,0.16698,1,1
3,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17624,0.24067,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.0571e-06,0.17621,0.16539,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0017641,0.17617,0.18807,1,1
3,GO FATTY ACID TRANSPORT,0.00074557,0.17603,0.14663,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00038934,0.17601,0.17811,1,1
3,GO TONGUE DEVELOPMENT,0.041967,0.176,0.18708,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00024286,0.17577,0.17109,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00026003,0.1756,0.21319,1,1
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0056288,0.17553,0.14183,1,1
3,GO TRANSLATIONAL ELONGATION,0.013465,0.17542,0.16158,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.027188,0.17509,0.13759,1,1
3,GO RESPONSE TO IRON ION,0.033894,0.17507,0.16452,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034637,0.17498,0.13349,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.010773,0.17429,0.13354,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,7.013e-05,0.1737,0.18929,1,1
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.011326,0.17337,0.18942,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.001191,0.17325,0.2014,1,1
3,GO FATTY ACID CATABOLIC PROCESS,0.029719,0.17318,0.10427,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0059384,0.17227,0.16833,1,1
3,GO HISTONE H3 K4 TRIMETHYLATION,0.0011549,0.1718,0.17388,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0018173,0.17103,0.16244,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.023741,0.17074,0.14362,1,1
3,GO TRNA PROCESSING,0.00028792,0.17067,0.18298,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010506,0.17058,0.15908,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00047456,0.1704,0.19324,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.0047853,0.17033,0.16739,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00065623,0.17018,0.18945,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00067758,0.17004,0.16651,1,1
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.024288,0.16959,0.17512,1,1
3,GO HISTONE H3 K14 ACETYLATION,3.8583e-05,0.16925,0.19803,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.01282,0.16906,0.18254,1,1
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0011549,0.16896,0.19383,1,1
3,GO SIGNAL PEPTIDE PROCESSING,0.015574,0.16886,0.20077,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.044685,0.16862,0.13601,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00020448,0.16832,0.15555,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0037331,0.16819,0.1292,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.012203,0.16811,0.14494,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.040234,0.1681,0.11258,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.017549,0.16756,0.14457,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.001986,0.16732,0.14286,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02068,0.16725,0.14061,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.016339,0.16622,0.20905,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0029794,0.16586,0.1598,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0085714,0.16583,0.13942,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010245,0.16534,0.17512,1,1
3,GO PROTEIN IMPORT,0.0012662,0.1648,0.13747,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.0010528,0.16474,0.14218,1,1
3,GO RNA CATABOLIC PROCESS,0.00014935,0.16465,0.1721,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.011612,0.16398,0.15501,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.013139,0.16388,0.12266,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0017123,0.1636,0.14697,1,1
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014299,0.16358,0.1406,1,1
3,GO RRNA 3 END PROCESSING,0.0099891,0.16344,0.16479,1,1
3,GO LIPID MODIFICATION,0.0041716,0.16339,0.11393,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.0011199,0.16319,0.14502,1,1
3,GO PHOTOPERIODISM,0.03939,0.163,0.10823,1,1
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.012203,0.16294,0.15343,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.011326,0.16221,0.10233,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0087944,0.16216,0.15047,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00055855,0.16207,0.19833,1,1
3,GO THIOESTER METABOLIC PROCESS,0.0034322,0.16194,0.18439,1,1
3,GO TRNA 5 END PROCESSING,0.0014738,0.16194,0.20031,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0039469,0.16178,0.15564,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0071468,0.16149,0.16946,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.018836,0.1614,0.1086,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00038934,0.16111,0.20516,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.040234,0.16054,0.14725,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.0067808,0.16039,0.12688,1,1
3,GO TERPENOID METABOLIC PROCESS,0.026586,0.16011,0.13546,1,1
3,GO P BODY ASSEMBLY,0.00063551,0.1601,0.14729,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.024288,0.1601,0.15318,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00054072,0.15975,0.16627,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.0028141,0.15952,0.15662,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0026572,0.15939,0.14108,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.031059,0.15928,0.13353,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0015189,0.15906,0.17625,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0071468,0.15846,0.22047,1,1
3,GO SKIN DEVELOPMENT,0.023741,0.15835,0.17089,1,1
3,GO EPIDERMIS DEVELOPMENT,0.010506,0.1582,0.17522,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0034322,0.15803,0.21994,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0079323,0.15797,0.16325,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.0099891,0.15793,0.13075,1,1
3,GO STEROL HOMEOSTASIS,0.040234,0.15773,0.099474,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0050528,0.15741,0.17989,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.0075304,0.15736,0.1316,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00019753,0.15679,0.19295,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.045624,0.15644,0.1865,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0025083,0.15635,0.15286,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00081984,0.15548,0.15897,1,1
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.043763,0.15543,0.098774,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.0017123,0.15536,0.13833,1,1
3,GO INTERLEUKIN 17 PRODUCTION,0.013465,0.15451,0.13066,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.03245,0.15448,0.10485,1,1
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.037747,0.15387,0.10327,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00054072,0.15353,0.19197,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.15322,0.17236,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0011549,0.15296,0.11773,1,1
3,GO RESPONSE TO GAMMA RADIATION,0.00079435,0.15283,0.1899,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0014299,0.15279,0.2028,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.5308e-05,0.15277,0.15972,1,1
3,GO CHYLOMICRON ASSEMBLY,0.020205,0.15267,0.10948,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.007729,0.15259,0.23371,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.001986,0.15244,0.17054,1,1
3,GO TOXIN TRANSPORT,0.011612,0.15187,0.13264,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0042883,0.15178,0.16581,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.15147,0.13985,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,2.3418e-05,0.15134,0.17493,1,1
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0081404,0.15133,0.23203,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,8.7323e-05,0.15103,0.14832,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.013798,0.15094,0.11287,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.0066042,0.15075,0.12867,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0012662,0.14967,0.14197,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0097392,0.14944,0.1116,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.025414,0.14926,0.12859,1,1
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00069957,0.14889,0.11609,1,1
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.009256,0.14849,0.15098,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.018836,0.14834,0.12912,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.0025083,0.14824,0.13442,1,1
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0045306,0.14791,0.18977,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0059384,0.14788,0.20213,1,1
3,GO B CELL DIFFERENTIATION,0.0087944,0.14779,0.11694,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0025083,0.14771,0.16408,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.037747,0.14767,0.096891,1,1
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.019283,0.14744,0.13175,1,1
3,GO STEROL METABOLIC PROCESS,0.024288,0.14728,0.092281,1,1
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.8583e-05,0.14657,0.14386,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.027803,0.14583,0.10977,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0083534,0.14582,0.18035,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0013457,0.14555,0.13664,1,1
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0013054,0.14554,0.15599,1,1
3,GO IMPORT INTO NUCLEUS,0.022165,0.14532,0.11197,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00092958,0.14511,0.13625,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.0059384,0.1451,0.11218,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0069616,0.1451,0.1561,1,1
3,GO GMP METABOLIC PROCESS,0.024846,0.14505,0.16515,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0033369,0.14488,0.1124,1,1
3,GO HISTONE PHOSPHORYLATION,0.00081984,0.14481,0.13203,1,1
3,GO INNER EAR MORPHOGENESIS,0.020205,0.14476,0.12936,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.00072223,0.14451,0.13866,1,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0030654,0.14404,0.12769,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.14395,0.22883,1,1
3,GO DIGESTION,0.030383,0.14378,0.090594,1,1
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.001872,0.14324,0.14252,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0025817,0.14295,0.14807,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.012203,0.14273,0.10797,1,1
3,GO GOLGI RIBBON FORMATION,0.031059,0.14271,0.13085,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.0032441,0.14267,0.11376,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,4.1617e-05,0.14217,0.19552,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.013139,0.14184,0.12243,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0006154,0.14149,0.121,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.14111,0.1198,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.0604e-05,0.14079,0.16829,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0019282,0.14069,0.1252,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.041093,0.14062,0.15157,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012508,0.14059,0.14893,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.025994,0.14045,0.14335,1,1
3,GO MALE SEX DIFFERENTIATION,0.015574,0.14021,0.13832,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.016734,0.14017,0.15993,1,1
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00353,0.13959,0.11711,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.010773,0.13947,0.11202,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.001986,0.13931,0.16377,1,1
3,GO NON RECOMBINATIONAL REPAIR,0.0014299,0.13901,0.11734,1,1
3,GO REGULATION OF ORGAN GROWTH,0.033894,0.13834,0.12596,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0022992,0.13778,0.12507,1,1
3,GO COPII COATED VESICLE CARGO LOADING,0.037747,0.13743,0.093374,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.015953,0.13733,0.11238,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,5.4121e-05,0.13709,0.13758,1,1
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.02068,0.13683,0.12415,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001986,0.13672,0.12658,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.018398,0.13665,0.13636,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0057817,0.13629,0.12634,1,1
3,GO BASE EXCISION REPAIR,0.0010206,0.13621,0.13639,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.1192e-05,0.13601,0.12954,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.041093,0.13541,0.098591,1,1
3,GO TISSUE HOMEOSTASIS,0.013139,0.1354,0.092127,1,1
3,GO REGULATION OF T CELL CHEMOTAXIS,0.025994,0.13531,0.16907,1,1
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00049035,0.13527,0.14849,1,1
3,GO NUCLEAR EXPORT,5.0226e-05,0.13523,0.16528,1,1
3,GO DNA GEOMETRIC CHANGE,1.6455e-05,0.13397,0.16783,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0050528,0.13364,0.15621,1,1
3,GO TELOMERE ORGANIZATION,0.00029782,0.13287,0.13882,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0022332,0.13282,0.11892,1,1
3,GO MRNA 3 END PROCESSING,8.1192e-05,0.13165,0.15532,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.030383,0.13121,0.15578,1,1
3,GO MRNA TRANSCRIPTION,0.014138,0.13119,0.14171,1,1
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00012964,0.13118,0.13134,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02268,0.13047,0.14898,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.022165,0.13007,0.098426,1,1
3,GO VIRAL RELEASE FROM HOST CELL,0.010773,0.12974,0.1335,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0014299,0.12965,0.13797,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.0033369,0.12951,0.12847,1,1
3,GO HISTONE UBIQUITINATION,0.031059,0.12923,0.081861,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.025994,0.12906,0.10994,1,1
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.036948,0.12901,0.12515,1,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.0037331,0.12848,0.13599,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0045306,0.128,0.13562,1,1
3,GO EXIT FROM MITOSIS,0.01282,0.1279,0.098681,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00017186,0.12781,0.12316,1,1
3,GO OXIDATIVE DEMETHYLATION,0.025994,0.12765,0.090446,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.038561,0.1275,0.1283,1,1
3,GO CELL CELL RECOGNITION,0.026586,0.12718,0.098306,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.011904,0.12678,0.18035,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.0024367,0.12657,0.10739,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.016734,0.12586,0.12472,1,1
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.041967,0.12579,0.12027,1,1
3,GO RNA PROCESSING,3.4421e-05,0.12572,0.16152,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.00079435,0.12562,0.1332,1,1
3,GO KERATINIZATION,0.025994,0.12552,0.18132,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.0097392,0.12543,0.21557,1,1
3,GO POLYOL METABOLIC PROCESS,0.001191,0.12529,0.14861,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.12488,0.11946,1,1
3,GO HISTONE H3 DEACETYLATION,0.011904,0.12442,0.12474,1,1
3,GO RESPONSE TO IONIZING RADIATION,0.0007696,0.12418,0.16681,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.0041716,0.12386,0.11172,1,1
3,GO GENE SILENCING,5.508e-06,0.12385,0.13907,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.023741,0.12359,0.09924,1,1
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00087311,0.12353,0.16414,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0015189,0.12331,0.12039,1,1
3,GO OXIDATION REDUCTION PROCESS,0.0045306,0.12301,0.11022,1,1
3,GO PROTEIN SUMOYLATION,3.4421e-05,0.12271,0.13421,1,1
3,GO MRNA METABOLIC PROCESS,1.7118e-05,0.12248,0.14894,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.0047853,0.12222,0.13145,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.0021689,0.12218,0.18815,1,1
3,GO MRNA CLEAVAGE,0.00021167,0.12208,0.14874,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00074557,0.12201,0.15557,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.018836,0.12185,0.11987,1,1
3,GO MRNA TRANSPORT,0.00022676,0.1215,0.14785,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.001986,0.12111,0.11249,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0010206,0.1211,0.11727,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0021062,0.12089,0.12252,1,1
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0038387,0.12049,0.10945,1,1
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.012203,0.1204,0.099253,1,1
3,GO EAR MORPHOGENESIS,0.0062634,0.12018,0.14534,1,1
3,GO LIPID METABOLIC PROCESS,0.0029794,0.12016,0.093843,1,1
3,GO LIPID CATABOLIC PROCESS,0.027188,0.12006,0.07731,1,1
3,GO ACTIN NUCLEATION,0.0085714,0.11917,0.12397,1,1
3,GO BODY FLUID SECRETION,0.0049174,0.11914,0.1296,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.02843,0.11904,0.11588,1,1
3,GO PROTEIN NEDDYLATION,0.02166,0.11873,0.10961,1,1
3,GO REGULATION OF MYELINATION,0.026586,0.11862,0.11447,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00019079,0.11822,0.14927,1,1
3,GO LIPID HOMEOSTASIS,0.023205,0.11811,0.084156,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00057693,0.11795,0.14871,1,1
3,GO NUCLEAR TRANSPORT,0.0012662,0.11762,0.12208,1,1
3,GO EPITHELIAL TUBE FORMATION,0.0071468,0.1167,0.14776,1,1
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0025083,0.11639,0.10776,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.020205,0.11613,0.12997,1,1
3,GO DNA BIOSYNTHETIC PROCESS,0.0013457,0.11565,0.096928,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0028141,0.11562,0.11311,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0014299,0.11549,0.11659,1,1
3,GO RESPONSE TO UV,0.001662,0.11535,0.13673,1,1
3,GO RNA CAPPING,0.0075304,0.11512,0.09999,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022332,0.11423,0.12333,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.011612,0.11377,0.095786,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041967,0.11371,0.11386,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.0025083,0.11348,0.12878,1,1
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0022992,0.1134,0.11392,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0029794,0.11337,0.14379,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023205,0.11295,0.092148,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.0094949,0.11289,0.10223,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00084609,0.11254,0.13447,1,1
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.011047,0.11244,0.094214,1,1
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0067808,0.11242,0.089633,1,1
3,GO RESPONSE TO ALCOHOL,0.042857,0.11204,0.084471,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.00016595,0.11197,0.12128,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.029068,0.11173,0.09598,1,1
3,GO POLYAMINE METABOLIC PROCESS,0.027188,0.11154,0.12868,1,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0075304,0.11133,0.097153,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00084609,0.11121,0.13329,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0073363,0.11097,0.086476,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.011612,0.11083,0.080932,1,1
3,GO RNA EXPORT FROM NUCLEUS,9.0551e-05,0.11068,0.17069,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.0085714,0.11007,0.13481,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0034322,0.11001,0.12959,1,1
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.007729,0.10989,0.13571,1,1
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.020205,0.10979,0.11394,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.026586,0.10972,0.11891,1,1
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0001165,0.10956,0.14472,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.040234,0.10911,0.093241,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0069616,0.10818,0.12496,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.0019282,0.1079,0.27769,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0090226,0.10781,0.10079,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.004408,0.10774,0.080633,1,1
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.016734,0.107,0.10545,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.02268,0.10697,0.083028,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.0007696,0.10681,0.11294,1,1
3,GO MRNA PROCESSING,0.00013433,0.10673,0.12377,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.0033369,0.10672,0.10286,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0067808,0.1067,0.10033,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.00035231,0.10664,0.11339,1,1
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00016023,0.10552,0.11528,1,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.1617e-05,0.10498,0.11054,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.045624,0.10488,0.10611,1,1
3,GO TUBE FORMATION,0.0087944,0.10442,0.13705,1,1
3,GO GOLGI VESICLE TRANSPORT,0.0028957,0.10273,0.087268,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.011326,0.1026,0.090222,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022165,0.10246,0.078972,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.001872,0.10198,0.11746,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00084609,0.10158,0.11675,1,1
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.036948,0.1012,0.071555,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.043763,0.10086,0.14201,1,1
3,GO HISTONE H3 ACETYLATION,0.00038934,0.10023,0.10638,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00024286,0.099617,0.12281,1,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00016023,0.099248,0.10584,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0013872,0.098422,0.13266,1,1
3,GO ACTIN MEDIATED CELL CONTRACTION,0.031748,0.098225,0.11822,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.038561,0.098218,0.077351,1,1
3,GO RNA LOCALIZATION,9.0551e-05,0.098195,0.15685,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.025414,0.097938,0.092131,1,1
3,GO DNA METHYLATION,0.001191,0.097405,0.11385,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.036164,0.097182,0.078226,1,1
3,GO MRNA EXPORT FROM NUCLEUS,0.00032948,0.097151,0.15323,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.031748,0.097136,0.0924,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.036164,0.097096,0.088946,1,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.018836,0.096858,0.064618,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0087944,0.096056,0.10869,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.010506,0.095767,0.11516,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.029719,0.095448,0.082843,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0017123,0.09529,0.11351,1,1
3,GO REGULATION OF DNA REPAIR,0.027803,0.095058,0.072378,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0059384,0.094865,0.11924,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0057817,0.094424,0.14149,1,1
3,GO STEM CELL DIFFERENTIATION,0.010773,0.094058,0.12095,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00353,0.093801,0.099404,1,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00072223,0.093578,0.089556,1,1
3,GO RNA SPLICING,0.00032948,0.093084,0.12073,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.0094949,0.092643,0.08035,1,1
3,GO DNA CONFORMATION CHANGE,0.0022992,0.092533,0.094702,1,1
3,GO CHROMATIN REMODELING,0.00029782,0.092448,0.11632,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.023741,0.091637,0.084245,1,1
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.4346e-05,0.090771,0.1302,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.0051916,0.090737,0.078205,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.023741,0.089775,0.1034,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011904,0.08948,0.086803,1,1
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00047456,0.088858,0.12069,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.02166,0.088762,0.10133,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0075304,0.088757,0.10111,1,1
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.001228,0.087903,0.084858,1,1
3,GO CELLULAR RESPONSE TO UV,0.0060989,0.087743,0.11549,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.02843,0.08723,0.082009,1,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.041093,0.086364,0.078517,1,1
3,GO CELL CYCLE PHASE TRANSITION,0.0073363,0.086257,0.08139,1,1
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.041967,0.085751,0.082296,1,1
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.085516,0.089922,1,1
3,GO SNRNA METABOLIC PROCESS,0.0022992,0.085496,0.10364,1,1
3,GO MACROMOLECULE CATABOLIC PROCESS,0.0038387,0.084422,0.077762,1,1
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.017969,0.083117,0.075529,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,0.02843,0.083088,0.072255,1,1
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00072223,0.0828,0.098703,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0039469,0.081934,0.09326,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.033894,0.081705,0.097138,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0019282,0.08097,0.10037,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.041967,0.080511,0.07287,1,1
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.014841,0.080452,0.10521,1,1
3,GO STEROID METABOLIC PROCESS,0.026586,0.08016,0.066894,1,1
3,GO SELECTIVE AUTOPHAGY,0.017969,0.079739,0.093905,1,1
3,GO DOUBLE STRAND BREAK REPAIR,0.0016129,0.079692,0.10174,1,1
3,GO CHROMOSOME SEPARATION,0.026586,0.078615,0.076513,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001986,0.078376,0.089469,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.017969,0.077976,0.11981,1,1
3,GO REGULATION OF CHROMOSOME SEPARATION,0.019739,0.077307,0.098388,1,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.018836,0.07674,0.095021,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.034637,0.075331,0.060103,1,1
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.014138,0.075052,0.091265,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0051916,0.072273,0.070045,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0090226,0.071385,0.10286,1,1
3,GO REGULATION OF RNA SPLICING,0.017137,0.071372,0.089751,1,1
3,GO RESPONSE TO RADIATION,0.0075304,0.071316,0.071314,1,1
3,GO DNA METABOLIC PROCESS,0.00065623,0.069042,0.076051,1,1
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0085714,0.06879,0.068234,1,1
3,GO REGULATION OF DNA METABOLIC PROCESS,0.0029794,0.068134,0.078725,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.041967,0.067885,0.086184,1,1
3,GO DNA MODIFICATION,0.0015653,0.06723,0.078711,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.009256,0.067219,0.079738,1,1
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.02843,0.065806,0.083378,1,1
3,GO DNA INTEGRITY CHECKPOINT,0.029068,0.065549,0.081761,1,1
3,GO MACROAUTOPHAGY,0.027803,0.065165,0.054319,1,1
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0020453,0.063603,0.10135,1,1
3,GO MITOTIC NUCLEAR DIVISION,0.03939,0.06225,0.069712,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.018398,0.061532,0.092842,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.027188,0.060788,0.066093,1,1
3,GO DNA REPAIR,0.0016129,0.060215,0.077932,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.004408,0.058792,0.059091,1,1
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.037747,0.057915,0.083609,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.042857,0.057435,0.049978,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.02068,0.056633,0.048629,1,1
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.023741,0.053938,0.075505,1,1
3,GO RESPONSE TO LIGHT STIMULUS,0.027188,0.053593,0.06027,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.03245,0.051571,0.06987,1,1
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0085714,0.049786,0.06961,1,1
3,GO DNA RECOMBINATION,0.017137,0.049753,0.079231,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.033894,0.048029,0.064391,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.024288,0.047121,0.047038,1,1
3,GO CHROMOSOME ORGANIZATION,0.0099891,0.040902,0.062854,1,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020205,0.040675,0.04923,1,1
3,GO COVALENT CHROMATIN MODIFICATION,0.033894,0.036669,0.05146,1,1
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.035158,0.067746,1,1
4,GO BLEB ASSEMBLY,1.1237e-07,1.6202,1.4836,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.3218e-05,1.537,1.3321,1,1
4,GO MEMBRANE RAFT ASSEMBLY,9.4334e-07,1.4257,1.6075,1,1
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.2317,1.0334,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,7.8282e-05,1.2056,1.0142,1,1
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.071e-07,1.1934,1.1733,1,1
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.6603e-06,1.1702,1.1577,1,1
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,6.5896e-07,1.1589,1.0076,1,1
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.8084e-07,1.134,1.0144,1,1
4,GO TROPHOBLAST CELL MIGRATION,1.0207e-07,1.0912,0.96928,1,1
4,GO RESPONSE TO INTERFERON ALPHA,4.5813e-07,1.076,1.1429,1,1
4,GO T HELPER 2 CELL DIFFERENTIATION,3.9926e-07,1.0692,1.0034,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.6228e-06,1.0476,1.0026,1,1
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.8251e-06,1.0451,0.9169,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00017796,1.0416,0.74827,1,1
4,GO NEUTROPHIL HOMEOSTASIS,3.9926e-07,1.0348,0.98055,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.8084e-07,1.0286,1.0431,1,1
4,GO HYALURONAN CATABOLIC PROCESS,3.6563e-08,1.0272,1.1005,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,8.1192e-05,1.0145,0.8732,1,1
4,GO RESPONSE TO INTERFERON BETA,1.4044e-06,1.0058,1.0056,1,1
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.8958e-07,0.99939,1.0022,1,1
4,GO GLYCOPROTEIN CATABOLIC PROCESS,8.4155e-08,0.99651,0.92658,1,1
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,7.9801e-06,0.97653,0.82404,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.4878e-05,0.96933,0.81612,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.4772e-07,0.93268,0.98915,1,1
4,GO NEGATIVE REGULATION OF CELL KILLING,7.9801e-06,0.92892,0.80681,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.0033e-05,0.92141,0.81434,1,1
4,GO REGULATION OF METANEPHROS DEVELOPMENT,5.4272e-08,0.92007,0.9478,1,1
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,9.8628e-07,0.91994,0.86583,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,1.5201e-05,0.9193,0.8749,1,1
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,1.5816e-05,0.91599,0.78809,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00016595,0.91524,0.68482,1,1
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.2424e-08,0.91414,0.94863,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.4728e-06,0.90936,0.87337,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.5896e-07,0.90321,0.82466,1,1
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.6228e-06,0.89257,1.0796,1,1
4,GO HEMIDESMOSOME ASSEMBLY,1.6455e-05,0.88469,1.1712,1,1
4,GO T HELPER 1 CELL DIFFERENTIATION,3.0264e-07,0.87942,0.82221,1,1
4,GO ENDODERMAL CELL DIFFERENTIATION,4.9191e-08,0.87035,0.93596,1,1
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,8.628e-07,0.86993,0.81337,1,1
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00016023,0.8676,0.79602,1,1
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.4044e-06,0.86521,0.72344,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,8.0176e-08,0.86182,0.87975,1,1
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.0683e-06,0.85999,0.77134,1,1
4,GO COLLAGEN BIOSYNTHETIC PROCESS,6.2859e-08,0.85508,0.85239,1,1
4,GO MEMBRANE RAFT ORGANIZATION,1.3441e-06,0.85217,0.95192,1,1
4,GO BONE TRABECULA FORMATION,0.00011241,0.84028,0.79195,1,1
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.5122e-07,0.83422,0.79977,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.4994e-06,0.83326,0.67467,1,1
4,GO CD40 SIGNALING PATHWAY,9.2696e-08,0.82693,0.78863,1,1
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.5691e-07,0.82175,0.78534,1,1
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.8084e-07,0.81999,0.76049,1,1
4,GO INFLAMMATORY RESPONSE TO WOUNDING,1.0311e-06,0.81759,0.93372,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.4334e-07,0.81364,0.87121,1,1
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,5.2837e-06,0.80982,0.86645,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.9904e-06,0.80446,0.63411,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.9301e-06,0.80137,0.65367,1,1
4,GO ZYMOGEN INHIBITION,5.753e-07,0.79652,0.80434,1,1
4,GO PLASMINOGEN ACTIVATION,0.00010092,0.79105,0.62348,1,1
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.3763e-07,0.79033,0.73223,1,1
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.4728e-06,0.78315,0.65368,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.0829e-07,0.78271,0.78567,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,1.8521e-05,0.7774,0.63198,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,9.8628e-07,0.77482,0.67983,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.77167,0.65046,1,1
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0033e-05,0.76869,0.61658,1,1
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.4044e-06,0.76756,0.72141,1,1
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.5122e-07,0.76737,0.74242,1,1
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00081984,0.76704,0.61104,1,1
4,GO CHRONIC INFLAMMATORY RESPONSE,4.4572e-08,0.76567,0.81147,1,1
4,GO ENDODERM FORMATION,6.6003e-08,0.76452,0.82532,1,1
4,GO HIPPO SIGNALING,2.0784e-06,0.75833,0.62243,1,1
4,GO CHAPERONE MEDIATED AUTOPHAGY,5.8301e-05,0.75597,0.61384,1,1
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,8.2505e-07,0.75166,0.72035,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00012512,0.75149,0.63767,1,1
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.8077e-06,0.74902,0.80662,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.1776e-06,0.74323,0.65467,1,1
4,GO CYSTEINE METABOLIC PROCESS,7.547e-05,0.74235,0.59077,1,1
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.2308e-06,0.74179,0.68499,1,1
4,GO EPIBOLY,9.2696e-08,0.73565,0.79916,1,1
4,GO LATERAL MESODERM DEVELOPMENT,9.3916e-06,0.73191,0.60779,1,1
4,GO GAP JUNCTION ASSEMBLY,8.628e-07,0.73129,0.67873,1,1
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2366e-07,0.72952,0.67823,1,1
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,5.6999e-08,0.72741,0.72055,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.6455e-05,0.72536,0.70767,1,1
4,GO CELLULAR RESPONSE TO X RAY,3.1888e-05,0.72155,0.55245,1,1
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.5774e-06,0.72044,0.66677,1,1
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.2424e-08,0.71993,0.71921,1,1
4,GO RESPONSE TO MURAMYL DIPEPTIDE,4.3763e-07,0.71959,0.66344,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.4674e-06,0.71211,0.66611,1,1
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.3441e-06,0.70893,0.67334,1,1
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.70463,0.61357,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.4712e-06,0.70343,0.72451,1,1
4,GO LEUKOCYTE AGGREGATION,0.00023468,0.69722,0.5829,1,1
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.2879e-07,0.69195,0.66353,1,1
4,GO MULTI ORGANISM CELLULAR PROCESS,3.4772e-07,0.68664,0.84811,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.2837e-06,0.68636,0.60558,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00044439,0.68562,0.62353,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,9.3916e-06,0.68372,0.6945,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,4.0073e-05,0.68327,0.5481,1,1
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.8131e-07,0.68278,0.6349,1,1
4,GO VASCULOGENESIS,3.6563e-08,0.68204,0.6538,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,7.889e-07,0.67903,0.81183,1,1
4,GO FIBRINOLYSIS,6.5896e-07,0.67892,0.82778,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.5331e-06,0.67604,0.59747,1,1
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.906e-06,0.66631,0.71738,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.0073e-05,0.66583,0.57596,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,4.3763e-07,0.66483,0.71001,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.5816e-05,0.66109,0.47875,1,1
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.5759e-05,0.66063,0.59806,1,1
4,GO T CELL EXTRAVASATION,7.6603e-06,0.66048,0.67073,1,1
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.1964e-05,0.66029,0.73701,1,1
4,GO REGULATION OF PINOCYTOSIS,3.9418e-06,0.65699,0.66586,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,6.0504e-05,0.65196,0.59068,1,1
4,GO SKIN MORPHOGENESIS,1.7118e-05,0.65191,0.78369,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,8.3127e-06,0.64875,0.61738,1,1
4,GO SALIVARY GLAND DEVELOPMENT,2.4692e-06,0.64757,0.62551,1,1
4,GO APOPTOTIC CELL CLEARANCE,1.3605e-07,0.64512,0.72745,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,2.3654e-06,0.64366,0.64371,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.4121e-05,0.6423,0.51051,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00011241,0.64199,0.61132,1,1
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0001165,0.64162,0.53407,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.7578e-07,0.64148,0.62761,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.2111e-07,0.64007,0.6592,1,1
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6729e-06,0.6392,0.59043,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.0226e-05,0.63898,0.52941,1,1
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,6.4994e-06,0.63626,0.71843,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.9841e-06,0.63346,0.67457,1,1
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,7.2754e-05,0.63336,0.53998,1,1
4,GO PIGMENT GRANULE MATURATION,5.0226e-05,0.63062,0.46882,1,1
4,GO NEGATIVE REGULATION OF CELL AGING,2.7104e-08,0.62907,0.63903,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.6603e-06,0.62864,0.53364,1,1
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.9301e-06,0.62737,0.71842,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,1.104e-05,0.62689,0.52799,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.1617e-05,0.62645,0.52547,1,1
4,GO NOTOCHORD DEVELOPMENT,6.2985e-07,0.62633,0.70423,1,1
4,GO ENDODERM DEVELOPMENT,1.6452e-07,0.62469,0.66681,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.6452e-07,0.62358,0.678,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,2.4346e-05,0.62346,0.50282,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,3.0689e-05,0.62256,0.57686,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,9.7801e-06,0.62202,0.65902,1,1
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.61556,0.56702,1,1
4,GO DNA DEAMINATION,1.5816e-05,0.61555,0.60349,1,1
4,GO AMYLOID BETA CLEARANCE,8.4155e-08,0.61524,0.54825,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,9.389e-05,0.61339,0.55027,1,1
4,GO VAGINA DEVELOPMENT,3.3202e-07,0.61256,0.65971,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,2.1663e-05,0.61217,0.53119,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.4044e-06,0.61151,0.55407,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,3.0576e-06,0.61138,0.49239,1,1
4,GO SNRNA PROCESSING,0.00055855,0.60934,0.62006,1,1
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0081404,0.60817,0.41231,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00016595,0.60764,0.55067,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,7.9801e-06,0.60628,0.69415,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,5.0683e-06,0.60619,0.49758,1,1
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2658e-06,0.60537,0.57039,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,1.4609e-05,0.60305,0.62135,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.8251e-06,0.60224,0.65497,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.0221e-07,0.60223,0.61496,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.17e-07,0.60211,0.64619,1,1
4,GO COLLAGEN METABOLIC PROCESS,7.889e-07,0.60033,0.59808,1,1
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.2366e-07,0.59871,0.52701,1,1
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,5.2837e-06,0.59842,0.57506,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.8251e-06,0.5982,0.58861,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.2985e-07,0.59693,0.70293,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,5.508e-06,0.59621,0.47806,1,1
4,GO LIVER REGENERATION,5.6999e-08,0.59611,0.6007,1,1
4,GO BIOLOGICAL PHASE,0.00030804,0.59458,0.58572,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,1.8251e-06,0.59451,0.52684,1,1
4,GO HEME METABOLIC PROCESS,1.2308e-06,0.59409,0.53114,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.001872,0.59369,0.71041,1,1
4,GO REGULATION OF FIBRINOLYSIS,3.5759e-05,0.59308,0.60062,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,2.7343e-05,0.59277,0.51514,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.8958e-07,0.59276,0.61529,1,1
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.2308e-06,0.59159,0.654,1,1
4,GO CELLULAR RESPONSE TO IRON ION,1.2962e-05,0.59125,0.54788,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,1.2962e-05,0.58993,0.51416,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.349e-05,0.58951,0.57788,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.0689e-05,0.58926,0.65964,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,1.7118e-05,0.5891,0.56174,1,1
4,GO MUCUS SECRETION,0.0028957,0.58748,0.46948,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.6228e-06,0.58588,0.6777,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,4.8612e-06,0.58529,0.60886,1,1
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,5.0226e-05,0.58365,0.46739,1,1
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,8.6584e-06,0.58286,0.49544,1,1
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.0829e-07,0.58243,0.58483,1,1
4,GO MACROPHAGE PROLIFERATION,4.0073e-05,0.57999,0.56675,1,1
4,GO ELASTIC FIBER ASSEMBLY,0.00016595,0.57954,0.70907,1,1
4,GO BONE TRABECULA MORPHOGENESIS,0.0022332,0.57928,0.47339,1,1
4,GO MODULATION BY HOST OF VIRAL PROCESS,8.8325e-08,0.57919,0.6336,1,1
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.3605e-07,0.57918,0.63182,1,1
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,6.2367e-06,0.57865,0.60154,1,1
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00013433,0.57848,0.48403,1,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.9904e-06,0.57823,0.50676,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.2837e-06,0.57606,0.63028,1,1
4,GO AORTIC VALVE DEVELOPMENT,9.3916e-06,0.57598,0.53352,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,4.1112e-06,0.57423,0.62196,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,1.0184e-05,0.57321,0.5496,1,1
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00026903,0.57251,0.61432,1,1
4,GO ENTRY INTO HOST,3.17e-07,0.57198,0.59247,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4674e-06,0.57079,0.49872,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.104e-05,0.56938,0.502,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,2.9532e-05,0.56806,0.73866,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.6455e-05,0.56519,0.46243,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.0194e-07,0.5628,0.61117,1,1
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0022992,0.56159,0.39377,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.6307e-05,0.55988,0.46954,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.55959,0.50843,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4712e-06,0.55853,0.53271,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.2862e-06,0.55774,0.48513,1,1
4,GO CELLULAR RESPONSE TO DSRNA,1.725e-07,0.557,0.57794,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.042857,0.55357,0.34697,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,9.7346e-05,0.55336,0.48007,1,1
4,GO REGULATION OF GLOMERULAR FILTRATION,0.00024286,0.5528,0.58782,1,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.0207e-07,0.55218,0.53285,1,1
4,GO TYPE 2 IMMUNE RESPONSE,7.9801e-06,0.5506,0.54977,1,1
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,2.0784e-06,0.5505,0.52172,1,1
4,GO CYTOLYSIS,1.2862e-06,0.54962,0.4966,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.4977e-07,0.5495,0.64045,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.17e-07,0.54697,0.52031,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.0576e-06,0.54645,0.5054,1,1
4,GO RESPONSE TO X RAY,5.4977e-07,0.54565,0.5777,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00042998,0.54443,0.45712,1,1
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00026903,0.54429,0.45909,1,1
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0007696,0.54281,0.3958,1,1
4,GO INTERLEUKIN 1 PRODUCTION,5.2837e-06,0.53987,0.48705,1,1
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,7.9801e-06,0.53874,0.50146,1,1
4,GO COLLAGEN CATABOLIC PROCESS,1.8251e-06,0.53677,0.57596,1,1
4,GO MESODERMAL CELL DIFFERENTIATION,1.5331e-06,0.53434,0.46425,1,1
4,GO ZYMOGEN ACTIVATION,1.9263e-05,0.53383,0.52862,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.7955e-07,0.5333,0.57902,1,1
4,GO TOLERANCE INDUCTION,0.00020448,0.53304,0.48451,1,1
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.8084e-07,0.53268,0.54957,1,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.5816e-05,0.53094,0.54671,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,8.1192e-05,0.53002,0.51754,1,1
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,3.8131e-07,0.5296,0.53414,1,1
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.033166,0.52838,0.29197,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,1.4674e-06,0.52806,0.50398,1,1
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,5.2837e-06,0.52665,0.47363,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,7.2754e-05,0.52653,0.442,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.2971e-07,0.52641,0.6023,1,1
4,GO XENOBIOTIC CATABOLIC PROCESS,0.0012662,0.52614,0.54319,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.025414,0.52405,0.29166,1,1
4,GO FORMATION OF PRIMARY GERM LAYER,1.2971e-07,0.52372,0.52548,1,1
4,GO SKELETAL MUSCLE TISSUE REGENERATION,2.4692e-06,0.52328,0.47487,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.8077e-06,0.52287,0.43441,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.2533e-07,0.52137,0.50961,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0001165,0.52076,0.45073,1,1
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0311e-06,0.51992,0.47903,1,1
4,GO VIRAL GENOME REPLICATION,1.5331e-06,0.51779,0.45913,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,0.51762,0.50648,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.5896e-07,0.51749,0.45881,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00023468,0.51714,0.43271,1,1
4,GO CELLULAR RESPONSE TO SALT STRESS,2.9301e-06,0.51547,0.55253,1,1
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00034072,0.51399,0.49181,1,1
4,GO RESPONSE TO INTERFERON GAMMA,3.1904e-06,0.51373,0.51566,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.3287e-06,0.51344,0.4293,1,1
4,GO RESPONSE TO TYPE I INTERFERON,7.2754e-05,0.51342,0.60157,1,1
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0007696,0.51309,0.42695,1,1
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.001986,0.51179,0.468,1,1
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.5427e-07,0.51143,0.51989,1,1
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.51114,0.43642,1,1
4,GO REGULATION OF MEMBRANE INVAGINATION,4.8379e-05,0.51054,0.50322,1,1
4,GO PULMONARY VALVE DEVELOPMENT,2.9532e-05,0.51006,0.52798,1,1
4,GO COLLAGEN FIBRIL ORGANIZATION,4.1802e-07,0.50975,0.75103,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,3.9418e-06,0.50831,0.45685,1,1
4,GO SEMI LUNAR VALVE DEVELOPMENT,7.0571e-06,0.5083,0.51712,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.986e-08,0.50793,0.51951,1,1
4,GO T CELL MEDIATED IMMUNITY,5.7413e-06,0.50749,0.46847,1,1
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.8131e-07,0.50644,0.445,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,8.4205e-05,0.50559,0.48982,1,1
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,2.8418e-05,0.50512,0.6686,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,2.1702e-06,0.50384,0.64394,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,1.5201e-05,0.50369,0.49493,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.5759e-05,0.50344,0.39801,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,2.7578e-07,0.50231,0.50057,1,1
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.9904e-06,0.50181,0.43838,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.4044e-06,0.50099,0.59299,1,1
4,GO NCRNA 3 END PROCESSING,0.0023671,0.50049,0.41998,1,1
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,3.1904e-06,0.49913,0.51372,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00055855,0.49904,0.43655,1,1
4,GO PEPTIDE CROSS LINKING,9.0551e-05,0.49844,0.51113,1,1
4,GO POSITIVE REGULATION OF ERAD PATHWAY,3.4772e-07,0.49818,0.48082,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,1.1267e-06,0.49778,0.5467,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.2862e-06,0.49739,0.54362,1,1
4,GO SNRNA METABOLIC PROCESS,0.00014935,0.49715,0.50159,1,1
4,GO LYMPHANGIOGENESIS,6.8936e-07,0.49659,0.49766,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00021909,0.49644,0.44276,1,1
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.013e-05,0.49636,0.51062,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0024367,0.49603,0.40703,1,1
4,GO RESPONSE TO HYPEROXIA,3.1888e-05,0.49576,0.50399,1,1
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,2.3418e-05,0.4957,0.60339,1,1
4,GO STORE OPERATED CALCIUM ENTRY,9.7801e-06,0.49539,0.40482,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00042998,0.49536,0.45955,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0006154,0.49409,0.42515,1,1
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0006154,0.49387,0.4633,1,1
4,GO PHAGOCYTOSIS RECOGNITION,4.6597e-05,0.49342,0.56282,1,1
4,GO DETECTION OF BIOTIC STIMULUS,5.9841e-06,0.49201,0.48496,1,1
4,GO GERMINAL CENTER FORMATION,0.00014935,0.49189,0.45072,1,1
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.3654e-06,0.48985,0.42737,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,8.3127e-06,0.48682,0.50153,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.0194e-07,0.4858,0.48739,1,1
4,GO PINOCYTOSIS,6.0198e-07,0.48579,0.6063,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.2859e-08,0.48568,0.49808,1,1
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.9904e-06,0.48502,0.45136,1,1
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00014418,0.48496,0.38321,1,1
4,GO PROTEIN OXIDATION,0.00028792,0.48447,0.48241,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.3287e-06,0.48156,0.47304,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.7801e-06,0.48118,0.48285,1,1
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.8583e-05,0.48084,0.41102,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040247,0.48059,0.3766,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00013433,0.48017,0.48185,1,1
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,4.2876e-06,0.47981,0.5046,1,1
4,GO RESPONSE TO ANGIOTENSIN,6.0198e-07,0.47974,0.47927,1,1
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00037661,0.4782,0.39544,1,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.47789,0.43376,1,1
4,GO VIRAL RNA GENOME REPLICATION,8.8325e-08,0.47778,0.45863,1,1
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014418,0.47666,0.37759,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,9.2696e-08,0.4766,0.42306,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00025131,0.47632,0.37753,1,1
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.00069957,0.47561,0.34712,1,1
4,GO PEPTIDYL PROLINE MODIFICATION,9.8628e-07,0.47554,0.39637,1,1
4,GO NIK NF KAPPAB SIGNALING,4.7955e-07,0.4751,0.42039,1,1
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.2862e-06,0.47487,0.50251,1,1
4,GO CYTOKINE METABOLIC PROCESS,1.5331e-06,0.47403,0.41655,1,1
4,GO BLOOD VESSEL REMODELING,2.0833e-05,0.47379,0.43883,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00021909,0.47378,0.45168,1,1
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00011241,0.47378,0.46108,1,1
4,GO REGULATION OF TRANSPOSITION,0.00014418,0.47325,0.46463,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.47301,0.53275,1,1
4,GO HYALURONAN METABOLIC PROCESS,1.1237e-07,0.47297,0.52167,1,1
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0047853,0.4729,0.35353,1,1
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,5.753e-07,0.47243,0.4334,1,1
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.7955e-07,0.47221,0.49545,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.5308e-05,0.47181,0.44513,1,1
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.2962e-05,0.47136,0.48344,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9904e-06,0.47106,0.45275,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0087944,0.47047,0.40213,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0010528,0.46949,0.46298,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0014738,0.46929,0.37036,1,1
4,GO ENAMEL MINERALIZATION,0.00072223,0.4692,0.423,1,1
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,1.7806e-05,0.46886,0.43651,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.5308e-05,0.46844,0.45581,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.46829,0.42022,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,4.3763e-07,0.46814,0.50586,1,1
4,GO DEFENSE RESPONSE TO VIRUS,9.3916e-06,0.46678,0.41691,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.43498,1,1
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.4977e-07,0.46666,0.50854,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9418e-06,0.4665,0.41569,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.6455e-05,0.46553,0.46816,1,1
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.001662,0.46536,0.31918,1,1
4,GO MATURATION OF LSU RRNA,2.9532e-05,0.46526,0.46768,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,3.1904e-06,0.46434,0.45831,1,1
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.5308e-05,0.46346,0.50702,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0012662,0.46336,0.39519,1,1
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,6.7728e-06,0.46328,0.52107,1,1
4,GO RESPONSE TO INTERLEUKIN 12,2.7578e-07,0.4632,0.44563,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0024367,0.4632,0.38962,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.9904e-06,0.46315,0.41691,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00045924,0.46295,0.33024,1,1
4,GO REGULATION OF MRNA BINDING,3.3287e-06,0.4627,0.41994,1,1
4,GO OSTEOBLAST DEVELOPMENT,0.00022676,0.46245,0.40815,1,1
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.4421e-05,0.46232,0.46111,1,1
4,GO BONE GROWTH,7.0571e-06,0.4616,0.52384,1,1
4,GO PROTEIN ACTIVATION CASCADE,5.0683e-06,0.46127,0.40035,1,1
4,GO LYMPH VESSEL MORPHOGENESIS,1.1964e-05,0.46093,0.43354,1,1
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00010845,0.4598,0.52745,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.020205,0.4594,0.23727,1,1
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,6.2985e-07,0.45774,0.50017,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00022676,0.45763,0.41872,1,1
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.033166,0.45761,0.29427,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,5.2837e-06,0.45696,0.45234,1,1
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.5427e-07,0.45695,0.43908,1,1
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.8521e-05,0.45626,0.40839,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,6.2367e-06,0.45585,0.4609,1,1
4,GO RESPONSE TO PROGESTERONE,0.0017641,0.45583,0.32059,1,1
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.2658e-06,0.4558,0.46274,1,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.45573,0.4068,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00016023,0.45571,0.4926,1,1
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.00081984,0.4554,0.34936,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.2876e-06,0.45535,0.36981,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,3.4421e-05,0.45525,0.39758,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,8.3127e-06,0.45515,0.49197,1,1
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.5774e-06,0.45481,0.39375,1,1
4,GO ANIMAL ORGAN REGENERATION,2.3975e-07,0.45455,0.50144,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6322e-07,0.45439,0.3975,1,1
4,GO PROTEASOME ASSEMBLY,4.1617e-05,0.45437,0.3364,1,1
4,GO REGULATION OF MYOBLAST FUSION,0.00023468,0.45363,0.50937,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.4268e-07,0.45311,0.41291,1,1
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,1.2962e-05,0.45257,0.48879,1,1
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,2.2879e-07,0.4525,0.50145,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.628e-07,0.45234,0.47687,1,1
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.2505e-07,0.45233,0.44963,1,1
4,GO MRNA TRANSCRIPTION,1.4039e-05,0.45148,0.38383,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.3654e-06,0.45052,0.39493,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.5331e-06,0.45007,0.39722,1,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.889e-07,0.44967,0.50353,1,1
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00017796,0.44966,0.36998,1,1
4,GO MUSCLE CELL FATE COMMITMENT,0.00027832,0.44965,0.41466,1,1
4,GO REPLICATIVE SENESCENCE,0.00353,0.44847,0.39897,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,5.4121e-05,0.44817,0.48627,1,1
4,GO CYTOPLASMIC TRANSLATION,0.00010845,0.44817,0.37787,1,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,9.4334e-07,0.44781,0.41043,1,1
4,GO VIRAL TRANSLATION,1.3441e-06,0.44742,0.46639,1,1
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00019079,0.44657,0.48508,1,1
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00010845,0.44599,0.40653,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9904e-06,0.44516,0.41648,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,2.2658e-06,0.44452,0.37293,1,1
4,GO PARAXIAL MESODERM DEVELOPMENT,7.8282e-05,0.44444,0.4301,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.6902e-06,0.44436,0.45121,1,1
4,GO CELLULAR COPPER ION HOMEOSTASIS,2.5308e-05,0.44397,0.53678,1,1
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00014935,0.4436,0.4002,1,1
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,4.4712e-06,0.44329,0.41603,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00031859,0.44306,0.32562,1,1
4,GO REGULATION OF TRANSLATIONAL TERMINATION,1.8521e-05,0.44305,0.39401,1,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.725e-07,0.4425,0.43634,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.3287e-06,0.44232,0.48818,1,1
4,GO MYELOID CELL APOPTOTIC PROCESS,7.547e-05,0.44199,0.42664,1,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.0012662,0.44186,0.37157,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,4.5813e-07,0.44172,0.37855,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.1663e-05,0.44164,0.43129,1,1
4,GO EMBRYO IMPLANTATION,2.6322e-07,0.44132,0.5358,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.8612e-06,0.44108,0.53545,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.1904e-06,0.44026,0.40879,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00050664,0.43989,0.47689,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6015e-06,0.43934,0.44559,1,1
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,6.4994e-06,0.43912,0.42886,1,1
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.011047,0.43852,0.43959,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0014299,0.43804,0.52162,1,1
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0014299,0.43786,0.51255,1,1
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00063551,0.4374,0.51307,1,1
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00063551,0.4374,0.63563,1,1
4,GO RESPONSE TO FLUID SHEAR STRESS,5.0194e-07,0.43604,0.48761,1,1
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,6.2786e-05,0.43596,0.39399,1,1
4,GO INTERLEUKIN 2 PRODUCTION,5.753e-07,0.43407,0.45456,1,1
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,5.2533e-07,0.43302,0.41205,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,3.3132e-05,0.43244,0.39143,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00029782,0.43191,0.44502,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.7343e-05,0.43171,0.38489,1,1
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.4121e-05,0.43024,0.3901,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00069957,0.43016,0.44846,1,1
4,GO RECEPTOR CATABOLIC PROCESS,2.5774e-06,0.42956,0.43152,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00040247,0.4288,0.41113,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.6015e-06,0.42879,0.42076,1,1
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.906e-06,0.42869,0.58892,1,1
4,GO MAMMARY GLAND MORPHOGENESIS,1.104e-05,0.42862,0.4467,1,1
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,6.0504e-05,0.42837,0.37197,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00016595,0.42826,0.4472,1,1
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.42797,0.32597,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00045924,0.42784,0.37855,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.027188,0.42765,0.24147,1,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0045306,0.42732,0.38713,1,1
4,GO RIBOSOME ASSEMBLY,0.00021909,0.42689,0.37441,1,1
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0010859,0.42653,0.33772,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.5759e-05,0.42639,0.37995,1,1
4,GO FIBROBLAST MIGRATION,1.5331e-06,0.42632,0.42232,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.0033e-05,0.4263,0.43865,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.2366e-07,0.42609,0.46131,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00041602,0.42578,0.43941,1,1
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0031536,0.42541,0.3265,1,1
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2366e-07,0.42501,0.39274,1,1
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.42457,0.54563,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,1.8521e-05,0.42362,0.38165,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,7.0571e-06,0.42352,0.41672,1,1
4,GO REGULATION OF FIBROBLAST MIGRATION,4.1112e-06,0.42312,0.44122,1,1
4,GO REGULATION OF HIPPO SIGNALING,0.00025131,0.42276,0.3656,1,1
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.045624,0.42165,0.24348,1,1
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.8301e-05,0.42162,0.37248,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0010859,0.42149,0.38134,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00045924,0.42118,0.48267,1,1
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0001547,0.42069,0.34638,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,3.1888e-05,0.42058,0.38257,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.1663e-05,0.42048,0.38773,1,1
4,GO CERAMIDE CATABOLIC PROCESS,6.0504e-05,0.4201,0.38148,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1776e-06,0.42008,0.42852,1,1
4,GO VIRAL LIFE CYCLE,3.0264e-07,0.41928,0.42543,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0001547,0.41923,0.36848,1,1
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0038387,0.41914,0.53671,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.2454e-05,0.41881,0.36178,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,8.6584e-06,0.4188,0.38209,1,1
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.0689e-05,0.41844,0.39791,1,1
4,GO REGULATION OF RIBOSOME BIOGENESIS,7.6603e-06,0.41807,0.49516,1,1
4,GO VASCULAR TRANSPORT,0.0028141,0.41798,0.51373,1,1
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00020448,0.41777,0.40296,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00014935,0.41754,0.59989,1,1
4,GO MULTI ORGANISM LOCALIZATION,4.9191e-08,0.41721,0.4244,1,1
4,GO TELOMERASE RNA LOCALIZATION,0.00010845,0.41699,0.36499,1,1
4,GO REGULATION OF GASTRULATION,2.3975e-07,0.41601,0.41245,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00032948,0.41595,0.33092,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.2524e-05,0.4159,0.39301,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00030804,0.41575,0.33338,1,1
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,4.6623e-06,0.41524,0.44584,1,1
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.4143,0.36184,1,1
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.4772e-07,0.4132,0.40957,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,9.3916e-06,0.4132,0.36957,1,1
4,GO IMMATURE T CELL PROLIFERATION,3.8583e-05,0.41288,0.45111,1,1
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.349e-05,0.41274,0.38678,1,1
4,GO REGULATION OF STEROL TRANSPORT,6.2985e-07,0.41259,0.38198,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0015653,0.41227,0.31667,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,9.8628e-07,0.41222,0.40637,1,1
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,2.5308e-05,0.41174,0.33445,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00069957,0.41129,0.29911,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41099,0.39983,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00019079,0.41069,0.37711,1,1
4,GO I KAPPAB PHOSPHORYLATION,3.3132e-05,0.41068,0.3092,1,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,9.0221e-07,0.41033,0.42967,1,1
4,GO RESPONSE TO SALT STRESS,2.6902e-06,0.41028,0.3857,1,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0028141,0.41024,0.33095,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00019753,0.40996,0.35024,1,1
4,GO MATURATION OF SSU RRNA,9.0551e-05,0.40983,0.37767,1,1
4,GO COPPER ION HOMEOSTASIS,2.0784e-06,0.40959,0.50766,1,1
4,GO REGULATION OF STEM CELL DIFFERENTIATION,1.5331e-06,0.40922,0.37514,1,1
4,GO PLATELET AGGREGATION,5.0683e-06,0.40867,0.36513,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.40854,0.45453,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.00029782,0.40834,0.342,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,2.2658e-06,0.40805,0.45816,1,1
4,GO INTERLEUKIN 17 PRODUCTION,8.2505e-07,0.40798,0.48558,1,1
4,GO HISTONE SERINE PHOSPHORYLATION,4.1112e-06,0.40748,0.44665,1,1
4,GO INTERACTION WITH SYMBIONT,5.508e-06,0.40735,0.35444,1,1
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,2.0033e-05,0.40725,0.58454,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.1617e-05,0.40626,0.43064,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,5.7413e-06,0.40615,0.41037,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.0604e-05,0.40562,0.39872,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.9801e-06,0.4053,0.47221,1,1
4,GO EXOCRINE SYSTEM DEVELOPMENT,7.013e-05,0.40486,0.43489,1,1
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,2.2524e-05,0.40417,0.49295,1,1
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00023468,0.40416,0.33159,1,1
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0036303,0.40393,0.40015,1,1
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,5.7413e-06,0.40352,0.48342,1,1
4,GO INTERLEUKIN 8 PRODUCTION,1.4609e-05,0.40344,0.37777,1,1
4,GO TRANSLATIONAL INITIATION,5.2139e-05,0.403,0.3605,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.3441e-06,0.40259,0.38901,1,1
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00037661,0.40258,0.356,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.1617e-05,0.40231,0.4844,1,1
4,GO CELL SUBSTRATE ADHESION,1.4044e-06,0.40222,0.41372,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.628e-07,0.40216,0.40876,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,6.7728e-06,0.40163,0.34615,1,1
4,GO FOREGUT MORPHOGENESIS,1.349e-05,0.40157,0.45945,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.4121e-05,0.40103,0.33543,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.0030654,0.40084,0.57233,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.8282e-05,0.39932,0.38795,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00065623,0.39931,0.39145,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.6902e-06,0.39927,0.36682,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00017186,0.39849,0.49779,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.5813e-07,0.39777,0.43334,1,1
4,GO INTERFERON BETA PRODUCTION,0.0001165,0.39715,0.2995,1,1
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00014935,0.39707,0.28036,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.7728e-06,0.39685,0.33904,1,1
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.023741,0.39657,0.31789,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,5.2139e-05,0.39652,0.36547,1,1
4,GO PRIMARY MIRNA PROCESSING,8.7323e-05,0.39624,0.38327,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.3441e-06,0.39594,0.33394,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.2308e-06,0.39547,0.50288,1,1
4,GO SPROUTING ANGIOGENESIS,1.2962e-05,0.3953,0.35812,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.1702e-06,0.39518,0.33824,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2454e-05,0.39516,0.43612,1,1
4,GO HAIR FOLLICLE MATURATION,0.0015653,0.39467,0.32374,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00030804,0.39438,0.35727,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00090094,0.39437,0.32512,1,1
4,GO PULMONARY VALVE MORPHOGENESIS,0.001191,0.39434,0.51396,1,1
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0019282,0.39327,0.3967,1,1
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.023741,0.39315,0.30851,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,2.9532e-05,0.39301,0.46268,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0030654,0.39272,0.38591,1,1
4,GO B CELL MEDIATED IMMUNITY,2.5774e-06,0.39219,0.35276,1,1
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00016595,0.39211,0.31308,1,1
4,GO PLATELET DEGRANULATION,2.6902e-06,0.39201,0.45925,1,1
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,3.3287e-06,0.39165,0.3422,1,1
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.104e-05,0.39129,0.34261,1,1
4,GO OSTEOCLAST DEVELOPMENT,5.9841e-06,0.39084,0.41501,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.9418e-06,0.39052,0.43315,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.029719,0.39009,0.47437,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00021909,0.38987,0.34272,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0079323,0.38965,0.30906,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,8.0176e-08,0.38928,0.37665,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.4712e-06,0.38909,0.35891,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00013433,0.38888,0.32394,1,1
4,GO INTERACTION WITH HOST,6.2985e-07,0.38851,0.43434,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.9301e-06,0.38821,0.40493,1,1
4,GO CHONDROCYTE DEVELOPMENT,0.00017186,0.38817,0.39047,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.38815,0.35503,1,1
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00059588,0.38813,0.34016,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,9.7801e-06,0.38778,0.35051,1,1
4,GO T CELL APOPTOTIC PROCESS,1.6729e-06,0.38743,0.36383,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.6455e-05,0.38722,0.39392,1,1
4,GO REGULATION OF PROTEIN IMPORT,8.3127e-06,0.38711,0.37908,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4039e-05,0.38665,0.37537,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00098941,0.38633,0.40189,1,1
4,GO MUSCLE FILAMENT SLIDING,9.4334e-07,0.38628,0.41839,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,2.3975e-07,0.38616,0.38284,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00092958,0.3861,0.30747,1,1
4,GO RESPONSE TO ESTROGEN,1.9904e-06,0.38605,0.3778,1,1
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.001662,0.38604,0.4903,1,1
4,GO BASEMENT MEMBRANE ASSEMBLY,6.0504e-05,0.38559,0.56029,1,1
4,GO MATURATION OF 5 8S RRNA,0.00012512,0.38425,0.32521,1,1
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.00012074,0.38399,0.3414,1,1
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00029782,0.38396,0.30278,1,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00028792,0.38394,0.35911,1,1
4,GO ERBB2 SIGNALING PATHWAY,0.0001547,0.38381,0.29597,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00028792,0.38332,0.32387,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0022992,0.38332,0.331,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.018836,0.3829,0.29875,1,1
4,GO POSITIVE REGULATION OF TRANSLATION,4.9191e-08,0.38225,0.38719,1,1
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00054072,0.3818,0.35158,1,1
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0067808,0.38149,0.37362,1,1
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0010528,0.3813,0.38381,1,1
4,GO ARGININE METABOLIC PROCESS,0.00021909,0.38098,0.39643,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.0184e-05,0.38043,0.33361,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00028792,0.37978,0.38542,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0047853,0.37968,0.27982,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,1.104e-05,0.37912,0.34024,1,1
4,GO MEMBRANE INVAGINATION,1.0207e-07,0.37863,0.40224,1,1
4,GO NEGATIVE REGULATION OF CELL SIZE,4.6623e-06,0.37795,0.33384,1,1
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0015189,0.37771,0.42536,1,1
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,1.1964e-05,0.3776,0.31284,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.8251e-06,0.37732,0.36546,1,1
4,GO TYPE I INTERFERON PRODUCTION,1.4609e-05,0.37726,0.32799,1,1
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00020448,0.37719,0.3185,1,1
4,GO REGULATION OF PHAGOCYTOSIS,3.17e-07,0.37716,0.40851,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0038387,0.37671,0.42188,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0022332,0.37628,0.2832,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.1964e-05,0.37625,0.32639,1,1
4,GO GLAND MORPHOGENESIS,4.3218e-05,0.37522,0.41221,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,2.8418e-05,0.37495,0.38061,1,1
4,GO POSITIVE REGULATION OF HEART GROWTH,0.00026003,0.37486,0.31498,1,1
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00010845,0.37483,0.30565,1,1
4,GO REGULATION OF KIDNEY DEVELOPMENT,3.7145e-05,0.37481,0.35205,1,1
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,4.3218e-05,0.37455,0.41245,1,1
4,GO CARNITINE METABOLIC PROCESS,0.00040247,0.37435,0.34468,1,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00016023,0.37418,0.3585,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,3.7145e-05,0.37396,0.46547,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.8282e-05,0.37373,0.33779,1,1
4,GO VIRAL GENE EXPRESSION,1.7118e-05,0.37334,0.37695,1,1
4,GO POSITIVE REGULATION OF ORGAN GROWTH,1.9263e-05,0.37273,0.34379,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00029782,0.37209,0.29398,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,3.7791e-06,0.37192,0.39776,1,1
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.001872,0.3718,0.32209,1,1
4,GO FIBROBLAST PROLIFERATION,3.7145e-05,0.37164,0.3409,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,7.3528e-06,0.37147,0.36544,1,1
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.5201e-05,0.37096,0.33116,1,1
4,GO TRABECULA FORMATION,0.00052342,0.37094,0.45107,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.036948,0.37062,0.21831,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,3.0689e-05,0.36943,0.34969,1,1
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00065623,0.36932,0.33428,1,1
4,GO MEMBRANE DISASSEMBLY,0.00027832,0.36932,0.29925,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.5427e-07,0.36891,0.36789,1,1
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,4.0073e-05,0.3687,0.3934,1,1
4,GO RIG I SIGNALING PATHWAY,3.4421e-05,0.36825,0.37021,1,1
4,GO REGULATION OF LIPASE ACTIVITY,1.4609e-05,0.36824,0.2794,1,1
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00081984,0.36805,0.36957,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0041716,0.3679,0.29498,1,1
4,GO GLIAL CELL ACTIVATION,3.3132e-05,0.36788,0.36745,1,1
4,GO CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.36766,0.33175,1,1
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0006154,0.36671,0.35586,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.36639,0.27119,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.013e-05,0.366,0.32724,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.3127e-06,0.36579,0.42378,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0054795,0.36563,0.38914,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0034322,0.36536,0.29737,1,1
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00034072,0.36523,0.39902,1,1
4,GO ERAD PATHWAY,1.2308e-06,0.36505,0.30767,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00069957,0.36504,0.34157,1,1
4,GO REGULATION OF COAGULATION,2.7343e-05,0.3648,0.4143,1,1
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,2.9532e-05,0.36479,0.3134,1,1
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0015653,0.36442,0.38977,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,5.2837e-06,0.36359,0.35386,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.8521e-05,0.36351,0.39524,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.9418e-06,0.36329,0.49364,1,1
4,GO FOCAL ADHESION ASSEMBLY,7.3528e-06,0.36329,0.40534,1,1
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4712e-06,0.36285,0.40413,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00016595,0.36279,0.272,1,1
4,GO MESODERM MORPHOGENESIS,2.8891e-07,0.36274,0.38224,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.4609e-05,0.36256,0.31787,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00095906,0.36245,0.35396,1,1
4,GO GENITALIA MORPHOGENESIS,0.0017641,0.36221,0.33722,1,1
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.349e-05,0.3622,0.37599,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00079435,0.36213,0.36151,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.001228,0.36203,0.28489,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010092,0.36198,0.29342,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.4346e-05,0.36163,0.35248,1,1
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00079435,0.36051,0.35195,1,1
4,GO VASCULATURE DEVELOPMENT,4.1112e-06,0.36033,0.31669,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.045624,0.36024,0.21688,1,1
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0015189,0.36023,0.33471,1,1
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0051916,0.36023,0.28318,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00049035,0.36016,0.43747,1,1
4,GO GASTRULATION,2.1831e-07,0.35998,0.38701,1,1
4,GO RESPONSE TO VIRUS,4.2876e-06,0.3591,0.36356,1,1
4,GO NEGATIVE REGULATION OF GENE SILENCING,7.2754e-05,0.35868,0.29828,1,1
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0604e-05,0.35848,0.4102,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.5308e-05,0.35847,0.29108,1,1
4,GO FOREBRAIN MORPHOGENESIS,0.027188,0.35829,0.19678,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.7346e-05,0.35799,0.29216,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00021909,0.35799,0.26595,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,9.7801e-06,0.35757,0.39709,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0010206,0.35754,0.31076,1,1
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.027188,0.35714,0.23848,1,1
4,GO HYPOTONIC RESPONSE,0.00016595,0.35712,0.32895,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,6.2786e-05,0.35696,0.29233,1,1
4,GO WOUND HEALING,8.6584e-06,0.35685,0.33441,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.0833e-05,0.35633,0.32695,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.0036303,0.3562,0.31111,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0024367,0.35608,0.43759,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,5.2837e-06,0.35555,0.37305,1,1
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.3441e-06,0.35527,0.37314,1,1
4,GO REGULATION OF PROTEIN MATURATION,2.6902e-06,0.35515,0.36714,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00034072,0.35492,0.39162,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0062634,0.35477,0.27362,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.7118e-05,0.35458,0.31043,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.0021689,0.3545,0.29184,1,1
4,GO ENDOTHELIAL CELL MIGRATION,1.5201e-05,0.35421,0.3406,1,1
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.5308e-05,0.35415,0.33292,1,1
4,GO SERTOLI CELL DEVELOPMENT,0.0023671,0.35364,0.31022,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,8.3127e-06,0.35336,0.36198,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6174e-05,0.35295,0.32769,1,1
4,GO MATERNAL PLACENTA DEVELOPMENT,5.2139e-05,0.35283,0.38232,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,7.9801e-06,0.35225,0.31169,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0015189,0.3522,0.35896,1,1
4,GO RESPONSE TO MANGANESE ION,7.6603e-06,0.3521,0.34046,1,1
4,GO PIGMENT ACCUMULATION,0.0001547,0.35138,0.32351,1,1
4,GO NUCLEOSIDE SALVAGE,0.00095906,0.35108,0.43139,1,1
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00044439,0.35092,0.31778,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.9263e-05,0.35072,0.3416,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,0.3507,0.28609,1,1
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.3654e-06,0.35015,0.34466,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.1888e-05,0.34969,0.26324,1,1
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.4421e-05,0.34844,0.38486,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00038934,0.34802,0.30143,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.0571e-06,0.3479,0.32981,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.7323e-05,0.34714,0.43855,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00031859,0.34688,0.34565,1,1
4,GO L GLUTAMATE IMPORT,0.00038934,0.34672,0.35787,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.6902e-06,0.34652,0.36698,1,1
4,GO LENS FIBER CELL DEVELOPMENT,0.001872,0.34601,0.37409,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00045924,0.34569,0.39439,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00011241,0.34546,0.31263,1,1
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.0375e-08,0.34525,0.34067,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0007696,0.34498,0.27082,1,1
4,GO NCRNA PROCESSING,2.5308e-05,0.34461,0.30403,1,1
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.3418e-05,0.34451,0.37511,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.9904e-06,0.34431,0.34938,1,1
4,GO TISSUE MIGRATION,3.8583e-05,0.34364,0.30732,1,1
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,2.0033e-05,0.34364,0.3351,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00022676,0.34331,0.37889,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0075304,0.3431,0.2846,1,1
4,GO BLOOD VESSEL MORPHOGENESIS,2.5774e-06,0.34289,0.32212,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6729e-06,0.34281,0.39055,1,1
4,GO INNER CELL MASS CELL PROLIFERATION,0.00021909,0.34226,0.37044,1,1
4,GO PEPTIDE CATABOLIC PROCESS,1.104e-05,0.34213,0.29851,1,1
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0016129,0.34158,0.34907,1,1
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0090226,0.34122,0.24725,1,1
4,GO REGULATION OF HISTONE PHOSPHORYLATION,6.7596e-05,0.34108,0.34712,1,1
4,GO PROTEIN HYDROXYLATION,0.0046564,0.34105,0.3742,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.010245,0.34058,0.29353,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.0779e-06,0.34036,0.42456,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00059588,0.33985,0.30223,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.33959,0.27452,1,1
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00054072,0.33946,0.30081,1,1
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,4.4878e-05,0.33939,0.34297,1,1
4,GO T CELL MIGRATION,4.8379e-05,0.33927,0.30731,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00054072,0.33911,0.36866,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.33876,0.30838,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0023671,0.33853,0.39066,1,1
4,GO NATURAL KILLER CELL ACTIVATION,4.4712e-06,0.33817,0.33046,1,1
4,GO CARTILAGE DEVELOPMENT,2.1663e-05,0.33751,0.29274,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.5201e-05,0.33746,0.27946,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.349e-05,0.33712,0.45658,1,1
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0604e-05,0.33709,0.33633,1,1
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.5813e-07,0.33696,0.32253,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.00013433,0.33692,0.27269,1,1
4,GO CORTICAL CYTOSKELETON ORGANIZATION,4.5813e-07,0.33631,0.34936,1,1
4,GO PROSTATIC BUD FORMATION,0.00087311,0.33585,0.45168,1,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.33546,0.31306,1,1
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021062,0.3352,0.31817,1,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0059384,0.33518,0.39457,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,9.3916e-06,0.3351,0.30708,1,1
4,GO FIBROBLAST ACTIVATION,0.0010859,0.3347,0.35971,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,3.3287e-06,0.33466,0.40503,1,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,9.7346e-05,0.33419,0.30144,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,5.4121e-05,0.3341,0.2725,1,1
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.7806e-05,0.3341,0.39181,1,1
4,GO REGULATION OF CALCIUM ION IMPORT,0.00081984,0.33395,0.21264,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00021167,0.33394,0.27285,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,4.4712e-06,0.33393,0.3397,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.3418e-05,0.33349,0.40185,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.5813e-07,0.33348,0.40688,1,1
4,GO IRON ION HOMEOSTASIS,1.9904e-06,0.33337,0.29119,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.00012964,0.33307,0.2633,1,1
4,GO DECIDUALIZATION,0.0028141,0.33303,0.3997,1,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.00012964,0.33299,0.35197,1,1
4,GO ENDOCARDIAL CUSHION FORMATION,0.010245,0.3324,0.25072,1,1
4,GO MYOBLAST DIFFERENTIATION,7.9801e-06,0.33197,0.34007,1,1
4,GO AMYLOID FIBRIL FORMATION,0.0037331,0.33182,0.31092,1,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00044439,0.33181,0.33212,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00057693,0.3317,0.37076,1,1
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,7.547e-05,0.33161,0.29919,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00081984,0.33142,0.23567,1,1
4,GO REGULATION OF VASCULATURE DEVELOPMENT,6.4994e-06,0.33124,0.3086,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0041716,0.33107,0.28048,1,1
4,GO PROTEIN TARGETING TO VACUOLE,9.7801e-06,0.331,0.28905,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,5.2837e-06,0.33076,0.32005,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.33076,0.24713,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.7145e-05,0.33059,0.28758,1,1
4,GO RESPONSE TO WOUNDING,9.7801e-06,0.33042,0.28797,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,4.3218e-05,0.33019,0.26161,1,1
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.00016023,0.33008,0.29939,1,1
4,GO TISSUE REGENERATION,5.6174e-05,0.32996,0.316,1,1
4,GO SPINDLE MIDZONE ASSEMBLY,5.0226e-05,0.32992,0.32222,1,1
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00035231,0.32987,0.34705,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.7413e-06,0.32971,0.2984,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00049035,0.32957,0.31638,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,3.7791e-06,0.32946,0.39779,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,8.1192e-05,0.32881,0.26985,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.8612e-06,0.3284,0.31024,1,1
4,GO PIGMENT METABOLIC PROCESS,6.2367e-06,0.32794,0.31283,1,1
4,GO REGENERATION,5.753e-07,0.32782,0.31146,1,1
4,GO TOOTH MINERALIZATION,0.0038387,0.32768,0.28371,1,1
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00081984,0.32768,0.29554,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.327,0.31905,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0022992,0.32691,0.34381,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.32652,0.35008,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00041602,0.3263,0.36731,1,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.0007696,0.32583,0.25501,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0032441,0.32576,0.32374,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00044439,0.32549,0.35337,1,1
4,GO MACROPHAGE APOPTOTIC PROCESS,0.00049035,0.3253,0.38365,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,2.0033e-05,0.32525,0.30646,1,1
4,GO MUSCLE CELL PROLIFERATION,5.9841e-06,0.32517,0.32699,1,1
4,GO COMPLEMENT ACTIVATION,2.6902e-06,0.32499,0.32038,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.2454e-05,0.32487,0.28297,1,1
4,GO ASYMMETRIC CELL DIVISION,0.00036427,0.32482,0.28376,1,1
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0025083,0.32481,0.30746,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00045924,0.32476,0.26561,1,1
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0021062,0.32454,0.25603,1,1
4,GO CELL REDOX HOMEOSTASIS,1.4609e-05,0.32449,0.29923,1,1
4,GO MACROPHAGE DIFFERENTIATION,8.4205e-05,0.32447,0.35753,1,1
4,GO REGULATION OF HEART GROWTH,2.6307e-05,0.32407,0.27893,1,1
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.3441e-06,0.32407,0.28376,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00029782,0.3239,0.30095,1,1
4,GO MONOCYTE CHEMOTAXIS,0.00026903,0.32306,0.33732,1,1
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00030804,0.32259,0.28955,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.02843,0.32249,0.18206,1,1
4,GO LYMPH VESSEL DEVELOPMENT,0.0021689,0.32248,0.33873,1,1
4,GO RESPONSE TO INTERLEUKIN 1,3.0576e-06,0.32236,0.35341,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00037661,0.32232,0.33249,1,1
4,GO REGULATION OF RNA BINDING,1.8251e-06,0.32229,0.32726,1,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0024367,0.32228,0.31841,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.015953,0.32214,0.31562,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.3287e-06,0.32205,0.35429,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.322,0.34007,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.023205,0.32195,0.22463,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.001191,0.32189,0.28596,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2876e-06,0.32185,0.31692,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0011549,0.32181,0.23169,1,1
4,GO NEURAL CREST CELL MIGRATION,0.0042883,0.32181,0.25404,1,1
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0010206,0.32125,0.31164,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.00021909,0.3212,0.30991,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00036427,0.32043,0.21272,1,1
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00042998,0.32013,0.28712,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00021167,0.319,0.3633,1,1
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.9301e-06,0.31874,0.33197,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0027346,0.31856,0.29315,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0064317,0.31838,0.19883,1,1
4,GO ACTIVATION OF MAPKK ACTIVITY,2.5308e-05,0.31838,0.3141,1,1
4,GO HISTONE PHOSPHORYLATION,1.3441e-06,0.31819,0.30491,1,1
4,GO RESPONSE TO PARATHYROID HORMONE,9.389e-05,0.31814,0.35779,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00030804,0.31799,0.33109,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.4728e-06,0.31778,0.32173,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,9.0179e-06,0.31755,0.40472,1,1
4,GO NECROTIC CELL DEATH,7.8282e-05,0.31738,0.39379,1,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,1.349e-05,0.31729,0.3179,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,5.9841e-06,0.31723,0.40967,1,1
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0025083,0.31703,0.29035,1,1
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0097392,0.31662,0.27932,1,1
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.4044e-06,0.31659,0.35182,1,1
4,GO ASTROCYTE ACTIVATION,0.0010206,0.31652,0.31038,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00032948,0.31639,0.26239,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00047456,0.31617,0.30627,1,1
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0067808,0.3156,0.43487,1,1
4,GO CYTOKINETIC PROCESS,3.0689e-05,0.31522,0.29585,1,1
4,GO SYNCYTIUM FORMATION,5.4121e-05,0.31517,0.32681,1,1
4,GO PROTEIN DEGLYCOSYLATION,0.00014418,0.31509,0.32332,1,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0021062,0.31497,0.36082,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.0033e-05,0.31461,0.32994,1,1
4,GO INNATE IMMUNE RESPONSE,1.4039e-05,0.31441,0.27788,1,1
4,GO REGULATION OF SPROUTING ANGIOGENESIS,5.6174e-05,0.31417,0.33699,1,1
4,GO PLASMA MEMBRANE TUBULATION,1.1776e-06,0.31413,0.37146,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.1112e-06,0.31412,0.29353,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00016595,0.31346,0.23128,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.5816e-05,0.31333,0.3292,1,1
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.03939,0.31279,0.1933,1,1
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00036427,0.3127,0.29517,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00018427,0.31232,0.31437,1,1
4,GO LIPOPROTEIN LOCALIZATION,0.00013917,0.31231,0.39721,1,1
4,GO RNA 5 END PROCESSING,0.00026903,0.31199,0.28801,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,5.9841e-06,0.31172,0.30218,1,1
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010462,0.31172,0.29202,1,1
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00013433,0.31169,0.28328,1,1
4,GO KERATINOCYTE MIGRATION,8.7323e-05,0.31165,0.3432,1,1
4,GO INTRACELLULAR MRNA LOCALIZATION,2.2524e-05,0.31153,0.37744,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,1.3441e-06,0.31129,0.28248,1,1
4,GO VESICLE CARGO LOADING,0.00010845,0.31075,0.29275,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.00038934,0.31035,0.26265,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,8.1192e-05,0.30967,0.27815,1,1
4,GO RRNA METABOLIC PROCESS,0.00012964,0.30964,0.30083,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00063551,0.30959,0.29875,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,9.0551e-05,0.30957,0.37805,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.30918,0.29374,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,1.7118e-05,0.30894,0.43469,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,6.5149e-05,0.30894,0.29085,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.001872,0.30877,0.28226,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.2658e-06,0.30865,0.35243,1,1
4,GO GONADOTROPIN SECRETION,0.0071468,0.30838,0.26456,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.017137,0.30809,0.26241,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,2.3418e-05,0.30748,0.25106,1,1
4,GO REGULATION OF HEART MORPHOGENESIS,0.0025817,0.30672,0.30695,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00031859,0.3067,0.34436,1,1
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,7.3528e-06,0.30614,0.29803,1,1
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,4.4712e-06,0.30588,0.28108,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,6.0504e-05,0.30587,0.29954,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00049035,0.30567,0.27372,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.1192e-05,0.30565,0.33582,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00012074,0.30545,0.25859,1,1
4,GO TRNA 5 LEADER REMOVAL,0.0001547,0.30539,0.31858,1,1
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.007729,0.30531,0.20372,1,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,4.0073e-05,0.30525,0.25966,1,1
4,GO RESPONSE TO DSRNA,9.8628e-07,0.30518,0.37605,1,1
4,GO MACROPHAGE MIGRATION,3.9418e-06,0.30506,0.36068,1,1
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.3218e-05,0.30485,0.3339,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.001872,0.30485,0.26523,1,1
4,GO NCRNA METABOLIC PROCESS,5.2139e-05,0.30479,0.26796,1,1
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.9418e-06,0.30478,0.307,1,1
4,GO CELL MATRIX ADHESION,1.7118e-05,0.30469,0.34271,1,1
4,GO NUCLEAR ENVELOPE REASSEMBLY,1.2454e-05,0.30468,0.26794,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.6902e-06,0.30461,0.29689,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.046579,0.30444,0.39175,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,8.1192e-05,0.30437,0.34894,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2962e-05,0.304,0.40382,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00029782,0.30389,0.29192,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.00019753,0.30383,0.29042,1,1
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.889e-07,0.30344,0.24135,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.2524e-05,0.30341,0.28314,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00044439,0.30304,0.3445,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.906e-06,0.30251,0.44456,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0014738,0.30227,0.30753,1,1
4,GO TRANSLATIONAL TERMINATION,0.00057693,0.30227,0.24308,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0081404,0.30201,0.24022,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00012074,0.30194,0.32051,1,1
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,4.1617e-05,0.30191,0.34806,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,2.1702e-06,0.30181,0.35084,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.3441e-06,0.30171,0.3822,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.00055855,0.30164,0.26104,1,1
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.001191,0.30159,0.27792,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00014418,0.30158,0.24673,1,1
4,GO SELECTIVE AUTOPHAGY,3.17e-07,0.30121,0.32186,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,2.2524e-05,0.30117,0.30233,1,1
4,GO MUSCLE CELL MIGRATION,0.023205,0.30077,0.22351,1,1
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.7145e-05,0.30073,0.26853,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.0604e-05,0.30055,0.31976,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00067758,0.30023,0.27416,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.0037331,0.30007,0.31925,1,1
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.4994e-06,0.30003,0.29449,1,1
4,GO T CELL CYTOKINE PRODUCTION,9.3916e-06,0.29996,0.40732,1,1
4,GO URETER DEVELOPMENT,0.011904,0.29983,0.23486,1,1
4,GO LIPID IMPORT INTO CELL,0.0032441,0.29972,0.25292,1,1
4,GO STEROL TRANSPORT,2.5308e-05,0.29969,0.26096,1,1
4,GO SPERM EGG RECOGNITION,1.3441e-06,0.29954,0.27761,1,1
4,GO ETHANOL OXIDATION,0.031059,0.2994,0.30429,1,1
4,GO RRNA MODIFICATION,0.0021689,0.2993,0.22642,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.02843,0.29922,0.36721,1,1
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.1112e-06,0.29899,0.25283,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,8.6584e-06,0.29871,0.3205,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00034072,0.29858,0.28637,1,1
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0056288,0.29853,0.36097,1,1
4,GO LYMPHOCYTE MIGRATION,5.6174e-05,0.29851,0.24202,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.29845,0.36124,1,1
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00084609,0.29836,0.27165,1,1
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0041716,0.29829,0.22142,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.29795,0.27465,1,1
4,GO AMINO SUGAR METABOLIC PROCESS,7.9801e-06,0.29783,0.28569,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.001872,0.29761,0.31318,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00026003,0.29748,0.25978,1,1
4,GO REGULATION OF MESODERM DEVELOPMENT,0.020205,0.29705,0.24385,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.6455e-05,0.2969,0.34688,1,1
4,GO RIBOSOME BIOGENESIS,0.00010092,0.29663,0.31796,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00010845,0.29605,0.31195,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.2879e-07,0.296,0.29876,1,1
4,GO RNA CATABOLIC PROCESS,4.5813e-07,0.29577,0.27874,1,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,5.7413e-06,0.29555,0.2837,1,1
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.4421e-05,0.29543,0.27075,1,1
4,GO CHOLESTEROL EFFLUX,4.2876e-06,0.29542,0.32058,1,1
4,GO RESPONSE TO CYTOKINE,7.6603e-06,0.29539,0.30307,1,1
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00067758,0.2953,0.26988,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.2524e-05,0.29524,0.31439,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00032948,0.29502,0.23839,1,1
4,GO REGULATION OF MRNA CATABOLIC PROCESS,2.6902e-06,0.29489,0.25646,1,1
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013457,0.29486,0.2767,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,3.9418e-06,0.2947,0.3112,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021909,0.29444,0.35579,1,1
4,GO CYTOKINE PRODUCTION,1.2454e-05,0.2941,0.26883,1,1
4,GO REGULATION OF CELL AGING,1.4268e-07,0.29407,0.33608,1,1
4,GO INTERLEUKIN 5 PRODUCTION,0.014486,0.29383,0.26868,1,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.0779e-06,0.29365,0.25265,1,1
4,GO T CELL CHEMOTAXIS,4.6597e-05,0.29304,0.27183,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00012512,0.29295,0.34201,1,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,8.7323e-05,0.2926,0.26392,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,9.0179e-06,0.29254,0.2905,1,1
4,GO COAGULATION,1.0604e-05,0.29223,0.29182,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00038934,0.29203,0.23173,1,1
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,6.0504e-05,0.29202,0.33534,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0031536,0.29199,0.23119,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0036303,0.29141,0.2024,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.014486,0.29138,0.3076,1,1
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00012512,0.29119,0.28939,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.628e-07,0.29105,0.33379,1,1
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00055855,0.29089,0.32118,1,1
4,GO NUCLEOSIDE METABOLIC PROCESS,1.4039e-05,0.29078,0.25405,1,1
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0053338,0.29072,0.23229,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0007696,0.29044,0.34819,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,8.3127e-06,0.29034,0.31033,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00065623,0.29023,0.18154,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.02166,0.2901,0.25645,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.29,0.24499,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0001165,0.28977,0.30431,1,1
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00013917,0.28974,0.29384,1,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00018427,0.28965,0.41056,1,1
4,GO TRACHEA MORPHOGENESIS,0.0020453,0.28909,0.25979,1,1
4,GO TRNA 5 END PROCESSING,0.00010845,0.28894,0.3013,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.2139e-05,0.2886,0.28375,1,1
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00012964,0.28779,0.30882,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.6597e-05,0.28766,0.26542,1,1
4,GO SERTOLI CELL DIFFERENTIATION,0.0028141,0.28759,0.26741,1,1
4,GO COPPER ION TRANSPORT,6.2786e-05,0.28722,0.31354,1,1
4,GO RESPONSE TO BACTERIUM,1.7806e-05,0.2872,0.26679,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.2962e-05,0.28709,0.25178,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,5.508e-06,0.28707,0.2629,1,1
4,GO SYMBIOTIC PROCESS,1.6452e-07,0.28705,0.28642,1,1
4,GO HYPEROSMOTIC RESPONSE,0.00035231,0.2865,0.27454,1,1
4,GO MITRAL VALVE DEVELOPMENT,0.044685,0.28646,0.31554,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,9.0551e-05,0.28628,0.34389,1,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013917,0.28627,0.28142,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.001662,0.28595,0.2762,1,1
4,GO OSTEOBLAST DIFFERENTIATION,1.7806e-05,0.28589,0.29213,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0069616,0.28584,0.47379,1,1
4,GO CELL CELL RECOGNITION,5.4977e-07,0.28569,0.30051,1,1
4,GO TRNA WOBBLE BASE MODIFICATION,0.0025083,0.2856,0.19463,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.00040247,0.28499,0.26649,1,1
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.28445,0.31518,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.00021167,0.28443,0.42295,1,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00016023,0.28441,0.32742,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,5.0226e-05,0.28405,0.28948,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00090094,0.28405,0.20127,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,8.3127e-06,0.28401,0.25233,1,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28401,0.33848,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.2454e-05,0.2838,0.26806,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.28378,0.24471,1,1
4,GO CORONARY VASCULATURE DEVELOPMENT,7.2754e-05,0.28367,0.31239,1,1
4,GO CHEMOKINE PRODUCTION,0.0019282,0.2836,0.25622,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00090094,0.28352,0.27363,1,1
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.0264e-07,0.28314,0.2503,1,1
4,GO MYOBLAST FUSION,0.00042998,0.28309,0.32007,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,2.3418e-05,0.28291,0.2761,1,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00019079,0.28284,0.26959,1,1
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,7.8282e-05,0.28274,0.27209,1,1
4,GO ASTROCYTE DEVELOPMENT,0.00019753,0.28267,0.31259,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.022165,0.28263,0.22768,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.9418e-06,0.28244,0.25902,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00016595,0.28222,0.21555,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.349e-05,0.2822,0.27405,1,1
4,GO RESPONSE TO PROTOZOAN,0.0013457,0.28213,0.28525,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,0.013465,0.28171,0.1997,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.28144,0.31943,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.011904,0.28094,0.20273,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,4.4878e-05,0.28075,0.29044,1,1
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.28061,0.36608,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00029782,0.28031,0.19958,1,1
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00010845,0.2803,0.29885,1,1
4,GO REGULATION OF GENE SILENCING,3.6228e-06,0.28012,0.24958,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0060989,0.27924,0.2909,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0019282,0.27913,0.23043,1,1
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0021062,0.2791,0.2719,1,1
4,GO TISSUE REMODELING,0.00024286,0.27882,0.26365,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.031059,0.27824,0.17693,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0054795,0.27822,0.21743,1,1
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00054072,0.27804,0.22018,1,1
4,GO REGULATION OF ORGAN GROWTH,3.8131e-07,0.27763,0.32653,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00087311,0.2776,0.2834,1,1
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00019079,0.27752,0.34228,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.021165,0.27745,0.32363,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.2837e-06,0.27713,0.28953,1,1
4,GO PROTEIN FOLDING,3.3287e-06,0.27687,0.26021,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.00024286,0.27682,0.25774,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00092958,0.2768,0.20452,1,1
4,GO NEGATIVE REGULATION OF DNA REPAIR,8.3127e-06,0.27674,0.26394,1,1
4,GO ERK1 AND ERK2 CASCADE,1.4039e-05,0.27594,0.24463,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.00059588,0.27529,0.19027,1,1
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00021167,0.27523,0.30172,1,1
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.046579,0.27522,0.23118,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00022676,0.27517,0.25052,1,1
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00045924,0.27502,0.29665,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,9.7346e-05,0.27492,0.28283,1,1
4,GO CELLULAR RESPONSE TO LIPID,8.4205e-05,0.27488,0.2049,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00017186,0.27479,0.28495,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.2754e-05,0.27396,0.34051,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.7118e-05,0.27379,0.41789,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,1.5201e-05,0.27378,0.22928,1,1
4,GO RESPONSE TO IONIZING RADIATION,3.9418e-06,0.27378,0.27594,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00034072,0.2735,0.28797,1,1
4,GO TRANSPOSITION,0.017137,0.27334,0.22313,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.3654e-06,0.2732,0.2455,1,1
4,GO LYMPHOCYTE CHEMOTAXIS,4.4712e-06,0.27312,0.30196,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.1192e-05,0.273,0.27723,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00069957,0.27278,0.3624,1,1
4,GO NUCLEOBASE METABOLIC PROCESS,0.00079435,0.27238,0.26115,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.015953,0.27228,0.21594,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.7346e-05,0.27212,0.23555,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00031859,0.27188,0.20007,1,1
4,GO MESODERM DEVELOPMENT,7.3528e-06,0.27184,0.23371,1,1
4,GO DNA LIGATION,0.00010462,0.27181,0.3051,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,7.547e-05,0.27171,0.22488,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00036427,0.27157,0.29141,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.00011241,0.27149,0.22639,1,1
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.031748,0.27144,0.3077,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00057693,0.27143,0.31548,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION,3.6414e-07,0.27113,0.28569,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,8.4205e-05,0.27105,0.21603,1,1
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.3441e-06,0.27062,0.34139,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.0571e-06,0.27041,0.31506,1,1
4,GO PEPTIDE BIOSYNTHETIC PROCESS,4.8612e-06,0.27039,0.24794,1,1
4,GO BONE MORPHOGENESIS,0.00020448,0.27018,0.27187,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00034072,0.26968,0.28374,1,1
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.001228,0.26909,0.30736,1,1
4,GO ACUTE PHASE RESPONSE,0.0085714,0.26901,0.26263,1,1
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.020205,0.26879,0.20972,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0037331,0.26864,0.25061,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00045924,0.26843,0.22655,1,1
4,GO PHAGOCYTOSIS,1.0311e-06,0.26827,0.3337,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.0013054,0.26819,0.2135,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.26815,0.27566,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,5.8301e-05,0.268,0.2303,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,9.0551e-05,0.26768,0.43824,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00010092,0.26759,0.25239,1,1
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00052342,0.26751,0.28039,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.2837e-06,0.2675,0.29041,1,1
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.5816e-05,0.26748,0.2561,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0014299,0.26717,0.31539,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.0779e-06,0.26716,0.2717,1,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00013433,0.26705,0.2505,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0036303,0.26677,0.28222,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.2754e-05,0.26676,0.24832,1,1
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00030804,0.26664,0.28785,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0016129,0.26639,0.21985,1,1
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,1.7118e-05,0.2662,0.28269,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0041716,0.26596,0.26727,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,7.013e-05,0.2657,0.37263,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001228,0.26549,0.23186,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0024367,0.26525,0.26204,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0071468,0.26523,0.279,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,4.3763e-07,0.26522,0.2728,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0045306,0.2651,0.28188,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0049174,0.26495,0.24024,1,1
4,GO GTP METABOLIC PROCESS,0.00011241,0.26495,0.32762,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00050664,0.26473,0.2916,1,1
4,GO REGULATION OF PROTEOLYSIS,1.349e-05,0.26473,0.21005,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.00055855,0.2647,0.19294,1,1
4,GO SEQUESTERING OF METAL ION,0.0039469,0.26461,0.23234,1,1
4,GO CELL AGING,2.8077e-06,0.26455,0.22643,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.0013457,0.26451,0.43266,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.26443,0.23141,1,1
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0079323,0.26441,0.24154,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0040578,0.2644,0.22187,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00010845,0.26425,0.24193,1,1
4,GO TOXIN TRANSPORT,0.0022332,0.26416,0.18484,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0025817,0.26397,0.21574,1,1
4,GO DETECTION OF OTHER ORGANISM,0.0064317,0.26393,0.28754,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.7474e-06,0.26387,0.29351,1,1
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00029782,0.26345,0.24997,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00095906,0.26343,0.22679,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.027803,0.26329,0.16236,1,1
4,GO PROTEIN KINASE B SIGNALING,2.2524e-05,0.26305,0.21807,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00017796,0.26292,0.20864,1,1
4,GO VIRION ASSEMBLY,0.00050664,0.26279,0.18733,1,1
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0011199,0.26272,0.28011,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00050664,0.26264,0.25771,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.023741,0.26256,0.30675,1,1
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.016734,0.26253,0.23149,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.3418e-05,0.26219,0.24309,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.5774e-06,0.26207,0.25923,1,1
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00021909,0.26194,0.24287,1,1
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0013457,0.26187,0.21405,1,1
4,GO XENOBIOTIC TRANSPORT,0.00055855,0.26183,0.258,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00019079,0.2616,0.24078,1,1
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.00016595,0.26157,0.27308,1,1
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.00010092,0.26154,0.23798,1,1
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0094949,0.2611,0.3145,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,4.4878e-05,0.261,0.21933,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,6.7596e-05,0.261,0.19902,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.018836,0.26097,0.1915,1,1
4,GO REGULATION OF STEM CELL PROLIFERATION,0.016734,0.26096,0.15377,1,1
4,GO AUTOPHAGOSOME MATURATION,3.8583e-05,0.26078,0.26899,1,1
4,GO FATTY ACID BETA OXIDATION,0.00026903,0.26068,0.2486,1,1
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,4.1802e-07,0.26052,0.23059,1,1
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0083534,0.26052,0.20388,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.0047853,0.2604,0.21311,1,1
4,GO TRANSEPITHELIAL TRANSPORT,0.00035231,0.26035,0.25813,1,1
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.0045306,0.26021,0.19797,1,1
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011326,0.26015,0.29195,1,1
4,GO RNA 3 END PROCESSING,0.00016023,0.26012,0.20803,1,1
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.012203,0.25969,0.26277,1,1
4,GO RNA DESTABILIZATION,2.8418e-05,0.25959,0.25233,1,1
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00030804,0.2593,0.27285,1,1
4,GO CHYLOMICRON ASSEMBLY,0.010245,0.25909,0.23147,1,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00022676,0.2588,0.20508,1,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0094949,0.25865,0.33269,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00050664,0.25858,0.23649,1,1
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.044685,0.25853,0.35487,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.2837e-06,0.25824,0.25679,1,1
4,GO IMMUNE EFFECTOR PROCESS,9.3916e-06,0.25819,0.28073,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.6228e-06,0.25786,0.23765,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.0683e-06,0.25781,0.26207,1,1
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00012074,0.25738,0.23465,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.4878e-05,0.25729,0.21329,1,1
4,GO NUCLEAR PORE ORGANIZATION,0.00035231,0.25727,0.27444,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00012964,0.25725,0.24706,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.1267e-06,0.25672,0.28241,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.0013054,0.25651,0.23903,1,1
4,GO CHONDROCYTE PROLIFERATION,0.0046564,0.25635,0.39489,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00010462,0.25612,0.29357,1,1
4,GO DE NOVO PROTEIN FOLDING,0.00042998,0.25611,0.20853,1,1
4,GO PEPTIDE METABOLIC PROCESS,1.6729e-06,0.25568,0.23244,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00040247,0.25562,0.21628,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,2.4692e-06,0.25531,0.24124,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00021167,0.25529,0.26062,1,1
4,GO MACROPHAGE CHEMOTAXIS,2.7343e-05,0.25482,0.3462,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.015203,0.25475,0.24057,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.6455e-05,0.2547,0.29413,1,1
4,GO PROSTATE GLAND DEVELOPMENT,0.00052342,0.25454,0.37431,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.00047456,0.25446,0.27334,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.3132e-05,0.2544,0.23957,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.029068,0.25432,0.19462,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00050664,0.25428,0.21171,1,1
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0017641,0.25408,0.25202,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.5774e-06,0.2537,0.31297,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00057693,0.25364,0.31053,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00026003,0.25364,0.24404,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0097392,0.25352,0.24873,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0026572,0.25345,0.28558,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,9.7801e-06,0.25303,0.25075,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.9926e-07,0.25298,0.25389,1,1
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,2.9532e-05,0.25276,0.29501,1,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.0571e-06,0.25242,0.22575,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5308e-05,0.25221,0.22122,1,1
4,GO TRANSLATIONAL ELONGATION,0.0013054,0.25147,0.20506,1,1
4,GO INFLAMMATORY RESPONSE,6.0504e-05,0.25125,0.25003,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.00023468,0.25104,0.24269,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.00012074,0.25096,0.25952,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00013433,0.25094,0.23384,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.027188,0.25089,0.21473,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0024367,0.25077,0.21169,1,1
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.508e-06,0.25066,0.24796,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00012512,0.2499,0.28194,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.0033369,0.24977,0.19764,1,1
4,GO RRNA METHYLATION,0.0038387,0.24974,0.20013,1,1
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.044685,0.24946,0.22732,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.24934,0.25232,1,1
4,GO CERAMIDE TRANSPORT,0.0051916,0.24917,0.23399,1,1
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00081984,0.2481,0.20718,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00027832,0.24798,0.26553,1,1
4,GO OSTEOCLAST DIFFERENTIATION,3.8583e-05,0.24794,0.2167,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0029794,0.24757,0.22647,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.045624,0.24744,0.26618,1,1
4,GO FACE DEVELOPMENT,0.00019753,0.24712,0.26851,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00038934,0.24708,0.21103,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.033894,0.24701,0.19671,1,1
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.014486,0.24699,0.2645,1,1
4,GO REGULATION OF VIRAL TRANSCRIPTION,2.3418e-05,0.24693,0.25389,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.0012662,0.24666,0.20636,1,1
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.017969,0.24652,0.32456,1,1
4,GO PODOSOME ASSEMBLY,0.00014935,0.24635,0.35735,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00017796,0.24615,0.23006,1,1
4,GO CARDIOLIPIN METABOLIC PROCESS,0.023741,0.24609,0.16462,1,1
4,GO RESPONSE TO TESTOSTERONE,0.00012512,0.24601,0.25949,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8379e-05,0.24585,0.23346,1,1
4,GO MITOCHONDRIAL DNA REPLICATION,0.00027832,0.24564,0.2019,1,1
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00069957,0.24532,0.19117,1,1
4,GO PROTEIN TARGETING TO MEMBRANE,0.0015653,0.24528,0.22923,1,1
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.020205,0.24469,0.17548,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019753,0.24461,0.21987,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.4039e-05,0.24432,0.24738,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0010206,0.24424,0.24016,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.00049035,0.24414,0.24841,1,1
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.00027832,0.24414,0.23153,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0006154,0.24362,0.41866,1,1
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00012512,0.24347,0.23648,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010206,0.24322,0.27225,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.00353,0.24287,0.25971,1,1
4,GO RESPONSE TO STEROID HORMONE,0.00032948,0.24275,0.19098,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.037747,0.24242,0.14342,1,1
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0036303,0.24221,0.23287,1,1
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0033369,0.2422,0.2106,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0012662,0.24212,0.24947,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0015189,0.242,0.18954,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,1.1964e-05,0.24185,0.28568,1,1
4,GO REGULATION OF MITOPHAGY,0.015574,0.24166,0.19585,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00042998,0.24163,0.22332,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.24144,0.16769,1,1
4,GO DNA DEALKYLATION,0.00090094,0.24115,0.22595,1,1
4,GO CELLULAR IRON ION HOMEOSTASIS,2.7343e-05,0.24098,0.21455,1,1
4,GO METANEPHROS DEVELOPMENT,0.00067758,0.24092,0.22046,1,1
4,GO NEURAL TUBE PATTERNING,0.0017123,0.2407,0.23859,1,1
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.0033e-05,0.24064,0.21516,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00041602,0.24056,0.24421,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.029719,0.24051,0.16689,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001191,0.24048,0.22184,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.22474,1,1
4,GO HEART VALVE DEVELOPMENT,0.00040247,0.23972,0.29763,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,5.8301e-05,0.23944,0.23673,1,1
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.3654e-06,0.23932,0.25068,1,1
4,GO DEFENSE RESPONSE,4.0073e-05,0.2391,0.22623,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,9.389e-05,0.23904,0.21096,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00063551,0.23885,0.25566,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.0021689,0.23881,0.22263,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014935,0.2387,0.35059,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00036427,0.23868,0.24054,1,1
4,GO MEMBRANE BIOGENESIS,0.0049174,0.23859,0.23502,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.23845,0.30052,1,1
4,GO TUBE MORPHOGENESIS,6.7596e-05,0.23845,0.22029,1,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,5.2139e-05,0.23811,0.21855,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00069957,0.23806,0.18497,1,1
4,GO CELLULAR DEFENSE RESPONSE,0.0032441,0.23782,0.2735,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00031859,0.23766,0.25083,1,1
4,GO TONGUE DEVELOPMENT,0.011326,0.23753,0.26438,1,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0010206,0.23747,0.32472,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.6597e-05,0.23722,0.32263,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019283,0.2372,0.18478,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.23709,0.22861,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.6455e-05,0.23703,0.27242,1,1
4,GO PLATELET ACTIVATION,0.00057693,0.23675,0.22268,1,1
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,6.7596e-05,0.23633,0.20332,1,1
4,GO STRESS FIBER ASSEMBLY,0.00090094,0.23576,0.22714,1,1
4,GO PEPTIDYL ARGININE N METHYLATION,0.029719,0.23566,0.16109,1,1
4,GO RESPONSE TO RETINOIC ACID,7.013e-05,0.2356,0.25855,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0047853,0.23473,0.19888,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0067808,0.23455,0.20173,1,1
4,GO AMINE CATABOLIC PROCESS,0.00050664,0.23447,0.32449,1,1
4,GO TRNA PROCESSING,0.00049035,0.23411,0.18611,1,1
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.024288,0.23397,0.35347,1,1
4,GO CANONICAL WNT SIGNALING PATHWAY,0.00018427,0.23384,0.18895,1,1
4,GO LIPID STORAGE,0.00059588,0.23358,0.23299,1,1
4,GO PROTEIN TARGETING,3.0689e-05,0.23319,0.20101,1,1
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.9301e-06,0.23313,0.25943,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0038387,0.23311,0.17584,1,1
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.4728e-06,0.2331,0.26174,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.00013917,0.23293,0.2282,1,1
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,8.7323e-05,0.23279,0.26466,1,1
4,GO NCRNA EXPORT FROM NUCLEUS,0.0014738,0.23279,0.21045,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.1493e-05,0.23268,0.35401,1,1
4,GO P38MAPK CASCADE,9.7346e-05,0.23257,0.31846,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.6597e-05,0.23253,0.2062,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00011241,0.23229,0.24078,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00052342,0.23176,0.34295,1,1
4,GO MYELOID CELL HOMEOSTASIS,1.349e-05,0.23169,0.22021,1,1
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,3.0689e-05,0.23146,0.36514,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.023741,0.23124,0.1539,1,1
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.0067808,0.23099,0.23929,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00036427,0.23093,0.2591,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.009256,0.23089,0.19531,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,8.628e-07,0.23084,0.22357,1,1
4,GO SCHWANN CELL DIFFERENTIATION,0.00041602,0.2308,0.20351,1,1
4,GO POSITIVE CHEMOTAXIS,0.0041716,0.23075,0.22772,1,1
4,GO CRISTAE FORMATION,0.025414,0.23065,0.18741,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.0027346,0.23029,0.23109,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.010773,0.23012,0.35613,1,1
4,GO MITOPHAGY,0.00019079,0.2301,0.23929,1,1
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,3.6228e-06,0.22991,0.22802,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.2658e-06,0.22984,0.24722,1,1
4,GO REGULATION OF MRNA 3 END PROCESSING,0.00014935,0.2298,0.21116,1,1
4,GO REGULATION OF IMMUNE RESPONSE,1.9263e-05,0.22979,0.2163,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.22927,0.33993,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0007696,0.22915,0.17588,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.00090094,0.22889,0.25738,1,1
4,GO NUCLEAR EXPORT,5.7413e-06,0.22858,0.21112,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.7596e-05,0.22768,0.29144,1,1
4,GO TRABECULA MORPHOGENESIS,0.00081984,0.22732,0.27815,1,1
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,5.8301e-05,0.22731,0.20156,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00014418,0.22728,0.24797,1,1
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0024367,0.22693,0.19282,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,8.1192e-05,0.22691,0.21576,1,1
4,GO REGULATION OF HEMOPOIESIS,5.6174e-05,0.22687,0.19816,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00087311,0.22681,0.22472,1,1
4,GO AGING,1.5816e-05,0.22677,0.20055,1,1
4,GO TRNA MODIFICATION,0.00069957,0.22664,0.19317,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0041716,0.22631,0.22911,1,1
4,GO STEROL IMPORT,0.00054072,0.22611,0.41555,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00010845,0.22582,0.21368,1,1
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0033369,0.22574,0.20098,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,9.0551e-05,0.2257,0.26549,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.019739,0.2255,0.18337,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.00065623,0.22529,0.17424,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00050664,0.22526,0.20777,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.8628e-07,0.2252,0.19916,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00021167,0.22515,0.19671,1,1
4,GO CELL PROLIFERATION IN HINDBRAIN,0.010773,0.22489,0.20424,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0001165,0.22483,0.22212,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.001228,0.22459,0.22025,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.0551e-05,0.22457,0.26763,1,1
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00059588,0.22453,0.26205,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,6.0504e-05,0.22409,0.20911,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0083534,0.22404,0.17624,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00017186,0.22367,0.23643,1,1
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00021167,0.22364,0.18372,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.00074557,0.22337,0.16108,1,1
4,GO CELL KILLING,0.00353,0.22321,0.15694,1,1
4,GO LEUKOCYTE PROLIFERATION,0.0016129,0.22312,0.17812,1,1
4,GO T CELL PROLIFERATION,0.00049035,0.22309,0.20584,1,1
4,GO RESPONSE TO ISCHEMIA,0.00020448,0.22309,0.20778,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.0011199,0.22304,0.18797,1,1
4,GO ASTROCYTE DIFFERENTIATION,0.010506,0.2228,0.16056,1,1
4,GO PLATELET MORPHOGENESIS,0.00059588,0.22279,0.22458,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0020453,0.22265,0.21424,1,1
4,GO REGULATION OF DNA RECOMBINATION,0.00011241,0.22209,0.21219,1,1
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.010773,0.22193,0.16857,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.1617e-05,0.22182,0.21175,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0083534,0.2217,0.18214,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00055855,0.22142,0.17329,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00028792,0.22106,0.16628,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0016129,0.22086,0.19128,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,6.0504e-05,0.22078,0.18192,1,1
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0079323,0.22059,0.2959,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.1617e-05,0.21995,0.2163,1,1
4,GO BODY FLUID SECRETION,0.00024286,0.21983,0.21425,1,1
4,GO NUCLEUS LOCALIZATION,0.031059,0.2198,0.13251,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.004408,0.21975,0.20282,1,1
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,5.0194e-07,0.21971,0.20108,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00084609,0.21958,0.19592,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.21957,0.19601,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00050664,0.21924,0.2112,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0021062,0.2191,0.26958,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4609e-05,0.21904,0.23487,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,3.5759e-05,0.21884,0.21656,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0087944,0.21884,0.15379,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.017137,0.2188,0.18169,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00012074,0.21856,0.26116,1,1
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.2366e-07,0.21854,0.18213,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0038387,0.21852,0.19732,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.046579,0.21813,0.1638,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.2181,0.20968,1,1
4,GO EMBRYONIC EYE MORPHOGENESIS,0.011326,0.21793,0.21866,1,1
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,2.5308e-05,0.2176,0.20256,1,1
4,GO TRNA METABOLIC PROCESS,0.00081984,0.21758,0.17844,1,1
4,GO INTERFERON GAMMA PRODUCTION,4.1617e-05,0.21747,0.26656,1,1
4,GO RNA MODIFICATION,0.00010462,0.21727,0.1981,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.21723,0.31674,1,1
4,GO CARDIAC SEPTUM DEVELOPMENT,0.00036427,0.21677,0.2428,1,1
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00024286,0.21654,0.19111,1,1
4,GO REGULATION OF URINE VOLUME,0.00027832,0.21647,0.24044,1,1
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,8.628e-07,0.21628,0.21255,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00019079,0.216,0.20061,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.02268,0.21565,0.14186,1,1
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.015953,0.21551,0.26259,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0099891,0.21541,0.16482,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,6.2367e-06,0.21526,0.1974,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0028957,0.21509,0.222,1,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,9.389e-05,0.21501,0.26076,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0069616,0.21454,0.28703,1,1
4,GO GRANULOCYTE MIGRATION,0.00018427,0.21445,0.27623,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0011549,0.21418,0.18974,1,1
4,GO NEURAL CREST CELL DIFFERENTIATION,0.024288,0.2141,0.19236,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00353,0.2141,0.15204,1,1
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0010528,0.214,0.21006,1,1
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0067808,0.21346,0.18073,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0016129,0.21295,0.22479,1,1
4,GO T CELL ACTIVATION,0.00011241,0.21262,0.20769,1,1
4,GO REGULATION OF CELL ACTIVATION,0.00012074,0.21229,0.19659,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00055855,0.21222,0.21259,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.012203,0.2118,0.19708,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00072223,0.21173,0.19311,1,1
4,GO CELL ACTIVATION,2.4346e-05,0.21138,0.23077,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,2.4692e-06,0.21113,0.24364,1,1
4,GO FIBROBLAST APOPTOTIC PROCESS,0.027803,0.21105,0.21071,1,1
4,GO AMIDE BIOSYNTHETIC PROCESS,2.2524e-05,0.21076,0.19654,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.0011199,0.21067,0.21199,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0066042,0.21061,0.18612,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0023671,0.21055,0.23087,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.21022,0.21092,1,1
4,GO HEAD MORPHOGENESIS,0.001228,0.21003,0.25997,1,1
4,GO BLASTOCYST GROWTH,0.0011549,0.20993,0.25414,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.20992,0.17176,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.0020453,0.2099,0.17151,1,1
4,GO CIRCULATORY SYSTEM DEVELOPMENT,2.0833e-05,0.20966,0.22543,1,1
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,7.2754e-05,0.20944,0.1976,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,7.8282e-05,0.20914,0.21995,1,1
4,GO MESENCHYME DEVELOPMENT,0.00018427,0.20907,0.22643,1,1
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0075304,0.20905,0.17936,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0013457,0.20895,0.24051,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00021167,0.20871,0.19465,1,1
4,GO PROTEIN DENEDDYLATION,0.0028957,0.2087,0.18314,1,1
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0011549,0.20869,0.18418,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,7.2756e-08,0.20857,0.19434,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.2454e-05,0.20805,0.20492,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.019283,0.20772,0.26496,1,1
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.014841,0.20766,0.16415,1,1
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.5774e-06,0.20742,0.26238,1,1
4,GO RESPONSE TO KETONE,0.0025817,0.2073,0.16483,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0034322,0.20702,0.16825,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,3.8583e-05,0.20697,0.27622,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,2.0833e-05,0.20677,0.22,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00084609,0.20671,0.22566,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.027803,0.2067,0.17768,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.010506,0.2065,0.20352,1,1
4,GO LEUKOCYTE MIGRATION,0.0018173,0.20628,0.19037,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,7.013e-05,0.20545,0.19957,1,1
4,GO CELLULAR RESPONSE TO HEAT,0.00065623,0.20544,0.17946,1,1
4,GO RETINOL METABOLIC PROCESS,0.0030654,0.20526,0.20344,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,5.8301e-05,0.20521,0.20799,1,1
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.023205,0.20499,0.16649,1,1
4,GO RUFFLE ORGANIZATION,0.0049174,0.20481,0.14416,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00017186,0.2047,0.18396,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00035231,0.20436,0.16841,1,1
4,GO MYELOID CELL DIFFERENTIATION,3.1888e-05,0.20436,0.17745,1,1
4,GO RESPONSE TO INTERLEUKIN 7,0.036164,0.20434,0.1784,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.0184e-05,0.2041,0.19524,1,1
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.019283,0.20391,0.2282,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015953,0.20391,0.13791,1,1
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.016339,0.2033,0.11167,1,1
4,GO RESPONSE TO CHEMOKINE,0.0046564,0.20321,0.21045,1,1
4,GO NEUROINFLAMMATORY RESPONSE,0.0030654,0.20285,0.25006,1,1
4,GO RRNA 3 END PROCESSING,0.0007696,0.20283,0.21338,1,1
4,GO CELLULAR AMIDE METABOLIC PROCESS,7.9801e-06,0.2026,0.18922,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00011241,0.20259,0.24387,1,1
4,GO REGULATION OF LIPID STORAGE,0.00098941,0.2024,0.23675,1,1
4,GO RESPONSE TO LIPID,0.00050664,0.20226,0.17103,1,1
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0014738,0.20221,0.21435,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,9.0221e-07,0.20184,0.21059,1,1
4,GO RESPONSE TO VITAMIN A,0.033166,0.2018,0.17107,1,1
4,GO COENZYME A METABOLIC PROCESS,0.0081404,0.20169,0.16161,1,1
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.009256,0.20168,0.16842,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,2.0833e-05,0.20137,0.20105,1,1
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,9.8628e-07,0.20085,0.19278,1,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.20079,0.23505,1,1
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00353,0.20072,0.22242,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00059588,0.20058,0.15261,1,1
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0037331,0.20055,0.14382,1,1
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.017969,0.20052,0.22345,1,1
4,GO OSSIFICATION,0.00035231,0.20032,0.20839,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00090094,0.20027,0.21205,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.042857,0.2002,0.21202,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,6.2786e-05,0.20019,0.23458,1,1
4,GO RESPONSE TO TUMOR CELL,0.02068,0.19979,0.18965,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00054072,0.19975,0.21189,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.00059588,0.19966,0.20134,1,1
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00098941,0.19961,0.21676,1,1
4,GO HISTONE H2B UBIQUITINATION,0.03245,0.19959,0.14264,1,1
4,GO REGULATION OF CELL ADHESION,0.0018173,0.19957,0.18596,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,2.8418e-05,0.19935,0.22296,1,1
4,GO MITOTIC CYTOKINESIS,0.00098941,0.19935,0.20065,1,1
4,GO RNA LOCALIZATION,0.00014418,0.19924,0.1994,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.046579,0.19912,0.13684,1,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0011199,0.19894,0.2288,1,1
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0010206,0.19888,0.14647,1,1
4,GO LYMPHOCYTE ACTIVATION,6.0504e-05,0.19873,0.19493,1,1
4,GO MIDBODY ABSCISSION,0.036948,0.19861,0.15932,1,1
4,GO ANIMAL ORGAN FORMATION,0.011612,0.19861,0.17696,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,3.8583e-05,0.19829,0.23625,1,1
4,GO DENDRITIC SPINE MAINTENANCE,0.0097392,0.19811,0.21452,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.0001547,0.19803,0.19568,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013798,0.19799,0.13291,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.0075304,0.19784,0.20477,1,1
4,GO RNA METHYLATION,0.00036427,0.19755,0.19289,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.4039e-05,0.19732,0.21747,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.047551,0.19702,0.20995,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.8301e-05,0.19652,0.22774,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.0099891,0.19631,0.19245,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0013054,0.19624,0.22164,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,3.4421e-05,0.1959,0.17428,1,1
4,GO VESICLE TARGETING,0.00022676,0.19585,0.20778,1,1
4,GO RESPONSE TO PH,0.0059384,0.1958,0.22017,1,1
4,GO BODY MORPHOGENESIS,0.0034322,0.1955,0.18575,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00087311,0.19549,0.18451,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0011199,0.19541,0.16215,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00017796,0.19523,0.19532,1,1
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0017123,0.19516,0.20363,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00059588,0.1951,0.19527,1,1
4,GO PROTEIN PROCESSING,0.00026003,0.195,0.20121,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,1.4609e-05,0.19489,0.17723,1,1
4,GO ORGAN GROWTH,0.00035231,0.19464,0.20728,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.0016129,0.19399,0.29642,1,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00014935,0.19373,0.17788,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0017123,0.1935,0.16075,1,1
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.020205,0.1932,0.20995,1,1
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.0085714,0.19307,0.14719,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.011047,0.19275,0.1393,1,1
4,GO PROTEIN STABILIZATION,2.5308e-05,0.19262,0.16595,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.0067808,0.19166,0.33297,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0022992,0.19149,0.16246,1,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00021909,0.19129,0.15629,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026003,0.19102,0.18544,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0014299,0.1906,0.18118,1,1
4,GO REGULATION OF BIOMINERALIZATION,0.0010859,0.19057,0.25392,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00059588,0.19048,0.18427,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00045924,0.19045,0.17865,1,1
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00031859,0.19045,0.23669,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.0011549,0.19036,0.15651,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00011241,0.19027,0.18405,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.19026,0.17321,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0029794,0.19014,0.244,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00022676,0.19012,0.15191,1,1
4,GO SECRETION BY TISSUE,0.035393,0.18996,0.14018,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00044439,0.18992,0.16934,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.00010092,0.18989,0.18737,1,1
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00012512,0.18969,0.19343,1,1
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.00087311,0.18956,0.20799,1,1
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.011612,0.18919,0.17235,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00031859,0.18913,0.2035,1,1
4,GO RESPONSE TO REDOX STATE,0.043763,0.18902,0.19195,1,1
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.001986,0.18883,0.19264,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013457,0.18867,0.17886,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.00065623,0.18864,0.15251,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0023671,0.18811,0.16059,1,1
4,GO PROTEIN HOMOTETRAMERIZATION,1.5816e-05,0.1879,0.19314,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029794,0.18769,0.15195,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,6.5149e-05,0.18746,0.15525,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00013917,0.18744,0.17949,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.8418e-05,0.18716,0.15285,1,1
4,GO NEURAL TUBE DEVELOPMENT,0.0017641,0.18715,0.18699,1,1
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00054072,0.18713,0.22555,1,1
4,GO HISTONE DEACETYLATION,0.00084609,0.18712,0.12623,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0054795,0.18689,0.18642,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.00031859,0.18651,0.18943,1,1
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00087311,0.18644,0.18778,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001986,0.18639,0.1638,1,1
4,GO PROTEIN DEMANNOSYLATION,0.014841,0.18607,0.18077,1,1
4,GO ENDOTHELIAL CELL PROLIFERATION,0.00047456,0.18591,0.19967,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0016129,0.18588,0.21972,1,1
4,GO DRUG METABOLIC PROCESS,0.0033369,0.18571,0.15632,1,1
4,GO PROTEIN MATURATION,0.00012074,0.18535,0.15531,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,6.5896e-07,0.18526,0.17336,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.753e-07,0.18517,0.16516,1,1
4,GO RNA PROCESSING,8.4205e-05,0.18508,0.17478,1,1
4,GO ORGANELLE INHERITANCE,0.0018173,0.18502,0.17036,1,1
4,GO SULFUR COMPOUND TRANSPORT,4.0073e-05,0.18493,0.21395,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.019739,0.1848,0.14375,1,1
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031859,0.1848,0.20281,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.0046564,0.18468,0.27762,1,1
4,GO CELLULAR RESPONSE TO UV,0.00072223,0.18438,0.16825,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.029719,0.1843,0.11571,1,1
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0014299,0.18419,0.17225,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0010859,0.18419,0.15436,1,1
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00024286,0.18407,0.24352,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0085714,0.18393,0.15841,1,1
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.025994,0.18383,0.14087,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029719,0.18369,0.13253,1,1
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00055855,0.18354,0.20198,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0024367,0.18333,0.15258,1,1
4,GO BONE DEVELOPMENT,9.0551e-05,0.18328,0.22452,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0038387,0.18328,0.21917,1,1
4,GO STEROL HOMEOSTASIS,0.026586,0.18324,0.1038,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0028141,0.18322,0.19665,1,1
4,GO REGULATION OF T CELL CHEMOTAXIS,0.02166,0.18316,0.16209,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0051916,0.18289,0.16357,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.18279,0.17211,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.906e-06,0.18255,0.19007,1,1
4,GO CELLULAR RESPONSE TO RADIATION,0.00011241,0.18229,0.17343,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0040578,0.18224,0.12682,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,6.7596e-05,0.18187,0.21036,1,1
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.6455e-05,0.18183,0.19656,1,1
4,GO OVULATION,0.045624,0.18151,0.21515,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0015653,0.18143,0.14491,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.0012662,0.18141,0.15887,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.022165,0.18114,0.14393,1,1
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0085714,0.18102,0.14807,1,1
4,GO PROTEIN NEDDYLATION,0.0013457,0.18063,0.18757,1,1
4,GO PEPTIDYL ARGININE METHYLATION,0.016339,0.18038,0.13803,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,2.0033e-05,0.18001,0.21106,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.7578e-07,0.17974,0.18268,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0028141,0.17962,0.17746,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0030654,0.17955,0.20751,1,1
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.0504e-05,0.1795,0.21432,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00092958,0.17948,0.14115,1,1
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0090226,0.17942,0.19612,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.17925,0.21327,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0027346,0.17916,0.17754,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.044685,0.17914,0.15418,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0025083,0.17912,0.15965,1,1
4,GO PEROXISOMAL TRANSPORT,0.0017641,0.17852,0.18946,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,1.1493e-05,0.17749,0.17449,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.17733,0.15447,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00021167,0.17714,0.15731,1,1
4,GO SCHWANN CELL DEVELOPMENT,0.0017123,0.177,0.1736,1,1
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0014738,0.1764,0.13026,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00047456,0.1761,0.19009,1,1
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00087311,0.1761,0.21891,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00020448,0.17599,0.16436,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0083534,0.17584,0.13091,1,1
4,GO T CELL DIFFERENTIATION IN THYMUS,7.8282e-05,0.17575,0.18998,1,1
4,GO TRNA TRANSPORT,0.0075304,0.17573,0.16343,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.00047456,0.17562,0.18106,1,1
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.2533e-07,0.17557,0.17718,1,1
4,GO RESPONSE TO HEAT,0.00014418,0.17537,0.18386,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.001662,0.17533,0.15365,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00016023,0.17514,0.19241,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.5774e-06,0.17487,0.17479,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,7.8282e-05,0.17459,0.20051,1,1
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00069957,0.17452,0.31239,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00072223,0.17438,0.13207,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0013457,0.17438,0.22613,1,1
4,GO GOLGI VESICLE TRANSPORT,1.1964e-05,0.17426,0.17047,1,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.0025083,0.17392,0.15294,1,1
4,GO RNA POLYADENYLATION,0.0013054,0.17382,0.15341,1,1
4,GO FOLIC ACID METABOLIC PROCESS,0.037747,0.17377,0.15295,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00050664,0.17367,0.17396,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0020453,0.17358,0.16878,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.023205,0.17357,0.12839,1,1
4,GO MITOTIC RECOMBINATION,0.0028957,0.17352,0.1951,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00031859,0.17309,0.18345,1,1
4,GO CELLULAR EXTRAVASATION,0.00079435,0.17306,0.20085,1,1
4,GO ANION HOMEOSTASIS,0.015203,0.17264,0.13523,1,1
4,GO REGULATION OF MAPK CASCADE,0.00023468,0.17259,0.15864,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.0010528,0.17242,0.1718,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.001191,0.17233,0.18895,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,0.0025817,0.17231,0.16563,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.019283,0.17217,0.13673,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,4.5813e-07,0.17186,0.17112,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0018173,0.17184,0.15918,1,1
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.03939,0.17179,0.24763,1,1
4,GO LYSOSOMAL TRANSPORT,0.00010845,0.17172,0.18502,1,1
4,GO PROTEIN IMPORT,7.2754e-05,0.1717,0.16619,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.001872,0.17148,0.16919,1,1
4,GO PEROXISOME ORGANIZATION,0.0010859,0.17129,0.18302,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.015203,0.17095,0.11923,1,1
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.5427e-07,0.17084,0.18106,1,1
4,GO REGULATION OF RESPONSE TO STRESS,2.7343e-05,0.17084,0.16487,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.023741,0.17062,0.14843,1,1
4,GO TRANSLESION SYNTHESIS,0.0015653,0.17043,0.15589,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.0226e-05,0.17043,0.18213,1,1
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.001191,0.17034,0.13539,1,1
4,GO VACUOLAR TRANSPORT,0.00034072,0.17011,0.15288,1,1
4,GO TUBE DEVELOPMENT,0.00052342,0.17006,0.17617,1,1
4,GO SPINDLE LOCALIZATION,8.1192e-05,0.16972,0.18164,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00079435,0.16955,0.15913,1,1
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0046564,0.1695,0.22304,1,1
4,GO REGULATION OF CATABOLIC PROCESS,5.4977e-07,0.1695,0.16452,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00023468,0.16919,0.13692,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00010092,0.16891,0.20301,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.001986,0.16882,0.15204,1,1
4,GO MRNA METABOLIC PROCESS,2.9532e-05,0.16862,0.16557,1,1
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0014738,0.16852,0.17512,1,1
4,GO INTERMEMBRANE LIPID TRANSFER,0.001191,0.16847,0.18006,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0085714,0.16846,0.12952,1,1
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.0576e-06,0.16817,0.16602,1,1
4,GO REGULATION OF NUCLEAR DIVISION,0.00019079,0.16809,0.13753,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.011904,0.16808,0.18896,1,1
4,GO NEUTROPHIL MIGRATION,0.0021062,0.16772,0.24021,1,1
4,GO AEROBIC RESPIRATION,0.036164,0.1676,0.098627,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.019283,0.16759,0.18154,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.013798,0.16757,0.13045,1,1
4,GO COPII COATED VESICLE CARGO LOADING,0.001228,0.16756,0.19716,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,7.5427e-07,0.16748,0.16734,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00034072,0.16718,0.18579,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00041602,0.16683,0.18232,1,1
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0027346,0.1665,0.14795,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.001872,0.16628,0.16832,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.0034322,0.16628,0.12961,1,1
4,GO OXALATE TRANSPORT,0.031748,0.16623,0.1071,1,1
4,GO ENDODERMAL CELL FATE COMMITMENT,0.029068,0.16599,0.17541,1,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022992,0.16567,0.18533,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0001547,0.16563,0.1419,1,1
4,GO PROTEIN REFOLDING,0.042857,0.1656,0.1569,1,1
4,GO NUCLEAR TRANSPORT,3.3132e-05,0.1655,0.15444,1,1
4,GO PROTEIN KINASE A SIGNALING,0.00016595,0.16514,0.21289,1,1
4,GO RNA CAPPING,0.00026003,0.16511,0.16282,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.001662,0.16474,0.1302,1,1
4,GO REGULATION OF MYELINATION,0.0094949,0.16445,0.14529,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.0041716,0.16433,0.21881,1,1
4,GO RESPONSE TO GONADOTROPIN,0.0059384,0.16422,0.27755,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.0571e-06,0.16403,0.20062,1,1
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0099891,0.16399,0.13145,1,1
4,GO VACUOLE ORGANIZATION,7.8282e-05,0.16375,0.15452,1,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,5.6174e-05,0.16367,0.15591,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00057693,0.16347,0.21328,1,1
4,GO RECEPTOR RECYCLING,0.0069616,0.16318,0.12983,1,1
4,GO RNA DECAPPING,0.00055855,0.16313,0.18146,1,1
4,GO POSITIVE REGULATION OF BINDING,0.00011241,0.16287,0.16396,1,1
4,GO REGULATION OF BONE MINERALIZATION,0.0057817,0.16279,0.23497,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.9904e-06,0.16278,0.15446,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0085714,0.16242,0.1752,1,1
4,GO TELOMERE ORGANIZATION,0.0006154,0.16219,0.13455,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.014486,0.16215,0.15314,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0020453,0.16205,0.17778,1,1
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.012508,0.16186,0.13872,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.00030804,0.16177,0.22715,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00030804,0.16169,0.15709,1,1
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.004408,0.16141,0.1827,1,1
4,GO ERBB SIGNALING PATHWAY,0.00041602,0.16126,0.22356,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.029719,0.16117,0.13968,1,1
4,GO PROTEIN POLYUBIQUITINATION,8.4205e-05,0.161,0.1464,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00047456,0.16094,0.14943,1,1
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00038934,0.16085,0.14692,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.019283,0.16063,0.088191,1,1
4,GO MUSCLE ADAPTATION,0.015203,0.1606,0.11148,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017969,0.16051,0.19455,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.16045,0.16635,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0022992,0.16038,0.16967,1,1
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0051916,0.16024,0.27498,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.0020453,0.15997,0.12801,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041093,0.15987,0.13846,1,1
4,GO NEURAL TUBE FORMATION,0.0053338,0.15981,0.17645,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0099891,0.1596,0.17829,1,1
4,GO PROTEOLYSIS,1.104e-05,0.15947,0.14891,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00030804,0.159,0.14214,1,1
4,GO REGULATION OF OSSIFICATION,0.0024367,0.15895,0.19695,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0011199,0.15852,0.17148,1,1
4,GO THYROID HORMONE METABOLIC PROCESS,0.025414,0.15842,0.14062,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0071468,0.15839,0.17502,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0057817,0.15826,0.13239,1,1
4,GO RESPONSE TO UV,0.00014418,0.15756,0.17273,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0085714,0.15752,0.16111,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00021909,0.15735,0.13334,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0081404,0.15712,0.2453,1,1
4,GO TISSUE MORPHOGENESIS,0.00026903,0.15708,0.17354,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.017969,0.15703,0.128,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00027832,0.15682,0.14603,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025083,0.15681,0.1229,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00059588,0.1568,0.15164,1,1
4,GO REGULATION OF RECEPTOR RECYCLING,0.00095906,0.15647,0.21339,1,1
4,GO SKELETAL SYSTEM DEVELOPMENT,0.0031536,0.15631,0.16135,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,8.7323e-05,0.15616,0.1751,1,1
4,GO MAINTENANCE OF LOCATION,3.4421e-05,0.156,0.17106,1,1
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.0030654,0.15593,0.19531,1,1
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0039469,0.15571,0.16732,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013465,0.15539,0.16702,1,1
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00098941,0.15513,0.13555,1,1
4,GO MITOTIC SPINDLE ORGANIZATION,0.001872,0.1551,0.15889,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0037331,0.15509,0.14149,1,1
4,GO PROTEIN CATABOLIC PROCESS,1.1267e-06,0.15492,0.1538,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.00353,0.15468,0.20365,1,1
4,GO POSTREPLICATION REPAIR,0.00079435,0.15468,0.13962,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0029794,0.15427,0.11791,1,1
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.033894,0.15404,0.092987,1,1
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.2139e-05,0.154,0.15608,1,1
4,GO LACTATION,0.0049174,0.15374,0.18083,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00072223,0.15358,0.17483,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.001986,0.15344,0.15305,1,1
4,GO RESPONSE TO DRUG,0.01282,0.15335,0.11107,1,1
4,GO MRNA TRANSPORT,0.00034072,0.15332,0.17623,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.2505e-07,0.15325,0.16724,1,1
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,3.0689e-05,0.15305,0.1769,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,9.0551e-05,0.15291,0.18315,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0050528,0.15287,0.25269,1,1
4,GO UV DAMAGE EXCISION REPAIR,0.0022332,0.15269,0.16893,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,2.0033e-05,0.15265,0.13936,1,1
4,GO REGULATION OF ERAD PATHWAY,9.0551e-05,0.1523,0.16679,1,1
4,GO REPLACEMENT OSSIFICATION,0.016734,0.15222,0.23853,1,1
4,GO HEART GROWTH,0.0046564,0.15184,0.1689,1,1
4,GO REGULATION OF CELL DEATH,0.00017796,0.15169,0.13612,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.036164,0.15166,0.13402,1,1
4,GO B CELL ACTIVATION,0.001191,0.15151,0.14117,1,1
4,GO RESPONSE TO GROWTH FACTOR,0.00087311,0.15137,0.15736,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00037661,0.15137,0.13301,1,1
4,GO REGULATION OF BINDING,0.00038934,0.15112,0.13773,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00069957,0.15091,0.13695,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.8418e-05,0.15067,0.16131,1,1
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.001872,0.15055,0.11492,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.0079323,0.15051,0.12664,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0013054,0.15048,0.15639,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.014138,0.15044,0.10252,1,1
4,GO RESPONSE TO LEPTIN,0.030383,0.15038,0.17542,1,1
4,GO MACROPHAGE ACTIVATION,0.015574,0.14995,0.15745,1,1
4,GO GOLGI VESICLE BUDDING,0.0011199,0.14979,0.17165,1,1
4,GO VACUOLAR ACIDIFICATION,0.0026572,0.14956,0.16886,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0031536,0.14927,0.13185,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00079435,0.14923,0.14819,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00030804,0.14921,0.14229,1,1
4,GO DNA BIOSYNTHETIC PROCESS,1.0311e-06,0.14876,0.16786,1,1
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.021165,0.14857,0.15604,1,1
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00018427,0.14825,0.1409,1,1
4,GO REGULATION OF PROTEIN BINDING,0.00036427,0.14769,0.15361,1,1
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00059588,0.14727,0.15713,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0060989,0.14723,0.10864,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.00037661,0.14712,0.14854,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.007729,0.14709,0.1382,1,1
4,GO NCRNA CATABOLIC PROCESS,0.026586,0.14695,0.15928,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0094949,0.14694,0.11495,1,1
4,GO POSITIVE REGULATION OF DNA BINDING,0.033166,0.14691,0.11648,1,1
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0022992,0.14677,0.18254,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.043763,0.14642,0.16522,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.024288,0.14612,0.16179,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00057693,0.14579,0.11465,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0066042,0.14541,0.16472,1,1
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.016339,0.14505,0.13921,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.00079435,0.14483,0.15391,1,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0094949,0.14467,0.14752,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.036164,0.1446,0.11369,1,1
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0033369,0.14453,0.17456,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00045924,0.1445,0.16244,1,1
4,GO REGULATION OF CHEMOTAXIS,0.001872,0.14433,0.1479,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00021167,0.1443,0.12773,1,1
4,GO CHROMOSOME LOCALIZATION,0.043763,0.14391,0.11104,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.0031536,0.14365,0.10986,1,1
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.026586,0.14317,0.16542,1,1
4,GO LAMELLIPODIUM ASSEMBLY,0.0083534,0.14304,0.16937,1,1
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0010528,0.14264,0.19171,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0064317,0.14253,0.1057,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00059588,0.14245,0.1825,1,1
4,GO COPII COATED VESICLE BUDDING,0.0029794,0.14234,0.16748,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.0049174,0.142,0.17805,1,1
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.14185,0.14042,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00044439,0.14181,0.13253,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0019282,0.14163,0.13483,1,1
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.020205,0.14161,0.15743,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.03245,0.14156,0.078346,1,1
4,GO GENITALIA DEVELOPMENT,0.0056288,0.14131,0.12734,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0038387,0.14115,0.15157,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013465,0.1411,0.11921,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0062634,0.14109,0.10622,1,1
4,GO PROTEIN LOCALIZATION TO ORGANELLE,6.2985e-07,0.14107,0.13724,1,1
4,GO LIPID CATABOLIC PROCESS,0.0034322,0.14087,0.10094,1,1
4,GO GOLGI ORGANIZATION,0.00069957,0.14082,0.13405,1,1
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0038387,0.14052,0.11408,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00026003,0.14043,0.13401,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00030804,0.13999,0.14349,1,1
4,GO MEIOTIC SPINDLE ORGANIZATION,0.024846,0.13973,0.12393,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.0033e-05,0.13946,0.13714,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.03939,0.13934,0.16737,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.0017123,0.13918,0.1302,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0022992,0.13909,0.16923,1,1
4,GO MESENCHYME MORPHOGENESIS,0.0032441,0.13908,0.30352,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00020448,0.13874,0.16069,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.033166,0.13863,0.12871,1,1
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.007729,0.1384,0.13802,1,1
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0039469,0.13829,0.1451,1,1
4,GO CELL CELL SIGNALING BY WNT,0.0050528,0.13812,0.12281,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.00095906,0.13811,0.1162,1,1
4,GO NUCLEUS ORGANIZATION,0.0006154,0.13804,0.12879,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.00079435,0.1377,0.11917,1,1
4,GO OUTFLOW TRACT MORPHOGENESIS,0.0042883,0.13749,0.26856,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00032948,0.13733,0.18307,1,1
4,GO APOPTOTIC PROCESS,8.4205e-05,0.13719,0.13308,1,1
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0050528,0.13715,0.1844,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.0504e-05,0.13711,0.14588,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.0019282,0.13704,0.10455,1,1
4,GO MYOTUBE DIFFERENTIATION,0.038561,0.13701,0.12585,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,2.4346e-05,0.13689,0.16824,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.1617e-05,0.1366,0.17834,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00050664,0.13641,0.12096,1,1
4,GO REGULATION OF GLIAL CELL MIGRATION,0.023205,0.13631,0.16326,1,1
4,GO ENDOSOME ORGANIZATION,0.0022992,0.13593,0.14671,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.00032948,0.13557,0.18446,1,1
4,GO SULFATE TRANSPORT,0.00069957,0.13554,0.14245,1,1
4,GO RNA SURVEILLANCE,0.00069957,0.13536,0.2054,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00036427,0.1353,0.14715,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.00034072,0.1351,0.11821,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00057693,0.13508,0.12335,1,1
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00090094,0.13452,0.13898,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.13449,0.13233,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,5.9841e-06,0.13425,0.13309,1,1
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.041967,0.1342,0.20415,1,1
4,GO REGULATION OF MITOTIC CELL CYCLE,0.0016129,0.13385,0.1127,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0024367,0.13337,0.18637,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.00095906,0.13325,0.10309,1,1
4,GO CELL CYCLE PHASE TRANSITION,0.0031536,0.13314,0.10457,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00031859,0.13283,0.14611,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0012662,0.13253,0.14007,1,1
4,GO STEM CELL DIFFERENTIATION,0.00021167,0.13218,0.17719,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.034637,0.13208,0.17067,1,1
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.033894,0.13204,0.095095,1,1
4,GO VIRAL BUDDING,0.013465,0.13148,0.1175,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0046564,0.1312,0.205,1,1
4,GO REGULATION OF CENTROSOME DUPLICATION,0.017969,0.13082,0.12895,1,1
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00092958,0.1301,0.1192,1,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00011241,0.13004,0.11411,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0060989,0.1297,0.11017,1,1
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.026586,0.12968,0.11388,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00016023,0.12951,0.1844,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00037661,0.12896,0.11847,1,1
4,GO GENE SILENCING,0.00010462,0.12893,0.13271,1,1
4,GO ORGANELLE DISASSEMBLY,5.8301e-05,0.12868,0.13596,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00014935,0.1286,0.13625,1,1
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.0001547,0.12799,0.13751,1,1
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0013872,0.12772,0.12044,1,1
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016339,0.12767,0.13858,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00079435,0.12744,0.11966,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0069616,0.12684,0.18514,1,1
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0099891,0.12646,0.12961,1,1
4,GO EXOCYTOSIS,0.0011199,0.12645,0.13749,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.12629,0.13249,1,1
4,GO NON RECOMBINATIONAL REPAIR,0.0018173,0.12626,0.13275,1,1
4,GO REGULATION OF CHROMOSOME SEPARATION,0.0062634,0.12624,0.16516,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0014299,0.12615,0.1125,1,1
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.045624,0.12612,0.092082,1,1
4,GO RESPONSE TO HORMONE,0.00092958,0.12561,0.12393,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017796,0.12559,0.21496,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.047551,0.12551,0.14491,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010506,0.12549,0.1282,1,1
4,GO MEMBRANE ORGANIZATION,0.00074557,0.12522,0.1104,1,1
4,GO NUCLEOTIDE EXCISION REPAIR,0.00016023,0.12504,0.13887,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.016734,0.12489,0.16986,1,1
4,GO HEART DEVELOPMENT,0.0017641,0.12473,0.14399,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001191,0.12398,0.11453,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,2.4346e-05,0.12394,0.12828,1,1
4,GO CELLULAR SENESCENCE,0.00092958,0.12384,0.13602,1,1
4,GO ENDOCYTOSIS,0.00030804,0.12359,0.14079,1,1
4,GO CELL DIVISION,0.0025083,0.12332,0.10628,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00081984,0.12304,0.093322,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.021165,0.12303,0.095374,1,1
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00057693,0.12281,0.14934,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.014138,0.12254,0.085709,1,1
4,GO REGULATION OF DNA REPAIR,0.0083534,0.12235,0.094956,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0042883,0.12232,0.099417,1,1
4,GO FLUID TRANSPORT,0.0037331,0.12221,0.1533,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.011612,0.12199,0.1263,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.00353,0.12187,0.10535,1,1
4,GO FAT CELL DIFFERENTIATION,0.035393,0.12163,0.090244,1,1
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.4121e-05,0.12139,0.13948,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001662,0.12047,0.10153,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.00021167,0.11983,0.12367,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0028141,0.11973,0.13848,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0028957,0.11934,0.093252,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.11933,0.14714,1,1
4,GO RESPONSE TO PEPTIDE,0.00059588,0.11882,0.11342,1,1
4,GO CYTOKINESIS,0.0085714,0.11861,0.10996,1,1
4,GO LAMELLIPODIUM ORGANIZATION,0.0046564,0.11799,0.18098,1,1
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0054795,0.11787,0.11109,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00012964,0.11735,0.15591,1,1
4,GO REGULATION OF DNA REPLICATION,0.0031536,0.11709,0.11091,1,1
4,GO CHROMOSOME SEPARATION,0.011047,0.11668,0.133,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.011904,0.11617,0.087073,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,5.2139e-05,0.11605,0.14524,1,1
4,GO REGULATION OF ATPASE ACTIVITY,0.0057817,0.11598,0.11393,1,1
4,GO REGULATION OF AUTOPHAGY,6.0504e-05,0.11411,0.13573,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00010845,0.11372,0.122,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00021909,0.11368,0.12092,1,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.019283,0.1135,0.1069,1,1
4,GO EMBRYONIC MORPHOGENESIS,0.0054795,0.11333,0.11892,1,1
4,GO APOPTOTIC DNA FRAGMENTATION,0.0010206,0.11315,0.11398,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0045306,0.11299,0.088532,1,1
4,GO ORGANELLE FISSION,0.0039469,0.11284,0.091543,1,1
4,GO SPINDLE ORGANIZATION,0.0047853,0.11271,0.11735,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.017969,0.11216,0.10068,1,1
4,GO MACROAUTOPHAGY,1.349e-05,0.11204,0.1404,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.033894,0.11183,0.13326,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0010859,0.11173,0.16527,1,1
4,GO FEMALE GAMETE GENERATION,0.0032441,0.11153,0.098412,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02268,0.11145,0.10073,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.00052342,0.11135,0.10608,1,1
4,GO MITOTIC CELL CYCLE,0.0018173,0.11133,0.10611,1,1
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.013139,0.11055,0.1361,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00081984,0.11018,0.13918,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0022332,0.11003,0.11418,1,1
4,GO METAPHASE PLATE CONGRESSION,0.047551,0.11002,0.10185,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.023741,0.10979,0.074936,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.013139,0.10969,0.13352,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.017969,0.10963,0.1815,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.030383,0.10947,0.10946,1,1
4,GO REGULATION OF CELL CYCLE PROCESS,0.001872,0.10946,0.096889,1,1
4,GO CHROMOSOME CONDENSATION,0.0042883,0.10909,0.1303,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.014486,0.10837,0.13675,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0013872,0.10813,0.10278,1,1
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.1888e-05,0.10751,0.11115,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.018398,0.10726,0.071363,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,2.3418e-05,0.10621,0.10747,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.00013917,0.10604,0.087885,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.029068,0.10572,0.088847,1,1
4,GO CARDIAC CHAMBER DEVELOPMENT,0.017137,0.10418,0.1412,1,1
4,GO MUSCLE ORGAN DEVELOPMENT,0.0014738,0.1039,0.13318,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0011549,0.10375,0.11415,1,1
4,GO MIRNA METABOLIC PROCESS,0.0085714,0.10365,0.13932,1,1
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.03245,0.10354,0.097241,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.02843,0.10328,0.12874,1,1
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.011047,0.10287,0.10008,1,1
4,GO PROTEIN TETRAMERIZATION,0.0025817,0.10143,0.11286,1,1
4,GO SNRNA TRANSCRIPTION,0.001986,0.10116,0.10652,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.012203,0.10063,0.12057,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.024846,0.10034,0.063311,1,1
4,GO NEGATIVE REGULATION OF BINDING,0.025414,0.10024,0.096378,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.027188,0.10013,0.078171,1,1
4,GO TUBE FORMATION,0.034637,0.099443,0.11719,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.043763,0.09936,0.080727,1,1
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0066042,0.098738,0.10349,1,1
4,GO NCRNA TRANSCRIPTION,0.022165,0.098729,0.091303,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0097392,0.098269,0.086968,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0028957,0.097498,0.11183,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.024846,0.097413,0.074603,1,1
4,GO CELL CYCLE PROCESS,0.0022332,0.097231,0.08863,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0012662,0.09651,0.10311,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0087944,0.096474,0.09702,1,1
4,GO REGULATION OF DNA METABOLIC PROCESS,0.00021167,0.096419,0.11056,1,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00028792,0.096304,0.1058,1,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.00084609,0.096052,0.1549,1,1
4,GO IRON ION TRANSPORT,0.004408,0.095384,0.099605,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0053338,0.095001,0.083618,1,1
4,GO MACROMOLECULE DEACYLATION,0.014486,0.094987,0.075986,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.012508,0.094728,0.073052,1,1
4,GO REGULATION OF CELL CYCLE,0.0050528,0.094704,0.075655,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.037747,0.094133,0.079676,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.00065623,0.093972,0.084718,1,1
4,GO G2 DNA DAMAGE CHECKPOINT,0.030383,0.093569,0.10741,1,1
4,GO HEART MORPHOGENESIS,0.018836,0.093436,0.13754,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.0071468,0.093215,0.090313,1,1
4,GO MULTI ORGANISM PROCESS,0.0018173,0.093044,0.074631,1,1
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036164,0.092595,0.089066,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.016339,0.090739,0.084969,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.016339,0.09071,0.094423,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0030654,0.090629,0.10176,1,1
4,GO LIPID METABOLIC PROCESS,0.013465,0.090616,0.064994,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.041093,0.090583,0.074688,1,1
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00028792,0.090572,0.10451,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.033894,0.090494,0.088325,1,1
4,GO DNA METABOLIC PROCESS,0.00032948,0.090433,0.095284,1,1
4,GO MITOTIC NUCLEAR DIVISION,0.0038387,0.089101,0.10667,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.015953,0.088978,0.088637,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.010773,0.088328,0.12562,1,1
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.041093,0.088072,0.14517,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03939,0.088046,0.052093,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00019753,0.087704,0.094827,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.001986,0.087693,0.10511,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.025414,0.087178,0.064114,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.015203,0.087098,0.085005,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.02843,0.086378,0.084402,1,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.029719,0.08636,0.088331,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00353,0.086264,0.064463,1,1
4,GO CELL CYCLE,0.0034322,0.085642,0.074152,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.029719,0.085261,0.04751,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00014418,0.085186,0.095811,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.004408,0.084723,0.075421,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0042883,0.084109,0.10169,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.029068,0.083987,0.081845,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.011326,0.083256,0.071316,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0075304,0.082353,0.075734,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.023205,0.081517,0.099039,1,1
4,GO RESPONSE TO RADIATION,0.0047853,0.081251,0.082213,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.012203,0.079508,0.06525,1,1
4,GO SPINDLE ASSEMBLY,0.010245,0.078785,0.089603,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00037661,0.077573,0.078478,1,1
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0017641,0.077566,0.081889,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.00079435,0.07732,0.13055,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.02843,0.076661,0.085266,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.033166,0.074179,0.081529,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.00049035,0.072895,0.095778,1,1
4,GO INTRACELLULAR TRANSPORT,0.00049035,0.072534,0.081128,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.03939,0.071957,0.073794,1,1
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.010245,0.070289,0.10369,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.018398,0.070249,0.07561,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0025083,0.069076,0.089662,1,1
4,GO POLYOL METABOLIC PROCESS,0.02843,0.069025,0.066218,1,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.019739,0.068697,0.051409,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.036164,0.064064,0.06263,1,1
4,GO DOUBLE STRAND BREAK REPAIR,0.012508,0.063461,0.09116,1,1
4,GO DNA REPAIR,0.0083534,0.062813,0.078005,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.033166,0.061943,0.046509,1,1
4,GO DNA RECOMBINATION,0.02843,0.060878,0.088485,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0087944,0.060013,0.11721,1,1
4,GO DNA MODIFICATION,0.042857,0.054972,0.070704,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.001228,1.595,1.1082,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0014738,1.2785,0.87372,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,3.5759e-05,1.1534,1.0164,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0049174,0.86861,0.63146,1,1
5,GO TOLERANCE INDUCTION,9.0551e-05,0.79848,0.65319,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.0184e-05,0.79225,0.76963,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.013e-05,0.76741,0.67909,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.0198e-07,0.76209,0.72414,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00026003,0.7586,0.60176,1,1
5,GO CYTIDINE TO URIDINE EDITING,9.7346e-05,0.75695,0.69284,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0045306,0.74103,0.47151,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.1617e-05,0.73465,0.60251,1,1
5,GO HISTAMINE SECRETION,3.8131e-07,0.72337,0.73754,1,1
5,GO INTESTINAL LIPID ABSORPTION,3.7791e-06,0.7002,0.72519,1,1
5,GO LIPID DROPLET FORMATION,4.1112e-06,0.68312,0.66798,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00024286,0.67863,0.67598,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00019753,0.67254,0.58923,1,1
5,GO PROGESTERONE METABOLIC PROCESS,0.00011241,0.66483,0.83595,1,1
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,2.2658e-06,0.66398,0.61389,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0034322,0.65551,0.42978,1,1
5,GO GERMINAL CENTER FORMATION,0.00028792,0.65307,0.48635,1,1
5,GO ACTIN FILAMENT NETWORK FORMATION,0.00045924,0.64318,0.48715,1,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.0050528,0.6351,0.73378,1,1
5,GO LIPID DIGESTION,1.8521e-05,0.63109,0.63657,1,1
5,GO HISTAMINE TRANSPORT,7.5427e-07,0.62544,0.69388,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,0.001986,0.6241,0.40034,1,1
5,GO RESPONSE TO TYPE I INTERFERON,5.6174e-05,0.62117,0.56919,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0060989,0.62052,0.49202,1,1
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00026903,0.61038,0.53316,1,1
5,GO DOPAMINE BIOSYNTHETIC PROCESS,5.6174e-05,0.60329,0.6517,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,8.7323e-05,0.60164,0.46818,1,1
5,GO FRUCTOSE METABOLIC PROCESS,0.00012074,0.601,0.59376,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,2.0833e-05,0.59551,0.55942,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00010462,0.59431,0.53866,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,5.6174e-05,0.5878,0.44741,1,1
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.8418e-05,0.58705,0.63466,1,1
5,GO KETONE CATABOLIC PROCESS,0.0010859,0.5768,0.44009,1,1
5,GO INTESTINAL ABSORPTION,1.4268e-07,0.56542,0.66905,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.00017796,0.56022,0.47149,1,1
5,GO RENAL ABSORPTION,8.1192e-05,0.55776,0.60535,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00028792,0.55518,0.51692,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0010528,0.55424,0.45749,1,1
5,GO MUCUS SECRETION,0.0010206,0.54137,0.56132,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013433,0.5404,0.48555,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00014418,0.53496,0.47167,1,1
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.013465,0.53226,0.36655,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0001165,0.53182,0.50749,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.8379e-05,0.53059,0.59967,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.5201e-05,0.52584,0.42336,1,1
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00010092,0.52234,0.51027,1,1
5,GO RESPONSE TO NITROSATIVE STRESS,0.00042998,0.52216,0.45078,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.0030654,0.52105,0.46733,1,1
5,GO SPHINGOMYELIN METABOLIC PROCESS,2.4692e-06,0.51774,0.47307,1,1
5,GO DETECTION OF OTHER ORGANISM,7.2754e-05,0.51251,0.50962,1,1
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00011241,0.51147,0.51198,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0033369,0.5105,0.3203,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0020453,0.50922,0.40564,1,1
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0013054,0.50882,0.39476,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.9841e-06,0.50785,0.51604,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00081984,0.50693,0.44981,1,1
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00012074,0.50689,0.45679,1,1
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.7578e-07,0.50437,0.56719,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,6.0504e-05,0.50359,0.39755,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00035231,0.50336,0.38358,1,1
5,GO O GLYCAN PROCESSING,5.9841e-06,0.50276,0.46731,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.7343e-05,0.50249,0.4584,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0014299,0.50157,0.42259,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.4346e-05,0.50041,0.50008,1,1
5,GO PHAGOLYSOSOME ASSEMBLY,1.3441e-06,0.49854,0.50941,1,1
5,GO ACTIN FILAMENT SEVERING,0.00067758,0.49705,0.42133,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,4.6597e-05,0.49381,0.45899,1,1
5,GO LEYDIG CELL DIFFERENTIATION,0.00081984,0.4922,0.48268,1,1
5,GO RETINAL METABOLIC PROCESS,0.001986,0.49188,0.52796,1,1
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.011612,0.48947,0.51972,1,1
5,GO RESPONSE TO EPINEPHRINE,0.042857,0.48808,0.26761,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.0683e-06,0.48662,0.42751,1,1
5,GO REGULATION OF INTEGRIN ACTIVATION,3.0264e-07,0.48327,0.53978,1,1
5,GO EOSINOPHIL MIGRATION,0.0014299,0.47488,0.36962,1,1
5,GO BARBED END ACTIN FILAMENT CAPPING,0.0010528,0.47485,0.40612,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,0.00030804,0.47484,0.52464,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.6307e-05,0.47188,0.47517,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00055855,0.47018,0.48307,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,7.013e-05,0.46993,0.46538,1,1
5,GO TOXIN METABOLIC PROCESS,2.1663e-05,0.46698,0.45058,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00049035,0.46398,0.40456,1,1
5,GO RESPONSE TO COLD,7.9801e-06,0.46218,0.41448,1,1
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0056288,0.46153,0.44468,1,1
5,GO RESPONSE TO PAIN,3.1888e-05,0.45858,0.40482,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00030804,0.45851,0.43903,1,1
5,GO SIGNAL PEPTIDE PROCESSING,1.8521e-05,0.45727,0.44363,1,1
5,GO L PHENYLALANINE METABOLIC PROCESS,0.00012512,0.45549,0.61832,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,9.0551e-05,0.45388,0.4722,1,1
5,GO REGULATION OF NEURON MATURATION,7.547e-05,0.45111,0.3883,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00047456,0.4481,0.39227,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00017796,0.44663,0.45397,1,1
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00017186,0.44564,0.42333,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.00032948,0.44547,0.49353,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00095906,0.44317,0.36414,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.0689e-05,0.44309,0.49486,1,1
5,GO REGULATION OF PLATELET AGGREGATION,0.00047456,0.44262,0.38037,1,1
5,GO QUINONE METABOLIC PROCESS,0.00017186,0.44188,0.60099,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0010528,0.43887,0.44065,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00021909,0.4379,0.38644,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.4421e-05,0.43506,0.43057,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.104e-05,0.43454,0.40746,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.6584e-06,0.43392,0.43303,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0045306,0.43366,0.43595,1,1
5,GO ZYMOGEN ACTIVATION,0.0011199,0.43288,0.34615,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,7.547e-05,0.43264,0.43139,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00069957,0.42911,0.36709,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00019753,0.4289,0.35909,1,1
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.00031859,0.42826,0.41661,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0013457,0.42803,0.40118,1,1
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00063551,0.42742,0.47377,1,1
5,GO STEROID ESTERIFICATION,0.00057693,0.42618,0.44161,1,1
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00092958,0.42492,0.45874,1,1
5,GO RESPONSE TO DIETARY EXCESS,0.00024286,0.42341,0.40412,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00037661,0.42238,0.35749,1,1
5,GO BONE RESORPTION,1.0604e-05,0.41918,0.40198,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41896,0.47625,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00050664,0.41676,0.34899,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00069957,0.41668,0.32637,1,1
5,GO REGULATION OF PLATELET ACTIVATION,5.6174e-05,0.41524,0.3829,1,1
5,GO CELLULAR DEFENSE RESPONSE,5.7413e-06,0.41362,0.40672,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,8.1192e-05,0.41214,0.46545,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,5.4121e-05,0.41074,0.42419,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00030804,0.41051,0.2772,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0006154,0.40981,0.39689,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.001228,0.40557,0.36528,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00022676,0.40535,0.32619,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.4346e-05,0.40424,0.36678,1,1
5,GO RESPONSE TO REDOX STATE,0.00013433,0.40371,0.34136,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0037331,0.40342,0.3067,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,8.628e-07,0.40273,0.41913,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.013139,0.40209,0.3146,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.8612e-06,0.40096,0.42054,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,9.0551e-05,0.39978,0.43684,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.0075304,0.39944,0.36235,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00042998,0.39914,0.46557,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0031536,0.3968,0.31806,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00022676,0.39488,0.37825,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,0.00057693,0.39478,0.32956,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0032441,0.39441,0.41761,1,1
5,GO B CELL APOPTOTIC PROCESS,4.1617e-05,0.39426,0.37509,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,1.2962e-05,0.39393,0.32402,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0050528,0.39184,0.29555,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,1.9263e-05,0.39175,0.36445,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0011199,0.39108,0.34979,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0028957,0.39027,0.34664,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0013054,0.38964,0.33267,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0019282,0.38922,0.40662,1,1
5,GO MUSCLE ATROPHY,0.014486,0.38846,0.25192,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.014486,0.38547,0.24938,1,1
5,GO SECONDARY METABOLIC PROCESS,0.00045924,0.38505,0.37219,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00024286,0.3804,0.37632,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,6.7728e-06,0.37974,0.34782,1,1
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0007696,0.37956,0.32038,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00035231,0.37869,0.28868,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00026003,0.37828,0.40162,1,1
5,GO UBIQUINONE METABOLIC PROCESS,1.2962e-05,0.37784,0.33519,1,1
5,GO CELLULAR RESPONSE TO COPPER ION,0.009256,0.37731,0.4486,1,1
5,GO N GLYCAN PROCESSING,0.0027346,0.37707,0.28529,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00057693,0.37651,0.44756,1,1
5,GO PROTEIN DEMANNOSYLATION,0.00012964,0.37576,0.37107,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00049035,0.3757,0.31813,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0038387,0.37543,0.34254,1,1
5,GO ACUTE PHASE RESPONSE,0.00050664,0.37529,0.31419,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0025817,0.37376,0.30106,1,1
5,GO SEROTONIN METABOLIC PROCESS,0.00038934,0.37333,0.44811,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00023468,0.37295,0.33619,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0045306,0.3729,0.35744,1,1
5,GO DEFENSE RESPONSE TO VIRUS,0.00049035,0.37246,0.24669,1,1
5,GO REGULATION OF BONE REMODELING,2.1663e-05,0.37214,0.40465,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00065623,0.37136,0.28481,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00072223,0.3709,0.35599,1,1
5,GO VASODILATION,0.0019282,0.37029,0.34479,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00067758,0.37023,0.34526,1,1
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00045924,0.36998,0.28181,1,1
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0083534,0.36985,0.41914,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,7.013e-05,0.36856,0.41137,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00024286,0.36847,0.37118,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0097392,0.368,0.31805,1,1
5,GO DIGESTION,2.2524e-05,0.36779,0.32442,1,1
5,GO POSITIVE REGULATION OF CELL SIZE,3.1888e-05,0.36769,0.39111,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00090094,0.36693,0.35493,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.2308e-06,0.36681,0.36379,1,1
5,GO METHIONINE METABOLIC PROCESS,1.8521e-05,0.36572,0.34464,1,1
5,GO DIGESTIVE SYSTEM PROCESS,1.4039e-05,0.36568,0.30343,1,1
5,GO LUNG CELL DIFFERENTIATION,0.0031536,0.3648,0.38648,1,1
5,GO VITAMIN D METABOLIC PROCESS,0.00041602,0.36476,0.32099,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.36464,0.43125,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00041602,0.3645,0.33746,1,1
5,GO PHAGOSOME ACIDIFICATION,3.0264e-07,0.36432,0.40446,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0018173,0.36391,0.30017,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.00092958,0.36387,0.25644,1,1
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0018173,0.36363,0.37597,1,1
5,GO REGULATION OF ICOSANOID SECRETION,2.3654e-06,0.36362,0.40815,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.0097392,0.36263,0.30502,1,1
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.00012512,0.36254,0.40627,1,1
5,GO RESPONSE TO COPPER ION,0.00045924,0.36221,0.4471,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,5.2139e-05,0.36186,0.36155,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.00013917,0.3605,0.35251,1,1
5,GO CYCLOOXYGENASE PATHWAY,0.0030654,0.35993,0.43109,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.00014935,0.35971,0.32602,1,1
5,GO RESPONSE TO INTERLEUKIN 2,3.8583e-05,0.35966,0.304,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0028141,0.35902,0.37902,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,5.6174e-05,0.35866,0.3568,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00072223,0.35842,0.35951,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,0.35821,0.31433,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,8.1192e-05,0.35799,0.2916,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010773,0.35755,0.26061,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,4.8379e-05,0.35748,0.34444,1,1
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0039469,0.35686,0.45027,1,1
5,GO ETHER METABOLIC PROCESS,0.00079435,0.35661,0.25756,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0007696,0.35647,0.42804,1,1
5,GO PLASMINOGEN ACTIVATION,0.0066042,0.35479,0.36225,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0045306,0.35421,0.40305,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.014841,0.35301,0.26511,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0073363,0.35295,0.20588,1,1
5,GO T CELL MEDIATED IMMUNITY,0.0031536,0.35209,0.24712,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00014935,0.35156,0.33417,1,1
5,GO ETHANOL OXIDATION,0.0073363,0.35129,0.4518,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00036427,0.35023,0.25939,1,1
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0010206,0.35001,0.32516,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.0001547,0.34972,0.28019,1,1
5,GO PROSTANOID METABOLIC PROCESS,0.0037331,0.34924,0.3598,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00021909,0.34699,0.26545,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0012662,0.34606,0.21633,1,1
5,GO LYTIC VACUOLE ORGANIZATION,6.2985e-07,0.3459,0.35296,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0029794,0.34547,0.48018,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00059588,0.34508,0.31461,1,1
5,GO RESPONSE TO LITHIUM ION,6.7596e-05,0.34401,0.44157,1,1
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00084609,0.34301,0.35981,1,1
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0025083,0.34252,0.3106,1,1
5,GO FOAM CELL DIFFERENTIATION,0.00041602,0.34185,0.28263,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.34168,0.27563,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.00024286,0.34148,0.29761,1,1
5,GO INTRACELLULAR STEROL TRANSPORT,7.2754e-05,0.34116,0.35287,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.00032948,0.34078,0.30163,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0032441,0.34047,0.42809,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,6.2786e-05,0.33995,0.3421,1,1
5,GO TISSUE REMODELING,0.00012074,0.33875,0.27436,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,3.0689e-05,0.33872,0.32333,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00023468,0.33843,0.31497,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00025131,0.33837,0.27271,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0047853,0.33821,0.25471,1,1
5,GO STEROL METABOLIC PROCESS,0.00013433,0.33812,0.25991,1,1
5,GO INTEGRIN ACTIVATION,1.1964e-05,0.33812,0.32942,1,1
5,GO INSEMINATION,0.0010528,0.33772,0.32375,1,1
5,GO DIET INDUCED THERMOGENESIS,0.00098941,0.33721,0.26846,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0059384,0.33715,0.27802,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0050528,0.33698,0.32112,1,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00025131,0.33669,0.26342,1,1
5,GO RESPONSE TO INTERFERON GAMMA,0.0010528,0.33637,0.28898,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00038934,0.33635,0.29456,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00079435,0.33585,0.29532,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,6.2786e-05,0.33568,0.31106,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0062634,0.33558,0.22531,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0025083,0.33547,0.21868,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00023468,0.33538,0.31544,1,1
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0010528,0.3352,0.27264,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,6.5149e-05,0.33492,0.26524,1,1
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0087944,0.33439,0.32806,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.0226e-05,0.33416,0.34418,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.3418e-05,0.33401,0.33539,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0017123,0.33369,0.2582,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0036303,0.33354,0.25199,1,1
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.0049174,0.33281,0.29301,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0050528,0.33239,0.24251,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.017137,0.33182,0.21152,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0056288,0.33161,0.26893,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00016595,0.33112,0.30004,1,1
5,GO REGULATION OF TISSUE REMODELING,4.4878e-05,0.33003,0.34407,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0034322,0.32974,0.32185,1,1
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.0041716,0.32937,0.3547,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00017186,0.3282,0.24665,1,1
5,GO LIVER MORPHOGENESIS,0.0045306,0.32806,0.26302,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0014738,0.32806,0.24463,1,1
5,GO SNARE COMPLEX ASSEMBLY,0.001228,0.32791,0.24923,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.4878e-05,0.32754,0.43116,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00041602,0.32748,0.27563,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00040247,0.3268,0.3652,1,1
5,GO KETONE BIOSYNTHETIC PROCESS,0.00095906,0.32632,0.28205,1,1
5,GO VACUOLAR ACIDIFICATION,9.4334e-07,0.32598,0.38137,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,0.0001165,0.32526,0.32325,1,1
5,GO NATURAL KILLER CELL PROLIFERATION,0.0081404,0.32523,0.29142,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0015653,0.32517,0.34156,1,1
5,GO REGULATION OF LIGASE ACTIVITY,0.001872,0.32473,0.22931,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.0551e-05,0.3242,0.34054,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00057693,0.324,0.22407,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,2.8418e-05,0.32373,0.31214,1,1
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.009256,0.32364,0.22943,1,1
5,GO REGULATION OF PROSTAGLANDIN SECRETION,8.1192e-05,0.32356,0.35428,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0059384,0.32331,0.25916,1,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0025817,0.32253,0.26609,1,1
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0081404,0.32237,0.31962,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00016023,0.32182,0.33725,1,1
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00045924,0.32144,0.2766,1,1
5,GO STEROID METABOLIC PROCESS,3.7145e-05,0.32077,0.28562,1,1
5,GO EPITHELIAL CELL CELL ADHESION,0.00353,0.32076,0.39401,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.1888e-05,0.31964,0.31004,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.014138,0.3196,0.21199,1,1
5,GO PLATELET DEGRANULATION,0.0025817,0.31951,0.21585,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0022992,0.31902,0.36161,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0023671,0.31891,0.30124,1,1
5,GO REGULATION OF FIBRINOLYSIS,0.0016129,0.31856,0.36137,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0006154,0.31829,0.32873,1,1
5,GO VIRAL GENOME REPLICATION,0.0010206,0.31749,0.2135,1,1
5,GO REGULATION OF COAGULATION,0.0020453,0.31742,0.26559,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0097392,0.31738,0.25224,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00042998,0.31634,0.29601,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0031536,0.31629,0.19452,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00095906,0.31607,0.22435,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00049035,0.31549,0.28265,1,1
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012512,0.31542,0.25856,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.00017796,0.31471,0.36127,1,1
5,GO BONE REMODELING,0.00017186,0.31465,0.31798,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00026903,0.31463,0.30291,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0011199,0.31441,0.26403,1,1
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.00353,0.3141,0.20406,1,1
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0083534,0.3139,0.22265,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0010528,0.31388,0.29678,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.021165,0.31328,0.2521,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.00021167,0.31243,0.37474,1,1
5,GO LIPID TRANSLOCATION,0.00010092,0.31241,0.27833,1,1
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00079435,0.31219,0.3257,1,1
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,5.0226e-05,0.31186,0.35138,1,1
5,GO OSTEOBLAST PROLIFERATION,0.0010859,0.31181,0.27671,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.001872,0.31106,0.27125,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.0054795,0.3108,0.2618,1,1
5,GO MITOCHONDRIAL RNA PROCESSING,0.03245,0.31077,0.18466,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.010773,0.31065,0.19376,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00014418,0.31065,0.29524,1,1
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0012662,0.31023,0.26461,1,1
5,GO INNATE IMMUNE RESPONSE,0.00013917,0.30926,0.2254,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00353,0.30873,0.24209,1,1
5,GO CELL KILLING,3.4421e-05,0.3084,0.25053,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.010245,0.30823,0.25535,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,6.5149e-05,0.30815,0.25637,1,1
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.037747,0.30809,0.19097,1,1
5,GO APICAL JUNCTION ASSEMBLY,2.9532e-05,0.30793,0.35254,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00079435,0.30776,0.28592,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00054072,0.30743,0.20286,1,1
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00041602,0.30716,0.25465,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0001165,0.30665,0.23209,1,1
5,GO NADP METABOLIC PROCESS,0.0046564,0.30661,0.27088,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0015653,0.30637,0.31415,1,1
5,GO ICOSANOID METABOLIC PROCESS,6.0504e-05,0.30553,0.33174,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0020453,0.30543,0.36541,1,1
5,GO PHAGOSOME MATURATION,9.3916e-06,0.30491,0.31638,1,1
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0010528,0.30474,0.24271,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.4878e-05,0.30444,0.26026,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.1663e-05,0.3044,0.32786,1,1
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00084609,0.30423,0.33873,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.015574,0.30417,0.227,1,1
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0087944,0.30324,0.2926,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.2786e-05,0.30316,0.27202,1,1
5,GO STEROID HORMONE SECRETION,0.01282,0.30312,0.23023,1,1
5,GO IMMUNE EFFECTOR PROCESS,0.00019753,0.3028,0.21876,1,1
5,GO RESPONSE TO MINERALOCORTICOID,0.00042998,0.30248,0.27275,1,1
5,GO MAGNESIUM ION TRANSPORT,0.00038934,0.30229,0.27854,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.010245,0.30194,0.22058,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,9.0551e-05,0.3018,0.22063,1,1
5,GO KERATINIZATION,2.1663e-05,0.30131,0.28563,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.30119,0.26562,1,1
5,GO CORNIFICATION,2.7343e-05,0.30041,0.32396,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.7806e-05,0.2996,0.30815,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,8.1192e-05,0.29933,0.27584,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.001191,0.29919,0.23922,1,1
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00081984,0.29821,0.24265,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,0.00018427,0.29816,0.27373,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00017186,0.298,0.37212,1,1
5,GO MAST CELL ACTIVATION,9.7346e-05,0.29759,0.26852,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0060989,0.29704,0.23705,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.8282e-05,0.29679,0.2427,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00016595,0.29661,0.30331,1,1
5,GO REGULATION OF B CELL PROLIFERATION,4.3218e-05,0.29626,0.29402,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.00059588,0.29626,0.2636,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0046564,0.29585,0.24639,1,1
5,GO ARACHIDONIC ACID SECRETION,0.00014935,0.29571,0.26792,1,1
5,GO GOLGI TO ENDOSOME TRANSPORT,0.00026903,0.29541,0.2877,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00042998,0.29521,0.27359,1,1
5,GO RESPONSE TO VIRUS,0.00065623,0.29501,0.20697,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.547e-05,0.29489,0.24074,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0028957,0.29443,0.23994,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0027346,0.29426,0.2122,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,0.016734,0.29423,0.21863,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020448,0.29311,0.22879,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00017186,0.29306,0.39052,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,6.2786e-05,0.293,0.27206,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0064317,0.29142,0.26437,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00055855,0.2909,0.28981,1,1
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0014738,0.2909,0.21697,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00037661,0.29062,0.4777,1,1
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.011047,0.29061,0.27665,1,1
5,GO REGULATION OF RESPIRATORY BURST,8.4205e-05,0.29029,0.34377,1,1
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.001986,0.28972,0.32533,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0024367,0.28967,0.26528,1,1
5,GO HYPOTHALAMUS DEVELOPMENT,0.0014738,0.28963,0.2506,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00014418,0.28946,0.34636,1,1
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0053338,0.28941,0.22922,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0032441,0.28932,0.2974,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00026903,0.28903,0.30081,1,1
5,GO REGULATION OF ACROSOME REACTION,0.041093,0.28886,0.2877,1,1
5,GO PURINE NUCLEOTIDE TRANSPORT,1.5201e-05,0.28882,0.25766,1,1
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00090094,0.28852,0.27805,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0037331,0.28657,0.2902,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.5759e-05,0.28616,0.31218,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,8.1192e-05,0.28593,0.28014,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,2.2658e-06,0.28585,0.30316,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,4.4878e-05,0.28581,0.33616,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,8.4205e-05,0.28579,0.24809,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00059588,0.28556,0.26191,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0013054,0.28468,0.2015,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.014486,0.28467,0.20068,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00044439,0.2845,0.26346,1,1
5,GO PANCREATIC JUICE SECRETION,0.027188,0.28428,0.17685,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.00017186,0.28416,0.23172,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,8.1192e-05,0.28356,0.28587,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.02843,0.28344,0.1754,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0006154,0.28314,0.23192,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.011047,0.2831,0.29182,1,1
5,GO RESPIRATORY BURST,0.00036427,0.28287,0.26082,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.0025083,0.28271,0.31412,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00035231,0.28236,0.31859,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.00098941,0.28233,0.36122,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,0.00019079,0.28193,0.27366,1,1
5,GO ADRENAL GLAND DEVELOPMENT,0.00067758,0.28144,0.34788,1,1
5,GO PROSTAGLANDIN TRANSPORT,0.00072223,0.28119,0.32742,1,1
5,GO REGULATION OF CELL KILLING,0.00029782,0.28088,0.27949,1,1
5,GO MAST CELL MEDIATED IMMUNITY,0.00059588,0.28068,0.24409,1,1
5,GO PH REDUCTION,1.349e-05,0.28021,0.25938,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00013433,0.27992,0.22942,1,1
5,GO NUCLEOTIDE SALVAGE,0.022165,0.27959,0.23192,1,1
5,GO POLYOL TRANSPORT,0.0034322,0.27931,0.29303,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,0.00353,0.27903,0.38843,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00030804,0.279,0.22823,1,1
5,GO STEROL HOMEOSTASIS,0.00092958,0.2788,0.29376,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0045306,0.27804,0.17556,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0032441,0.27776,0.27927,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00030804,0.2773,0.28179,1,1
5,GO LIPID DROPLET ORGANIZATION,5.4121e-05,0.27719,0.28233,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.011612,0.27715,0.33825,1,1
5,GO RESPONSE TO ACIDIC PH,0.0067808,0.27704,0.25642,1,1
5,GO HAIR CELL DIFFERENTIATION,0.00021167,0.27699,0.24485,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0036303,0.27679,0.1906,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.1617e-05,0.27672,0.23271,1,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.00028792,0.27651,0.25395,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00025131,0.27624,0.24942,1,1
5,GO RESPONSE TO GROWTH HORMONE,4.6597e-05,0.2762,0.33554,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0013457,0.27588,0.24612,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00014418,0.27587,0.29703,1,1
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0001165,0.27562,0.26726,1,1
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0020453,0.27525,0.24862,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,0.27509,0.28011,1,1
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0094949,0.27499,0.20236,1,1
5,GO ETHANOL METABOLIC PROCESS,0.011612,0.27489,0.23299,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,5.2139e-05,0.27476,0.24581,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0015653,0.27445,0.19522,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00067758,0.2741,0.2362,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.00035231,0.27402,0.25211,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.001228,0.27394,0.20717,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0085714,0.27322,0.29862,1,1
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.00020448,0.27307,0.2906,1,1
5,GO INTERLEUKIN 10 PRODUCTION,0.00014935,0.27291,0.23048,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.015953,0.27288,0.23499,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.0042883,0.27285,0.2128,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0015653,0.27246,0.22745,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0031536,0.2724,0.24466,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00050664,0.27238,0.32273,1,1
5,GO REGULATION OF WOUND HEALING,0.00090094,0.27212,0.25133,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.036164,0.27207,0.23186,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.010506,0.27199,0.23084,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,7.9801e-06,0.271,0.25446,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.018836,0.27092,0.16558,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00092958,0.2706,0.23643,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00017796,0.27017,0.2455,1,1
5,GO ENDOCRINE PROCESS,0.00072223,0.26982,0.24261,1,1
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0028141,0.26971,0.30632,1,1
5,GO DIOL METABOLIC PROCESS,0.00037661,0.26943,0.31667,1,1
5,GO CHEMOKINE PRODUCTION,0.0033369,0.2693,0.18532,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00047456,0.26917,0.33952,1,1
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.007729,0.26892,0.19188,1,1
5,GO RETINOL METABOLIC PROCESS,0.0022992,0.26806,0.36166,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.02068,0.268,0.36813,1,1
5,GO RESPONSE TO PROGESTERONE,0.0019282,0.26796,0.22251,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.2677,0.18704,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00092958,0.26766,0.27667,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,4.0073e-05,0.26765,0.2486,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02268,0.26735,0.17901,1,1
5,GO PHOSPHOLIPID TRANSPORT,0.00010845,0.26702,0.21542,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00020448,0.2664,0.27192,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.011326,0.26636,0.27508,1,1
5,GO DOPAMINE TRANSPORT,0.0059384,0.26585,0.29574,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00014418,0.26582,0.21174,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00038934,0.26493,0.22303,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.041967,0.26416,0.22869,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00067758,0.26347,0.31313,1,1
5,GO CATECHOLAMINE UPTAKE,0.010245,0.26334,0.25017,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0090226,0.26317,0.23519,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00016023,0.26314,0.25681,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0011199,0.26295,0.26971,1,1
5,GO INTERLEUKIN 12 PRODUCTION,1.2454e-05,0.26287,0.28614,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00084609,0.26272,0.23414,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,4.0073e-05,0.26211,0.31186,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00020448,0.26194,0.22719,1,1
5,GO DEFENSE RESPONSE,0.00016023,0.26191,0.20323,1,1
5,GO GLYCOSYLATION,0.00016023,0.26164,0.24991,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.042857,0.26163,0.15744,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013872,0.26159,0.17711,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.1493e-05,0.26154,0.26822,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00014418,0.26145,0.23398,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.00095906,0.26127,0.28217,1,1
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0017641,0.26097,0.30467,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00054072,0.26047,0.21696,1,1
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.010773,0.26035,0.21384,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,0.00065623,0.26028,0.22172,1,1
5,GO SECRETION BY TISSUE,0.001228,0.25991,0.22575,1,1
5,GO LIPID LOCALIZATION,5.0226e-05,0.25988,0.24733,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00040247,0.25968,0.21854,1,1
5,GO OXALATE TRANSPORT,0.0023671,0.25907,0.18355,1,1
5,GO FATTY ACID CATABOLIC PROCESS,3.5759e-05,0.25898,0.26439,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0033369,0.25894,0.19761,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.027803,0.25865,0.30783,1,1
5,GO LYMPHOCYTE MIGRATION,0.0022332,0.25851,0.17523,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00045924,0.25827,0.24039,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00041602,0.25826,0.29628,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0083534,0.25823,0.25781,1,1
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.019739,0.25802,0.24526,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0022992,0.25794,0.17087,1,1
5,GO VITAMIN TRANSPORT,0.031748,0.25776,0.18818,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0030654,0.25773,0.20329,1,1
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0049174,0.25772,0.25298,1,1
5,GO RESPONSE TO PROTOZOAN,0.0039469,0.25771,0.18082,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00095906,0.25765,0.19642,1,1
5,GO PLASMA MEMBRANE FUSION,0.0085714,0.25726,0.22916,1,1
5,GO TRANSFERRIN TRANSPORT,2.3654e-06,0.25715,0.33681,1,1
5,GO TRANSCYTOSIS,0.00010092,0.25705,0.28904,1,1
5,GO HORMONE METABOLIC PROCESS,0.0011549,0.25697,0.25233,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,4.2876e-06,0.25673,0.24262,1,1
5,GO WATER HOMEOSTASIS,0.00032948,0.25618,0.25305,1,1
5,GO RESPONSE TO CADMIUM ION,0.0028141,0.25583,0.25395,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,7.2754e-05,0.25525,0.22634,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00034072,0.25523,0.20584,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00014418,0.25513,0.25464,1,1
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0042883,0.25495,0.2849,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.00029782,0.25493,0.18367,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.4878e-05,0.25483,0.24887,1,1
5,GO BONE CELL DEVELOPMENT,0.020205,0.25453,0.16607,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,2.6307e-05,0.25342,0.37322,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03245,0.253,0.22602,1,1
5,GO REGULATION OF B CELL ACTIVATION,0.00013433,0.25295,0.22491,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.013465,0.25255,0.31236,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.0001165,0.25242,0.24108,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.001662,0.25239,0.301,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00017186,0.25211,0.21794,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0051916,0.25182,0.28944,1,1
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0010528,0.25125,0.2748,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0025083,0.25122,0.21956,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0062634,0.25094,0.20749,1,1
5,GO NEUTROPHIL MIGRATION,0.00011241,0.25093,0.20653,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0037331,0.25083,0.17706,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00098941,0.25033,0.19148,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.03245,0.25027,0.26914,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0033369,0.2501,0.21393,1,1
5,GO TRANSPOSITION,0.010506,0.24996,0.2284,1,1
5,GO BILE ACID METABOLIC PROCESS,1.2454e-05,0.2499,0.36335,1,1
5,GO CYTOPLASM ORGANIZATION,0.00065623,0.2494,0.29273,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,5.0226e-05,0.24914,0.24111,1,1
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0064317,0.24897,0.36112,1,1
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0020453,0.24889,0.20419,1,1
5,GO NUCLEOTIDE TRANSPORT,9.0179e-06,0.24847,0.25147,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.8583e-05,0.24831,0.28572,1,1
5,GO DOPAMINE METABOLIC PROCESS,0.0032441,0.24764,0.27093,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0045306,0.24736,0.17238,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0015189,0.24733,0.19762,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00021167,0.24726,0.21624,1,1
5,GO AMELOGENESIS,0.014486,0.2471,0.21311,1,1
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001662,0.24706,0.28805,1,1
5,GO SPLEEN DEVELOPMENT,0.00098941,0.24694,0.20995,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00011241,0.24649,0.21768,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0046564,0.24639,0.25771,1,1
5,GO HEXOSE CATABOLIC PROCESS,0.012203,0.24629,0.18672,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00012074,0.24625,0.23907,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00044439,0.24618,0.24263,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0028141,0.24616,0.15451,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0025817,0.24599,0.22301,1,1
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.031748,0.24559,0.2459,1,1
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00059588,0.24553,0.22889,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0006154,0.24503,0.30822,1,1
5,GO B CELL PROLIFERATION,5.8301e-05,0.24475,0.23827,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001228,0.24451,0.15943,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0067808,0.24415,0.22906,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00098941,0.2441,0.19641,1,1
5,GO REGULATION OF ACTIN NUCLEATION,0.00010845,0.24365,0.29114,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00012074,0.24362,0.21168,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00095906,0.24353,0.19093,1,1
5,GO GRANULOCYTE MIGRATION,0.00035231,0.24218,0.19574,1,1
5,GO MACROMOLECULE DEPALMITOYLATION,8.4205e-05,0.24216,0.28294,1,1
5,GO INOSITOL METABOLIC PROCESS,8.1192e-05,0.24192,0.28492,1,1
5,GO PROTEIN HYDROXYLATION,0.027188,0.24171,0.18516,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0014299,0.24157,0.19887,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0053338,0.24101,0.28238,1,1
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0019282,0.24063,0.19096,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.8583e-05,0.24063,0.23035,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.00047456,0.24044,0.24951,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,5.6174e-05,0.24035,0.22593,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0083534,0.24021,0.17041,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.1617e-05,0.24018,0.23594,1,1
5,GO ZINC ION HOMEOSTASIS,0.01282,0.2401,0.27938,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00014935,0.24006,0.28179,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00040247,0.23999,0.25019,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.025414,0.23961,0.19399,1,1
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.011047,0.23954,0.17152,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.4878e-05,0.23909,0.28176,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0064317,0.2388,0.17491,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00030804,0.23878,0.19691,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00029782,0.23868,0.26859,1,1
5,GO T HELPER CELL LINEAGE COMMITMENT,0.0013457,0.23847,0.20395,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0042883,0.23843,0.22036,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00019753,0.23835,0.2844,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00020448,0.23803,0.23446,1,1
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.014841,0.23797,0.22836,1,1
5,GO STEROID CATABOLIC PROCESS,0.015574,0.23794,0.25614,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.02068,0.23755,0.19229,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0032441,0.2367,0.2125,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.010506,0.23666,0.20213,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,7.8282e-05,0.23643,0.19665,1,1
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0059384,0.23577,0.19898,1,1
5,GO RESPONSE TO CYTOKINE,0.00052342,0.23564,0.17878,1,1
5,GO ER OVERLOAD RESPONSE,0.0053338,0.23538,0.23825,1,1
5,GO REGULATION OF CELL PROJECTION SIZE,0.014138,0.23503,0.26482,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,6.2786e-05,0.2346,0.22926,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0054795,0.23459,0.17812,1,1
5,GO AMINE METABOLIC PROCESS,5.9841e-06,0.23456,0.27067,1,1
5,GO CELL CHEMOTAXIS,0.00035231,0.23395,0.18494,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0013872,0.23365,0.19946,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.00065623,0.2336,0.19767,1,1
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00040247,0.23356,0.31272,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.8583e-05,0.23268,0.24029,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.024288,0.23237,0.19172,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.23211,0.23726,1,1
5,GO PROTEIN AUTOPROCESSING,0.00095906,0.23172,0.3113,1,1
5,GO MITOCHONDRIAL TRNA PROCESSING,0.031748,0.23165,0.18529,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0013054,0.23116,0.21196,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.2786e-05,0.23115,0.23524,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,6.7728e-06,0.23109,0.30506,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0010528,0.23098,0.20005,1,1
5,GO REGULATION OF FERTILIZATION,0.0064317,0.23082,0.26249,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00050664,0.23058,0.22326,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0011199,0.23056,0.19728,1,1
5,GO RESPONSE TO BACTERIUM,0.00063551,0.22978,0.18277,1,1
5,GO B CELL HOMEOSTASIS,0.0013872,0.22922,0.23195,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.025994,0.2287,0.19321,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.3132e-05,0.22834,0.29643,1,1
5,GO RESPONSE TO ISCHEMIA,0.00050664,0.2282,0.22996,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0015653,0.22814,0.18495,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.00029782,0.22791,0.21903,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.018836,0.22788,0.20651,1,1
5,GO TISSUE HOMEOSTASIS,0.0001547,0.22779,0.19855,1,1
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.018836,0.22768,0.21907,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00055855,0.22744,0.25557,1,1
5,GO MEMBRANE FUSION,0.001662,0.22715,0.1704,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00030804,0.2271,0.1839,1,1
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0073363,0.22649,0.19137,1,1
5,GO LEUKOCYTE PROLIFERATION,0.00072223,0.22647,0.18518,1,1
5,GO STEROL TRANSPORT,0.00018427,0.22606,0.25475,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0064317,0.2259,0.18096,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.011047,0.22588,0.23746,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.0010859,0.22557,0.22665,1,1
5,GO LIPID STORAGE,0.0028957,0.22532,0.2097,1,1
5,GO RESPONSE TO PH,0.0079323,0.22501,0.16785,1,1
5,GO INFLAMMATORY RESPONSE,0.00044439,0.22501,0.18155,1,1
5,GO LEUKOCYTE MIGRATION,0.00079435,0.22495,0.18563,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0097392,0.22472,0.20437,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0050528,0.22464,0.22782,1,1
5,GO REGULATION OF CELLULAR PH,1.0604e-05,0.22449,0.21942,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0006154,0.22446,0.20203,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0013457,0.22445,0.2362,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0011199,0.2243,0.22958,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00018427,0.22425,0.28403,1,1
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0099891,0.22423,0.20755,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00024286,0.22377,0.24808,1,1
5,GO INSULIN SECRETION,0.00065623,0.2234,0.1778,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.0033369,0.22339,0.18604,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0046564,0.22337,0.26138,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00059588,0.22317,0.19741,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00012512,0.22264,0.18804,1,1
5,GO RESPONSE TO CAFFEINE,0.013465,0.22238,0.19745,1,1
5,GO DENDRITIC CELL MIGRATION,0.045624,0.22226,0.12522,1,1
5,GO CELLULAR RESPONSE TO STARVATION,3.0689e-05,0.22215,0.22478,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0011549,0.2218,0.1944,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.0006154,0.22177,0.21417,1,1
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0045306,0.22124,0.19663,1,1
5,GO CYTOKINE PRODUCTION,0.00059588,0.221,0.18224,1,1
5,GO PIRNA METABOLIC PROCESS,0.0025083,0.22081,0.27728,1,1
5,GO REGULATION OF NUCLEASE ACTIVITY,0.0018173,0.22077,0.187,1,1
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.010245,0.2206,0.15086,1,1
5,GO INTERLEUKIN 6 PRODUCTION,0.00024286,0.22038,0.20823,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025083,0.2203,0.21662,1,1
5,GO REGULATION OF GLUCONEOGENESIS,2.3418e-05,0.21997,0.2692,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,7.9801e-06,0.21996,0.24413,1,1
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.016734,0.21993,0.14011,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.011326,0.21992,0.163,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0024367,0.21983,0.2288,1,1
5,GO INTERFERON ALPHA PRODUCTION,0.00041602,0.21978,0.2205,1,1
5,GO SKIN DEVELOPMENT,0.00065623,0.21965,0.17429,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0013054,0.21919,0.1983,1,1
5,GO REGULATION OF PH,2.4346e-05,0.21885,0.21161,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.7346e-05,0.21876,0.22664,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00084609,0.21827,0.30421,1,1
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00353,0.21799,0.21346,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.0047853,0.21795,0.17863,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.027188,0.21767,0.15092,1,1
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.017549,0.21764,0.22708,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.014486,0.21762,0.14241,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.2524e-05,0.21719,0.22685,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00026903,0.21701,0.20577,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0085714,0.217,0.16699,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00023468,0.2168,0.19128,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00353,0.21637,0.16787,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0025083,0.21635,0.239,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.016734,0.21634,0.18681,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00012512,0.21627,0.21217,1,1
5,GO MYOBLAST FUSION,0.010245,0.21617,0.1859,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,0.0016129,0.21614,0.3262,1,1
5,GO REGULATION OF ACTION POTENTIAL,0.029068,0.21524,0.16222,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0014299,0.21524,0.18217,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.8583e-05,0.21512,0.19224,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0015653,0.21504,0.16892,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0017123,0.2148,0.17141,1,1
5,GO EPIDERMIS DEVELOPMENT,0.00049035,0.21447,0.18021,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0099891,0.21434,0.16059,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.047551,0.21426,0.095456,1,1
5,GO POSITIVE CHEMOTAXIS,0.011612,0.21394,0.14272,1,1
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0013457,0.21382,0.17187,1,1
5,GO RESPONSE TO NUTRIENT,0.031059,0.21369,0.12431,1,1
5,GO RENAL SYSTEM PROCESS,0.0057817,0.21364,0.16174,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00072223,0.21355,0.206,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,0.0042883,0.21351,0.19742,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.014841,0.21314,0.15226,1,1
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0097392,0.21297,0.20229,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.029068,0.21274,0.16029,1,1
5,GO MUSCLE HYPERTROPHY,0.0028141,0.21248,0.15483,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00098941,0.21226,0.24961,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0032441,0.21215,0.24502,1,1
5,GO HETEROTYPIC CELL CELL ADHESION,0.022165,0.2121,0.16159,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.0087944,0.2118,0.17685,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00098941,0.21174,0.18914,1,1
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0025817,0.21173,0.17681,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.0069616,0.21123,0.17394,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0023671,0.21064,0.16572,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0081404,0.21063,0.23015,1,1
5,GO T CELL MIGRATION,0.036164,0.21061,0.14731,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.019739,0.21051,0.1657,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00042998,0.21041,0.18562,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001191,0.21027,0.14728,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0013457,0.21023,0.21478,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00081984,0.21015,0.21664,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0067808,0.2099,0.19937,1,1
5,GO SODIUM ION HOMEOSTASIS,0.011904,0.20987,0.15365,1,1
5,GO MANGANESE ION TRANSPORT,0.00055855,0.20972,0.22699,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0040578,0.20958,0.20814,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.013465,0.20917,0.21625,1,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.017969,0.20841,0.20662,1,1
5,GO PROSTAGLANDIN SECRETION,0.0051916,0.2082,0.23687,1,1
5,GO ENERGY HOMEOSTASIS,0.011904,0.20812,0.18023,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,7.8282e-05,0.20807,0.23706,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0025817,0.20789,0.17376,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,0.0014738,0.20768,0.21792,1,1
5,GO LIPID OXIDATION,0.0015189,0.20755,0.18368,1,1
5,GO WOUND HEALING,0.013139,0.20755,0.12551,1,1
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.0029794,0.20678,0.26057,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0087944,0.20673,0.13314,1,1
5,GO ALANINE TRANSPORT,0.02843,0.20669,0.23264,1,1
5,GO PIGMENTATION,0.0014738,0.20668,0.14268,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.00010845,0.20664,0.23767,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.00037661,0.20656,0.19339,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.045624,0.20639,0.12033,1,1
5,GO CYTOKINE SECRETION,0.00031859,0.20609,0.20188,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00036427,0.20586,0.19106,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.013465,0.20564,0.18664,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,3.8583e-05,0.20535,0.25272,1,1
5,GO CERAMIDE METABOLIC PROCESS,0.00022676,0.20504,0.22156,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00052342,0.20502,0.19451,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.2139e-05,0.2044,0.20599,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.033166,0.20415,0.11885,1,1
5,GO EXOCYTOSIS,0.00050664,0.20403,0.17241,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.043763,0.20384,0.12934,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,4.6597e-05,0.20381,0.2247,1,1
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.021165,0.20362,0.1503,1,1
5,GO REGULATION OF PEPTIDE SECRETION,5.6174e-05,0.20307,0.18571,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0023671,0.20276,0.19335,1,1
5,GO XENOBIOTIC TRANSPORT,0.0021062,0.20258,0.28098,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.029719,0.20258,0.20444,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.0013054,0.20203,0.17763,1,1
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.010506,0.20191,0.18162,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0022332,0.20179,0.16384,1,1
5,GO LEUKOCYTE CHEMOTAXIS,0.00069957,0.2017,0.17664,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0047853,0.20133,0.13265,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.0085714,0.20098,0.17376,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0023671,0.20086,0.15139,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0017641,0.20063,0.17318,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0013054,0.20061,0.17139,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.027803,0.20061,0.14432,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.02166,0.20058,0.16463,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00010462,0.20052,0.23285,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0040578,0.20045,0.2191,1,1
5,GO PLATELET MORPHOGENESIS,0.0069616,0.2003,0.17895,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,0.0018173,0.20009,0.21422,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.0016129,0.19955,0.15103,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0081404,0.19923,0.1615,1,1
5,GO FLUID TRANSPORT,0.001662,0.1989,0.18216,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.015203,0.19889,0.16152,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.013798,0.19877,0.13898,1,1
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.025414,0.19871,0.2558,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.0024367,0.19855,0.15137,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.020205,0.19848,0.21323,1,1
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0010859,0.19841,0.16906,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,8.1192e-05,0.19839,0.24006,1,1
5,GO ANDROGEN METABOLIC PROCESS,0.0020453,0.19835,0.34705,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0023671,0.19813,0.15343,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00059588,0.19809,0.16742,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0046564,0.19775,0.20029,1,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.010245,0.19752,0.16138,1,1
5,GO CELL ACTIVATION,0.0007696,0.19749,0.16178,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00012964,0.19706,0.22934,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0069616,0.19698,0.15337,1,1
5,GO ENDOCYTIC RECYCLING,0.0054795,0.19645,0.13056,1,1
5,GO MONOCYTE CHEMOTAXIS,0.029719,0.19628,0.14171,1,1
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.017137,0.1959,0.19561,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0056288,0.19581,0.14386,1,1
5,GO T CELL DIFFERENTIATION,0.0006154,0.19552,0.14542,1,1
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.013139,0.19547,0.14052,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.023205,0.19543,0.14855,1,1
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.043763,0.19533,0.19829,1,1
5,GO ALPHA BETA T CELL ACTIVATION,0.00038934,0.1952,0.19967,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00090094,0.19511,0.22925,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.041093,0.19501,0.17895,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0090226,0.19491,0.15299,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.00047456,0.1948,0.20134,1,1
5,GO REGULATION OF DEFENSE RESPONSE,0.00023468,0.19476,0.18269,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00079435,0.19473,0.18704,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0049174,0.19466,0.20802,1,1
5,GO RESPONSE TO CHEMOKINE,0.00055855,0.19381,0.17008,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.013139,0.19368,0.13512,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.00074557,0.19303,0.23461,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0018173,0.1929,0.17494,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.001872,0.19276,0.15239,1,1
5,GO ADAPTIVE THERMOGENESIS,4.0073e-05,0.19274,0.19495,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0046564,0.19265,0.15308,1,1
5,GO MANNOSYLATION,9.389e-05,0.19248,0.237,1,1
5,GO B CELL ACTIVATION,0.00023468,0.19246,0.17771,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,0.00037661,0.19227,0.22955,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.029068,0.19224,0.22076,1,1
5,GO B CELL DIFFERENTIATION,0.00016023,0.19222,0.18799,1,1
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.041967,0.19208,0.12225,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00010462,0.19204,0.21478,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.0010206,0.19201,0.15824,1,1
5,GO REGULATION OF TUBE SIZE,0.010506,0.19152,0.14446,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.001228,0.19148,0.16561,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00055855,0.19148,0.17753,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.021165,0.19136,0.17225,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0021062,0.19135,0.15958,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.004408,0.19128,0.13195,1,1
5,GO FATTY ACID TRANSPORT,0.00029782,0.19122,0.21129,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.19117,0.20296,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.046579,0.19048,0.11241,1,1
5,GO RESPONSE TO ALCOHOL,0.0040578,0.19008,0.1309,1,1
5,GO PEPTIDE SECRETION,0.00021167,0.18936,0.17735,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.00065623,0.18933,0.20526,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00041602,0.18924,0.19521,1,1
5,GO RESPONSE TO DSRNA,0.0015189,0.18921,0.15628,1,1
5,GO PEPTIDE HORMONE SECRETION,0.0006154,0.18902,0.17128,1,1
5,GO PROTEIN KINASE B SIGNALING,0.021165,0.18885,0.10458,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0046564,0.18789,0.12942,1,1
5,GO GOLGI VESICLE BUDDING,0.00055855,0.18785,0.19255,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00059588,0.18766,0.16247,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00067758,0.18756,0.18688,1,1
5,GO RESPONSE TO FATTY ACID,0.0051916,0.18725,0.18384,1,1
5,GO VITAMIN METABOLIC PROCESS,0.010506,0.18715,0.1901,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.017969,0.18694,0.15402,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.0504e-05,0.18693,0.21754,1,1
5,GO MEMBRANE DEPOLARIZATION,0.041093,0.18687,0.13738,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,0.18686,0.13589,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00027832,0.1866,0.17389,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.0071468,0.1865,0.16551,1,1
5,GO CARBOHYDRATE TRANSPORT,2.9532e-05,0.18637,0.2338,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0015653,0.18636,0.20073,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,0.18603,0.16685,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0042883,0.186,0.17605,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.00042998,0.18595,0.17079,1,1
5,GO HUMORAL IMMUNE RESPONSE,0.00016595,0.18547,0.19416,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.027188,0.18546,0.10646,1,1
5,GO RESPONSE TO TUMOR CELL,0.012508,0.18509,0.24446,1,1
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00055855,0.18505,0.25845,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0050528,0.18503,0.22842,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00095906,0.18464,0.14599,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,9.389e-05,0.18436,0.15782,1,1
5,GO REGULATION OF HORMONE LEVELS,0.00030804,0.18423,0.1962,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.0022332,0.18398,0.14508,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.016734,0.18393,0.13882,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,3.3132e-05,0.18382,0.2438,1,1
5,GO REGULATION OF INSULIN SECRETION,0.0013457,0.18372,0.15971,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.0017123,0.18338,0.15163,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0066042,0.183,0.14519,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.036948,0.18294,0.16187,1,1
5,GO PLATELET ACTIVATION,0.0028141,0.18276,0.15408,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.023741,0.18272,0.12438,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.0028141,0.18252,0.19897,1,1
5,GO OXIDATION REDUCTION PROCESS,0.00052342,0.18239,0.18113,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00029782,0.18234,0.1721,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.00050664,0.1823,0.15238,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00079435,0.18225,0.15974,1,1
5,GO SEQUESTERING OF CALCIUM ION,0.0069616,0.18212,0.14141,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.0025083,0.1821,0.16805,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0054795,0.18207,0.17494,1,1
5,GO PROTON TRANSMEMBRANE TRANSPORT,1.0604e-05,0.18201,0.21909,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0040578,0.18135,0.1207,1,1
5,GO RESPONSE TO WOUNDING,0.029719,0.18134,0.10248,1,1
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.031059,0.18127,0.1254,1,1
5,GO REGULATION OF CELL CELL ADHESION,0.0020453,0.18111,0.16323,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00020448,0.18069,0.17096,1,1
5,GO T CELL ACTIVATION,0.0013457,0.18052,0.15344,1,1
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.0083534,0.18034,0.17202,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.00012512,0.18001,0.1836,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.0045306,0.17991,0.15615,1,1
5,GO IRON ION TRANSPORT,0.00016023,0.17984,0.22826,1,1
5,GO REGULATION OF CELL ACTIVATION,0.0067808,0.17976,0.12326,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00063551,0.17973,0.17906,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0090226,0.17926,0.19996,1,1
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.018836,0.17891,0.11009,1,1
5,GO VACUOLE ORGANIZATION,2.0833e-05,0.17877,0.21386,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0025083,0.1785,0.1941,1,1
5,GO MUSCLE ADAPTATION,0.0075304,0.17813,0.12896,1,1
5,GO RESPONSE TO KETONE,0.0047853,0.17806,0.14423,1,1
5,GO HORMONE TRANSPORT,0.00067758,0.17802,0.17457,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0010206,0.17785,0.14467,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.02843,0.1778,0.1781,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.1777,0.17335,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.0011549,0.1777,0.14964,1,1
5,GO VESICLE TARGETING,0.0071468,0.17762,0.17558,1,1
5,GO RESPONSE TO METAL ION,0.00012512,0.17748,0.1923,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02068,0.17741,0.2731,1,1
5,GO PROTEIN REFOLDING,0.0081404,0.17737,0.20564,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0010206,0.1769,0.20251,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.00045924,0.17685,0.20732,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0012662,0.17684,0.15209,1,1
5,GO ACTIN NUCLEATION,0.00018427,0.17668,0.18363,1,1
5,GO CHOLESTEROL STORAGE,0.023205,0.17658,0.17158,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0010859,0.17649,0.30123,1,1
5,GO T CELL LINEAGE COMMITMENT,0.0015653,0.17639,0.16855,1,1
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.001228,0.17635,0.1806,1,1
5,GO CELLULAR PIGMENTATION,0.0010206,0.17593,0.17422,1,1
5,GO LIPID METABOLIC PROCESS,0.00063551,0.17583,0.1703,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.0029794,0.17574,0.14191,1,1
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0034322,0.17561,0.2096,1,1
5,GO VASCULAR WOUND HEALING,0.037747,0.17554,0.26176,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.020205,0.17533,0.13686,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.017137,0.17523,0.14556,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00024286,0.17502,0.22283,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.042857,0.17485,0.13788,1,1
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00098941,0.17468,0.15197,1,1
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.013139,0.17446,0.17864,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0020453,0.17446,0.16643,1,1
5,GO LYMPHOCYTE ACTIVATION,0.0037331,0.17441,0.12344,1,1
5,GO LIPID HOMEOSTASIS,0.0036303,0.17434,0.20163,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0010859,0.17424,0.15013,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.0011549,0.17421,0.15782,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.014841,0.17385,0.13494,1,1
5,GO TRANSITION METAL ION HOMEOSTASIS,0.0087944,0.17374,0.13977,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0059384,0.17372,0.12269,1,1
5,GO ORGANIC ANION TRANSPORT,0.00035231,0.17355,0.17745,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.022165,0.17348,0.11786,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,0.0016129,0.17346,0.12083,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,9.7346e-05,0.17334,0.19616,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0006154,0.17316,0.19033,1,1
5,GO PANCREAS DEVELOPMENT,0.031059,0.17308,0.14136,1,1
5,GO T CELL HOMEOSTASIS,0.011612,0.173,0.13676,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.8282e-05,0.17293,0.174,1,1
5,GO RESPONSE TO GONADOTROPIN,0.0069616,0.17287,0.19012,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.7343e-05,0.17264,0.19056,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00092958,0.17256,0.13877,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.035393,0.17249,0.16572,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.001662,0.17248,0.17149,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0007696,0.17245,0.15462,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.014138,0.17218,0.17746,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0011549,0.17216,0.16207,1,1
5,GO RESPONSE TO STARVATION,7.013e-05,0.17201,0.20796,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0050528,0.17188,0.12845,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,0.0031536,0.17169,0.1257,1,1
5,GO RESPONSE TO ETHER,0.0042883,0.17168,0.17156,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0014738,0.17159,0.20643,1,1
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00038934,0.17099,0.17491,1,1
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.02268,0.17087,0.16965,1,1
5,GO REGULATION OF HORMONE SECRETION,0.00092958,0.17049,0.1645,1,1
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0060989,0.17048,0.37114,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.03245,0.17046,0.094167,1,1
5,GO METAL ION HOMEOSTASIS,0.0025083,0.17028,0.11768,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.021165,0.17012,0.13241,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0010859,0.17,0.20553,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0030654,0.16985,0.15968,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.024846,0.16932,0.21878,1,1
5,GO RESPONSE TO FUNGUS,0.00052342,0.16914,0.16709,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.015953,0.16913,0.1812,1,1
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.019283,0.16825,0.16261,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.047551,0.16822,0.1331,1,1
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0064317,0.16801,0.16302,1,1
5,GO ORGANELLE FUSION,0.0036303,0.16774,0.14043,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00098941,0.16772,0.18635,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0064317,0.16753,0.14146,1,1
5,GO REGULATION OF BONE DEVELOPMENT,0.040234,0.16751,0.12357,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0083534,0.16749,0.12124,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0028957,0.16732,0.12509,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16684,0.16511,1,1
5,GO REGULATION OF LIPID STORAGE,0.012203,0.1666,0.15364,1,1
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.017549,0.16644,0.13224,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.0015189,0.16619,0.15652,1,1
5,GO PEROXISOME ORGANIZATION,0.00095906,0.16595,0.1872,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.015574,0.16559,0.11582,1,1
5,GO REGULATION OF ANION TRANSPORT,0.0028141,0.16548,0.20503,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0029794,0.16548,0.21365,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00010845,0.16508,0.20645,1,1
5,GO FATTY ACID BETA OXIDATION,0.0040578,0.16475,0.18441,1,1
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00047456,0.16468,0.16361,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0062634,0.16452,0.1089,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0049174,0.1645,0.18042,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.02268,0.16418,0.21689,1,1
5,GO LEUKOCYTE DIFFERENTIATION,0.00098941,0.16396,0.13833,1,1
5,GO COPII COATED VESICLE BUDDING,0.00098941,0.16374,0.18146,1,1
5,GO PROTEIN MATURATION,0.00049035,0.16372,0.18017,1,1
5,GO T CELL PROLIFERATION,0.0017123,0.16368,0.17664,1,1
5,GO PROTEIN PROCESSING,0.00020448,0.16338,0.22712,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0010206,0.1633,0.15214,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0050528,0.16327,0.19613,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.034637,0.16238,0.1149,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0054795,0.1623,0.1292,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0015189,0.16209,0.14029,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.01282,0.16178,0.13099,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,7.3528e-06,0.16131,0.19479,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.0022992,0.16105,0.13282,1,1
5,GO LIPID CATABOLIC PROCESS,0.00011241,0.16072,0.20844,1,1
5,GO REGULATION OF HEMOPOIESIS,0.0016129,0.16063,0.12366,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0024367,0.16041,0.14254,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0021062,0.16025,0.14959,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0073363,0.1598,0.15526,1,1
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.034637,0.15954,0.094751,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.02068,0.15946,0.16672,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0026572,0.15933,0.15704,1,1
5,GO TEMPERATURE HOMEOSTASIS,0.00063551,0.15927,0.1562,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00074557,0.15927,0.12876,1,1
5,GO ION HOMEOSTASIS,0.0025817,0.15913,0.12237,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0010206,0.15895,0.1594,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0037331,0.15866,0.11294,1,1
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.045624,0.1586,0.15163,1,1
5,GO GLUCOSE METABOLIC PROCESS,5.4121e-05,0.15841,0.21158,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0062634,0.15814,0.16473,1,1
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0006154,0.15808,0.19125,1,1
5,GO RETINA HOMEOSTASIS,0.013465,0.15804,0.086411,1,1
5,GO PEROXISOMAL TRANSPORT,0.0010859,0.1578,0.19567,1,1
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0014299,0.15757,0.19373,1,1
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.014138,0.15731,0.13913,1,1
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.023741,0.15722,0.13037,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0051916,0.15688,0.14793,1,1
5,GO RESPONSE TO STEROL,0.019283,0.15683,0.16427,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0006154,0.15638,0.17574,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,6.5149e-05,0.15634,0.1849,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.00017796,0.15629,0.15386,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0031536,0.15628,0.15427,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012203,0.15628,0.11642,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.001872,0.15603,0.14535,1,1
5,GO GLOMERULUS DEVELOPMENT,0.011047,0.15573,0.17121,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,5.2139e-05,0.15567,0.2189,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.010773,0.15566,0.1252,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,0.035393,0.15559,0.10463,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0038387,0.15553,0.14946,1,1
5,GO DEFENSE RESPONSE TO FUNGUS,0.0024367,0.1552,0.15377,1,1
5,GO SECRETION,0.0011199,0.1552,0.14562,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0022992,0.15473,0.15692,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0030654,0.15465,0.1285,1,1
5,GO OOCYTE DIFFERENTIATION,0.0039469,0.15421,0.13059,1,1
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.031059,0.15419,0.12799,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,0.001872,0.15356,0.16019,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0087944,0.15335,0.13735,1,1
5,GO LIPID EXPORT FROM CELL,0.017549,0.15325,0.22148,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.042857,0.15316,0.15622,1,1
5,GO RESPONSE TO LIPID,0.013139,0.1531,0.10695,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0015189,0.15309,0.2163,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00353,0.15272,0.12875,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0032441,0.15251,0.15237,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,0.00057693,0.1525,0.17123,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.007729,0.15246,0.23876,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,0.00087311,0.15212,0.11392,1,1
5,GO REGULATION OF PROTEOLYSIS,0.0030654,0.15178,0.12789,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.011612,0.15133,0.12534,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,0.0014299,0.15129,0.15735,1,1
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0049174,0.15094,0.16553,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.012203,0.15039,0.14093,1,1
5,GO ORGANIC ACID CATABOLIC PROCESS,0.0023671,0.15028,0.17941,1,1
5,GO AGING,0.00353,0.15011,0.11297,1,1
5,GO ENDOSOME ORGANIZATION,0.0015189,0.14987,0.16091,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.03939,0.14963,0.098944,1,1
5,GO KILLING OF CELLS OF OTHER ORGANISM,8.7323e-05,0.14959,0.19819,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.017137,0.14945,0.12436,1,1
5,GO TERPENOID METABOLIC PROCESS,0.036164,0.14937,0.15135,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.02843,0.14919,0.099202,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0051916,0.14888,0.13929,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,0.012203,0.14872,0.14195,1,1
5,GO ANION TRANSPORT,0.00055855,0.14867,0.15739,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.018398,0.14855,0.16449,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0010206,0.14847,0.16428,1,1
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0066042,0.14839,0.16224,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.017549,0.14822,0.1404,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.0087944,0.14791,0.1112,1,1
5,GO REGULATION OF CELL ADHESION,0.011904,0.14791,0.12435,1,1
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.029719,0.14709,0.21293,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,0.001228,0.14701,0.15675,1,1
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.035393,0.14694,0.23029,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.001662,0.14636,0.2108,1,1
5,GO RUFFLE ORGANIZATION,0.011047,0.14629,0.16156,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0060989,0.14613,0.12185,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.02166,0.14598,0.11251,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.0015189,0.14598,0.16463,1,1
5,GO EPITHELIUM DEVELOPMENT,0.00353,0.14597,0.10948,1,1
5,GO CHEMICAL HOMEOSTASIS,0.00065623,0.14585,0.14127,1,1
5,GO FC RECEPTOR SIGNALING PATHWAY,0.0027346,0.14571,0.12392,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.01282,0.14537,0.21217,1,1
5,GO BICARBONATE TRANSPORT,0.036948,0.14484,0.11017,1,1
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.027803,0.14384,0.11958,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0051916,0.1438,0.14415,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0083534,0.14369,0.13494,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.02268,0.14359,0.21309,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.027188,0.14343,0.17987,1,1
5,GO RESPONSE TO DRUG,0.015953,0.14342,0.11739,1,1
5,GO ALCOHOL CATABOLIC PROCESS,0.0033369,0.14341,0.16321,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.0053338,0.14341,0.1537,1,1
5,GO CHLORIDE TRANSPORT,0.0064317,0.14306,0.12034,1,1
5,GO REGULATION OF APPETITE,0.037747,0.14274,0.10477,1,1
5,GO ORGANIC ACID TRANSPORT,0.0010859,0.14266,0.17627,1,1
5,GO GLUCOSE IMPORT,0.012203,0.14231,0.14501,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.031059,0.14187,0.20066,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0042883,0.1417,0.14483,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.001662,0.14165,0.12292,1,1
5,GO MYOTUBE DIFFERENTIATION,0.0087944,0.14153,0.11972,1,1
5,GO CELL CELL ADHESION,0.026586,0.14152,0.10623,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00081984,0.14149,0.14657,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00028792,0.14125,0.15712,1,1
5,GO POSITIVE REGULATION OF SECRETION,0.00032948,0.14092,0.16704,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.0099891,0.14085,0.14415,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0062634,0.14082,0.13051,1,1
5,GO MACROPHAGE ACTIVATION,0.0046564,0.14042,0.13833,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.021165,0.13993,0.090873,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0041716,0.13984,0.12225,1,1
5,GO RESPONSE TO HORMONE,0.0097392,0.13961,0.11007,1,1
5,GO RESPONSE TO CALCIUM ION,0.0042883,0.13945,0.16354,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.010506,0.13929,0.13828,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0025083,0.13891,0.12064,1,1
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0081404,0.13886,0.16764,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0075304,0.13818,0.16378,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0056288,0.13817,0.16063,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0040578,0.13772,0.14685,1,1
5,GO REGULATION OF CELL MATURATION,0.02843,0.13751,0.12766,1,1
5,GO LYSOSOME LOCALIZATION,0.0056288,0.13734,0.13469,1,1
5,GO RESPONSE TO STEROID HORMONE,0.01282,0.13727,0.11867,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00037661,0.13643,0.1456,1,1
5,GO PROTEIN MANNOSYLATION,0.02166,0.13642,0.14684,1,1
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0051916,0.13632,0.17425,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0069616,0.13625,0.11594,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038387,0.13573,0.11213,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.0062634,0.13563,0.10523,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.012508,0.13544,0.099211,1,1
5,GO VESICLE ORGANIZATION,0.0049174,0.13508,0.14123,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.023205,0.13472,0.1089,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.0039469,0.13458,0.11098,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00074557,0.13435,0.15021,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00025131,0.13427,0.12333,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.038561,0.13386,0.12799,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.025414,0.13354,0.22498,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.03939,0.13345,0.13241,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.013139,0.13292,0.12861,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0073363,0.13288,0.14095,1,1
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.009256,0.13285,0.1547,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0041716,0.13283,0.17298,1,1
5,GO ORGANELLE DISASSEMBLY,0.0022992,0.13216,0.14329,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,0.1319,0.15407,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0057817,0.13187,0.20485,1,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.015574,0.13183,0.096047,1,1
5,GO CELL MATURATION,0.0067808,0.13174,0.10707,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00047456,0.13163,0.15005,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0013457,0.13153,0.15684,1,1
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.004408,0.13131,0.12035,1,1
5,GO REGULATION OF T CELL ACTIVATION,0.0047853,0.13116,0.13419,1,1
5,GO NOTCH SIGNALING PATHWAY,0.0024367,0.13085,0.1498,1,1
5,GO SPERM CAPACITATION,0.0075304,0.13052,0.19378,1,1
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.024846,0.1302,0.09784,1,1
5,GO T CELL SELECTION,0.0029794,0.13011,0.12654,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.031059,0.13,0.10313,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.12949,0.11775,1,1
5,GO DETECTION OF STIMULUS,0.00044439,0.12943,0.11189,1,1
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.0010859,0.12907,0.17645,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.001986,0.12904,0.1535,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.026586,0.12845,0.10922,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0029794,0.12834,0.17856,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0041716,0.12751,0.10841,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,0.024846,0.12742,0.12377,1,1
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0064317,0.12728,0.13325,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.041093,0.12703,0.14879,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00353,0.12683,0.13161,1,1
5,GO ENDOCRINE HORMONE SECRETION,0.02843,0.12666,0.11493,1,1
5,GO GOLGI ORGANIZATION,0.00029782,0.12648,0.15547,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.035393,0.12625,0.26063,1,1
5,GO RESPONSE TO SALT,0.027188,0.12624,0.11463,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.038561,0.12525,0.092534,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011326,0.12494,0.12343,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.010773,0.12491,0.12364,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.017969,0.12442,0.13,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.031748,0.12431,0.12671,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0090226,0.12427,0.14075,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.017137,0.12427,0.10569,1,1
5,GO REGULATION OF CHEMOTAXIS,0.034637,0.12418,0.08489,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0081404,0.12395,0.11293,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0030654,0.1239,0.15497,1,1
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.043763,0.12383,0.14731,1,1
5,GO INORGANIC ANION TRANSPORT,0.0040578,0.12351,0.12003,1,1
5,GO PROTEOLYSIS,0.0006154,0.1234,0.12484,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,0.00034072,0.12338,0.12816,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.00055855,0.12326,0.14275,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0010859,0.12317,0.11643,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.029068,0.12301,0.091045,1,1
5,GO CARNITINE SHUTTLE,0.027803,0.1229,0.1727,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0006154,0.12213,0.14559,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.017549,0.122,0.12812,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,0.029068,0.12197,0.10204,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.038561,0.12195,0.088431,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0013054,0.12176,0.151,1,1
5,GO TISSUE MIGRATION,0.043763,0.12168,0.10444,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.12166,0.11586,1,1
5,GO GLAND DEVELOPMENT,0.0067808,0.12154,0.10051,1,1
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.014486,0.12096,0.096356,1,1
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0026572,0.12083,0.10144,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.00034072,0.12063,0.20355,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.014138,0.12043,0.11484,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.011612,0.12006,0.099414,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0054795,0.11988,0.10818,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.041093,0.11949,0.092124,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,0.0066042,0.11927,0.098682,1,1
5,GO REGULATION OF CELL DEATH,0.014486,0.11905,0.083207,1,1
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.014486,0.11893,0.12607,1,1
5,GO AUTOPHAGY OF MITOCHONDRION,0.011904,0.11863,0.1419,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.029068,0.11837,0.089178,1,1
5,GO HOMEOSTATIC PROCESS,0.00069957,0.11836,0.11617,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028141,0.1183,0.11803,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0036303,0.11824,0.11887,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.015953,0.11737,0.089085,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.015574,0.11729,0.14621,1,1
5,GO ACID SECRETION,0.043763,0.11727,0.10267,1,1
5,GO REGULATION OF TOR SIGNALING,0.00079435,0.1169,0.11259,1,1
5,GO TOR SIGNALING,0.00017186,0.11657,0.1027,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.011904,0.11653,0.13549,1,1
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.026586,0.11645,0.13682,1,1
5,GO RESPONSE TO INSULIN,0.0014738,0.11637,0.14527,1,1
5,GO REGULATION OF SECRETION,0.0027346,0.11612,0.12459,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.024288,0.11599,0.1386,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.0038387,0.11597,0.11928,1,1
5,GO PROTEIN DESTABILIZATION,0.0031536,0.11572,0.13854,1,1
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0013054,0.11567,0.15131,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0049174,0.11548,0.13873,1,1
5,GO CIRCULATORY SYSTEM PROCESS,0.011326,0.11543,0.10121,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.012203,0.11504,0.10729,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.0034322,0.11449,0.13789,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.043763,0.11428,0.18742,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.007729,0.11396,0.13514,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0099891,0.11327,0.11742,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0057817,0.11264,0.104,1,1
5,GO APOPTOTIC PROCESS,0.009256,0.11227,0.087336,1,1
5,GO DNA CATABOLIC PROCESS,0.0013457,0.11206,0.11895,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0037331,0.11159,0.11216,1,1
5,GO MULTICELLULAR ORGANISM AGING,0.0073363,0.11083,0.11939,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,0.011612,0.11066,0.080677,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.01282,0.11053,0.099778,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.025994,0.11049,0.11733,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.010773,0.11019,0.10737,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.024846,0.10963,0.10072,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0013054,0.10927,0.14069,1,1
5,GO LIPID MODIFICATION,0.007729,0.1092,0.12482,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0056288,0.10896,0.16603,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.027188,0.10872,0.06607,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.0062634,0.1086,0.10884,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0099891,0.10803,0.13959,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,0.02268,0.10741,0.10597,1,1
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.02268,0.10726,0.098575,1,1
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.018398,0.10723,0.12137,1,1
5,GO REGULATION OF PROTEIN BINDING,0.045624,0.10695,0.089897,1,1
5,GO ELECTRON TRANSPORT CHAIN,0.0049174,0.10666,0.18681,1,1
5,GO SOMITOGENESIS,0.0083534,0.10662,0.11581,1,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.025994,0.10659,0.076665,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.016339,0.1063,0.087591,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.009256,0.10567,0.097975,1,1
5,GO COPULATION,0.044685,0.10553,0.14981,1,1
5,GO RESPONSE TO PEPTIDE,0.015953,0.1055,0.09001,1,1
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.017549,0.10525,0.12662,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0026572,0.10517,0.13835,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0012662,0.10476,0.11107,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0026572,0.10445,0.11162,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0079323,0.10435,0.10268,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.0032441,0.10361,0.11942,1,1
5,GO RESPONSE TO INTERLEUKIN 4,0.029719,0.10346,0.10948,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.027803,0.10264,0.091698,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.036948,0.10258,0.074682,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.026586,0.10254,0.093188,1,1
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0097392,0.10214,0.13757,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.012508,0.1018,0.091728,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.018398,0.10106,0.091516,1,1
5,GO BIOMINERALIZATION,0.038561,0.10063,0.10094,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.0079323,0.10057,0.089231,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02068,0.10028,0.10505,1,1
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.029068,0.10015,0.10875,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0071468,0.099483,0.10894,1,1
5,GO REGULATION OF MAPK CASCADE,0.041093,0.099178,0.087104,1,1
5,GO ION TRANSPORT,0.0033369,0.099175,0.12184,1,1
5,GO CELLULAR HOMEOSTASIS,0.011047,0.098054,0.096008,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.016734,0.098044,0.0857,1,1
5,GO CALCIUM MEDIATED SIGNALING,0.011047,0.097807,0.076248,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.030383,0.097399,0.09324,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.040234,0.097285,0.075554,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.012203,0.096242,0.098265,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.027188,0.096205,0.074728,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.027803,0.095282,0.075004,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.022165,0.094645,0.08995,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.026586,0.093963,0.089689,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.026586,0.093785,0.11694,1,1
5,GO CYTOSOLIC TRANSPORT,0.0053338,0.093246,0.09342,1,1
5,GO THIOESTER METABOLIC PROCESS,0.0083534,0.092179,0.15416,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.031748,0.091296,0.083947,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.021165,0.091116,0.073563,1,1
5,GO BLASTOCYST DEVELOPMENT,0.0039469,0.090379,0.099227,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.014841,0.090048,0.085673,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.015574,0.089968,0.082417,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.045624,0.089935,0.11153,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.034637,0.089694,0.07346,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.033166,0.089531,0.14521,1,1
5,GO MITOCHONDRIAL TRANSPORT,0.01282,0.089046,0.079461,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.009256,0.089029,0.089044,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.024846,0.088533,0.083444,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0053338,0.087897,0.10118,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.02843,0.087258,0.08894,1,1
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.033166,0.086627,0.153,1,1
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0051916,0.085158,0.10601,1,1
5,GO CATION TRANSPORT,0.017549,0.084517,0.096406,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.03939,0.083621,0.10373,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.027803,0.08291,0.16147,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.010245,0.082358,0.15993,1,1
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.042857,0.082147,0.12879,1,1
5,GO SENSORY PERCEPTION,0.029068,0.079775,0.062783,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.015953,0.079585,0.08823,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.0099891,0.077557,0.091261,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.027803,0.077348,0.07539,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.046579,0.076584,0.064806,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.025414,0.076461,0.075029,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.037747,0.072115,0.081091,1,1
5,GO MYELOID CELL DEVELOPMENT,0.02268,0.06812,0.1015,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.033894,0.065166,0.10125,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.034637,0.056118,0.067794,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.037747,0.055313,0.064386,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.018398,0.053464,0.065435,1,1
5,GO INTRACELLULAR TRANSPORT,0.023741,0.053311,0.057337,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.02268,0.051353,0.087305,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.019739,0.048722,0.064724,1,1
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
6,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
6,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
6,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
6,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
6,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
6,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,1,1
6,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,1,1
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
6,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,1,1
6,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,1,1
6,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
6,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
6,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,1,1
6,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
6,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
6,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
6,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
6,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
6,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
6,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
6,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
6,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
6,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,1,1
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
6,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
6,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
6,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
6,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
6,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
6,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
6,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
6,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
6,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
6,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
6,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
6,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
6,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
6,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
6,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
6,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
6,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,1
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
6,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
6,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
6,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,1,1
6,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
6,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
6,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,1,1
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
6,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,1,1
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,1,1
6,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
6,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
6,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
6,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
6,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
6,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
6,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
6,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,1,1
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,1,1
6,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
6,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
6,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
6,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
6,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,1,1
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
6,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
6,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
6,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,1,1
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
6,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
6,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
6,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,1,1
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
6,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
6,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
6,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,1
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
6,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
6,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
6,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
6,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
6,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
6,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,1,1
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
6,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,1,1
6,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,1,1
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
6,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
6,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
6,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
6,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,1,1
6,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
6,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
6,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
6,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
6,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
6,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
6,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
6,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
6,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
6,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
6,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
6,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,1,1
6,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
6,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,1,1
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
6,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,1,1
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
6,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
6,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,1,1
6,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,1,1
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
6,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,1,1
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,1,1
6,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
6,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
6,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
6,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,1,1
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
6,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
6,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
6,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
6,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,1,1
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,1,1
6,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,1,1
6,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
6,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,1
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
6,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,1,1
6,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
6,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,1,1
6,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
6,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,1,1
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
6,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
6,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
6,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
6,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
6,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
6,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
6,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
6,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
6,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,1
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
6,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
6,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
6,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
6,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
6,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
6,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
6,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
6,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
6,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
6,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
6,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
6,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
6,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
6,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
6,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,1,1
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,1,1
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,1
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,1,1
6,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,1,1
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
6,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,1,1
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
6,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,1,1
6,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
6,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
6,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
6,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
6,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
6,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,1,1
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
6,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
6,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
6,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
6,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,1,1
6,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
6,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,1
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
6,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
6,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,1,1
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,1
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
6,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
6,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,1
6,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,1,1
6,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
6,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,1,1
6,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
6,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
6,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
6,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
6,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,1,1
6,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,1,1
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,1
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,1
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
6,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
6,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,1,1
6,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
6,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
6,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
6,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
6,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
6,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
6,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
6,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
6,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
6,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
6,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
6,GO MATING,0.033166,0.12237,0.091484,1,1
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
6,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
6,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
6,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,1,1
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,1
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
6,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
6,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,1,1
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,1,1
6,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,1,1
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
6,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,1
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,1,1
6,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
6,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,1,1
6,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
6,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
6,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
6,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
6,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
6,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,1,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
6,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,1
6,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
6,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,1,1
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,1,1
6,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,1,1
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,1,1
6,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,1,1
6,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
6,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
6,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,1,1
6,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,1,1
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
7,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,1.5201e-05,1.0472,0.90548,1,1
7,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,5.9841e-06,0.90597,1.0108,1,1
7,GO GABAERGIC NEURON DIFFERENTIATION,2.1702e-06,0.68717,0.7666,1,1
7,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0017123,0.64763,0.49011,1,1
7,GO ADENOHYPOPHYSIS DEVELOPMENT,7.2754e-05,0.61888,0.606,1,1
7,GO MECHANOSENSORY BEHAVIOR,0.001228,0.59272,0.53396,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0015653,0.55704,0.47044,1,1
7,GO INNER DYNEIN ARM ASSEMBLY,0.00010092,0.53434,0.50788,1,1
7,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00045924,0.52776,0.60567,1,1
7,GO RETINAL GANGLION CELL AXON GUIDANCE,2.2524e-05,0.52225,0.57146,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00010092,0.50898,0.38187,1,1
7,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.4421e-05,0.50846,0.57311,1,1
7,GO SUBPALLIUM DEVELOPMENT,3.0576e-06,0.49145,0.48554,1,1
7,GO SYNAPTIC VESICLE CLUSTERING,0.00019079,0.48694,0.60249,1,1
7,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0034322,0.48653,0.5448,1,1
7,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00036427,0.48278,0.44306,1,1
7,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.001872,0.48135,0.51505,1,1
7,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0016129,0.45866,0.53175,1,1
7,GO DETECTION OF CALCIUM ION,0.00063551,0.44595,0.36355,1,1
7,GO OLFACTORY LOBE DEVELOPMENT,6.4994e-06,0.44227,0.44332,1,1
7,GO POSITIVE REGULATION OF BEHAVIOR,0.00016595,0.43389,0.35066,1,1
7,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0036303,0.43385,0.48183,1,1
7,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,2.9301e-06,0.43118,0.40785,1,1
7,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0037331,0.42824,0.43524,1,1
7,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00087311,0.42609,0.3715,1,1
7,GO HEART FIELD SPECIFICATION,0.00050664,0.42319,0.4163,1,1
7,GO BEHAVIORAL RESPONSE TO COCAINE,0.001872,0.42002,0.39376,1,1
7,GO TELENCEPHALON REGIONALIZATION,0.02166,0.41896,0.31714,1,1
7,GO RESPONSE TO FORSKOLIN,0.010506,0.41714,0.26898,1,1
7,GO NEUROTRANSMITTER REUPTAKE,0.00034072,0.41564,0.33381,1,1
7,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0039469,0.41061,0.37468,1,1
7,GO SEROTONIN TRANSPORT,0.00095906,0.40872,0.33248,1,1
7,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00024286,0.40273,0.41787,1,1
7,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00031859,0.40215,0.33977,1,1
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00057693,0.39947,0.36481,1,1
7,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.9263e-05,0.39931,0.54263,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,2.6307e-05,0.39911,0.371,1,1
7,GO UTERUS DEVELOPMENT,0.0011549,0.39532,0.30409,1,1
7,GO GLIAL CELL FATE COMMITMENT,0.011047,0.39161,0.37077,1,1
7,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00012964,0.38782,0.34953,1,1
7,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0062634,0.38445,0.34534,1,1
7,GO NEUROTRANSMITTER UPTAKE,0.00036427,0.38178,0.28941,1,1
7,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00018427,0.37925,0.39102,1,1
7,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.00026003,0.37915,0.42595,1,1
7,GO REGULATION OF MESODERM DEVELOPMENT,0.00019753,0.37897,0.28855,1,1
7,GO STARTLE RESPONSE,0.00019753,0.37447,0.46168,1,1
7,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0001165,0.37244,0.39749,1,1
7,GO EXPLORATION BEHAVIOR,0.0011549,0.37138,0.34996,1,1
7,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0085714,0.36419,0.34725,1,1
7,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0011549,0.36303,0.45766,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00040247,0.36111,0.33342,1,1
7,GO REFLEX,0.0069616,0.35881,0.27648,1,1
7,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,9.0551e-05,0.35306,0.364,1,1
7,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.017137,0.35288,0.24833,1,1
7,GO AXONAL FASCICULATION,0.0029794,0.35188,0.35444,1,1
7,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00031859,0.34417,0.31337,1,1
7,GO MOTILE CILIUM ASSEMBLY,0.00022676,0.34322,0.31428,1,1
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.00023468,0.34294,0.28668,1,1
7,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00014418,0.34294,0.36883,1,1
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00041602,0.34167,0.33587,1,1
7,GO REGULATION OF RECEPTOR CLUSTERING,0.0017641,0.34133,0.35637,1,1
7,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00069957,0.33678,0.41003,1,1
7,GO CIRCADIAN SLEEP WAKE CYCLE,0.00016595,0.3362,0.29993,1,1
7,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0014299,0.33479,0.2921,1,1
7,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0056288,0.33308,0.26323,1,1
7,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0010528,0.33293,0.30591,1,1
7,GO MICROTUBULE DEPOLYMERIZATION,6.5149e-05,0.33239,0.30961,1,1
7,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.0040578,0.32775,0.24172,1,1
7,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00021167,0.3255,0.31628,1,1
7,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0027346,0.32442,0.2719,1,1
7,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0075304,0.32431,0.40412,1,1
7,GO RESPONSE TO ISOQUINOLINE ALKALOID,2.3418e-05,0.32341,0.32914,1,1
7,GO HEART INDUCTION,0.014138,0.32237,0.37259,1,1
7,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0039469,0.32202,0.29285,1,1
7,GO PREPULSE INHIBITION,0.023741,0.319,0.40783,1,1
7,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.00027832,0.31834,0.33988,1,1
7,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00074557,0.3179,0.39642,1,1
7,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0026572,0.31781,0.30593,1,1
7,GO COMMISSURAL NEURON AXON GUIDANCE,0.038561,0.31743,0.22101,1,1
7,GO GLYCINE TRANSPORT,0.0085714,0.31556,0.2556,1,1
7,GO LONG TERM SYNAPTIC DEPRESSION,0.00014418,0.31419,0.31159,1,1
7,GO FOREBRAIN GENERATION OF NEURONS,3.4421e-05,0.31294,0.34518,1,1
7,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00084609,0.30667,0.35005,1,1
7,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0090226,0.30581,0.37492,1,1
7,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.011904,0.30484,0.33474,1,1
7,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.035393,0.30296,0.20175,1,1
7,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.004408,0.30199,0.29611,1,1
7,GO MESODERMAL CELL FATE SPECIFICATION,0.0054795,0.3016,0.25339,1,1
7,GO RESPONSE TO EPINEPHRINE,0.029719,0.30133,0.27175,1,1
7,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00011241,0.30091,0.3514,1,1
7,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0018173,0.29923,0.29236,1,1
7,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0051916,0.29781,0.39693,1,1
7,GO REGULATION OF CILIUM BEAT FREQUENCY,4.4878e-05,0.29696,0.33265,1,1
7,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0011199,0.29669,0.34729,1,1
7,GO GAMMA DELTA T CELL DIFFERENTIATION,0.02843,0.29516,0.29207,1,1
7,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.044685,0.29463,0.19279,1,1
7,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0073363,0.29301,0.20409,1,1
7,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00034072,0.29297,0.32711,1,1
7,GO RECEPTOR LOCALIZATION TO SYNAPSE,7.547e-05,0.28884,0.3578,1,1
7,GO RESPONSE TO COCAINE,0.00011241,0.28865,0.27084,1,1
7,GO GLUTAMATE SECRETION,0.0015189,0.28665,0.25336,1,1
7,GO RESPONSE TO AUDITORY STIMULUS,0.0017123,0.28608,0.36231,1,1
7,GO BONE MATURATION,0.012508,0.28556,0.24226,1,1
7,GO SYNAPTIC VESICLE DOCKING,0.0020453,0.2854,0.31535,1,1
7,GO EXTRACELLULAR TRANSPORT,0.001191,0.28456,0.27301,1,1
7,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00010462,0.284,0.30471,1,1
7,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.4205e-05,0.28342,0.37102,1,1
7,GO RESPONSE TO POTASSIUM ION,0.02843,0.28196,0.20068,1,1
7,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.001662,0.28175,0.25109,1,1
7,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0024367,0.27884,0.29941,1,1
7,GO NEURON RECOGNITION,0.00032948,0.27769,0.33641,1,1
7,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0036303,0.2766,0.22958,1,1
7,GO REGULATION OF VESICLE FUSION,0.030383,0.27604,0.22127,1,1
7,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.038561,0.27557,0.27342,1,1
7,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.033894,0.2754,0.31575,1,1
7,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00024286,0.27523,0.20539,1,1
7,GO LONG TERM SYNAPTIC POTENTIATION,0.00019753,0.27466,0.25277,1,1
7,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00036427,0.27382,0.30352,1,1
7,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0060989,0.27285,0.28277,1,1
7,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0046564,0.27103,0.20515,1,1
7,GO REGULATION OF FILOPODIUM ASSEMBLY,0.00022676,0.271,0.2781,1,1
7,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0013054,0.26989,0.3281,1,1
7,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0015189,0.26968,0.24344,1,1
7,GO FILOPODIUM ASSEMBLY,0.00022676,0.2682,0.24745,1,1
7,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00047456,0.26806,0.3052,1,1
7,GO RESPONSE TO INSECTICIDE,0.0018173,0.26766,0.30361,1,1
7,GO NEURONAL ACTION POTENTIAL,0.015203,0.26585,0.23796,1,1
7,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.016339,0.26481,0.23247,1,1
7,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0033369,0.26343,0.20568,1,1
7,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.011904,0.26285,0.25616,1,1
7,GO ANTEROGRADE AXONAL TRANSPORT,3.1888e-05,0.26258,0.24836,1,1
7,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0073363,0.26234,0.21468,1,1
7,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0028957,0.26156,0.18038,1,1
7,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0053338,0.26067,0.23707,1,1
7,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.011904,0.25989,0.2021,1,1
7,GO CATECHOLAMINE UPTAKE,0.040234,0.2598,0.18973,1,1
7,GO ADULT LOCOMOTORY BEHAVIOR,0.00059588,0.25895,0.23034,1,1
7,GO FOREBRAIN NEURON DEVELOPMENT,0.0017641,0.25892,0.33187,1,1
7,GO MESODERMAL CELL FATE COMMITMENT,0.02268,0.25878,0.19883,1,1
7,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0010528,0.25855,0.20705,1,1
7,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0014299,0.25763,0.2717,1,1
7,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0073363,0.25614,0.28617,1,1
7,GO LONG TERM MEMORY,0.00030804,0.25606,0.26381,1,1
7,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.021165,0.25596,0.2564,1,1
7,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.001662,0.25571,0.21411,1,1
7,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,7.8282e-05,0.25381,0.28567,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,4.4878e-05,0.25316,0.23249,1,1
7,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0097392,0.25243,0.25372,1,1
7,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.027803,0.25188,0.28128,1,1
7,GO SYNAPTIC VESICLE LOCALIZATION,3.1888e-05,0.25183,0.32623,1,1
7,GO POSITIVE REGULATION OF FERTILIZATION,0.042857,0.25035,0.1849,1,1
7,GO PROTEIN LOCALIZATION TO SYNAPSE,5.8301e-05,0.24948,0.35311,1,1
7,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.011904,0.24796,0.2125,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00035231,0.24719,0.2232,1,1
7,GO SYNAPTIC VESICLE TRANSPORT,1.4039e-05,0.24705,0.26883,1,1
7,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0021062,0.24688,0.19235,1,1
7,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0038387,0.24654,0.20846,1,1
7,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0011199,0.24633,0.31691,1,1
7,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0017641,0.24569,0.22949,1,1
7,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00027832,0.24536,0.29423,1,1
7,GO WALKING BEHAVIOR,0.00029782,0.24391,0.28964,1,1
7,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0010528,0.24367,0.24339,1,1
7,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0013872,0.24332,0.25259,1,1
7,GO PRESYNAPSE ORGANIZATION,0.0071468,0.24212,0.204,1,1
7,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00092958,0.24161,0.22539,1,1
7,GO RESPONSE TO PARATHYROID HORMONE,0.0067808,0.24123,0.20829,1,1
7,GO RECEPTOR CLUSTERING,0.0011549,0.24092,0.29132,1,1
7,GO REGULATION OF SYNAPTIC PLASTICITY,0.00021909,0.24081,0.24542,1,1
7,GO EXCITATORY SYNAPSE ASSEMBLY,0.0014299,0.23746,0.41407,1,1
7,GO NEUROTRANSMITTER TRANSPORT,2.6307e-05,0.23722,0.29226,1,1
7,GO RESPONSE TO DOPAMINE,0.00011241,0.23626,0.20425,1,1
7,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.8583e-05,0.2357,0.27214,1,1
7,GO MESENCHYME MORPHOGENESIS,0.016734,0.23481,0.17064,1,1
7,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0073363,0.23376,0.23193,1,1
7,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.041093,0.23291,0.17274,1,1
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0010206,0.23183,0.24202,1,1
7,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.023741,0.22994,0.18493,1,1
7,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012074,0.22906,0.33648,1,1
7,GO LIPOPROTEIN LOCALIZATION,0.0064317,0.229,0.15581,1,1
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0016129,0.22732,0.22891,1,1
7,GO NEUROTRANSMITTER SECRETION,2.1663e-05,0.22547,0.3093,1,1
7,GO SECONDARY PALATE DEVELOPMENT,0.0032441,0.22544,0.23041,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0018173,0.22381,0.23131,1,1
7,GO RESPONSE TO INACTIVITY,0.0067808,0.22351,0.21941,1,1
7,GO RHYTHMIC BEHAVIOR,0.00090094,0.22344,0.18221,1,1
7,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00074557,0.22211,0.25039,1,1
7,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00041602,0.22132,0.27715,1,1
7,GO ADHERENS JUNCTION ASSEMBLY,0.019283,0.22118,0.15772,1,1
7,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0021062,0.22066,0.22512,1,1
7,GO REGULATION OF NEUROTRANSMITTER LEVELS,4.6597e-05,0.21869,0.26752,1,1
7,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0062634,0.21733,0.21637,1,1
7,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0085714,0.21634,0.15347,1,1
7,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0034322,0.21578,0.23198,1,1
7,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.018836,0.21476,0.11938,1,1
7,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0081404,0.21444,0.22113,1,1
7,GO AXONEME ASSEMBLY,0.0022332,0.21293,0.24907,1,1
7,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.001986,0.21142,0.21508,1,1
7,GO CALCIUM ION IMPORT INTO CYTOSOL,0.031059,0.20782,0.20738,1,1
7,GO PROTEIN POLYGLUTAMYLATION,0.0015653,0.2072,0.2106,1,1
7,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.001191,0.20655,0.18244,1,1
7,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0081404,0.20635,0.19262,1,1
7,GO MALE MEIOTIC NUCLEAR DIVISION,0.016339,0.20631,0.10976,1,1
7,GO RESPONSE TO ALKALOID,3.5759e-05,0.20611,0.20609,1,1
7,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0025083,0.20596,0.15457,1,1
7,GO GENETIC IMPRINTING,0.0013872,0.20554,0.212,1,1
7,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.017969,0.20454,0.15041,1,1
7,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00012512,0.20411,0.27404,1,1
7,GO ADULT BEHAVIOR,0.00018427,0.20375,0.22098,1,1
7,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00011241,0.20353,0.26472,1,1
7,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00074557,0.20344,0.22736,1,1
7,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.014486,0.20327,0.16429,1,1
7,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00034072,0.2024,0.25756,1,1
7,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.001872,0.20214,0.20358,1,1
7,GO MOTOR NEURON AXON GUIDANCE,0.018398,0.20194,0.14969,1,1
7,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,1.5816e-05,0.20174,0.19198,1,1
7,GO MICROTUBULE BUNDLE FORMATION,0.00016595,0.20104,0.21681,1,1
7,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0017641,0.20088,0.16085,1,1
7,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.00069957,0.20038,0.31225,1,1
7,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.033894,0.20007,0.16775,1,1
7,GO GENITALIA DEVELOPMENT,0.036164,0.19975,0.12192,1,1
7,GO RESPONSE TO CATECHOLAMINE,9.7346e-05,0.19891,0.21686,1,1
7,GO PRESYNAPTIC ENDOCYTOSIS,0.0010206,0.19874,0.21474,1,1
7,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0075304,0.19846,0.23114,1,1
7,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0025817,0.19833,0.20251,1,1
7,GO LOCALIZATION WITHIN MEMBRANE,0.00022676,0.19733,0.24293,1,1
7,GO DENDRITE DEVELOPMENT,0.00010845,0.19589,0.20353,1,1
7,GO DENDRITE EXTENSION,0.00028792,0.1942,0.32875,1,1
7,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00090094,0.19418,0.20426,1,1
7,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.012508,0.19282,0.16394,1,1
7,GO MEMBRANE DEPOLARIZATION,0.0064317,0.19252,0.18324,1,1
7,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0028141,0.1923,0.17841,1,1
7,GO LOCOMOTORY BEHAVIOR,0.0028957,0.19195,0.16738,1,1
7,GO REGULATION OF BEHAVIOR,0.00090094,0.19153,0.20994,1,1
7,GO DENDRITE MORPHOGENESIS,0.00035231,0.1915,0.22514,1,1
7,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.031059,0.19106,0.2687,1,1
7,GO MEMORY,0.00059588,0.18952,0.17276,1,1
7,GO ACROSOME REACTION,0.00037661,0.18915,0.21087,1,1
7,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.010245,0.18826,0.26211,1,1
7,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.00037661,0.18752,0.18713,1,1
7,GO BRAIN MORPHOGENESIS,0.013798,0.18741,0.13956,1,1
7,GO MICROTUBULE POLYMERIZATION,0.00017796,0.18707,0.19073,1,1
7,GO DENDRITIC SPINE MORPHOGENESIS,0.0041716,0.18705,0.23775,1,1
7,GO SYNAPTIC VESICLE RECYCLING,0.00067758,0.18682,0.21853,1,1
7,GO REGULATION OF AXONOGENESIS,0.0010206,0.18542,0.2,1,1
7,GO TRANSMISSION OF NERVE IMPULSE,0.0032441,0.18427,0.2262,1,1
7,GO RESPONSE TO ACETYLCHOLINE,0.0020453,0.18273,0.30865,1,1
7,GO REGULATION OF GOLGI ORGANIZATION,0.00032948,0.18183,0.1805,1,1
7,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00054072,0.18049,0.15785,1,1
7,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0021689,0.18048,0.24302,1,1
7,GO ETHANOL CATABOLIC PROCESS,0.018836,0.17991,0.17578,1,1
7,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0018173,0.17823,0.26191,1,1
7,GO ENDOCARDIAL CUSHION FORMATION,0.017137,0.17797,0.2034,1,1
7,GO NEURON MIGRATION,0.00059588,0.17753,0.23537,1,1
7,GO CEREBELLAR CORTEX DEVELOPMENT,0.023205,0.17654,0.14068,1,1
7,GO ENDODERMAL CELL FATE COMMITMENT,0.0020453,0.17648,0.19481,1,1
7,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.0012662,0.17617,0.14773,1,1
7,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.033166,0.17546,0.23106,1,1
7,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.019283,0.1748,0.29289,1,1
7,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00023468,0.17459,0.21258,1,1
7,GO SYNAPTIC SIGNALING,0.00012512,0.17429,0.20476,1,1
7,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00063551,0.17423,0.28186,1,1
7,GO SLEEP,0.0049174,0.17335,0.15974,1,1
7,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00019753,0.17316,0.19649,1,1
7,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.044685,0.17268,0.25308,1,1
7,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00054072,0.1726,0.16213,1,1
7,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00010092,0.17194,0.2102,1,1
7,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.023741,0.17172,0.13317,1,1
7,GO REGULATION OF MEMBRANE POTENTIAL,0.0020453,0.17163,0.16755,1,1
7,GO REGULATION OF CILIUM MOVEMENT,0.023205,0.1711,0.13807,1,1
7,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.036164,0.17071,0.16356,1,1
7,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00092958,0.17039,0.16575,1,1
7,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0060989,0.16979,0.27553,1,1
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00040247,0.16921,0.23842,1,1
7,GO MONOAMINE TRANSPORT,0.013798,0.16789,0.21453,1,1
7,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.014841,0.16719,0.16333,1,1
7,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0047853,0.16685,0.18176,1,1
7,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0016129,0.16606,0.21126,1,1
7,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0041716,0.16605,0.17375,1,1
7,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0029794,0.16594,0.18235,1,1
7,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.00098941,0.1655,0.14391,1,1
7,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.014486,0.16482,0.14936,1,1
7,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0038387,0.16387,0.15564,1,1
7,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0032441,0.16352,0.15496,1,1
7,GO MEIOTIC CHROMOSOME SEPARATION,0.0045306,0.16276,0.1415,1,1
7,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00084609,0.1626,0.18534,1,1
7,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00098941,0.1626,0.15094,1,1
7,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,5.2139e-05,0.1617,0.17274,1,1
7,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.00057693,0.16166,0.26908,1,1
7,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.02268,0.16155,0.13684,1,1
7,GO COGNITION,0.00072223,0.15786,0.14953,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0046564,0.15696,0.20041,1,1
7,GO HYPOTHALAMUS DEVELOPMENT,0.040234,0.15672,0.17399,1,1
7,GO NEURON PROJECTION GUIDANCE,0.007729,0.15607,0.14612,1,1
7,GO REGULATION OF CARDIAC CONDUCTION,0.016734,0.15598,0.1228,1,1
7,GO REGULATION OF NEURON MIGRATION,0.021165,0.15579,0.14417,1,1
7,GO REGULATION OF DENDRITE DEVELOPMENT,0.0019282,0.15379,0.16087,1,1
7,GO ESTROGEN BIOSYNTHETIC PROCESS,0.02166,0.15302,0.14238,1,1
7,GO FOREBRAIN CELL MIGRATION,0.015953,0.15223,0.14742,1,1
7,GO AXON DEVELOPMENT,0.0022992,0.15208,0.15996,1,1
7,GO CELL PART MORPHOGENESIS,0.00087311,0.15066,0.15303,1,1
7,GO MEIOTIC CHROMOSOME SEGREGATION,0.0019282,0.15036,0.13315,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0023671,0.15035,0.20757,1,1
7,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.038561,0.14978,0.13435,1,1
7,GO LIMBIC SYSTEM DEVELOPMENT,0.0071468,0.14929,0.12454,1,1
7,GO NEUROTRANSMITTER METABOLIC PROCESS,0.047551,0.14857,0.16747,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0017123,0.14837,0.15003,1,1
7,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0029794,0.14673,0.15041,1,1
7,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0049174,0.14651,0.14028,1,1
7,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.011612,0.14464,0.15658,1,1
7,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0029794,0.1437,0.14315,1,1
7,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.001662,0.14311,0.12904,1,1
7,GO ACTION POTENTIAL,0.0054795,0.14272,0.16232,1,1
7,GO FEMALE GENITALIA DEVELOPMENT,0.044685,0.1413,0.12511,1,1
7,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00034072,0.14045,0.15271,1,1
7,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.02068,0.14009,0.10703,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0036303,0.13941,0.27111,1,1
7,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.018398,0.13846,0.16909,1,1
7,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.007729,0.13841,0.1787,1,1
7,GO VESICLE DOCKING,0.015953,0.13836,0.11237,1,1
7,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.01282,0.13788,0.13391,1,1
7,GO NEURON PROJECTION EXTENSION,0.0033369,0.13732,0.15664,1,1
7,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0085714,0.137,0.11331,1,1
7,GO CELLULAR RESPONSE TO ALKALOID,0.03939,0.13471,0.13529,1,1
7,GO MEIOSIS I CELL CYCLE PROCESS,0.0013457,0.13322,0.13195,1,1
7,GO REGULATION OF MICROTUBULE BASED PROCESS,1.1493e-05,0.13277,0.1421,1,1
7,GO POSITIVE REGULATION OF AXONOGENESIS,0.011326,0.13259,0.15848,1,1
7,GO RESPONSE TO AMINE,0.027803,0.1315,0.15913,1,1
7,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00021167,0.13092,0.13141,1,1
7,GO HIPPOCAMPUS DEVELOPMENT,0.018398,0.12877,0.11779,1,1
7,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0024367,0.12829,0.12934,1,1
7,GO DICARBOXYLIC ACID TRANSPORT,0.0024367,0.12821,0.13842,1,1
7,GO EXOCYTIC PROCESS,0.0025817,0.12731,0.17601,1,1
7,GO VISUAL BEHAVIOR,0.0040578,0.12713,0.12881,1,1
7,GO REGULATION OF NEURON DIFFERENTIATION,0.001872,0.12684,0.13145,1,1
7,GO RESPIRATORY SYSTEM PROCESS,0.0054795,0.12671,0.19332,1,1
7,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.017549,0.12645,0.11231,1,1
7,GO POSITIVE REGULATION OF OSSIFICATION,0.022165,0.12572,0.14044,1,1
7,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.02268,0.12537,0.11325,1,1
7,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.023741,0.12453,0.10259,1,1
7,GO CILIUM MOVEMENT,0.033894,0.1242,0.11324,1,1
7,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00072223,0.12404,0.13289,1,1
7,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.010245,0.12391,0.13906,1,1
7,GO NEURON DEVELOPMENT,0.00081984,0.12333,0.13413,1,1
7,GO REGULATION OF RECEPTOR INTERNALIZATION,0.013139,0.12285,0.12911,1,1
7,GO MICROTUBULE BASED TRANSPORT,0.00057693,0.1226,0.14679,1,1
7,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.027803,0.12253,0.14357,1,1
7,GO REGULATION OF PROTEIN POLYMERIZATION,0.0032441,0.12241,0.10419,1,1
7,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.00353,0.12099,0.16244,1,1
7,GO SENSORY PERCEPTION OF PAIN,0.014486,0.11942,0.11375,1,1
7,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0042883,0.11915,0.10491,1,1
7,GO CELLULAR COMPONENT MORPHOGENESIS,0.0014738,0.11911,0.13379,1,1
7,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.009256,0.11811,0.091169,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001662,0.11772,0.12214,1,1
7,GO DENDRITIC SPINE DEVELOPMENT,0.0046564,0.11696,0.18233,1,1
7,GO CARDIAC MUSCLE CELL PROLIFERATION,0.03939,0.11507,0.10923,1,1
7,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,3.0689e-05,0.11392,0.13968,1,1
7,GO CELL RECOGNITION,0.014486,0.11368,0.099334,1,1
7,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0094949,0.11246,0.10096,1,1
7,GO HOMOLOGOUS RECOMBINATION,0.031059,0.10962,0.10074,1,1
7,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0021689,0.10603,0.10849,1,1
7,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00065623,0.10585,0.13522,1,1
7,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.016734,0.10563,0.085724,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0083534,0.10508,0.11004,1,1
7,GO POSITIVE REGULATION OF EXOCYTOSIS,0.017137,0.10295,0.12031,1,1
7,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.031059,0.10262,0.097725,1,1
7,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.045624,0.10241,0.095348,1,1
7,GO RESPONSE TO NERVE GROWTH FACTOR,0.0049174,0.10228,0.1301,1,1
7,GO NEURON DIFFERENTIATION,0.0010859,0.099475,0.12172,1,1
7,GO MICROTUBULE BASED MOVEMENT,0.014138,0.099067,0.09451,1,1
7,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0014738,0.09895,0.087035,1,1
7,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.029719,0.098181,0.13037,1,1
7,GO CELL PROJECTION ORGANIZATION,0.00044439,0.097926,0.10901,1,1
7,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.027803,0.0978,0.12113,1,1
7,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.042857,0.097751,0.062565,1,1
7,GO REGULATION OF CYTOKINESIS,0.015574,0.096861,0.10759,1,1
7,GO TELENCEPHALON DEVELOPMENT,0.0018173,0.096782,0.12124,1,1
7,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023205,0.096206,0.11792,1,1
7,GO CELL PROJECTION ASSEMBLY,0.017969,0.095885,0.072966,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.021165,0.095594,0.14466,1,1
7,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0030654,0.095587,0.090015,1,1
7,GO PROTEIN POLYMERIZATION,0.004408,0.095581,0.088215,1,1
7,GO PROTEIN DEPHOSPHORYLATION,0.00090094,0.095468,0.086083,1,1
7,GO GERM CELL DEVELOPMENT,0.0094949,0.09487,0.0883,1,1
7,GO PATTERN SPECIFICATION PROCESS,0.017549,0.094383,0.086591,1,1
7,GO ANATOMICAL STRUCTURE MATURATION,0.0060989,0.094168,0.098116,1,1
7,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.010506,0.093999,0.07304,1,1
7,GO PEPTIDYL THREONINE MODIFICATION,0.0049174,0.093987,0.085076,1,1
7,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0047853,0.092207,0.11917,1,1
7,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0075304,0.091907,0.086515,1,1
7,GO FOREBRAIN DEVELOPMENT,0.007729,0.091793,0.10147,1,1
7,GO REGULATION OF EXOCYTOSIS,0.010245,0.090643,0.11005,1,1
7,GO NEGATIVE REGULATION OF NEURON DEATH,0.0049174,0.088231,0.071103,1,1
7,GO SPECIFICATION OF SYMMETRY,0.019739,0.087158,0.073371,1,1
7,GO NEUROGENESIS,0.0015653,0.084082,0.10564,1,1
7,GO HEAD DEVELOPMENT,0.0053338,0.081805,0.088921,1,1
7,GO MICROTUBULE BASED PROCESS,0.001191,0.08169,0.081316,1,1
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.029068,0.080696,0.082698,1,1
7,GO REGULATION OF CELL DEVELOPMENT,0.0046564,0.080333,0.091845,1,1
7,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0059384,0.079168,0.083056,1,1
7,GO SPERMATID DIFFERENTIATION,0.0073363,0.07902,0.106,1,1
7,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.034637,0.078185,0.060649,1,1
7,GO CELL MORPHOGENESIS,0.015203,0.078161,0.087112,1,1
7,GO MEIOTIC CELL CYCLE,0.040234,0.075999,0.06808,1,1
7,GO VESICLE LOCALIZATION,0.0028141,0.075661,0.076558,1,1
7,GO NEURON APOPTOTIC PROCESS,0.010506,0.072912,0.060876,1,1
7,GO POSITIVE REGULATION OF RNA SPLICING,0.034637,0.071972,0.065009,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.041967,0.069069,0.082146,1,1
7,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.026586,0.068731,0.050505,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011326,0.067116,0.091414,1,1
7,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.02068,0.061505,0.059419,1,1
7,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.02268,0.058908,0.051264,1,1
7,GO MEIOTIC CELL CYCLE PROCESS,0.019739,0.057476,0.07292,1,1
